
<html lang="en"     class="pb-page"  data-request-id="6cad6dec-ba71-4879-a045-018d708ce7ac"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.0c01504;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-4;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors" /></meta><meta name="dc.Creator" content="Umut  Salgin-Goksen" /></meta><meta name="dc.Creator" content="Gokcen  Telli" /></meta><meta name="dc.Creator" content="Acelya  Erikci" /></meta><meta name="dc.Creator" content="Ezgi  Dedecengiz" /></meta><meta name="dc.Creator" content="Banu Cahide  Tel" /></meta><meta name="dc.Creator" content="F. Betul  Kaynak" /></meta><meta name="dc.Creator" content="Kemal  Yelekci" /></meta><meta name="dc.Creator" content="Gulberk  Ucar" /></meta><meta name="dc.Creator" content="Nesrin  Gokhan-Kelekci" /></meta><meta name="dc.Description" content="Thirty compounds having 1-[2-(5-substituted-2-benzoxazolinone-3-yl) acetyl]-3,5-disubstitutedphenyl-2-pyrazoline structure and nine compounds having N′-(1,3-disubstitutedphenylallylidene)-2-(5-subs..." /></meta><meta name="Description" content="Thirty compounds having 1-[2-(5-substituted-2-benzoxazolinone-3-yl) acetyl]-3,5-disubstitutedphenyl-2-pyrazoline structure and nine compounds having N′-(1,3-disubstitutedphenylallylidene)-2-(5-subs..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 3, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01504" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01504" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01504" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01504" /></link>
        
    
    

<title>New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01504" /></meta><meta property="og:title" content="New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0014.jpeg" /></meta><meta property="og:description" content="Thirty compounds having 1-[2-(5-substituted-2-benzoxazolinone-3-yl) acetyl]-3,5-disubstitutedphenyl-2-pyrazoline structure and nine compounds having N′-(1,3-disubstitutedphenylallylidene)-2-(5-substituted-2-benzoxazolinone-3-yl)acetohydrazide skeleton were synthesized and evaluated as monoamine oxidase (MAO) inhibitors. All of the compounds exhibited selective MAO-A inhibitor activity in the nanomolar or low micromolar range. The results of the molecular docking for hydrazone derivatives supported the in vitro results. Five compounds, 6 (0.008 μM, Selectivity Index (SI): 9.70 × 10–4), 7 (0.009 μM, SI: 4.55 × 10–5), 14 (0.001 μM, SI: 8.00 × 10–4), 21 (0.009 μM, SI: 1.37 × 10–5), and 42 (0.010 μM, SI: 5.40 × 10–6), exhibiting the highest inhibition and selectivity toward hMAO-A and nontoxic to hepatocytes were assessed for antidepressant activity as acute and subchronic in mice. All of these five compounds showed significant antidepressant activity with subchronic administration consistent with the increase in the brain serotonin levels and the compounds crossed the blood–brain barrier according to parallel artificial membrane permeation assay. Compounds 14, 21, and 42 exhibited an ex vivo MAO-A profile, which is highly consistent with the in vitro data." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01504"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01504">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01504&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01504&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01504&amp;href=/doi/10.1021/acs.jmedchem.0c01504" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1989-2009</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01468" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01521" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Umut Salgin-Goksen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Umut Salgin-Goksen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, 06100 Sıhhiye, Ankara, Turkey</div><div class="loa-info-affiliations-info">Turkish Medicines and Medical Devices Agency, Analyses and Control Laboratories, 06100 Ankara, Turkey</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Umut++Salgin-Goksen">Umut Salgin-Goksen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gokcen Telli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gokcen Telli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, Faculty of Pharmacy, Hacettepe University, 06100 Sıhhiye, Ankara, Turkey</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gokcen++Telli">Gokcen Telli</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Acelya Erikci</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Acelya Erikci</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Faculty of Pharmacy, Lokman Hekim University, 06510 Söğütözü, Ankara, Turkey</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Acelya++Erikci">Acelya Erikci</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ezgi Dedecengiz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ezgi Dedecengiz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics Engineering, Faculty of Engineering, Hacettepe University, 06800 Beytepe, Ankara, Turkey</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ezgi++Dedecengiz">Ezgi Dedecengiz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Banu Cahide Tel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Banu Cahide Tel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, Faculty of Pharmacy, Hacettepe University, 06100 Sıhhiye, Ankara, Turkey</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Banu+Cahide++Tel">Banu Cahide Tel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">F. Betul Kaynak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">F. Betul Kaynak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physics Engineering, Faculty of Engineering, Hacettepe University, 06800 Beytepe, Ankara, Turkey</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=F.+Betul++Kaynak">F. Betul Kaynak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kemal Yelekci</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kemal Yelekci</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Bioinformatics and Genetics, Faculty of Engineering and Natural Sciences, Kadir Has University, 34083 Fatih, Istanbul, Turkey</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kemal++Yelekci">Kemal Yelekci</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0052-4926" title="Orcid link">http://orcid.org/0000-0002-0052-4926</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gulberk Ucar</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gulberk Ucar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Faculty of Pharmacy, Hacettepe University, 06100 Sıhhiye, Ankara, Turkey</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#543321383631263f7a21373526143339353d387a373b39"><span class="__cf_email__" data-cfemail="4324362f212631286d3620223103242e222a2f6d202c2e">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gulberk++Ucar">Gulberk Ucar</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Nesrin Gokhan-Kelekci</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nesrin Gokhan-Kelekci</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, 06100 Sıhhiye, Ankara, Turkey</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#4f20212a3c3d26210f28222e2623612c2022"><span class="__cf_email__" data-cfemail="610e0f041213080f21060c00080d4f020e0c">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nesrin++Gokhan-Kelekci">Nesrin Gokhan-Kelekci</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7383-8443" title="Orcid link">http://orcid.org/0000-0001-7383-8443</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01504&amp;href=/doi/10.1021%2Facs.jmedchem.0c01504" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1989–2009</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 3, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 August 2020</li><li><span class="item_label"><b>Published</b> online</span>3 February 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 February 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01504" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01504</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1989%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DUmut%2BSalgin-Goksen%252C%2BGokcen%2BTelli%252C%2BAcelya%2BErikci%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D4%26contentID%3Dacs.jmedchem.0c01504%26title%3DNew%2B2-Pyrazoline%2Band%2BHydrazone%2BDerivatives%2Bas%2BPotent%2Band%2BSelective%2BMonoamine%2BOxidase%2BA%2BInhibitors%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2009%26publicationDate%3DFebruary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01504"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">903</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01504" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Umut&quot;,&quot;last_name&quot;:&quot;Salgin-Goksen&quot;},{&quot;first_name&quot;:&quot;Gokcen&quot;,&quot;last_name&quot;:&quot;Telli&quot;},{&quot;first_name&quot;:&quot;Acelya&quot;,&quot;last_name&quot;:&quot;Erikci&quot;},{&quot;first_name&quot;:&quot;Ezgi&quot;,&quot;last_name&quot;:&quot;Dedecengiz&quot;},{&quot;first_name&quot;:&quot;Banu&quot;,&quot;last_name&quot;:&quot;Cahide Tel&quot;},{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;Betul Kaynak&quot;},{&quot;first_name&quot;:&quot;Kemal&quot;,&quot;last_name&quot;:&quot;Yelekci&quot;},{&quot;first_name&quot;:&quot;Gulberk&quot;,&quot;last_name&quot;:&quot;Ucar&quot;},{&quot;first_name&quot;:&quot;Nesrin&quot;,&quot;last_name&quot;:&quot;Gokhan-Kelekci&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;1989-2009&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01504&quot;},&quot;abstract&quot;:&quot;Thirty compounds having 1-[2-(5-substituted-2-benzoxazolinone-3-yl) acetyl]-3,5-disubstitutedphenyl-2-pyrazoline structure and nine compounds having N′-(1,3-disubstitutedphenylallylidene)-2-(5-substituted-2-benzoxazolinone-3-yl)acetohydrazide skeleton were synthesized and evaluated as monoamine oxidase (MAO) inhibitors. All of the compounds exhibited selective MAO-A inhibitor activity in the nanomolar or low micromolar range. The results of the molecular docking for hydrazone derivatives supported the in vitro results. Five compounds, 6 (0.008 μM, Selectivity Index (SI): 9.70 × 10–4), 7 (0.009 μM, SI: 4.55 × 10–5), 14 (0.001 μM, SI: 8.00 × 10–4), 21 (0.009 μM, SI: 1.37 × 10–5), and 42 (0.010 μM, SI: 5.40 × 10–6), exhibiting the highest inhibition and selectivity toward hMAO-A and nontoxic to hepatocytes were assessed for antidepressant activity as acute and subchronic in mice. All of these five compounds showed significant antidepressant activity with subchronic administration consistent with the increase in &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01504&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01504" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01504&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01504" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01504&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01504" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01504&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01504&amp;href=/doi/10.1021/acs.jmedchem.0c01504" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01504" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01504" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01504%26sid%3Dliteratum%253Aachs%26pmid%3D33533632%26genre%3Darticle%26aulast%3DSalgin-Goksen%26date%3D2021%26atitle%3DNew%2B2-Pyrazoline%2Band%2BHydrazone%2BDerivatives%2Bas%2BPotent%2Band%2BSelective%2BMonoamine%2BOxidase%2BA%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D4%26spage%3D1989%26epage%3D2009%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292335" title="Chlorine">Chlorine</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/jmcmar.2021.64.issue-4/20210225/jmcmar.2021.64.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Thirty compounds having 1-[2-(5-substituted-2-benzoxazolinone-3-yl) acetyl]-3,5-disubstitutedphenyl-2-pyrazoline structure and nine compounds having <i>N</i>′-(1,3-disubstitutedphenylallylidene)-2-(5-substituted-2-benzoxazolinone-3-yl)acetohydrazide skeleton were synthesized and evaluated as monoamine oxidase (MAO) inhibitors. All of the compounds exhibited selective MAO-A inhibitor activity in the nanomolar or low micromolar range. The results of the molecular docking for hydrazone derivatives supported the <i>in vitro</i> results. Five compounds, <b>6</b> (0.008 μM, Selectivity Index (SI): 9.70 × 10<sup>–4</sup>), <b>7</b> (0.009 μM, SI: 4.55 × 10<sup>–5</sup>), <b>14</b> (0.001 μM, SI: 8.00 × 10<sup>–4</sup>), <b>21</b> (0.009 μM, SI: 1.37 × 10<sup>–5</sup>), and <b>42</b> (0.010 μM, SI: 5.40 × 10<sup>–6</sup>), exhibiting the highest inhibition and selectivity toward hMAO-A and nontoxic to hepatocytes were assessed for antidepressant activity as acute and subchronic in mice. All of these five compounds showed significant antidepressant activity with subchronic administration consistent with the increase in the brain serotonin levels and the compounds crossed the blood–brain barrier according to parallel artificial membrane permeation assay. Compounds <b>14, 21</b>, and <b>42</b> exhibited an <i>ex vivo</i> MAO-A profile, which is highly consistent with the <i>in vitro</i> data.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77452" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77452" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Depression is an important psychiatric disease and has a high incidence in the world. According to the World Health Organization, 350 million people are diagnosed with depression. It was predicted that between 2020 and 2030, depression will be the second important reason for disability in the world.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Depression can lead to the development of several second-order diseases besides the stress that is caused to the patients and their families.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2−5)</a> It was reported that anxiety disorders are observed before or during depression in 10–21% of children and adolescents.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Monoamine oxidase inhibitors (MAOIs) were the first class of antidepressants to be developed. MAOIs are known for their mood-enhancing effect by virtue of blocking the breakdown of neurotransmitters by monoamine oxidase (MAO) (EC 1.4.3.4). Two isoforms of MAO have been discovered, which exhibit distinct interests to inhibitors and varying specificities to substrates.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Adrenaline, noradrenalin, and serotonin are metabolized mostly with MAO-A<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and β-phenylethylamine, and benzylamine is metabolized with MAO-B.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Dopamine and some essential amines like tyramine interact with both isoforms of MAO.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> MAOIs are especially classified into two main categories in the clinic. The antidepressant activity is mostly associated with inhibition of MAO-A and the consequent ability to counter the decrement in brain noradrenaline (NE), dopamine (DA), and especially serotonin (5-HT) levels during the depression.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> MAO-B inhibitors could be preferred in Alzheimer’s and Parkinson’s diseases.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> The use of MAOIs to treat major depressive disorders declined sharply after it was found that inhibition of MAO can lead to a severe cardiovascular event called the “cheese effect”, which is observed after intake of tyramine-containing foods. Studies focused on improving novel selective and reversible MAOIs with low tyramine potentiation properties.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">Since MAOIs can increase 5-HT, NE, and DA simultaneously in the brain, they have been considered for usage in treatment resistance depression instead of combination therapies such as combining an inhibitor of 5-HT-NE reuptake inhibitor with a certain dopaminergic drug or pairing a dopamine agonist with a selective serotonin reuptake inhibitor (SSRI) and a tricyclic antidepressants (TCA).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The findings also indicate that these inhibitors have remarkable neuroprotective effects.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The recently designed and synthesized highly selective and reversible MAOIs offer new opportunities for the development of superior antidepressant and antiparkinsonian agents through the selective inhibition of MAO-A and MAO-B, respectively.</div><div class="NLM_p">Classical MAOIs are analogues of natural MAO substrates and have a structure similar to that of phenylethylamines containing a reactive group, such as propargylamine and hydrazine, which allows the binding to the enzyme via covalent adducts resulting from bioactivation of the inhibitor to an electrophilic intermediate.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> 2-Pyrazoline derivatives are cyclic hydrazine moieties that are formed by the cyclization of linear hydrazine derivatives.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Derivatives obtained by substitutions on the 2-pyrazoline nucleus preferably at the N1, C3, and C5 positions show a remarkable effect on the central nervous system (CNS).<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16−18)</a> Chimenti et al. demonstrated that either the N1 acetyl group or N1-propanoyl substitution at position 1 increased potency and selectivity of these inhibitors.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a></div><div class="NLM_p">Toloxatone (Humoryl) is the lead compound of aryloxazolidinones that are the relatively new classes of MAOIs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). It is the first selective and reversible inhibitor of MAO-A and represented as an antidepressant to clinical use.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Chemical modifications of toloxatone generated more selective cimoxatone and befloxatone derivatives that are active at nanomolar concentrations.<a onclick="showRef(event, 'ref11 ref23'); return false;" href="javascript:void(0);" class="ref ref11 ref23">(11,23)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Aryloxazolidinone derivatives of MAOIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">According to the specified finding mentioned and the intent of developing new more selective and potent MAO-A inhibitors, we designed and synthesized some novel hybrid compounds bearing oxazolidinone and diazo cores (30 new 2-pyrazoline and 9 new hydrazone derivatives) as selective, potent MAO-A inhibitors with contribution of the docking studies (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). They were screened <i>in vitro</i> to determine their inhibitory actions on MAO isotypes. Since the biological activity of MAOIs depends heavily on their ability to cross the blood–brain barrier (BBB), the BBB permeability of selected new compounds was determined with the parallel artificial membrane permeation assay of BBB (PAMPA–BBB). Additionally, the potential acute and subchronic antidepressant activities of five compounds that exhibited the highest inhibitory selectivity and potency toward hMAO-A were determined. Since depression and its comorbid disorders are related to serotonin and dopamine interactions in the prefrontal cortex, the levels of 5-HT, DA, and 5-hydroxyindoleacetic acid (5-HIAA) and MAO activity were determined in brain tissues of experimental animals to evaluate the status of related neurotransmitters, their metabolites, and the MAO-metabolizing enzyme. Our data indicated that the compounds had an antidepressant-like activity in mice by the possible interaction with the serotonergic and monoaminergic systems.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overall design strategy for 2-pyrazoline and hydrazone derivatives (the color code indicates common chemical structures).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis and Structure of the Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">A novel series of 1-[2-((5-methyl/chloro)-2-benzoxazolinone-3-yl)acetyl]-3,5-diaryl-2-pyrazoline <b>5–34</b> and <i>N</i>′-[(1,3-diaryl)allylidene]-2-[(5-methyl/chloro)-2-benzoxazolinone-3-yl]acetohydrazide <b>35–43</b> derivatives were synthesized according to the protocols summarized in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The conditions of reactions and the characterization of compounds are explained in the <a class="ref internalNav" href="#sec2_4" aria-label="Experimental Section">Experimental Section</a>.</div><div class="NLM_p">2-Benzoxaolinone <b>1a</b> and 5-methyl-2-benzoxazolinone <b>1b</b> were synthesized according to literature methods using 2-aminophenol/4-methyl-2-aminophenol and urea.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> 5-Chloro-2-benzoxazolinone <b>1c</b> was commercially available. Ethyl ((5-methyl/chloro)-2-benzoxazolinone-3-yl) acetate derivatives <b>2a–2c</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> were carried out by heating (5-methyl/chloro)-2-benzoxazolinone <b>1a–1c</b> with ethyl chloroacetate in K<sub>2</sub>CO<sub>3</sub>/acetone. The acid hydrazides <b>3a–3c</b> were prepared by nucleophilic substitution of <b>2a–2c</b> with hydrazine hydrate in ethanol.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26−28)</a> Treatment of appropriate aldehydes with acetophenone derivatives under basic conditions using the Claisen–Schmidt condensation<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> gave α,β-unsaturated carbonyl compounds (chalcones) <b>4a–4j</b>.</div><div class="NLM_p last">The reaction of hydrazides <b>3a–3c</b> with chalcones <b>4a–4j</b> in n-propanol under acidic condition yielded the corresponding 2-pyrazoline <b>5–34</b> and hydrazone derivatives <b>35–43</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Due to the low stability of hydrazones and difficulties in their isolation, not all hydrazone compounds could be reached. The structures of the synthesized compounds were determined using IR, <sup>1</sup>H NMR, <sup>13</sup>C NMR, and electrospray ionization mass spectrometry (ESI-MS) techniques. The purity of compounds was determined by elemental analyses; the results were within ±0.4% of the theoretical values. Due to limited laboratory facilities, chiral separation of only one compound was made, the configurations of the separated enantiomers were determined by Vibrational Circular Dichroism, and their activities were examined.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The spectra of synthesized compounds are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> X-ray Crystal Structure</h3><div class="NLM_p last">The molecular structure of compounds <b>10</b> and <b>43</b> consists of two discrete entities. <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Table S1</a> summarizes their main geometrical characteristics according to the numbering scheme (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Figures S1 and S2</a>). The most significant differences between these two compounds are the presence of a central pyrazoline ring in compound <b>10</b> and hydrazone moiety in compound <b>43</b> (The packing arrangements of both compounds are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Figures S3 and S4</a>.) In the crystal lattices of both compounds, there are multiple intermolecular interactions and strong intra- and intermolecular hydrogen bonds are responsible for the packing of the molecules (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Tables S2 and S3</a>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Druglikeness and ADMET Predictions</h3><div class="NLM_p last">Druglikeness of the designed compounds were predicted using AdmetSAR 2.0 server (<a href="http://lmmd.ecust.edu.cn/admetsar1" class="extLink">http://lmmd.ecust.edu.cn/admetsar1</a>)—a program that estimates the ADMET properties based on substructure pattern recognition and then uses a support vector machine algorithm to build a model.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The chemical information of each designed compound was input in “smiles” format and the corresponding ADMET properties were estimated (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Table S4</a>, Supporting Information). All designed compounds were found to be drug-like having obeyed Lipinski’s “Rule of 5”<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and Jorgensen’s “Rule of 3”.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> All of the physicochemical parameters assessed were within the range of drug candidacy.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Evaluation of <i>In Vitro</i> Biological Screening Results and Molecular Modeling Data</h3><div class="NLM_p">hMAO activities were determined using Amplex Red MAO assay kit. The synthesized compounds were screened for their hMAO inhibitory activities using moclobemide (A-selective, reversible), selegiline (B-selective, irreversible), and lazabemide (B-selective, reversible) as reference inhibitors (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1A</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">1B</a>). Specific enzyme activities were calculated as 0.175 ± 0.012 nmol/mg/min (<i>n</i> = 3) for hMAO-A and 0.135 ± 0.009 nmol/mg/min (<i>n</i> = 3) for hMAO-B. Selectivity indexes (SI) were expressed as <i>K<sub>i</sub></i>(MAO-A)/<i>K<sub>i</sub></i>(MAO-B).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1A. Experimental <i>K<sub>i</sub></i> Values of hMAO-Isoform Inhibition for Novel Newly Synthesized 2-Pyrazoline Derivatives and Reference Compounds<a class="ref internalNav" href="#t1Afn3" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0010.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0012.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1Afn1"><div class="footnote" id="t1Afn1"><sup><sup>a</sup></sup><p class="last">SI was calculated as <i>K<sub>i</sub></i>(MAO-A)/<i>K<sub>i</sub></i>(MAO-B).</p></div><div class="footnote" id="t1Afn2"><sup><sup>b</sup></sup><p class="last">Data demonstrate the mean ± standard error of the mean (SEM) of three independent experiments.</p></div><div class="footnote" id="t1Afn3"><sup><sup>c</sup></sup><p class="last">Moclobemide and all synthesized compounds were found as reversible, competitive MAO-A inhibitors, while Selegiline (irreversible) and Lazabemide (reversible) were found as competitive MAO-B inhibitors.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1B. Calculated and Experimental <i>K<sub>i</sub></i> Values of hMAO-Isoform Inhibition for Novel Newly Synthesized Hydrazone Derivatives and Reference Compounds<a class="ref internalNav" href="#t1Bfn3" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1Bfn1"><div class="footnote" id="t1Bfn1"><sup><sup>a</sup></sup><p class="last">SI was calculated as <i>K<sub>i</sub></i>(MAO-A)/<i>K<sub>i</sub></i>(MAO-B).</p></div><div class="footnote" id="t1Bfn2"><sup><sup>b</sup></sup><p class="last">Data demonstrate the mean ± SEM of three independent experiments.</p></div><div class="footnote" id="t1Bfn3"><sup><sup>c</sup></sup><p class="last">Moclobemide and all synthesized compounds were found as reversible, competitive MAO-A inhibitors, while Selegiline (irreversible) and Lazabemide (reversible) were found as competitive MAO-B inhibitors.</p></div></div><div></div></div><div class="NLM_p">Docking calculations were performed using AutoDock to determine binding affinities of the synthesized hydrazone derivatives (compounds <b>35–43</b>) with MAO-A and MAO-B. Accelrys’ (Biovia) Discovery Studio Protocols and visualization programs were used to render the poses of docked inhibitors in the active site of MAO-A and MAO-B isozymes. However, the computational inhibition constants obtained for each enantiomer of compounds <b>5–34</b> were not compared with the experimental inhibition constant measurements which were obtained for racemic forms. Thus, a correlation analysis would be insignificant for these compounds in the present study. All two-dimensional (2D) and three-dimensional (3D) pictures were produced using Biovia 4.6 visualization program. Two effective and selective compounds from hydrazone (<b>38</b> and <b>42</b>) group interacting with MAO-A and MAO-B were chosen.</div><div class="NLM_p">Most of the newly synthesized pyrazolines (compounds <b>5–34</b>) and hydrazones (compounds <b>35–43</b>) inhibited hMAO-A potently and selectively. Among pyrazoline derivatives, compound <b>14</b> having 4-methoxy group at R<sub>2</sub> and 2-chlorine at R<sub>3</sub> exhibited the highest inhibitory activity toward hMAO-A with a <i>K<sub>i</sub></i> value of 0.001 μM. This compound was more potent than moclobemide, the known selective and reversible MAO-A inhibitor inhibiting hMAO-A with the <i>K<sub>i</sub></i> value of 0.010 ± 0.001 μM.</div><div class="NLM_p">Experimental data showed that the compound <b>21</b>, bearing 4-methoxy group at R<sub>2</sub> and 2,3-dimethoxy groups at R<sub>3</sub> inhibited hMAO-A potently with a <i>K<sub>i</sub></i> value of 0.009 μM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1A</a></a>).</div><div class="NLM_p"><i>In vitro</i> screening data demonstrating that hydrazone derivative compounds <b>35</b>, <b>36</b>, <b>38</b>, <b>41</b>, and <b>43</b> showed the most inhibitory potency toward hMAO-A with the same <i>K<sub>i</sub></i> value of 0.001 μM indicated that the hMAO-A inhibitory ability of newly synthesized hydrazones is remarkably better than that of moclobemide (<i>K<sub>i</sub></i> = 0.10 μM) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">1B</a></a>).</div><div class="NLM_p">Molecular modeling studies of compound <b>38</b>, which is a hydrazone derivative of pyrazoline derivative, and compound <b>14</b> were also carried out for MAO-A and MAO-B isozymes (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A shows the orientation of compound <b>38</b> in the active site of MAO-A (<i>K<sub>i</sub></i> = 0.394 × 10<sup>–3</sup> μM). The benzoxazolinone ring of the inhibitor is inserted between TYR407 and TYR444 making a π–π stacked interaction with TYR444 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). Another hydrogen bond forms between the carbonyl groups of the inhibitor and TYR407. PHE352 forms a strong π–π interaction with the chlorophenyl ring of the inhibitor. CYS323 residue forms a π–sulfur interaction with the same ring. A hydrogen bond is formed between the NH moiety of the inhibitor and ILE207 backbone carbonyl group. In addition to these effective interactions, various hydrophobic and van der Waals interactions contribute to generating a better MAO-A inhibitor compared to MAO-B isozyme (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A–C) 3D representations of compound <b>38</b> docked in the MAO-A (2Z5X) (A) active site. Magnified view of the active site (B). 2D interaction diagrams of compound <b>38</b> with amino acid residues lining the MAO-A active site (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A–C) 3D representations of compound <b>38</b> docked in the MAO-B (2V5Z) (B) active site. Magnified view of the active site (B). 2D interaction diagrams of compound <b>38</b> with amino acid residues lining the MAO-B active site (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A shows compound <b>38</b> in the active site of MAO-B. The benzoxazolinone ring of the inhibitor is oriented away from the hydrophobic cage, making only one π-lone pair interaction with GLN206 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). The carbonyl group of the benzoxazolinone ring and double-bonded nitrogen atom of the inhibitor make two hydrogen bonds with CYS172 and TYR326, respectively. Various hydrophobic and van der Waals interactions occur between compound <b>38</b> and the active-site residues of MAO-B (<i>K<sub>i</sub></i> = 23.69 μM) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C).</div><div class="NLM_p">Among the hydrazones, compound <b>42</b> appeared the most selective hMAO-A inhibitor with an SI value of 5.40 × 10<sup>–6</sup> (calculated SI: 4.30 × 10<sup>–7</sup>). The selectivity of compound <b>42</b> toward hMAO-A isoform (<i>K<sub>i</sub></i> = 0.010 μM) was much higher than that of moclobemide (SI = 0.013) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">1B</a></a>). According to the docking data, the benzoxazolinone ring of compound <b>42</b> was sandwiched between the TYR444 and TYR407 residues in the active site of hMAO-A making two strong π–π interactions with these residues while hMAO-B has only one π–π interaction between phenyl and TYR435, making compound <b>42</b> more potent hMAO-A inhibitor (<i>K<sub>i</sub></i> = 0.004 μM) than that of hMAO-B (<i>K<sub>i</sub></i> = 9300.00 μM) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Figure S5</a>).</div><div class="NLM_p">As a result, we found a good correlation between the experimental and calculated data for the hydrazones since these compounds do not have stereoisomers, and the correlation between the calculated and experimental data for these compounds can be successfully demonstrated.</div><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Reversibility</h4><div class="NLM_p">The reversibility tests were performed for the most potent and selective hMAO-A inhibitors in this series (compounds <b>6</b>, <b>7</b>, <b>14</b>, <b>21</b>, <b>41</b>, <b>42</b>, and <b>43</b>) using the dialysis method (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">2</a></a>). The compounds are found to be reversible hMAO inhibitors that have remarkable advantages compared to irreversible inhibitors with important side effects.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Reversibility of hMAO Inhibition by the Selected Novel Derivatives<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">test compounds incubated with hMAO</th><th class="colsep0 rowsep0" align="center" char="±">hMAO-A activity before dialysis (%)</th><th class="colsep0 rowsep0" align="center" char="±">hMAO-A activity after dialysis (%)</th><th class="colsep0 rowsep0" align="center" char="±">hMAO-B activity before dialysis (%)</th><th class="colsep0 rowsep0" align="center" char="±">hMAO-B activity after dialysis (%)</th><th class="colsep0 rowsep0" align="center">reversibility</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">with no inhibitor</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 0.00</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">selegiline</td><td class="colsep0 rowsep0" align="char" char="±">89.96 ± 2.25</td><td class="colsep0 rowsep0" align="char" char="±">90.01 ± 2.00</td><td class="colsep0 rowsep0" align="char" char="±">51.80 ± 2.30</td><td class="colsep0 rowsep0" align="char" char="±">52.40 ± 2.03</td><td class="colsep0 rowsep0" align="left">irreversible</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lazabemide</td><td class="colsep0 rowsep0" align="char" char="±">11.00 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">97.00 ± 1.16</td><td class="colsep0 rowsep0" align="char" char="±">89.00 ± 1.05</td><td class="colsep0 rowsep0" align="char" char="±">99.00 ± 1.70</td><td class="colsep0 rowsep0" align="left">reversible</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">moclobemide</td><td class="colsep0 rowsep0" align="char" char="±">36.00 ± 1.19</td><td class="colsep0 rowsep0" align="char" char="±">93.77 ± 2.16</td><td class="colsep0 rowsep0" align="char" char="±">88.00 ± 1.53</td><td class="colsep0 rowsep0" align="char" char="±">89.55 ± 1.90</td><td class="colsep0 rowsep0" align="left">reversible</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="char" char="±">24.55 ± 1.09</td><td class="colsep0 rowsep0" align="char" char="±">91.74 ± 1.93</td><td class="colsep0 rowsep0" align="char" char="±">85.00 ± 1.61</td><td class="colsep0 rowsep0" align="char" char="±">92.25 ± 1.66</td><td class="colsep0 rowsep0" align="left">reversible</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="char" char="±">23.11 ± 2.47</td><td class="colsep0 rowsep0" align="char" char="±">94.00 ± 3.21</td><td class="colsep0 rowsep0" align="char" char="±">78.90 ± 1.35</td><td class="colsep0 rowsep0" align="char" char="±">94.80 ± 2.07</td><td class="colsep0 rowsep0" align="left">reversible</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="char" char="±">18.11 ± 1.05</td><td class="colsep0 rowsep0" align="char" char="±">90.16 ± 1.88</td><td class="colsep0 rowsep0" align="char" char="±">78.20 ± 1.60</td><td class="colsep0 rowsep0" align="char" char="±">91.50 ± 2.64</td><td class="colsep0 rowsep0" align="left">reversible</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="char" char="±">22.16 ± 1.00</td><td class="colsep0 rowsep0" align="char" char="±">92.55 ± 1.39</td><td class="colsep0 rowsep0" align="char" char="±">74.19 ± 3.00</td><td class="colsep0 rowsep0" align="char" char="±">94.16 ± 3.71</td><td class="colsep0 rowsep0" align="left">reversible</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="char" char="±">19.55 ± 1.84</td><td class="colsep0 rowsep0" align="char" char="±">92.24 ± 2.60</td><td class="colsep0 rowsep0" align="char" char="±">77.29 ± 2.90</td><td class="colsep0 rowsep0" align="char" char="±">97.00 ± 2.33</td><td class="colsep0 rowsep0" align="left">reversible</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="char" char="±">20.16 ± 1.06</td><td class="colsep0 rowsep0" align="char" char="±">93.57 ± 2.46</td><td class="colsep0 rowsep0" align="char" char="±">82.37 ± 2.31</td><td class="colsep0 rowsep0" align="char" char="±">95.21 ± 3.27</td><td class="colsep0 rowsep0" align="left">reversible</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="char" char="±">21.91 ± 2.09</td><td class="colsep0 rowsep0" align="char" char="±">93.26 ± 3.00</td><td class="colsep0 rowsep0" align="char" char="±">77.22 ± 1.64</td><td class="colsep0 rowsep0" align="char" char="±">93.41 ± 2.11</td><td class="colsep0 rowsep0" align="left">reversible</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Data demonstrate mean ± SEM (<i>n</i> = 3).</p></div></div></div></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Cytotoxicity</h4><div class="NLM_p">The cytotoxicities of the most potent and selective compounds (compounds <b>6</b>, <b>7</b>, <b>14</b>, <b>21</b>, <b>41</b>, <b>42</b>, and <b>43</b>) were tested in HepG2 cells at three concentrations (7.5, 15, and 30 μM). Data indicated that the selected compounds, except compound <b>6</b>, which was slightly toxic to the cells at a concentration of 30 μM and at the title concentrations, were not toxic to hepatic cells (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">3</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>In Vitro</i> Cytotoxicity of the Selected Novel Derivatives<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">viability (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center" char="±">7.5 μM</th><th class="colsep0 rowsep0" align="center" char="±">15 μM</th><th class="colsep0 rowsep0" align="center" char="±">30 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">selegiline</td><td class="colsep0 rowsep0" align="char" char="±"><i>90.00</i> ± 3.55</td><td class="colsep0 rowsep0" align="char" char="±"><i>87.2</i>3 ± <i>2.90</i></td><td class="colsep0 rowsep0" align="char" char="±"><i>84.00</i> ± <i>2.70</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lazabemide</td><td class="colsep0 rowsep0" align="char" char="±"><i>92.40</i> ± <i>2.00</i></td><td class="colsep0 rowsep0" align="char" char="±"><i>89.66</i> ± 3.00</td><td class="colsep0 rowsep0" align="char" char="±"><i>85.60</i> ± <i>2.76</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">moclobemide</td><td class="colsep0 rowsep0" align="char" char="±"><i>90.80</i> ± <i>2.87</i></td><td class="colsep0 rowsep0" align="char" char="±"><i>88.50</i> ± <i>2.90</i></td><td class="colsep0 rowsep0" align="char" char="±"><i>86.00</i> ± <i>2.39</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="char" char="±">96.25 ± 2.05</td><td class="colsep0 rowsep0" align="char" char="±">88.29 ± 1.00</td><td class="colsep0 rowsep0" align="char" char="±">77.33 ± 1.97*</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="char" char="±">90.39 ± 3.00</td><td class="colsep0 rowsep0" align="char" char="±">88.25 ± 1.13</td><td class="colsep0 rowsep0" align="char" char="±">85.27 ± 3.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="char" char="±">91.23 ± 4.54</td><td class="colsep0 rowsep0" align="char" char="±">89.97 ± 2.03</td><td class="colsep0 rowsep0" align="char" char="±">85.00 ± 1.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="char" char="±">100.80 ± 5.60</td><td class="colsep0 rowsep0" align="char" char="±">99.60 ± 4.00</td><td class="colsep0 rowsep0" align="char" char="±">84.93 ± 8.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="char" char="±">91.35 ± 4.17</td><td class="colsep0 rowsep0" align="char" char="±">89.00 ± 2.66</td><td class="colsep0 rowsep0" align="char" char="±">87.67 ± 1.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="char" char="±">118.30 ± 4.50</td><td class="colsep0 rowsep0" align="char" char="±">99.12 ± 4.55</td><td class="colsep0 rowsep0" align="char" char="±">88.55 ± 2.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="char" char="±">92.11 ± 3.36</td><td class="colsep0 rowsep0" align="char" char="±">90.61 ± 3.73</td><td class="colsep0 rowsep0" align="char" char="±">87.40 ± 1.35</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Data demonstrate mean ± SEM (<i>n</i> = 3).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">The viability of cell was calculated as a percentage of the control. *<i>p</i> < 0.05 vs control.</p></div></div></div></div><div id="sec2_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> BBB Permeation</h4><div class="NLM_p">Since neuroactive drugs are required to cross the BBB to function,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> PAMPA–BBB was performed to assess the capability of newly synthesized derivatives to cross the BBB. The assay was validated by comparing the permeabilities of nine commercial drugs with presented values (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">4</a></a>). A linear correlation was obtained with a plot of experimental vs bibliographic data (<i>R</i><sup>2</sup> = 0.9934). According to the limits evaluated by Di et al.,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> the novel compounds were classified as follows: Pe (10<sup>–6</sup> cm s<sup>–1</sup>) > 4.00: CNS+ (high BBB permeation anticipated)</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Permeability of the Commercial Drugs Utilized for Assay Validation and of the Selected Novel Derivatives Determined Using the PAMPA–BBB Assay</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">permeability (10<sup>–6</sup> cm s<sup>–1</sup>)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">bibliography<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±">experimental</th><th class="colsep0 rowsep0" align="center">prediction</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">testosterone</td><td class="colsep0 rowsep0" align="char" char=".">17.0</td><td class="colsep0 rowsep0" align="char" char="±">16.00 ± 1.54</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">verapamil</td><td class="colsep0 rowsep0" align="char" char=".">16.0</td><td class="colsep0 rowsep0" align="char" char="±">15.03 ± 1.23</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β-estradiol</td><td class="colsep0 rowsep0" align="char" char=".">12.0</td><td class="colsep0 rowsep0" align="char" char="±">9.99 ± 0.67</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">progesterone</td><td class="colsep0 rowsep0" align="char" char=".">9.3</td><td class="colsep0 rowsep0" align="char" char="±">7.55 ± 0.56</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">corticosterone</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char="±">4.11 ± 0.35</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">piroxicam</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char="±">2.20 ± 0.11</td><td class="colsep0 rowsep0" align="left">CNS+/–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hydrocortisone</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char="±">1.58 ± 0.12</td><td class="colsep0 rowsep0" align="left">CNS–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lomefloxacin</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char="±">0.99 ± 0.06</td><td class="colsep0 rowsep0" align="left">CNS–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dopamine</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.02</td><td class="colsep0 rowsep0" align="left">CNS–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">8.90 ± 0.76</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">9.44 ± 1.04</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">11.00 ± 0.97</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">8.05 ± 0.78</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">14.55 ± 1.10</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">15.60± 1.34</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">14.02 ± 1.35</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Dimethylsulfoxide (DMSO, 1% w/v) at 5 mg/mL was used to dissolve the compounds. They are diluted with PBS/EtOH (70:30). The compounds reached a 50 μg/mL final concentration.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Bibliography is from ref <a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a>.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Data demonstrate mean ± SEM of three independent experiments.</p></div></div></div><div class="NLM_p">Pe (10<sup>–6</sup> cm s<sup>–1</sup>) < 2.00: CNS– (low BBB permeation anticipated)</div><div class="NLM_p">Pe (10<sup>–6</sup> cm s<sup>–1</sup>) from 4.00 to 2.00: CNS ± (uncertain BBB permeation)</div><div class="NLM_p">Of the most selective and potent compounds exhibiting MAO-A activity, <b>6</b>, <b>7</b>, <b>14</b>, <b>21</b>, <b>41</b>, <b>42</b>, and <b>43</b> were included in the assay. As seen in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">5</a></a>, they can successfully pass the BBB. Compounds <b>41, 42</b>, and <b>43</b> exhibited the highest permeability considering that they may easily pass the BBB and achieve the targets in the CNS, which were in accordance with our design strategy. This result supports us to perform more detailed studies with these novel prodrugs.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Brain-Tissue MAO-A, 5-HT, DA, 5-HIAA, and 3,4-dihydroxyphenylacetic acid (DOPAC) Levels after the Acute and Subchronic Administrations of Test Compounds in Mice (<i>n</i> = 6)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center" char="±">MAO-A (nmol/min/mg)</th><th class="colsep0 rowsep0" align="center" char="±">5-HT (μg/g tissue)</th><th class="colsep0 rowsep0" align="center" char="±">DA (μg/g tissue)</th><th class="colsep0 rowsep0" align="center" char="±">5-HIAA (μg/g tissue)</th><th class="colsep0 rowsep0" align="center" char="±">DOPAC (μg/g tissue)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Acute Administration</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="char" char="±">0.40 ± 0.012</td><td class="colsep0 rowsep0" align="char" char="±">0.80 ± 0.006</td><td class="colsep0 rowsep0" align="char" char="±">7.08 ± 0.58</td><td class="colsep0 rowsep0" align="char" char="±">0.28 ± 0.011</td><td class="colsep0 rowsep0" align="char" char="±">1.22 ± 0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">moclobemide</td><td class="colsep0 rowsep0" align="char" char="±">0.35 ± 0.011<sup>**</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.83 ± 0.012 *</td><td class="colsep0 rowsep0" align="char" char="±">7.10 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.012*</td><td class="colsep0 rowsep0" align="char" char="±">1.24 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound <b>6</b></td><td class="colsep0 rowsep0" align="char" char="±">0.31 ± 0.007<sup>** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.88 ± 0.011 <sup>***ψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.08 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.009 *</td><td class="colsep0 rowsep0" align="char" char="±">1.23 ± 0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound <b>7</b></td><td class="colsep0 rowsep0" align="char" char="±">0.28 ± 0.007<sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.91 ± 0.012 <sup>*** ψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.08 ± 0.37</td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.007*</td><td class="colsep0 rowsep0" align="char" char="±">1.23 ± 0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound <b>14</b></td><td class="colsep0 rowsep0" align="char" char="±">0.25 ± 0.009<sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.98 ± 0.009 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.10 ± 0.42</td><td class="colsep0 rowsep0" align="char" char="±">0.35 ± 0.009<sup>* ψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.24 ± 0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound <b>21</b></td><td class="colsep0 rowsep0" align="char" char="±">0.23 ± 0.014<sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.10 ± 0.026 <sup>***ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.13 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">0.35 ± 0.012<sup>** ψ ψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.25 ± 0.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound <b>42</b></td><td class="colsep0 rowsep0" align="char" char="±">0.20 ± 0.014<sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.24 ± 0.114<sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.16 ± 0.38</td><td class="colsep0 rowsep0" align="char" char="±">0.45 ± 0.011<sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.25 ± 0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Subchronic Administration</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="char" char="±">0.40 ± 0.005</td><td class="colsep0 rowsep0" align="char" char="±">0.78 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">7.45 ± 0.22</td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">1.54 ± 0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">moclobemide</td><td class="colsep0 rowsep0" align="char" char="±">0.33 ± 0.014*</td><td class="colsep0 rowsep0" align="char" char="±">0.91 ± 0.01 <sup>***</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.40 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">0.23 ± 0.01<sup>**</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.52 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound <b>6</b></td><td class="colsep0 rowsep0" align="char" char="±">0.29 ± 0.005<sup>**</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.01 ± 0.03<sup>***ψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.30 ± 0.42</td><td class="colsep0 rowsep0" align="char" char="±">0.24 ± 0.05 *</td><td class="colsep0 rowsep0" align="char" char="±">1.59 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound <b>7</b></td><td class="colsep0 rowsep0" align="char" char="±">0.27 ± 0.006<sup>***ψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.04 ± 0.04 <sup>*** ψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.31 ± 0.55</td><td class="colsep0 rowsep0" align="char" char="±">0.24 ± 0.01 <sup>**</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.58 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound <b>14</b></td><td class="colsep0 rowsep0" align="char" char="±">0.24 ± 0.004<sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.19 ± 0.04 <sup>***ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.28 ± 0.65</td><td class="colsep0 rowsep0" align="char" char="±">0.31 ± 0.01 <sup>***ψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.57 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound <b>21</b></td><td class="colsep0 rowsep0" align="char" char="±">0.21 ± 0.005<sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.15 ± 0.02 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.43 ± 0.51</td><td class="colsep0 rowsep0" align="char" char="±">0.30 ± 0.01 <sup>***ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.52 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound <b>42</b></td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.009<sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.28 ± 0.01 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.43 ± 0.48</td><td class="colsep0 rowsep0" align="char" char="±">0.35 ± 0.01<sup>***ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.52 ± 0.18</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">*** <i>p</i> < 0.001, ** <i>p</i> < 0.01, * <i>p</i> < 0.05 vs control; ψψψ <i>p</i> < 0.001, ψψ <i>p</i> < 0.01, ψ <i>p</i> < 0.05 vs moclobemide.</p></div></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Structure–Activity Relationship</h3><div class="NLM_p">The structure–activity relationships of the newly synthesized 2-pyrazoline derivatives were evaluated by considering the substitutions on the benzoxazolinone ring at the first position (R<sub>1</sub>) and the phenyl rings at the third (R<sub>2</sub>) and fifth positions (R<sub>3</sub>). Although it is hard to make a definitive structure–activity relationship discussion, some generalizations could be postulated (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1A</a></a>).</div><div class="NLM_p">When compounds contain hydrogen, methyl, or chlorine at R<sub>1</sub>; no substitution at R<sub>2</sub>; and 4-methyl, 3-methoxy, or 3,4-dimethoxy substitutions at R<sub>3</sub> (compounds <b>5, 6, 7, 15, 16, 17, 25, 26</b>, and <b>27</b>) were compared, compounds <b>5, 6</b>, and <b>7</b> with no substitution at R<sub>1</sub> appeared to be more potent than the ones with methyl or chlorine at R<sub>1</sub>. Compounds <b>15, 16</b>, and <b>17</b>, which have a methyl group at R1, inhibited hMAO-A more potently than those having a chlorine at R<sub>1</sub> (compounds <b>25, 26</b>, and <b>27</b>). Among the compounds with 4-methyl groups at R<sub>3</sub> (<b>5</b>, <b>15</b>, and <b>25)</b>, the inhibitory potency of compounds <b>5</b> (R<sub>1</sub> = H) and <b>15</b> (R<sub>1</sub>:CH<sub>3</sub>) toward hMAO-A was found to be remarkably higher, about 10 times, than the inhibitory potency of compound <b>25</b>, which has a chlorine at R<sub>1</sub>. Among the compounds carrying a 3-methoxy group at R<sub>3</sub> (compounds <b>6, 16</b>, and <b>26</b>), compound <b>6</b> with no substitution at R<sub>1</sub> and compound <b>16</b> with a methyl group at R<sub>1</sub> strongly inhibited hMAO-A, whereas the inhibitory potency of compound <b>26</b> with a chlorine at R<sub>1</sub> was relatively lower. Among the compounds with a 3,4-dimethoxy substitution at R<sub>3</sub> (compounds <b>7, 17</b>, and <b>27</b>), compound <b>7</b> with no substitution at R<sub>1</sub> and R<sub>2</sub> appeared as a potent hMAO-A inhibitor, whereas the inhibitory potency of compound <b>17</b> with a methyl at R<sub>1</sub> was found to be lower than that of compound <b>7</b>. Compound <b>27</b> with a chlorine at R<sub>1</sub> showed the lowest inhibitory activity toward hMAO-A in this series.</div><div class="NLM_p">In comparison to compounds with no substitution or 2,3-dimethoxy substitution at R<sub>3</sub> carrying 4-methyl substitution at R<sub>2</sub> (compounds <b>8, 9, 18, 19, 28</b>, and <b>29</b>), the hMAO-A inhibitory potency of compounds with no substitution at R<sub>3</sub> (compounds <b>8, 18</b>, and <b>28</b>) was higher than those having a 2,3-dimethoxy substitution at R<sub>3</sub> (compounds <b>9, 19</b>, and <b>29</b>). Compounds <b>8</b> and <b>9</b> that have no substitution at R<sub>1</sub> showed more potent inhibitory activity toward hMAO-A than the others in this group.</div><div class="NLM_p">When compounds carrying 4-methoxy at R<sub>2</sub> and having no substitution or having 2,3-dimethoxy or 2-chlorine substitutions at R<sub>3</sub> (compounds <b>10, 11, 14, 20, 21, 24, 30, 31</b>, and <b>34</b>) were compared, it was found that the compounds having 2,3-dimethoxy at R<sub>3</sub> (compounds <b>11</b>, <b>21</b>, and <b>31</b>) possessed lower inhibitory activity toward hMAO-A than the other compounds in this group. Among the compounds having 2,3-dimethoxy at R<sub>3</sub> (compounds <b>11</b>, <b>21</b>, and <b>31</b>), compound <b>21</b> which is bearing methyl at R<sub>1</sub> appeared as the most potent hMAO-A inhibitor. Among the compounds having no substitution at R<sub>3</sub> (compounds <b>10</b>, <b>20</b>, and <b>30</b>), compound <b>30</b>, which carries chlorine at R<sub>1</sub>, appeared as the most potent hMAO-A inhibitor. Among the compounds having 2-chlorine at R<sub>3</sub> (compounds <b>14</b>, <b>24</b>, and <b>34</b>), compound <b>14</b>, which has no substitution at R<sub>1</sub>, appeared as the most potent hMAO-A inhibitor. Compound <b>14</b> was found to be the most potent hMAO-A inhibitor in the novel 2-pyrazolines presented here.</div><div class="NLM_p">When compounds having 2-chlorine at R<sub>3</sub> and 2-methoxy or 3-methoxy or 4-methoxy at R<sub>2</sub> (compounds <b>12</b>, <b>13</b>, <b>14</b>, <b>22</b>, <b>23</b>, <b>24</b>, <b>32</b>, <b>33</b>, and <b>34</b>) were compared, compounds with no substitution at R<sub>1</sub> (compounds <b>12, 13</b>, and <b>14</b>) were found to inhibit hMAO-A more potently than the others. Compounds carrying 4-methoxy at R<sub>2</sub> (compounds <b>14</b>, <b>24</b>, and <b>34</b>) inhibited hMAO-A more potently.</div><div class="NLM_p">When compounds carrying no substitution at R<sub>3</sub> and having 4-methyl or 4-methoxy substitutions at R<sub>2</sub> (compounds <b>8, 10, 18, 20, 28</b>, and <b>30</b>) were compared, it was noted that compounds <b>8</b> and <b>10</b> that have no substitution at R<sub>1</sub> inhibited hMAO-A more potently than the others. Compounds <b>28</b> and <b>30</b> with chlorine at R<sub>1</sub> showed better inhibitory potency toward hMAO-A compared to those carrying methyl at R<sub>1</sub>.</div><div class="NLM_p last">Hydrazones having 2-methoxy at R<sub>2</sub> and 2-chlorine at R<sub>3</sub> (compounds <b>37</b>, <b>40</b>, and <b>43</b>) were also evaluated. Compounds <b>37</b> with no substitution and compound <b>43</b> with chlorine substitution at R<sub>1</sub> were found to be more potent and selective inhibitors than compound <b>40</b> with a methyl group at R<sub>1</sub> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">1B</a></a>).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Behavioral Evaluation</h3><div class="NLM_p">Porsolt’s forced swim test (PFST) is based on behavioral despair, and it is a very commonly used method to evaluate antidepressant activity in drug development studies.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38−40)</a> An increase in the escape-directed behavior and the reduction of the immobility time indicate the antidepressant effect of tested compounds.<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41−43)</a> The acute and subchronic antidepressant effects of selected compounds <b>6, 7, 14, 21</b>, and <b>42</b> exhibiting the highest activity <i>in vitro</i> were assessed using PFST; moclobemide was used as the reference drug. To avoid the extra stress that may be caused by long-term oral gavage, 7-day subchronic application was preferred for the screening test. The <i>in vivo oral</i> dose of 30 mg/kg typically used in screening tests was used for testing the new compounds, while 20 mg/kg oral dose was used for moclobemide according to the previous data<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> and the daily therapeutic dosage for a 70 kg adult human is 300–600 mg. Pharmacological analyses were performed 1 h after a single-dose (30 mg/kg) administration to evaluate the acute effects of the compounds and to observe the acute alterations in basal monoamine levels. Since the therapeutic response of antidepressant therapy generally begins in weeks, experiments were also performed for 1 h after 7 days of subchronic administration of the compounds.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a></div><div class="NLM_p">Acute, oral administration of compounds <b>14</b>, <b>21</b>, and <b>42</b> decreased the immobility time similar to the moclobemide. However, the decrease was not statistically significant compared to control. Compounds <b>6</b> and <b>7</b> did not reduce the immobility time compared to the control (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). These data were from previous reports indicating that no behavioral changes are expected with a single-dose administration of antidepressants including moclobemide.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The immobility time was decreased after subchronic administration of compounds <b>6</b>, <b>7</b>, <b>14</b>, <b>21</b>, <b>42</b>, and moclobemide (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). No statistically significant differences were obtained between the groups.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A, B). Effects of a single-dose (A) and subchronic administrations (B) of the compounds and moclobemide on the immobility time in the PFST; <i>n</i> = 8–12, *<i>p</i> < 0.05. The immobility times of mice administrated with moclobemide or the test compounds were compared with the control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The compounds <b>14</b>, <b>21</b>, and <b>42</b> and moclobemide decreased immobility time with acute administration, and the increasing antidepressant activity reached statistical significance after subchronic administration. On the other hand, compounds <b>6</b> and <b>7</b> did not provide any reduction in the immobility time with a single dose and caused an important decrease in immobility time with recurring doses. Therefore, it can be suggested that the pharmacokinetics of compounds <b>6</b> and <b>7</b> may be undergoing some problems such as first-pass effects that prevent their activity after a single-dose administration.</div><div class="NLM_p">Following the behavioral assessments, the effects of acute and subchronic administrations of the compounds <b>6</b>, <b>7</b>, <b>14</b>, <b>21</b>, and <b>42</b> and moclobemide on the brain-tissue MAO-A selectivity were determined <i>ex vivo</i> by biochemical analysis. The MAO-A activity was reduced by both the acute and subchronic administrations of the test compounds in the brain (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">5</a></a>), suggesting that the compounds crossed the BBB. Subchronic administration of the new compounds and moclobemide caused more reduction in tissue MAO-A levels compared to acute administration. In agreement with the compounds’ relatively higher inhibitory potency and better selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1A</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">1B</a>), the compounds inhibited brain-tissue MAO-A activity more potently than that of moclobemide (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">5</a></a>). It is known that MAO catalyzes the deamination of biogenic amines including 5-HT and DA and produces 5-HIAA and DOPAC metabolites, respectively.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> 5-HT is more efficiently oxidized by MAO-A, while DA is a substrate for both subtypes. To examine the effect of the MAO-A inhibition on the brain levels of monoamines, brain-tissue levels of 5-HT, DA, and their main metabolites following the acute and subchronic administration of new compounds to mice were determined (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">5</a></a>). Brain-tissue 5-HT levels were significantly elevated, and 5-HIAA levels were reduced compared with those of the control group following both the acute and subchronic administrations of new compounds and moclobemide (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Tables <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">5</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">6</a>). It is known that the activity of MAO-A increases in depression and involves depletion of 5-HT in the brain; inhibition of MAO-A activity prevents the breakdown of 5-HT and increases 5-HT level in the synaptic cleft.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> On the other hand, the brain DA level was not affected by treatment with the new compounds and moclobemide. It was postulated that inhibition of MAO caused increased only in 5-HT concentrations and did not alter the DA level.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Dose–Response Study: Brain-Tissue MAO-A Activity; 5-HT, DA, 5-HIAA, and DOPAC Levels after the Subchronic Administration of Test Compounds <b>21</b> and <b>42</b> and Moclebemide in Mice (<i>n</i> = 6)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="±">MAO-A (nmol/min/mg)</th><th class="colsep0 rowsep0" align="center" char="±">5-HT (μg/g tissue)</th><th class="colsep0 rowsep0" align="center" char="±">DA (μg/g tissue)</th><th class="colsep0 rowsep0" align="center" char="±">5-HIAA (μg/g tissue)</th><th class="colsep0 rowsep0" align="center" char="±">DOPAC (μg/g tissue)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">0.39 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.78 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">7.45 ± 0.22</td><td class="colsep0 rowsep0" align="char" char="±">0.33 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">1.54 ± 0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">moclobemide</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char="±">0.41 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.78 ± 0.004</td><td class="colsep0 rowsep0" align="char" char="±">7.48 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.33 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">1.54 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="char" char="±">0.41 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.79 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">7.51 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">1.53 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="char" char="±">0.40 ± 0.06 *</td><td class="colsep0 rowsep0" align="char" char="±">0.82 ± 0.09 **</td><td class="colsep0 rowsep0" align="char" char="±">7.54 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.30 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">1.53 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="char" char="±">0.33 ± 0.01 <sup>**</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.91 ± 0.01 <sup>***</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.58 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">0.29 ± 0.01 <sup>**</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.53 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">compound <b>21</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char="±">0.39 ± 0.08 <sup>*** ψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.80 ± 0.05 <sup>** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.35 ± 0.61</td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.04 <sup>** ψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.46 ± 0.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="char" char="±">0.34 ± 0.05 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.85 ± 0.05 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.44 ± 0.67</td><td class="colsep0 rowsep0" align="char" char="±">0.30 ± 0.03 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.53 ± 0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="char" char="±">0.27 ± 0.06 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.99 ± 0.05 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.44 ± 0.41</td><td class="colsep0 rowsep0" align="char" char="±">0.29 ± 0.01 <sup>***</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.53 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="char" char="±">0.21 ± 0.04 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.10 ± 0.04 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.43 ± 0.51</td><td class="colsep0 rowsep0" align="char" char="±">0.22 ± 0.01 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.52 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">compound <b>42</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char="±">0.36 ± 0.03 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.81 ± 0.06 <sup>** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.45 ± 1.00</td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.03 *</td><td class="colsep0 rowsep0" align="char" char="±">1.53 ± 0.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="char" char="±">0.30 ± 0.05 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.83 ± 0.01 <sup>*** ψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.44 ± 0.89</td><td class="colsep0 rowsep0" align="char" char="±">0.30 ± 0.05 <sup>** ψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.53 ± 0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="char" char="±">0.25 ± 0.07 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">0.92 ± 0.02 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.43 ± 0.65</td><td class="colsep0 rowsep0" align="char" char="±">0.26 ± 0.01 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.52 ± 0.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.09 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.19 ± 0.04 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">7.43 ± 0.48</td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.01 <sup>*** ψψψ</sup></td><td class="colsep0 rowsep0" align="char" char="±">1.52 ± 0.18</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">*** <i>p</i> < 0.001, ** <i>p</i> < 0.01, * <i>p</i> < 0.05 vs control; ψψψ <i>p</i> < 0.001, ψψ <i>p</i> < 0.01, ψ <i>p</i> < 0.05 vs moclobemide.</p></div></div></div><div class="NLM_p">Our overall data demonstrate that new compounds strongly and selectively inhibit MAO-A and produce an antidepressant-like effect in mice possibly due to the increase in 5-HT brain levels caused by MAO-A inhibition. Although the compounds increased 5-HT levels in <i>ex vivo</i> analysis more than that of moclobemide, no difference was found in the antidepressant activity between the compounds and moclobemide. It can be thought that a 7-day subchronic treatment is not long enough for the compounds to show these marked changes in behavior.</div><div class="NLM_p">It was previously postulated that MAO-inhibitor treatments can alter the motor functions,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> which may affect the reliability of the PFST. Motor activity was assessed by open-field test (OFT) to eliminate any possible changes in the motor function. The distance moved in the box was measured following the administration to assess the locomotor activity. The new compounds and moclobemide caused no alteration in locomotor activity of mice (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Total distance traveled in the open-field test by mice administrated subchronically 30 mg/kg of the test compounds and 20 mg/kg moclobemide. <i>n</i> = 8–10.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Together with biochemical data, these findings indicate that the brain-tissue DA and DOPAC levels did not change following the administration of the new compounds, suggesting that the compounds did not have any significant side effects on the motor functions.</div><div class="NLM_p">We also performed dose–response studies with the two most efficient compounds to investigate minimum effective doses of compounds <b>21</b> (a 2-pyrazoline derivative) and <b>42</b> (a hydrazone derivative) in mice. These compounds and moclobemide were administered to mice at 1, 3, 10, and 30 mg/kg doses for 7 days of subchronic oral administration. In PFST, moclobemide decreased the immobility time at 10 mg/kg dose compared with the control group, while compounds <b>21</b> and <b>42</b> started to decrease the immobility time only at the 30 mg/kg dose (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). However, the dose–response curves indicate that moclobemide at 20 mg/kg dose reached <i>E</i><sub>max</sub> value (i.e., it reached its maximum antidepressant-like activity), while compounds <b>21</b> and <b>42</b> did not reach such a plateau or the maximum activity. Therefore, these compounds may provide better antidepressant activity than moclobemide at higher doses (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A, B). Dose–response data with the PFST at 1, 3,10, and 30 mg/kg doses of the test compounds and 1, 3, 10, and 20 mg/kg doses of moclobemide (A); <i>n</i> = 8–12, *<i>p</i> < 0.05. The immobility times of mice treated with test compounds or moclobemide were compared to those of the control mice. Dose–response curves of moclobemide and compounds <b>21</b> and <b>42</b>. Increase in the activity % of the most effective compounds and moclobemide with increasing doses (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25227" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25227" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Depression is a life-threatening and highly debilitating neuropsychiatric disease. Reduced activity of serotonin-related pathways plays a causal role in the pathophysiology of depression. MAOIs, particularly MAO-A inhibitors, are found efficient in atypical and treatment resistance depression, anxiety, and bipolar depression. However, MAOIs are rarely used as a consequence of safety and intolerability problems and dietary restrictions. Selective reversible inhibitors of MAO-A (RIMAs) were introduced in the 1980s. In clinics, moclobemide is the only RIMA available; therefore, new potent RIMAs with fewer side effects are needed.</div><div class="NLM_p">We have designed, prepared, and tested a new series of MAO-A-selective inhibitors based on the 2-pyrazoline and hydrazone scaffold. All of the compounds showed high inhibition in the nanomolar concentration and selectivity; in particular, compounds <b>14, 21</b>, and <b>42</b> showed important potency and selectivity compared to the reference drugs clorgyline and moclobemide. Examination of the structure of the compounds indicated that the hydrazone derivatives were more selective and potent inhibitors of the MAO-A enzyme than 2-pyrazolines. To better understand the mechanism of selectivity and interaction of the novel compound, molecular modeling studies were performed for providing rational guidance for the design of novel potential leads for drugs. The results of the molecular docking supported the <i>in vitro</i> results.</div><div class="NLM_p">The <i>in vitro</i> findings were confirmed <i>in vivo</i> by the PFST and <i>ex vivo</i> by measuring the alterations in the brain levels of 5-HT, DA, and their metabolites (5-HIAA, DOPAC) in mice. After acute administration, all compounds decreased 5-HIAA levels with a concomitant increase in 5-HT levels. However, these acute changes in brain monoamine levels were not reflected in behavior. On the other hand, all compounds exhibited statistically significant antidepressant activity after subchronic administration consistent with the increase in brain 5-HT and MAO-A levels. <i>Ex vivo</i> analysis showed that despite the high doses of test compounds being administered, the DA levels did not change compared to the control group, indicating a high MAO-A selectivity. Compounds <b>14, 21</b>, and <b>42</b>, the most potent and selective inhibitors of MAO-A, exhibited an <i>ex vivo</i> MAO-A profile, which is highly consistent with the <i>in vitro</i> data, indicating an increase in 5-HT and decrease in 5-HIAA brain levels.</div><div class="NLM_p">It is not surprising that the compounds are less effective <i>in vivo</i> than <i>in vitro</i>, as antidepressants are generally known to show greater activity with prolonged administration. It was suggested that the 7-day subchronic treatment is not long enough to observe that apparent behavioral alterations in mice resulted from the depleted brain monoamine levels, and a longer administration time may be needed to provide higher antidepressant activity. It should also be noted that the compounds may undergo some physiological changes in the body due to their pharmacokinetic properties.</div><div class="NLM_p">The dose–response curves (compounds <b>21</b> and <b>42</b>) suggested that the efficacy of the compounds might be higher than that of moclobemide and that the compounds may show higher activity with increasing doses. However, the potency of the compounds was lower than that of moclobemide at lower doses.</div><div class="NLM_p last">The selected seven compounds showed no toxicity on hepatic cells. PAMPA–BBB showed that these compounds can cross the BBB, indicating that it might be possible to develop novel selective MAO-A inhibitors, based on this class of compounds, with a potential for generating improved treatment options for depression and mood disorders.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemistry</h3><div class="NLM_p">All chemicals and solvents used in the chemical part were purchased from Merck A.G., Aldrich Chemical. Infrared (IR) spectra were ensured with a PerkinElmer SpectrumOne, Nicolet 520 FT-IR spectrometer, and the results were expressed in wavenumber (cm<sup>–1</sup>). <sup>1</sup>H NMR spectra were recorded on a Bruker 400 MHz UltraShield spectrometer utilizing dimethylsulfoxide or acetone with chemical shifts being reported as δ (ppm) from tetramethylsilane (TMS). <sup>13</sup>C NMR spectra were recorded on a Varian Mercury 400 MHz high-performance digital FT-NMR spectrometer utilizing dimethylsulfoxide or acetone with chemical shifts being reported as δ (ppm). Mass spectra were recorded using a Waters 2695 Alliance Micromass ZQ LC/MS spectrometer in methanol according to the ESI<sup>+</sup> technique. Melting points were determined using a Thomas Hoover Capillary melting point apparatus and were uncorrected. Thin-layer chromatography (TLC) was performed using Merck 60 F254 silica gel plates (E. Merck, Darmstadt, Germany). The purity of the compounds was checked by elemental analyses (C, H, N) performed on a LECO CHNS 932 analyzer in the laboratory of the Ankara University. All compounds were obtained with a purity of >95%. <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass interpretations and all spectral data of the synthesized compounds are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure for the Preparation of 1,3-Di(substituted)phenyl-2-propen-1-ones (4) (Chalcones)</h4><div class="NLM_p last">Chalcone derivatives were synthesized by condensing acetophenone (10 mmol) and benzaldehyde (10 mmol) derivatives in the presence of sodium hydroxide (12.5 mmol) in water and ethanol (5/3 mL) at 0 °C for 1 h. The solid mass separated out was filtered, dried, and crystallized from methanol.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a><b>4a</b>: m.p. 95–97 °C:<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> 95–96 °C (ethanol). <b>4b</b>: m.p. 62–63 °C:<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> 61–62 °C (ethanol). <b>4c</b>: m.p. 86,5–88,5 °C:<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> 90–92 °C. <b>4d</b>: m.p. 55–57 °C:<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (57–58 °C). <b>4e</b>: This compound has been synthesized previously,<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> but its spectral properties have not been elucidated. It is a yellow solid; yield 96% (2.699 g); mp 75,5–77,5 °C. IR cm<sup>–1</sup>: 3007, 2933, 2838 (C–H), 1660 (C═O), 1609, 1574, 1475, 1428 (C═C), 1266, 1227, 1180, 1069 (C–O–C). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 mHz) δ (ppm): 2.42 (s, 3H, −C<i>H</i><sub><i>3</i></sub>), 3.87 (s, 3H, −OC<i>H</i><sub><i>3</i></sub>), 3.88 (s, 3H, −OC<i>H</i><sub><i>3</i></sub>), 6.96 (dd, 1H, phenyl-H, J<sub>1</sub>:8.4 Hz, J<sub>2</sub>:1.2 Hz), 7.08 (t, 1H, phenyl-H), 7.25–7.26 (m, 1H, phenyl-H), 7.29 (d, 2H, 4-methylphenyl-2H, J: 8.0 Hz), 7.59 (d, 1H, −CO–C<i>H</i>=, J: 15.6 Hz), 7.93 (d, 2H, 4-methylphenyl-2H, J: 8.0 Hz), 8.08 (d, 1H, phenyl–C<i>H</i>=, J: 15.6 Hz). MS (ESI) m/z (%): 283 [M+H]<sup>+</sup> (100%). Elemental analysis calculated (%) for C<sub>18</sub>H<sub>18</sub>O<sub>3</sub>: C 76.57, H 6.43. Found: C 76.84, H 6.52. <b>4f</b>: m.p. 103–105 °C:<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> 103–105 °C (ethanol), <b>4g</b>: m.p. 102–103 °C:<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> 102–103 °C, <b>4h</b>: m.p. 56–58 °C:<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> 65–67 °C (methanol:water), <b>4i</b>: This compound has been synthesized previously,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> but its spectral properties have not been elucidated. It is a yellow solid; yield 95% (2.581 g); m.p. 55–57 °C. IR cm<sup>–1</sup>: 3070, 2938, 2837 (C–H), 1661 (C═O), 1589, 1466, 1430 (C═C), 1321, 1271, 1256, 1199, 1173, 1032 (C–O–C). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 mHz) δ (ppm): 3.86 (s, 3H, −OC<i>H</i><sub><i>3</i></sub>), 7.26 (dd, 1H, phenyl-H, J<sub>1</sub>:8.0 Hz, J<sub>2</sub>:2.0 Hz), 7.44–7.49 (m, 2H, phenyl-2H), 7.52 (d, 1H, phenyl-H, J: 8.0 Hz), 7.58 (dd, 1H, phenyl-H, J<sub>1</sub>:7.6 Hz, J<sub>2</sub>:1.6 Hz), 7.63 (m, 1H, phenyl-H,), 7.78 (d, 1H, phenyl-H, J: 7.6 Hz), 7.97 (d, 1H, −CO–C<i>H</i>=, J: 16.0 Hz), 8.05 (d, 1H, phenyl-C<i>H</i>=, J: 15.6 Hz), 8.24 (dd, 1H, phenyl-H, J<sub>1</sub>:7.2 Hz, J<sub>2</sub>:2.4 Hz). MS (ESI) m/z (%): 297 [M + Na + 2]<sup>+</sup> (36%), 296 [M + H + Na]<sup>+</sup>, 295 [M + Na]<sup>+</sup> (100%), 275 [M + H + 2]<sup>+</sup> (16%), 273 [M + H]<sup>+</sup> (49%), 237 [M<sup>+</sup> – Cl]<sup>+</sup>, 167 [(2-Cl)C<sub>6</sub>H<sub>4</sub>-CH═CH–CO+2]<sup>+</sup>, 165 [(2-Cl)C<sub>6</sub>H<sub>4</sub>–CH═CH–CO]<sup>+</sup>, 135 [(3-CH<sub>3</sub>O)C<sub>6</sub>H<sub>4</sub>–CO]<sup>+</sup>. Elemental analysis calculated (%) for C<sub>16</sub>H<sub>13</sub>ClO<sub>2</sub>: C 70.46, H 4.80; Found: C 69.58, H 4.81. <b>4j</b>: m.p 90–92 °C:<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> (<i>E</i> isomer 87.8–89.3 °C, methanol:dichloromethane).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> General Procedure for the Preparation of 1-[2-(5-Substituted-2-benzoxazolinone-3-yl)acetyl]-3,5-di(substituted)phenyl-2-pyrazolines (5–34) and <i>N</i>′-[1,3-Di(substitued)phenylallylidene]-2-(5-substituted-2-benzoxazolinone-3-yl)acetohydrazide (<b>35–43</b>)</h4><div class="NLM_p last">2-(5-Substituted-2-benzoxazolinone-3-yl)acetylhydrazine (3 mmol) was dissolved in 2 mL of <i>N</i>,<i>N</i>-dimethylformamide (DMF) and 20 mL of <i>n</i>-propanol. 1,3-Di(substituted)phenyl-2-propen-1-one (3 mmol) and eight drops of hydrochloric acid were added to this solution and refluxed for approximately 120 h. At the end of the reaction, pyrazoline, hydrazone, or a mixture of the two was obtained as the product. The reaction mixture was then cooled, and the solid precipitated was recrystallized. If solid was not precipitated or precipitated clearly, the solution was purified by column chromatography. Due to the low stability of hydrazones and difficulties in their isolation, not all hydrazone compounds could be reached.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-[2-(2-Benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(4-methylphenyl)-2-pyrazoline (<b>5</b>)</h4><div class="NLM_p last">White solid; mp 214.5–215.5 °C. IR cm<sup>–1</sup>: 3059, 2921 (C–H), 1778, 1668 (C═O), 1601, 1487, 1440 (C═C, C═N), 1365, 1314, 1231, 1148, 1018 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>: C 72.98, H 5.14, N 10.21. Found: C 72.73, H 5.24, N 10.39.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-[2-(2-Benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(3-methoxyphenyl)-2-pyrazoline (<b>6</b>)</h4><div class="NLM_p last">White solid; mp 185.5–187 °C. IR cm<sup>–1</sup>: 3067, 3037, 2844 (C–H), 1752, 1668 (C═O), 1596, 1490, 1433 (C═C, C═N), 1370, 1241, 1135, 1015 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>: C 70.25, H 4.95, N 9.83. Found: C 70.47, H 5.11, N 9.90.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-[2-(2-Benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(3,4-dimethoxyphenyl)-2-pyrazoline (<b>7</b>)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></h4><div class="NLM_p last">White solid; mp 204–204.5 °C. IR cm<sup>–1</sup>: 3069, 3000, 2944, 2839 (C–H), 1769, 1680 (C═O), 1603, 1520,1490, 1439 (C═C, C═N), 1369, 1237, 1140, 1020 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>24</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub>: C 68.26, H 5.07, N 9.19. Found: C 68.18, H 5.06, N 9.15.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-[2-(2-Benzoxazolinone-3-yl)acetyl]-3-(4-methylphenyl)-5-phenyl-2-pyrazoline (<b>8</b>)</h4><div class="NLM_p last">White solid; mp 200–201.5 °C. IR cm<sup>–1</sup>: 3067, 3040 (C–H), 1769, 1659 (C═O), 1603, 1483, 1440 (C═C, C═N), 1366, 1244, 1100, 1018 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>: C 72.98, H 5.14, N 10.21. Found: C 72.74, H 4.97, N 10.26.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-[2-(2-Benzoxazolinone-3-yl)acetyl]-3-(4-methylphenyl)-5-(2,3-dimethoxyphenyl-)-2-pyrazoline(<b>9</b>)</h4><div class="NLM_p last">Cream solid; mp 181–183 °C. IR cm<sup>–1</sup>: 2941, 2831 (C–H), 1762, 1673 (C═O), 1609, 1477, 1447 (C═C, C═N), 1367, 1300, 1271, 1078, 1022 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>27</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub>: C 68.78, H 5.34, N 8.91. Found C 68.81, H 5.03, N 9.11.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-[2-(2-Benzoxazolinone-3-yl)acetyl]-3-(4-methoxylphenyl)-5-phenyl-2-pyrazoline (<b>10</b>)</h4><div class="NLM_p last">Cream solid; mp 219–219.5 °C. IR cm<sup>–1</sup>: 2957, 2835 (C–H), 1762, 1656 (C═O), 1606, 1518, 1494, 1453 (C═C, C═N), 1370, 1316, 1264, 1108, 1045, (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>: C 70.25, H 4.95, N 9.83. Found: C 69.79, H 4.81, N 9.83.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-[2-(2-Benzoxazolinone-3-yl)acetyl]-3-(4-methoxylphenyl)-5-(2,3-dimethoxy-phenyl)-2-pyrazoline (<b>11</b>)</h4><div class="NLM_p last">Cream solid; mp 194–195 °C. IR cm<sup>–1</sup>: 3011, 2928, 2838 (C–H), 1766, 1676 (C═O), 1603, 1477, 1454 (C═C, C═N), 1390, 1251, 1172, 1072, 1026 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>27</sub>H<sub>25</sub>N<sub>3</sub>O<sub>6</sub>: C 66.52, H 5.17, N 8.62. Found: C 66.47, H 5.47, N 8.38.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-[2-(2-Benzoxazolinone-3-yl)acetyl]-3-(2-methoxylphenyl)-5-(2-chlorophenyl)-2-pyrazoline (<b>12</b>)</h4><div class="NLM_p last">Cream solid; mp 200–201 °C. IR cm<sup>–1</sup>: 1759, 1670 (C═O), 1599, 1492 (C═C, C═N), 1374, 1253, 1121, 1032 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub>: C 65.01, H 4.36, N 9.10. Found: C 64.75, H 4.31, N 9.02.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-[2-(2-Benzoxazolinone-3-yl)acetyl]-3-(3-methoxylphenyl)-5-(2-chlorophenyl)-2-pyrazoline (13)</h4><div class="NLM_p last">White solid; mp 220.5–221.5 °C. IR cm<sup>–1</sup>: 3060, 2931, 2835 (C–H), 1772, 1676 (C═O), 1560, 1463 (C═C, C═N), 1307, 1271, 1151, 1118, 1035 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub>: C 65.01, H4.36, N 9.10. Found: C 64.74, H 4.26, N 9.06.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-[2-(2-Benzoxazolinone-3-yl)acetyl]-3-(4-methoxylphenyl)-5-(2-chlorophenyl)-2-pyrazoline (<b>14</b>)</h4><div class="NLM_p last">White solid; mp 237–238 °C. IR cm<sup>–1</sup>: 3054, 2934, 2828 (C–H), 1759, 1666 (C═O), 1606, 1493, 1463 (C═C, C═N), 1398, 1248, 1175, 1039 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub>: C 65.01, H 4.36, N 9.10. Found: C 65.16, H 4.37, N 9.22.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-[2-(5-Methyl-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(4-methylphenyl)-2-pyrazoline (<b>15</b>)</h4><div class="NLM_p last">White solid; mp 185–186 °C. IR cm<sup>–1</sup>: 2925 (C–H), 1768, 1677 (C═O), 1495, 1440 (C═C, C═N), 1387, 1238, 1114, 1018 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>26</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>: C 73.39, H 5.45, N 9.88. Found: C 73.20, H 5.18, N 9.81.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-[2-(5-Methyl-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(3-methoxylphenyl)-2-pyrazoline (<b>16</b>)</h4><div class="NLM_p last">White-cream solid; mp 186–186.5 °C. IR cm<sup>–1</sup>: 3055, 2933, 2830 (C–H), 1758, 1671 (C═O), 1601, 1499, 1440 (C═C, C═N), 1389, 1258, 1241, 1136, 1042, 1022 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>26</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>: C 70.74, H 5.25, N 9.52. Found: C 70.80, H 5.31, N 9.53.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-[2-(5-Methyl-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(3,4-dimethoxylphenyl)-2-pyrazoline (<b>17</b>)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></h4><div class="NLM_p last">White solid; mp 175–176 °C. IR cm<sup>–1</sup>: 3067, 2937, 2838 (C–H), 1767, 1672 (C═O), 1515, 1499, 1448 (C═C, C═N), 1392, 1235, 1137, 1027 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>27</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub>: C 68.78, H 5.34, N 8.91. Found: C 68.40, H 5.31, N 8.84.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-[2-(5-Methyl-2-benzoxazolinone-3-yl)acetyl]-3-(4-methylphenyl)-5-phenyl-2-pyrazoline (<b>18</b>)</h4><div class="NLM_p last">Cream solid; mp 203–204.5 °C. IR cm<sup>–1</sup>: 3049, 3025, 2916 (C–H gerilim), 1756, 1675 (C═O), 1498, 1453 (C═C, C═N), 1393, 1240, 1135, 1026 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>26</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>: C 73.39, H 5.45, N 9.88. Found: C 72.98, H 5.69, N 9.81.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-[2-(5-Methyl-2-benzoxazolinone-3-yl)acetyl]-3-(4-methylphenyl)-5-(2,3-dimethoxyphenyl)-2-pyrazoline (<b>19</b>)</h4><div class="NLM_p last">Cream solid; mp 191.5–192.5 °C. IR cm<sup>–1</sup>: 2944, 2838 (C–H), 1778, 1672 (C═O), 1487, 1444 (C═C, C═N), 1377, 1266, 1085 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>28</sub>H<sub>27</sub>N<sub>3</sub>O<sub>5</sub>: C 69.26, H 5.60, N 8.65. Found: 69.30, H 5.56, N 8.73.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-[2-(5-Methyl-2-benzoxazolinone-3-yl)acetyl]-3-(4-methoxylphenyl)-5-phenyl-2-pyrazoline (<b>20</b>)</h4><div class="NLM_p last">Cream solid; mp 188–189.5 °C. IR cm<sup>–1</sup>: 1755, 1672 (C═O), 1605, 1452 (C═C, C═N), 1392, 1262, 1172, 1026 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>26</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>: C 70.74, H 5.25, N 9.52. Found: C 70.32, H 5.43, N 9.51.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-[2-(5-Methyl-2-benzoxazolinone-3-yl)acetyl]-3-(4-methoxylphenyl)-5-(2,3-dimethoxyphenyl)-2-pyrazoline (<b>21</b>)</h4><div class="NLM_p last">White solid; mp 211–212.5 °C. IR cm<sup>–1</sup>: 2941, 2834 (C–H), 1759, 1672 (C═O), 1605, 1495, 1444 (C═C, C═N), 1392, 1310, 1243, 1176, 1081 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>28</sub>H<sub>27</sub>N<sub>3</sub>O<sub>6</sub>: C 67.06, H 5.43, N 8.38. Found: C 67.15, H 5.71, N 8.38.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-[2-(5-Methyl-2-benzoxazolinone-3-yl)acetyl]-3-(2-methoxylphenyl)-5-(2-chlorophenyl)-2-pyrazoline (<b>22</b>)</h4><div class="NLM_p last">Cream solid; mp 200–202 °C. IR cm<sup>–1</sup>: 1767, 1668 (C═O), 1605, 1471, 1450 (C═C, C═N), 1393, 1240, 1027 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>26</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>4</sub>: C 65.62, H 4.66, N 8.83. Found: C 65.21, H 4.68, N 8.97.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-[2-(5-Methyl-2-benzoxazolinone-3-yl)acetyl]-3-(3-methoxylphenyl)-5-(2-chlorophenyl)-2-pyrazoline (<b>23</b>)</h4><div class="NLM_p last">Cream solid; mp 232.5–233.5 °C. IR cm<sup>–1</sup>: 1763, 1683 (C═O), 1609, 1573, 1443 (C═C, C═N), 1395, 1243, 1207, 1026 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>26</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>4</sub>: C 65.62, H 4.66, N 8.83. Found: C 65.46, H 4.60, N 8.88.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-[2-(5-Methyl-2-benzoxazolinone-3-yl)acetyl]-3-(4-methoxylphenyl)-5-(2-chlorophenyl)-2-pyrazoline (<b>24</b>)</h4><div class="NLM_p last">White solid; mp 221–222 °C. IR cm<sup>–1</sup>: 1771, 1664 (C═O), 1605, 1503, 1459 (C═C, C═N), 1392, 1255, 1172, 1014 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>26</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>4</sub>: C 65.62, H 4.66, N 8.83. Found: C 65.75, H 4.57, N 8.87.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-[2-(5-Chloro-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(4-methylphenyl)-2-pyrazoline (<b>25</b>)</h4><div class="NLM_p last">White solid; mp 174.5–175 °C. IR cm<sup>–1</sup>: 2951, 2925 (C–H), 1782, 1679 (C═O), 1610, 1489, 1441 (C═C, C═N), 1383, 1353, 1305, 1240, 1146, 1115, 1061, 1025 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>3</sub>: C 67.34, H 4.52, N 9.42. Found: C 67.15, H 4.72, N 9.59.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-[2-(5-Chloro-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(3-methoxylphenyl)-2-pyrazoline (<b>26</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></h4><div class="NLM_p last">Cream solid; mp 212–214 °C. IR cm<sup>–1</sup>: 3071, 3027, 2948, 2917, 2826 (C–H), 1763, 1669 (C═O), 1486, 1442 (C═C, C═N), 1384, 1257, 1240, 1020 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub>: C 65.01, H 4.36, N 9.10. Found: C 65.25, H 4.70, N 9.12.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-[2-(5-Chloro-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(3,4-methoxylphenyl)-2-pyrazoline (<b>27</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></h4><div class="NLM_p last">White solid; mp 197–199 °C. IR cm<sup>–1</sup>: 3070, 3000, 2937, 2842 (C–H), 1765, 1672 (C═O), 1617, 1488, 1448 (C═C, C═N), 1389, 1235, 1148, 1029 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>26</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>5</sub>: C 63.48, H 4.51, N 8.54. Found: C 63.10, H 4.44, N 8.70.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-[2-(5-Chloro-2-benzoxazolinone-3-yl)acetyl]-3-(4-methylphenyl)-5-phenyl-2-pyrazoline (<b>28</b>)</h4><div class="NLM_p last">White solid; mp 174–176 °C. IR cm<sup>–1</sup>: 3055, 2952 (C–H), 1775, 1676 (C═O), 1605, 1487, 1444 (C═C, C═N), 1385, 1318, 1243, 1014 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>3</sub>: C 67.34, H 4.52, N 9.42. Found: C 67.17, H 4.73, N 9.60.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-[2-(5-Chloro-2-benzoxazolinone-3-yl)acetyl]-3-(4-methylphenyl)-5-(2,3-dimethoxyphenyl)-2-pyrazoline (<b>29</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></h4><div class="NLM_p last">White solid; mp 183–184 °C. IR cm<sup>–1</sup>: 3019, 2960, 3944, 2838 (C–H), 1771, 1681 (C═O), 1613, 1484, 1442 (C═C, C═N), 1378, 1267, 1216, 1073, 1015 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>27</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>5</sub>: C 64.10, H 4.78, N 8.31. Found: C 64.00, H 4.74, N 8.54.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-[2-(5-Chloro-2-benzoxazolinone-3-yl)acetyl]-3-(4-methoxylphenyl)-5-phenyl-2-pyrazoline (<b>30</b>)</h4><div class="NLM_p last">Cream solid; mp 165–167 °C. IR cm<sup>–1</sup>: 2944, 2842 (C–H), 1775, 1668 (C═O), 1601, 1487, 1455 (C═C, C═N), 1381, 1251, 1176, 1018 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub>: C 65.01, H 4.36, N 9.10. Found: C 64.66, H 4.64, N 9.28.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-[2-(5-Chloro-2-benzoxazolinone-3-yl)acetyl]-3-(4-methoxylphenyl)-5-(2,3-dimethoxyphenyl)-2-pyrazoline (<b>31</b>)</h4><div class="NLM_p last">Cream solid; mp 132–134 °C. IR cm<sup>–1</sup>: 3014, 2951, 2831 (C–H), 1769, 1653 (C═O), 1613, 1520, 1490, 1463 (C═C, C═N), 1380, 1338, 1248, 1176, 1065, 1022, 1002 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>27</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>6</sub>.0,9CHCl<sub>3</sub>: C 53.24, H 3.99, N 6.68. Found: C 53.10, H 3.78, N 6.93.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-[2-(5-Chloro-2-benzoxazolinone-3-yl)acetyl]-3-(2-methoxylphenyl)-5-(2-chlorophenyl)-2-pyrazoline (<b>32</b>)</h4><div class="NLM_p last">White solid; mp 217.5–219 °C. IR cm<sup>–1</sup>: 3074, 2944, 2830 (C–H), 1763, 1668 (C═O), 1593, 1491, 1436 (C═C, C═N), 1385, 1239, 1121, 1022 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>4</sub>: C 60.50, H 3.86, N 8.47. Found: C 60.48, H 3.93, N 8.74.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 1-[2-(5-Chloro-2-benzoxazolinone-3-yl)acetyl]-3-(3-methoxylphenyl)-5-(2-chlorophenyl)-2-pyrazoline (<b>33</b>)</h4><div class="NLM_p last">White solid; mp 211–211.5 °C. IR cm<sup>–1</sup>: 3070, 2948, 2834 (C–H), 1767, 1676 (C═O), 1597, 1491, 1440 (C═C, C═N), 1381, 1306, 1235, 1117, 1018 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>4</sub>: C 60.50, H 3.86, N 8.47. Found: C 60.21, H 3.70, N 8.53.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-[2-(5-Chloro-2-benzoxazolinone-3-yl)acetyl]-3-(4-methoxylphenyl)-5-(2-chlorophenyl)-2-pyrazoline (<b>34</b>)</h4><div class="NLM_p last">Cream solid; mp 213–215 °C. IR cm<sup>–1</sup>: 3067, 2941, 2838 (C–H), 1779, 1664 (C═O), 1605, 1491, 1459 (C═C, C═N), 1385, 1251, 1172, 1109, 1030, 1014 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>4</sub>: C 60.50, H 3.86, N 8.47. Found: C 60.55, H 4.04, N 8.68.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>′-(1,3-Diphenylallylidene)-2-(2-benzoxazolinone-3-yl)acetohydrazide (<b>35</b>)</h4><div class="NLM_p last">Yellow solid; mp 162–163 °C. IR cm<sup>–1</sup>: 3201 (N–H), 3102, 3004, 2944 (C–H, aliphatic), 1756, 1678 (C═O), 1617, 1487, 1430 (C═C, C═N), 1372, 1229, 1097, 1022 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>24</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>: C 72.53, H 4.82, N 10.57. Found: C 72.39, H 4.73, N 10.57.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>′-[1-Phenyl-3-(3-methoxyphenyl)allylidene]-2-(2-benzoxazolinone-3-yl)acetohydrazide (<b>36</b>)</h4><div class="NLM_p last">Cream solid; mp 150–152 °C. IR cm<sup>–1</sup>: 1781, 1687 (C═O), 1604, 1488, 1435 (C═C, C═N), 1386, 1238, 1020 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>: C 70.25, H 4.95, N 9.83. Found: C 70.00, H 4.84, N 9.80.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>′-[1-(2-Methoxyphenyl)-3-(2-chlorophenyl)allylidene]-2-(2-benzoxazolinone-3-yl)acetohydrazide (37)</h4><div class="NLM_p last">Yellow solid; mp 212–213 °C. IR cm<sup>–1</sup>: 3208 (N–H), 3114, 3067, 3004, 2972, 2952, 2838 (C–H), 1768, 1687 (C═O), 1605, 1574, 1489, 1433 (C═C, C═N), 1364, 1241, 1107, 1085, 1020 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub>: C 65.01, H 4.36, N 9.10. Found: C 65.12, H 4.22, N 9.26.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>′-[1-(4-Methoxyphenyl)-3-(2-chlorophenyl)allylidene]-2-(2-benzoxazolinone-3-yl)acetohydrazide (38)</h4><div class="NLM_p last">Yellow solid; mp 184.5–185.5 °C. IR cm<sup>–1</sup>: 1783, 1683 (C═O), 1607, 1509, 1488 (C═C, C═N), 1365, 1252, 1174, 1102, 1021 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub>: C 65.01, H 4.36, N 9.10. Found: C 65.14, H 4.45, N 9.23.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>′-[1-(4-Methoxyphenyl)-3-phenylallylidene]-2-(5-methyl-2-benzoxazolinone-3-yl)acetohydrazide (<b>39</b>)</h4><div class="NLM_p last">Yellow solid; mp 139–142 °C. IR cm<sup>–1</sup>: 3192 (N–H), 2936, 2845 (C–H), 1775, 1668 (C═O), 1605, 1494, 1456 (C═C, C═N), 1381, 1305, 1241, 1175, 1129, 1023 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>26</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>: C 70.74, H 5.25, N 9.52. Found: C 70.67, H 5.05, N 9.69.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>′-[1-(2-Methoxyphenyl)-3-(2-chlorophenyl)allylidene]-2-(5-methyl-2-benzoxazolinone-3-yl)acetohydrazide (<b>40</b>)</h4><div class="NLM_p last">Yellow solid; mp 222–224 °C. IR cm<sup>–1</sup>: 3212 (N–H), 2834 (C–H), 1768, 1688 (C═O), 1597, 1492, 1433 (C═C, C═N), 1388, 1241, 1085, 1021 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>26</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>4</sub>: C 65.62, H 4.66, N 8.83. Found: C 65.53, H 4.86, N 9.03.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>′-[1-Phenyl-3-(2-methoxyphenyl)allylidene]-2-(5-chloro-2-benzoxazolinone-3-yl)acetohydrazide (<b>41</b>)</h4><div class="NLM_p last">Cream solid; mp 136–138 °C. IR cm<sup>–1</sup>: 1782, 1666 (C═O), 1619, 1528, 1490 (C═C, C═N), 1384, 1241, 1108, 1018 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub>: C 65.01, H 4.36, N 9.10. Found: C 65.37, H 4.43, N 9.30.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>′-[1-(4-Methoxyphenyl)-3-(2,3-dimethoxyphenyl)allylidene]-2-(5-chloro-2-benzoxazolinone-3-yl)acetohydrazide (42)</h4><div class="NLM_p last">White solid; mp 172–173.5 °C. IR cm<sup>–1</sup>: 3328 (N–H), 3060, 2933, 2833 (C–H), 1788, 1686 (C═O), 1608, 1572, 1493, 1441 (C═C, C═N), 1382, 1338, 1249, 1172, 1066, 1016, 1003 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>27</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>6</sub>: C 62.13, H 4.63, N 8.05. Found: C 62.08, H 4.69, N 8.25.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>′-[1-(2-Methoxyphenyl)-3-(2-chlorophenyl)allylidene]-2-(5-chloro-2-benzoxazolinone-3-yl)acetohydrazide (<b>43</b>)</h4><div class="NLM_p last">Yellow solid; mp 214–216 °C. IR cm<sup>–1</sup>: 3204 (N–H), 3087, 3004, 2942, 2839 (C–H), 1781, 1686 (C═O), 1604, 1572, 1490, 1434 (C═C, C═N), 1384, 1252, 1110, 1084, 1019 (C–O–C, C–N). For <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Supporting Information</a>. Elemental analysis calculated (%) for C<sub>25</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>4</sub>: C 60.50, H 3.86, N 8.47. Found: C 60.49, H 3.97, N 8.56.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> X-ray Crystal Structure Determination</h3><div class="NLM_p last">Data collection measurements for cream color single crystal of compound <b>10</b> and yellow color single crystal of compound <b>43</b> suitable for data collection were selected and performed at 293 K using an Agilent Xcalibur Eos diffractometer with CrysAlis PRO<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). The structure was solved by direct methods by SHELXS-97<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> within WINGX<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> suite of software. The refinement was carried out by full-matrix least-squares method on F<sup>2</sup> using SHELXL-97.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> All H atoms were constrained to ride on their parent atoms, with C–H = 0.93–0.98 Å, N–H = 0.86 Å and <i>U</i><sub>iso</sub>(H) =1.2<i>U</i><sub>eq</sub>(C,N,O). The crystallographic data as well as details of the data collection and refinement results for the compounds are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">Table S5</a>, Supporting Information.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Molecular diagrams were created using ORTEP-3.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Geometric calculations were performed using PLATON.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Molecular Modeling Studies</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Enzyme Preparation</h4><div class="NLM_p last">The crystal structure of hMAO-A, which is co-crystallized with harmine (a reversible inhibitor), and the crystal structure of hMAO-B, which is complexed with safinamide (a reversible inhibitor), were used for protein setup (<a href="http://www.rcsb.org)" class="extLink">http://www.rcsb.org)</a>, for MAO-A pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X">2Z5X</a>; hMAO-A in complex with harmine, resolution 2.2 Å<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> and for MAO-B pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z">2V5Z</a>; hMAO-B in complex with inhibitor safinamide, resolution 1.6 Å.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> All water molecules, inhibitors, and noninteracting ions were cleared from each structure before being used in the docking studies. The initial oxidized form of the FAD was used in all docking studies. One of the two subunits was taken as the target structure for MAO-A and MAO-B. Each protein’s geometry was first optimized by a fast Dreiding-like force field and then submitted to the “Clean Geometry” toolkit of Discovery Studio (Accelrys, Inc.) for a more complete check. Missing hydrogen atoms were added based on the protonation state of the titratable residues at a pH of 7.4. The ionic strength was set to 0.145, and the dielectric constant was set to 10.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Ligand Setup</h4><div class="NLM_p last">The 3D structures of ligand molecules were built, optimized at the (PM3) level, and saved in pdb format. The AutoDock Tools (vv.1.5.4) (ADT) 69 graphical user interface program<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> was employed to generate grid parameter file (gpf) and docking parameter file (dpf) as docking input files.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Docking Calculations</h3><div class="NLM_p last">Docking was carried out using AutoDock 4.2.6 program<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> using HPxw8600_Work_Station. The coordinates of the N5 atoms of the flavin cofactor were chosen as the grid centers for both MAO-A and MAO-B isozymes. The grid box sizes were adjusted to cover the entire binding site: X, Y, Z; 70, 70, 70 Å dimensions, respectively. Lamarckian genetic algorithm (LGA), which uses semiempirical force field with an improved unbound state model as well as its updated desolvation term, to estimate the free energy of binding, was utilized for the search of optimal ligand binding conformation. The detailed docking procedures are given elsewhere.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Accelrys Visualization 4.5 program was used for rendering the 2D and 3D pictures.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Biological Activity</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> MAO Activity Determination</h4><div class="NLM_p last">The chemicals and recombinant hMAO enzymes were obtained from Sigma-Aldrich (Munich, Germany). A fluorimetric method, Amplex Red MAO assay kit (Molecular Probes), was performed following the instructions of the manufacturer. p-Tyramine (0.05–0.50 mM) was used as the common substrate for both hMAO-A and -B. Recombinant enzymes were diluted in reaction buffer (containing 0.25 M sodium phosphate, pH 7.4). Enzyme solution (100 μL) was used for each reaction. H<sub>2</sub>O<sub>2</sub> working solution (20 mM) was diluted to the final concentration of 10 μM in reaction buffer and used as the positive control. The negative control was prepared as the reaction buffer without H<sub>2</sub>O<sub>2</sub>. The diluted enzyme samples and controls (100 μL) were pipetted into separate wells of a microplate. The reaction was started by adding 100 μL of the Amplex Red working solution to each microplate well. The mixtures were incubated for 30 min at room temperature in the dark. Fluorescence was measured at multiple time points (excitation: 530 nm and emission: 590 nm). The obtained control values were subtracted to correct the background fluorescence. The possible fluorescence due to nonenzymatic inhibition was determined by adding the compounds to solutions containing only the Amplex Red reagent. HRP activity was not inhibited by newly synthesized compounds in the test medium.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72,73)</a> MAO activity was expressed as nmol/h/mg.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Kinetic Determination</h3><div class="NLM_p last">Synthesized compounds with a maximum concentration of 1% were prepared in DMSO and used in a concentration range of 0.01 μM to 10.00 mM. Selegiline was dissolved also in DMSO in the concentration range of 0.01–100.00 μM. MAO inhibition was examined using Lineweaver–Burk plotting. <i>K<sub>i</sub></i> values were determined from the <i>x</i>-axis intercept as −<i>K<sub>i</sub></i>. Each <i>K<sub>i</sub></i> value is the representative of single determination, where the correlation coefficient (<i>R</i><sup>2</sup>) of the replot of the slopes versus the inhibitor concentrations was at least 0.98. SI was calculated as <i>K<sub>i</sub></i>(hMAO-A)/<i>K<sub>i</sub></i>(hMAO-B). The protein was determined using Pierce Coomassie (Bradford) Protein Assay Kit (Cat no: 23200), which is based on the Bradford method.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Reversibility Assay</h3><div class="NLM_p last">The dialysis method was performed as previously described for measuring the MAO inhibition.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Dialysis tubings with a molecular weight cutoff of 12 000 were used. Sample capacity was 0.5–10 mL. hMAO-A or hMAO-B enzymes (1 U/mL) and the inhibitors were incubated in potassium phosphate buffer (0.05 M, pH 7.4, 5% sucrose containing 1% DMSO) for 15 min at 37 °C. The inhibitor concentrations used were 4-fold of the IC<sub>50</sub> values for the inhibition of hMAO-A and -B. Reaction mixtures having the same amount of hMAO-A and -B were also preincubated with the reference inhibitors. Enzyme–inhibitor mixtures were subsequently dialyzed at 4 °C in dialysis buffer (100 mM potassium phosphate, pH 7.4, 5% sucrose). The dialysis buffer was replaced with fresh buffer two times during 24 h of dialysis. After the dialysis, dialyzed and undialyzed mixtures were simultaneously assayed for MAO-A activity to evaluate the reversibility of the inhibition produced by the test compounds. All reactions were carried out in triplicate, and the residual enzyme activity was expressed as mean ± SEM.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>In Vitro</i> Cytotoxicity Assay</h3><div class="NLM_p last">Cell viability was measured by MTT assay using Human hepatoma cells HepG2 (Invitrogen).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The novel compounds (1, 5, and 25 μM) or 0.1% DMSO as a vehicle control are used for the assay. Results were expressed as mean ± SEM. Differences are considered statistically significant at <i>p</i> < 0.05.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>In Vitro</i> Blood–Brain Barrier Permeation Assay (PAMPA–BBB)</h3><div class="NLM_p last">The brain penetration ability of the compounds was determined using a PAMPA–BBB according to a previous method (Cyprotex).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Briefly, compounds and the reference drugs dissolved in DMSO were diluted with PBS/EtOH (70:30) to give a final concentration of 25 μg/mL. The diluted solution (200 μL) was added to the donor wells, and PBS/EtOH (300 μL, 70:30) solution was added to the acceptor wells. The donor filter plate was placed on the acceptor plate and kept at 25°C for 16 h. The donor plate was removed, and the concentrations of the compounds in the wells were measured using a UV plate reader.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Pharmacological Tests</h3><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Animals</h4><div class="NLM_p last">Albino male CD-1 mice (20–25 g) were used. The animals were kept in a room at a constant temperature under 12 h day/12 h night period with ad libitum access to food and water. All animal experiments were performed with the permission of Hacettepe University Animal Experimentations Local Ethics Board (2012/39, 2014/20).</div></div><div id="sec4_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Drug Administration</h4><div class="NLM_p last">The compounds (30 mg/kg) and moclobemide (20 mg/kg) were administered orally with gavage in 200 μL of 0.5% carboxymethylcellulose (CMC) solution. The control group was only administrated with vehicle (0.5% CMC/200 μL/each dose). All experiments were performed at the same time of the day, 1 h after the last administration of the drugs. Doses of 1, 3, 10, and 20 mg/kg/day for moclobemide and 1, 3, 10, and 30 mg/kg/day for compounds were administered during 7 days for the dose–response study.</div></div><div id="sec4_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Porsolt’s Forced Swim Test (PFST)</h4><div class="NLM_p last">A modified Porsolt’s forced swim test was used for the evaluation of antidepressant activity of synthesized compounds.<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77,78)</a> Cylindrical glass tanks (19 cm height x 12 cm diameter) were used in the experiments. The cylinders were filled with water at 25 ± 1 °C, and the water depth was adjusted to 15 cm. The mice were individually forced to swim. The duration of immobility or struggling with only small limb movements in a period of 6 min was scored. Scoring was performed every 60 s for 6 min. Immobility was judged when the mice remained floating in the water, whereas struggling was judged when the mice made active motions necessary to maintain its head above water. Immobility was regarded as depression-like behavior (behavioral despair).</div></div><div id="sec4_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Open-Field Test (OFT)</h4><div class="NLM_p last">Open-field test was used for assessing the changes of locomotor activity of the mice. The test was performed according to Painsipp, Wultsch et al. (2008)<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> and Brunner, Farzi et al. (2014).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> The compounds and moclobemide were given subchronically as described above. Briefly, the mice were put in the center of a 50 × 50 × 30 cm<sup>3</sup> black plastic box individually and tracked for 5 min with a video camera system (VideoMot2, TSE). The total distance traveled in the box was measured in 5 min. After the behavioral tests, the mice were sacrificed by cervical dislocation and their brain tissue was isolated for biochemical experiments.</div></div><div id="sec4_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Determination of Monoamine Levels in Brain Tissue</h4><div id="sec4_10_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> Determination of MAO Activity</h5><div class="NLM_p last">Brain tissue was homogenized in 10 mM phosphate buffer pH 7.4 containing 0.25 M sucrose, following differential centrifugation to obtain the mitochondrial fraction.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Tissue protein content was determined using the Bradford method.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Tissue MAO-A and B activities were determined using monoamine oxidase assay kit (Sigma-Aldrich, MAK 136) according to the manufacturer’s instructions. The MAO activity was expressed as nmol/min/mg.</div></div><div id="sec4_10_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> Determination of Serotonin (5-HT) Level</h5><div class="NLM_p last">The brain tissue 5-HT content was determined after homogenization in phosphate buffer (pH 7.4) using Mouse 5-HT Elisa kit based on the competitive enzyme-linked immunosorbent assay (ELISA) using a monoclonal anti-5-HT antibody and a 5-HT-HRP conjugate. Catalog Number: MBS723181 (MyBioSource) The 5-HT concentration in each sample is interpolated from a prepared standard curve and expressed as μg/g tissue.</div></div><div id="sec4_10_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> Determination of Dopamine Level</h5><div class="NLM_p last">Dopamine concentration in brain tissue was determined after tissue homogenization in PBS using Mouse Dopamine ELISA Kit (Cat. no: MBS035672) (MyBioSource) according to the manufacturer’s manual. A standard curve was prepared using the professional curve fitting software, and results were expressed as μg/g tissue.</div></div><div id="sec4_10_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> Determination of Transmitter Metabolite Levels</h5><div class="NLM_p last">DOPAC and 5-HIAA were measured according to a previous method based on electrochemical detection by Nucleosil 5 C18 (Dionex) column.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> The mobile phase consisted of a 0.1 M citrate/acetate buffer pH 3.9 with 10% methanol, 1 M ethylenediamine tetraacetic acid (EDTA), and 1.2 heptane sulfonic acid. The detector voltage conditions were D1 (+0.05), D2 (−0.39), and the guard cell (+0.40). Results were expressed as μg/g tissue.</div></div><div id="sec4_10_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> Statistical Analysis</h5><div class="NLM_p last">Statistical analysis of biochemical tests was conducted using GraphPad Prism 4.03 (GraphPad Software, San Diego, CA, ABD) compatible with Windows. Student’s <i>t</i> test was used to achieve comparison between study groups. Results were expressed as mean ± SD, and <i>p</i> < 0.05 was accepted statistically significant. Data for pharmacological tests were analyzed by one-way analysis of variance (ANOVA) followed by <i>post hoc</i> Dunnet’s test. Data were expressed as mean ± SEM. <i>p</i> < 0.05 was accepted statistically significant.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01504" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07856" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07856" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01504?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01504</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Spectral data of the newly synthesized compounds; X-ray crystal structure; druglikeness and ADMET predictions; and additional molecular modeling data of selected compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for the newly synthesized compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf">jm0c01504_si_001.pdf (11.75 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_002.csv">jm0c01504_si_002.csv (20.47 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01504" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75158" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75158" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gulberk Ucar</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Faculty of Pharmacy, Hacettepe
University, 06100 Sıhhiye, Ankara, Turkey</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0661736a6463746d287365677446616b676f6a2865696b"><span class="__cf_email__" data-cfemail="197e6c757b7c6b72376c7a786b597e74787075377a7674">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nesrin Gokhan-Kelekci</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, 06100 Sıhhiye, Ankara, Turkey</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7383-8443" title="Orcid link">http://orcid.org/0000-0001-7383-8443</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#244b4a4157564d4a644349454d480a474b49"><span class="__cf_email__" data-cfemail="610e0f041213080f21060c00080d4f020e0c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Umut Salgin-Goksen</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, 06100 Sıhhiye, Ankara, Turkey</span>; 
    <span class="hlFld-Affiliation affiliation">Turkish
Medicines and Medical Devices Agency, Analyses
and Control Laboratories, 06100 Ankara, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gokcen Telli</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Faculty of Pharmacy, Hacettepe
University, 06100 Sıhhiye, Ankara, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Acelya Erikci</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Faculty of Pharmacy, Lokman
Hekim University, 06510 Söğütözü, Ankara, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ezgi Dedecengiz</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics Engineering, Faculty of Engineering, Hacettepe University, 06800 Beytepe, Ankara, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Banu Cahide Tel</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Faculty of Pharmacy, Hacettepe
University, 06100 Sıhhiye, Ankara, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. Betul Kaynak</span> - <span class="hlFld-Affiliation affiliation">Department
of Physics Engineering, Faculty of Engineering, Hacettepe University, 06800 Beytepe, Ankara, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kemal Yelekci</span> - <span class="hlFld-Affiliation affiliation">Department
of Bioinformatics and Genetics, Faculty of Engineering and Natural
Sciences, Kadir Has University, 34083 Fatih, Istanbul, Turkey</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0052-4926" title="Orcid link">http://orcid.org/0000-0002-0052-4926</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>N.G.K. designed the study; U.S.G. and N.G.K. synthesized the new compounds and evaluated their structures; E.D. and F.B.K. provided the X-ray crystal structure of the compounds; A.E. and G.U. carried out and evaluated the in vitro and ex vivo biochemical tests; G.T. and B.C.T. accomplished the pharmacological part; K.Y. performed the computational studies; G.T. and A.E. conducted the statistical analyses; N.G.K., G.U., and B.C.T. interpreted the data; N.G.K. and G.U. edited the manuscript and provided critical revisions; and N.G.K. is the guarantor.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">ACS includes X-ray crystallographic data for compounds <b>10</b> and <b>43</b>; druglikeness and ADMET properties, docking results of compounds <b>14</b><i>S</i>, <b>21</b><i>R</i>, and <b>42</b>; <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass interpretations; and all spectral data and molecular formula strings of the synthesized compounds. Crystallographic data for the structures reported in this paper have been deposited with the Cambridge Crystallographic Data Centre (The Director, CCDC, 12 Union Road, Cambridge, CB2 1EZ, U.K.; E-mail: <a href="/cdn-cgi/l/email-protection#4723223728342e3307242423246924262a69262469322c"><span class="__cf_email__" data-cfemail="ec88899c839f8598ac8f8f888fc28f8d81c28d8fc29987">[email protected]</span></a>; www: <a href="http://www.ccdc.cam.ac.uk" class="extLink">http://www.ccdc.cam.ac.uk</a>; fax: +44 1223 336033) and are available free of charge on request, quoting the Deposition No. CCDC 1411742 for (<b>10</b>) and 1411743 for (<b>43</b>).</p></div></li></ul></div><div class="ack" id="ACK-d7e5536-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by grants from The Scientific and Technological Research Council of Turkey (TUBITAK) (112T746) and the Hacettepe University Scientific Research Projects Coordination Unit (012D06301001 and 1527). The authors are thankful to Prof. Dr. Erhan Palaska for providing MS spectra. They thank Hacettepe University Technology Transfer Center for providing funding and English-language editing service.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">PFST</td><td class="NLM_def"><p class="first last">Porsolt’s forced swim test</p></td></tr><tr><td class="NLM_term">MAOIs</td><td class="NLM_def"><p class="first last">monoamine oxidase inhibitors</p></td></tr><tr><td class="NLM_term">SSRI</td><td class="NLM_def"><p class="first last">selective serotonin reuptake inhibitors</p></td></tr><tr><td class="NLM_term">TCA</td><td class="NLM_def"><p class="first last">tricyclic antidepressants</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeation assay</p></td></tr><tr><td class="NLM_term">OFT</td><td class="NLM_def"><p class="first last">open-field test</p></td></tr><tr><td class="NLM_term">5-HIAA</td><td class="NLM_def"><p class="first last">5-hydroxyindoleacetic acid</p></td></tr><tr><td class="NLM_term">DOPAC</td><td class="NLM_def"><p class="first last">3,4-dihydroxyphenylacetic acid</p></td></tr><tr><td class="NLM_term">RIMAs</td><td class="NLM_def"><p class="first last">selective reversible inhibitors of MAO-A</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-[4,5 dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">PBL</td><td class="NLM_def"><p class="first last">polar brain lipid</p></td></tr><tr><td class="NLM_term">CMC</td><td class="NLM_def"><p class="first last">carboxymethylcellulose</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37381" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37381" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 82 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">World Federation for Mental
Health</span>, <span class="NLM_year">2012</span>. <span> </span><span class="NLM_article-title">DEPRESSION: A Global
Crisis</span>. <a href="https://www.who.int/mental_health/management/depression/wfmh_paper_depression_wmhd_2012.pdf?Ua=1" class="extLink">https://www.who.int/mental_health/management/depression/wfmh_paper_depression_wmhd_2012.pdf?Ua=1</a> (accessed Jun 25, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=World+Federation+for+Mental%0AHealth&title=DEPRESSION%3A+A+Global%0ACrisis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2012%26atitle%3DDEPRESSION%253A%2520A%2520Global%250ACrisis" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, A. D.</span></span> <span> </span><span class="NLM_article-title">Alternative Projections of Mortality and Disability by Cause 1990-2020: Global Burden of Disease Study</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">1498</span>– <span class="NLM_lpage">1504</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(96)07492-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2FS0140-6736%2896%2907492-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=9167458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaK2szhtVaqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=1997&pages=1498-1504&author=C.+J.+Murrayauthor=A.+D.+Lopez&title=Alternative+Projections+of+Mortality+and+Disability+by+Cause+1990-2020%3A+Global+Burden+of+Disease+Study&doi=10.1016%2FS0140-6736%2896%2907492-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study</span></div><div class="casAuthors">Murray C J; Lopez A D</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">9064</span>),
    <span class="NLM_cas:pages">1498-504</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">BACKGROUND:  Plausible projections of future mortality and disability are a useful aid in decisions on priorities for health research, capital investment, and training.  Rates and patterns of ill health are determined by factors such as socioeconomic development, educational attainment, technological developments, and their dispersion among populations, as well as exposure to hazards such as tobacco.  As part of the Global Burden of Disease Study (GBD), we developed three scenarios of future mortality and disability for different age-sex groups, causes, and regions.  METHODS:  We used the most important disease and injury trends since 1950 in nine cause-of-death clusters.  Regression equations for mortality rates for each cluster by region were developed from gross domestic product per person (in international dollars), average number of years of education, time (in years, as a surrogate for technological change), and smoking intensity, which shows the cumulative effects based on data for 47 countries in 1950-90.  Optimistic, pessimistic, and baseline projections of the independent variables were made.  We related mortality from detailed causes to mortality from a cause cluster to project more detailed causes.  Based on projected numbers of deaths by cause, years of life lived with disability (YLDs) were projected from different relation models of YLDs to years of life lost (YLLs).  Population projections were prepared from World Bank projections of fertility and the projected mortality rates.  FINDINGS:  Life expectancy at birth for women was projected to increase in all three scenarios; in established market economies to about 90 years by 2020.  Far smaller gains in male life expectancy were projected than in females; in formerly socialist economies of Europe, male life expectancy may not increase at all.  Worldwide mortality from communicable maternal, perinatal, and nutritional disorders was expected to decline in the baseline scenario from 17.2 million deaths in 1990 to 10.3 million in 2020.  We projected that non-communicable disease mortality will increase from 28.1 million deaths in 1990 to 49.7 million in 2020.  Deaths from injury may increase from 5.1 million to 8.4 million.  Leading causes of disability-adjusted life years (DALYs) predicted by the baseline model were (in descending order): ischaemic heart disease, unipolar major depression, road-traffic accidents, cerebrovascular disease, chronic obstructive pulmonary disease, lower respiratory infections, tuberculosis, war injuries, diarrhoeal diseases, and HIV.  Tobacco-attributable mortality is projected to increase from 3.0 million deaths in 1990 to 8.4 million deaths in 2020.  INTERPRETATION:  Health trends in the next 25 years will be determined mainly by the ageing of the world's population, the decline in age-specific mortality rates from communicable, maternal, perinatal, and nutritional disorders, the spread of HIV, and the increase in tobacco-related mortality and disability.  Projections, by their nature, are highly uncertain, but we found some robust results with implications for health policy.  As part of the Global Burden of Disease Study, three scenarios of future mortality and disability were identified.  The scenarios were based on future health status as a function of projected changes in key socioeconomic variables that influence health status.  Regression equations for mortality rates for nine cause-of-death clusters were developed by region based on gross domestic product per person, average number of years of education, time (as a proxy for technological change), and smoking intensity.  Life expectancy at birth was projected, in all three scenarios, to increase for women (to about 90 years in established market economies by 2020), with far smaller gains in male life expectancy.  Worldwide, annual mortality from communicable maternal, perinatal, and nutritional disorders (group 1 causes) is expected to decline from 17.2 million to 10.3 million in 2020 in the baseline model.  Also expected is a very large increase in deaths from non-communicable diseases (group 2 causes) from 28.1 million in 1990 to 49.7 million in 2020.  Deaths from injuries (group 3) are projected to increase from 5.1 million to 8.4 million.  Diarrheal diseases, perinatal disorders, measles, and malaria are expected to decline dramatically as causes of death in the 1990-2020 period, while lung cancer, stomach cancer, war injuries, liver cancer, and HIV are expected to move up five or more places in the ranking.  In 2020, the 10 leading causes of disability-adjusted life-years (in descending order) are projected to be ischemic heart disease, unipolar major depression, road traffic accidents, cerebrovascular disease, chronic obstructive pulmonary disease, lower respiratory infections, tuberculosis, war injuries, diarrheal diseases, and HIV.  Tobacco-attributable mortality is projected to increase from 3.0 million in 1990 to 8.4 million in 2020 (9% of the worldwide mortality burden).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXx1ktA_8fRDDnmmyUf5qOfW6udTcc2eZmNUvZ5mqhPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szhtVaqsw%253D%253D&md5=8663247d3d31df40c48d824a647a8b6a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2896%2907492-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252896%252907492-2%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BJ.%26aulast%3DLopez%26aufirst%3DA.%2BD.%26atitle%3DAlternative%2520Projections%2520of%2520Mortality%2520and%2520Disability%2520by%2520Cause%25201990-2020%253A%2520Global%2520Burden%2520of%2520Disease%2520Study%26jtitle%3DLancet%26date%3D1997%26volume%3D349%26spage%3D1498%26epage%3D1504%26doi%3D10.1016%2FS0140-6736%2896%2907492-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musselman, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemeroff, C. B.</span></span> <span> </span><span class="NLM_article-title">The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment</span>. <i>Arch. Gen. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1001/archpsyc.55.7.580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1001%2Farchpsyc.55.7.580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=9672048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaK1czjsFOluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1998&pages=580-592&author=D.+L.+Musselmanauthor=D.+L.+Evansauthor=C.+B.+Nemeroff&title=The+relationship+of+depression+to+cardiovascular+disease%3A+epidemiology%2C+biology%2C+and+treatment&doi=10.1001%2Farchpsyc.55.7.580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment</span></div><div class="casAuthors">Musselman D L; Evans D L; Nemeroff C B</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">580-92</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">This article reviews the burgeoning literature on the relationship of mood disorders and heart disease.  Major depression and depressive symptoms, although commonly encountered in medical populations, are frequently underdiagnosed and undertreated in patients with cardiovascular disease (CVD).  This is of particular importance because several studies have shown depression and its associated symptoms to be a major risk factor for both the development of CVD and death after an index myocardial infarction.  This review of the extant literature is derived from MEDLINE searches (1966-1997) using the search terms "major depression," "psychiatry," "cardiovascular disease," and "pathophysiology." Studies investigating pathophysiological alterations related to CVD in depressed patients are reviewed.  The few studies on treatment of depression in patients with CVD are also described.  Treatment of depression in patients with CVD improves their dysphoria and other signs and symptoms of depression, improves quality of life, and perhaps even increases longevity.  Recommendations for future research are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQv6YMhZTa63FQKX3ooHxWjfW6udTcc2eZcBpPZQ6sfYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czjsFOluw%253D%253D&md5=365f9e9f0c687382a5f4ab09bb98766f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.55.7.580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.55.7.580%26sid%3Dliteratum%253Aachs%26aulast%3DMusselman%26aufirst%3DD.%2BL.%26aulast%3DEvans%26aufirst%3DD.%2BL.%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DThe%2520relationship%2520of%2520depression%2520to%2520cardiovascular%2520disease%253A%2520epidemiology%252C%2520biology%252C%2520and%2520treatment%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1998%26volume%3D55%26spage%3D580%26epage%3D592%26doi%3D10.1001%2Farchpsyc.55.7.580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michelson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galliven, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrousos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, P.</span></span> <span> </span><span class="NLM_article-title">Bone Mineral Density in Women with Depression</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>335</i></span>,  <span class="NLM_fpage">1176</span>– <span class="NLM_lpage">1181</span>, <span class="refDoi"> DOI: 10.1056/NEJM199610173351602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1056%2FNEJM199610173351602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=8815939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaK28zpvFShtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=1996&pages=1176-1181&author=D.+Michelsonauthor=C.+Stratakisauthor=L.+Hillauthor=J.+Reynoldsauthor=E.+Gallivenauthor=G.+Chrousosauthor=P.+Gold&title=Bone+Mineral+Density+in+Women+with+Depression&doi=10.1056%2FNEJM199610173351602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Bone mineral density in women with depression</span></div><div class="casAuthors">Michelson D; Stratakis C; Hill L; Reynolds J; Galliven E; Chrousos G; Gold P</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1176-81</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Depression is associated with alterations in behavior and neuroendocrine systems that are risk factors for decreased bone mineral density.  This study was undertaken to determine whether women with past or current major depression have demonstrable decreases in bone density.  METHODS:  We measured bone mineral density at the hip, spine, and radius in 24 women with past or current major depression and 24 normal women matched for age, body-mass index, menopausal status, and race, using dual-energy x-ray absorptiometry.  We also evaluated cortisol and growth hormone secretion, bone metabolism, and vitamin D-receptor alleles.  RESULTS:  As compared with the normal women, the mean (+/-SD) bone density in the women with past or current depression was 6.5 percent lower at the spine (1.00+/-0.15 vs. 1.07+/-0.09 g per square centimeter, P=0.02), 13.6 percent lower at the femoral neck (0.76+/-0.11 vs. 0.88+/-0.11 g per square centimeter, P<0.001), 13.6 percent lower at Ward's triangle (0.70+/-0.14 vs. 0.81+/-0.13 g per square centimeter, P<0.001), and 10.8 percent lower at the trochanter (0.66+/-0.11 vs. 0.74+/-0.08 g per square centimeter, P<0.001).  In addition, women with past or current depression had higher urinary cortisol excretion (71+/-29 vs. 51+/-19 micrograms per day [196+/-80 vs. 141+/-52 nmol per day], P=0.006), lower serum osteocalcin concentration (P=0.04), and lower urinary excretion of deoxypyridinoline (P=0.02).  CONCLUSIONS:  Past or current depression in women is associated with decreased bone mineral density.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTfCfbsJ2oADUg6wdEZmT2rfW6udTcc2eZcBpPZQ6sfYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zpvFShtg%253D%253D&md5=25a371981daa5a08577000cf2b6f38ee</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJM199610173351602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199610173351602%26sid%3Dliteratum%253Aachs%26aulast%3DMichelson%26aufirst%3DD.%26aulast%3DStratakis%26aufirst%3DC.%26aulast%3DHill%26aufirst%3DL.%26aulast%3DReynolds%26aufirst%3DJ.%26aulast%3DGalliven%26aufirst%3DE.%26aulast%3DChrousos%26aufirst%3DG.%26aulast%3DGold%26aufirst%3DP.%26atitle%3DBone%2520Mineral%2520Density%2520in%2520Women%2520with%2520Depression%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1996%26volume%3D335%26spage%3D1176%26epage%3D1181%26doi%3D10.1056%2FNEJM199610173351602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beach, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ives, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martire, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariyo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kop, W. J.</span></span> <span> </span><span class="NLM_article-title">Association Between Depression and Mortality in Older Adults: the Cardiovascular Health Study</span>. <i>Arch. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">1761</span>– <span class="NLM_lpage">1768</span>, <span class="refDoi"> DOI: 10.1001/archinte.160.12.1761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1001%2Farchinte.160.12.1761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10871968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BD3czjtlCqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2000&pages=1761-1768&author=R.+Schulzauthor=S.+R.+Beachauthor=D.+G.+Ivesauthor=L.+M.+Martireauthor=A.+A.+Ariyoauthor=W.+J.+Kop&title=Association+Between+Depression+and+Mortality+in+Older+Adults%3A+the+Cardiovascular+Health+Study&doi=10.1001%2Farchinte.160.12.1761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Association between depression and mortality in older adults: the Cardiovascular Health Study</span></div><div class="casAuthors">Schulz R; Beach S R; Ives D G; Martire L M; Ariyo A A; Kop W J</div><div class="citationInfo"><span class="NLM_cas:title">Archives of internal medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1761-8</span>
        ISSN:<span class="NLM_cas:issn">0003-9926</span>.
    </div><div class="casAbstract">BACKGROUND:  Studies of the association between depressive symptoms and mortality in elderly populations have yielded contradictory findings.  To address these discrepancies, we test this association using the most extensive array of sociodemographic and physical health control variables ever studied, to our knowledge, in a large population-based sample of elderly individuals.  OBJECTIVE:  To examine the relation between baseline depressive symptoms and 6-year all-cause mortality in older persons, systematically controlling for sociodemographic factors, clinical disease, subclinical disease, and health risk factors.  METHODS:  A total of 5201 men and women aged 65 years and older from 4 US communities participated in the study.  Depressive symptoms and 4 categories of covariates were assessed at baseline.  The primary outcome measure was 6-year mortality.  RESULTS:  Of the 5201 participants, 984 (18.9%) died within 6 years.  High baseline depressive symptoms were associated with a higher mortality rate (23.9%) than low baseline depression scores (17.7%) (unadjusted relative risk [RR], 1.41; 95% confidence interval [CI], 1.22-1.63).  Depression was also an independent predictor of mortality when controlling for sociodemographic factors (RR, 1.43; 95% CI, 1.23-1.66), prevalent clinical disease (RR, 1.25; 95% CI, 1.07-1.45), subclinical disease indicators (RR, 1.35; 95% CI, 1.15-1.58), or biological or behavioral risk factors (RR, 1.42; 95% CI, 1.22-1.65).  When the best predictors from all 4 classes of variables were included as covariates, high depressive symptoms remained an independent predictor of mortality (RR, 1.24; 95% CI, 1.06-1.46).  CONCLUSIONS:  High levels of depressive symptoms are an independent risk factor for mortality in community-residing older adults.  Motivational depletion may be a key underlying mechanism for the depression-mortality effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_dbJ_OElGFYYPsCkJIw00fW6udTcc2eZcBpPZQ6sfYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3czjtlCqug%253D%253D&md5=8afdd61834ce62f17cea3f2f5a3e5a1e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1001%2Farchinte.160.12.1761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.160.12.1761%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DR.%26aulast%3DBeach%26aufirst%3DS.%2BR.%26aulast%3DIves%26aufirst%3DD.%2BG.%26aulast%3DMartire%26aufirst%3DL.%2BM.%26aulast%3DAriyo%26aufirst%3DA.%2BA.%26aulast%3DKop%26aufirst%3DW.%2BJ.%26atitle%3DAssociation%2520Between%2520Depression%2520and%2520Mortality%2520in%2520Older%2520Adults%253A%2520the%2520Cardiovascular%2520Health%2520Study%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D2000%26volume%3D160%26spage%3D1761%26epage%3D1768%26doi%3D10.1001%2Farchinte.160.12.1761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seney, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibille, E.</span></span> <span> </span><span class="NLM_article-title">Sex Differences in Mood Disorders: Perspectives from Humans and Rodent Models</span>. <i>Biol. Sex Differ.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">17</span> <span class="refDoi"> DOI: 10.1186/s13293-014-0017-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1186%2Fs13293-014-0017-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=25520774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BC2MvgvVyjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=M.+L.+Seneyauthor=E.+Sibille&title=Sex+Differences+in+Mood+Disorders%3A+Perspectives+from+Humans+and+Rodent+Models&doi=10.1186%2Fs13293-014-0017-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Sex differences in mood disorders: perspectives from humans and rodent models</span></div><div class="casAuthors">Seney Marianne L; Sibille Etienne</div><div class="citationInfo"><span class="NLM_cas:title">Biology of sex differences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17</span>
        ISSN:<span class="NLM_cas:issn">2042-6410</span>.
    </div><div class="casAbstract">Mood disorders are devastating, often chronic illnesses characterized by low mood, poor affect, and anhedonia.  Notably, mood disorders are approximately twice as prevalent in women compared to men.  If sex differences in mood are due to underlying biological sex differences, a better understanding of the biology is warranted to develop better treatment or even prevention of these debilitating disorders.  In this review, our goals are to: 1) summarize the literature related to mood disorders with respect to sex differences in prevalence, 2) introduce the corticolimbic brain network of mood regulation, 3) discuss strategies and challenges of modeling mood disorders in mice, 4) discuss mechanisms underlying sex differences and how these can be tested in mice, and 5) discuss how our group and others have used a translational approach to investigate mechanisms underlying sex differences in mood disorders in humans and mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOCl0Oo1R-_MERNNga7KD-fW6udTcc2ebcmK-MTAWIHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvgvVyjsw%253D%253D&md5=2e9ca6457bc4a8a8f2969ba5f6b81bf2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2Fs13293-014-0017-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13293-014-0017-3%26sid%3Dliteratum%253Aachs%26aulast%3DSeney%26aufirst%3DM.%2BL.%26aulast%3DSibille%26aufirst%3DE.%26atitle%3DSex%2520Differences%2520in%2520Mood%2520Disorders%253A%2520Perspectives%2520from%2520Humans%2520and%2520Rodent%2520Models%26jtitle%3DBiol.%2520Sex%2520Differ.%26date%3D2014%26volume%3D5%26doi%3D10.1186%2Fs13293-014-0017-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collins, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span> <span> </span><span class="NLM_article-title">Multiple Forms Of Human Brain Mitochondrial Monoamine Oxidase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>225</i></span>,  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1038/225817a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1038%2F225817a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=5415111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaE3cXht1yrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=1970&pages=817-820&author=G.+G.+Collinsauthor=M.+Sandlerauthor=E.+D.+Williamsauthor=M.+B.+Youdim&title=Multiple+Forms+Of+Human+Brain+Mitochondrial+Monoamine+Oxidase&doi=10.1038%2F225817a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple forms of human brain mitochondrial monoamine oxidase</span></div><div class="casAuthors">Collins, Godfrey G. S.; Sandler, Merton; Williams, Edward Dillwyn; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">5235</span>),
    <span class="NLM_cas:pages">817-20</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The presence of at least 4 monoamine oxidase (I) isoenzymes was obsd. in human brain.  Their sp. activities differed from one area to another.  It was suggested that a simple regulatory mechanism existed by which an in traneuronal concn. of a particular amine was accompanied by the activation of a relatively specific isoenzyme of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsajQ4LcUEnLVg90H21EOLACvtfcHk0lijwCKr4ULjEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXht1yrurs%253D&md5=6d48451a49211b914136a880d842f64b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F225817a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F225817a0%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DG.%2BG.%26aulast%3DSandler%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DE.%2BD.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DMultiple%2520Forms%2520Of%2520Human%2520Brain%2520Mitochondrial%2520Monoamine%2520Oxidase%26jtitle%3DNature%26date%3D1970%26volume%3D225%26spage%3D817%26epage%3D820%26doi%3D10.1038%2F225817a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, J. P.</span></span> <span> </span><span class="NLM_article-title">Some Observations Upon A New Inhibitor Of Monoamine Oxidase In Brain Tissue</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1285</span>– <span class="NLM_lpage">1297</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(68)90066-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2F0006-2952%2868%2990066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=5659776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaF1cXktlCnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1968&pages=1285-1297&author=J.+P.+Johnston&title=Some+Observations+Upon+A+New+Inhibitor+Of+Monoamine+Oxidase+In+Brain+Tissue&doi=10.1016%2F0006-2952%2868%2990066-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Some observations on a new inhibitor of monoamine oxidase in brain tissue</span></div><div class="casAuthors">Johnston, J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1285-97</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The inhibition of monoamine oxidase (MAO) in vitro and in vivo by N-methyl-N-propargyl-3-(2,4-dichlorophenoxy)propylamine-HCl (M&B 9302) is described.  The kinetics of the MAO-M&B 9302 reaction show a unique abnormality as compared with known inhibitors.  The plot of percent inhibition vs. concn. of M&B 9302 does not show a simple sigmoid curve, but reveals a pair of sigmoid curves joined by a horizontal section where the inhibition is invariant.  The hypothesis that in the enzyme prepn., the MAO is a binary system of enzymes, each of which has a detectably different sensitivity to this particular inhibitor, is put forward and discussed.  Evidence after dialysis supports this hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdnWyFh0aO2rVg90H21EOLACvtfcHk0lijwCKr4ULjEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXktlCnsro%253D&md5=9987689810991f980e64f5b24665af02</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2868%2990066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252868%252990066-X%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DJ.%2BP.%26atitle%3DSome%2520Observations%2520Upon%2520A%2520New%2520Inhibitor%2520Of%2520Monoamine%2520Oxidase%2520In%2520Brain%2520Tissue%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1968%26volume%3D17%26spage%3D1285%26epage%3D1297%26doi%3D10.1016%2F0006-2952%2868%2990066-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, K.</span></span> <span> </span><span class="NLM_article-title">Some Puzzling Pharmacological Effects Of Monoamine Oxidase Inhibitors</span>. <i>Adv. Biochem. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">408</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=5066229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaE3sXhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1972&pages=393-408&author=J.+Knollauthor=K.+Magyar&title=Some+Puzzling+Pharmacological+Effects+Of+Monoamine+Oxidase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Puzzling pharmacological effects of monoamine oxidase [MAO] inhibitors</span></div><div class="casAuthors">Knoll, J.; Magyar, K.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biochemical Psychopharmacology</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">393-408</span>CODEN:
                <span class="NLM_cas:coden">ABPYBL</span>;
        ISSN:<span class="NLM_cas:issn">0065-2229</span>.
    </div><div class="casAbstract">A discussion and review with 17 refs. of some dissimilar effects various monoamine oxidase inhibitors may have on the metabolism of biogenic amines.  Studies with the optical isomers of Deprenil [2079-54-1] indicate that multiple forms of the enzyme monoamine oxidase may exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCM6fPp82whLVg90H21EOLACvtfcHk0lijwCKr4ULjEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhsA%253D%253D&md5=8a0fe1c36cedef71af1bde3b408913f9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnoll%26aufirst%3DJ.%26aulast%3DMagyar%26aufirst%3DK.%26atitle%3DSome%2520Puzzling%2520Pharmacological%2520Effects%2520Of%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DAdv.%2520Biochem.%2520Psychopharmacol.%26date%3D1972%26volume%3D5%26spage%3D393%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Carroll, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobbia, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tipton, K. F.</span></span> <span> </span><span class="NLM_article-title">The Deamination Of Dopamine By Human Brain Monoamine Oxidase. Specificity For The Two Enzyme Forms In Seven Brain Regions</span>. <i>Naunyn-Schmiedeberg’s Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>322</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1007/BF00500765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2FBF00500765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=6408492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaL3sXitFSmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=1983&pages=198-202&author=A.+M.+O%E2%80%99Carrollauthor=C.+J.+Fowlerauthor=J.+P.+Phillipsauthor=I.+Tobbiaauthor=K.+F.+Tipton&title=The+Deamination+Of+Dopamine+By+Human+Brain+Monoamine+Oxidase.+Specificity+For+The+Two+Enzyme+Forms+In+Seven+Brain+Regions&doi=10.1007%2FBF00500765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The deamination of dopamine by human brain monoamine oxidase.  Specificity for the two enzyme forms in seven brain regions</span></div><div class="casAuthors">O'Carroll, Anne Marie; Fowler, Christopher J.; Phillips, Jack P.; Tobbia, Iqdam; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">198-202</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">The deamination of dopamine (I)  [51-61-6] was studied in 7 regions of human brain.  Both A and B forms of monamine oxidase (MAO)  [9001-66-5] were active towards I.  The ratio of activities of MAO-A:MAO-B varied considerably from brain region to brain region, from about 1:1 for the cerebral and cerebellar cortex to about 1:2 for the pons and medulla oblongata.  Enzyme titrn. studies and comparisons of the substrate specificities of MAO-A and MAO-B across the brain indicated that I was metabolized by the same MAO active centers as other monoamines.  In the cerebral cortex, the Km values of MAO-A and -B towards I were 210 and 230 μM, resp., indicating that the relative contributions of these 2 forms towards the oxidn. of I will not be affected by changes in its concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd11w8nQN5OrVg90H21EOLACvtfcHk0li_U83VM_Ib7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitFSmtrk%253D&md5=ac03f33b62d3b917845cf5441904dac0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2FBF00500765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00500765%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Carroll%26aufirst%3DA.%2BM.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DPhillips%26aufirst%3DJ.%2BP.%26aulast%3DTobbia%26aufirst%3DI.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520Deamination%2520Of%2520Dopamine%2520By%2520Human%2520Brain%2520Monoamine%2520Oxidase.%2520Specificity%2520For%2520The%2520Two%2520Enzyme%2520Forms%2520In%2520Seven%2520Brain%2520Regions%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1983%26volume%3D322%26spage%3D198%26epage%3D202%26doi%3D10.1007%2FBF00500765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, J.</span></span> <span> </span><span class="NLM_article-title">Structural Aspects Of Monoamine Oxidase And Its Reversible Inhibition</span>. <i>Curr Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=9481038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK1cXisVWmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1998&pages=137-162&author=J.+Wouters&title=Structural+Aspects+Of+Monoamine+Oxidase+And+Its+Reversible+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structural aspects of monoamine oxidase and its reversible inhibition</span></div><div class="casAuthors">Wouters, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-162</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 152 refs. on the major structural aspects of MAO in relation to its primary sequence (site-directed mutagenesis, chimeric constructions) and secondary and three-dimensional structures.  The consequences of the inhibition of monoamine oxidase are considered, mainly focusing on the new generations of reversible and selective MAO inhibitors (utilized as antidepressants antiparkinsonian agents).  Recent efforts to design and develop these inhibitors are emphasized and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotbNNQZ7IslLVg90H21EOLACvtfcHk0li_U83VM_Ib7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisVWmurw%253D&md5=02266afed9ece8986df53752e9aab5cd</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWouters%26aufirst%3DJ.%26atitle%3DStructural%2520Aspects%2520Of%2520Monoamine%2520Oxidase%2520And%2520Its%2520Reversible%2520Inhibition%26jtitle%3DCurr%2520Med.%2520Chem.%26date%3D1998%26volume%3D5%26spage%3D137%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carreiras, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco, J. L.</span></span> <span> </span><span class="NLM_article-title">Recent Approaches To Novel Anti-Alzheimer Therapy</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3167</span>– <span class="NLM_lpage">3175</span>, <span class="refDoi"> DOI: 10.2174/1381612043383421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.2174%2F1381612043383421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=15544506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslCktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3167-3175&author=C.+Carreirasauthor=J.+L.+Marco&title=Recent+Approaches+To+Novel+Anti-Alzheimer+Therapy&doi=10.2174%2F1381612043383421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Recent approaches to novel anti-Alzheimer therapy</span></div><div class="casAuthors">Carreiras, M. C.; Marco, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3167-3175</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Insufficient cholinergic neurotransmission in AD is responsible for a progressive loss of cognition and motor capacities.  The cholinergic hypothesis has provided the rationale for the current treatment approaches based on acetylcholinesterase inhibitors.  However, recent data focus on the complex nature of AD and disclose the involvement of other neurotransmitters such as serotonin, noradrenalin, dopamine, histamine, excitatory amino acids, and neuropeptides, among others.  Interestingly, recent research has revealed that in severe AD brains the levels of AChE are considerably reduced whereas BuChE activity increases, thus aggravating the toxicity of βA.  In such instances, it is possible that BuChE may be a more suitable target than AChE.  Oxidative stress has been implicated in CNS degenerative disorders such as AD and PD.  Therefore, owing to their capacity to inhibit oxidative damage, MAOIs are potential candidates as anti-Alzheimer drugs.  More recently, a novel drug - TV3326 - was designed, based upon 2 pharmacophores: the carbamate moiety from Rivastigmine, an AChE inhibitor; and the propargyl group from Rasagiline, a MAO inhibitor.  This drug exhibits cholinesterase and selective brain MAO inhibitory activities, reduces apoptosis, and stimulates the processing of APPα, hence reducing the possibility of generation of the toxic βA.  Thus, TV3326 may be expected to contribute pos. to the cognitive benefits of Alzheimer's patients.  Anyhow, the development of drugs with several targets and diverse pharmacol. properties may conclusively demonstrate the most beneficial therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyyCavRdcJObVg90H21EOLACvtfcHk0li_U83VM_Ib7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslCktrY%253D&md5=a5c994c025780f2d02462eea9ad221e6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1381612043383421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043383421%26sid%3Dliteratum%253Aachs%26aulast%3DCarreiras%26aufirst%3DC.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26atitle%3DRecent%2520Approaches%2520To%2520Novel%2520Anti-Alzheimer%2520Therapy%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D3167%26epage%3D3175%26doi%3D10.2174%2F1381612043383421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finberg, J. P. M.</span></span> <span> </span><span class="NLM_article-title">Update On The Pharmacology Of Selective Inhibitors Of Mao-A And Mao-B: Focus On Modulation Of Cns Monoamine Neurotransmitter Release</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2014.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.pharmthera.2014.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=24607445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=133-152&author=J.+P.+M.+Finberg&title=Update+On+The+Pharmacology+Of+Selective+Inhibitors+Of+Mao-A+And+Mao-B%3A+Focus+On+Modulation+Of+Cns+Monoamine+Neurotransmitter+Release&doi=10.1016%2Fj.pharmthera.2014.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release</span></div><div class="casAuthors">Finberg, John P. M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-152</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Inhibitors of monoamine oxidase (MAO) were initially used in medicine following the discovery of their antidepressant action.  Subsequently their ability to potentiate the effects of an indirectly-acting sympathomimetic amine such as tyramine was discovered, leading to their limitation in clin. use, except for cases of treatment-resistant depression.  More recently, the understanding that: a) potentiation of indirectly-acting sympathomimetic amines is caused by inhibitors of MAO-A but not by inhibitors of MAO-B, and b) that reversible inhibitors of MAO-A cause minimal tyramine potentiation, has led to their re-introduction to clin. use for treatment of depression (reversible MAO-A inhibitors and new dose form MAO-B inhibitor) and treatment of Parkinson's disease (MAO-B inhibitors).  The profound neuroprotective properties of propargyl-based inhibitors of MAO-B in preclin. expts. have drawn attention to the possibility of employing these drugs for their neuroprotective effect in neurodegenerative diseases, and have raised the question of the involvement of the MAO-mediated reaction as a source of reactive free radicals.  Despite the long-standing history of MAO inhibitors in medicine, the way in which they affect neuronal release of monoamine neurotransmitters is still poorly understood.  In recent years, the detailed chem. structure of MAO-B and MAO-A has become available, providing new possibilities for synthesis of mechanism-based inhibitors.  This review describes the latest advances in understanding the way in which MAO inhibitors affect the release of the monoamine neurotransmitters dopamine, noradrenaline and serotonin (5-HT) in the CNS, with an accent on the importance of these effects for the clin. actions of the drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSGMvtQ1Ca5bVg90H21EOLACvtfcHk0li_U83VM_Ib7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslGht7o%253D&md5=0f31959bad34842d4aaaba7b8162e5b8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%2BM.%26atitle%3DUpdate%2520On%2520The%2520Pharmacology%2520Of%2520Selective%2520Inhibitors%2520Of%2520Mao-A%2520And%2520Mao-B%253A%2520Focus%2520On%2520Modulation%2520Of%2520Cns%2520Monoamine%2520Neurotransmitter%2520Release%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D143%26spage%3D133%26epage%3D152%26doi%3D10.1016%2Fj.pharmthera.2014.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padin, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arranz-Tagarro, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laguna</span></span> <span> </span><span class="NLM_article-title">History And Therapeutic Use Of MAO-A Inhibitors: A Historical Perspective Of MAO-A Inhibitors As Antidepressant Drug</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2275</span>– <span class="NLM_lpage">2282</span>, <span class="refDoi"> DOI: 10.2174/156802612805220011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.2174%2F156802612805220011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Gms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=2275-2282&author=M.+Yanezauthor=J.+F.+Padinauthor=J.+A.+Arranz-Tagarroauthor=M.+Caminaauthor=+Laguna&title=History+And+Therapeutic+Use+Of+MAO-A+Inhibitors%3A+A+Historical+Perspective+Of+MAO-A+Inhibitors+As+Antidepressant+Drug&doi=10.2174%2F156802612805220011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">History and therapeutic use of MAO-A inhibitors: a historical perspective of MAO-A inhibitors as antidepressant drug</span></div><div class="casAuthors">Yanez, Matilde; Padin, Juan Fernando; Arranz-Tagarro, Juan Alberto; Camina, Mercedes; Laguna, Reyes</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2275-2282</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the first generation of MAO inhibitors was developed, more than fifty years ago, this family of drugs has been ups and downs over the last decades.  Actually, interest in MAO inhibitors is reviving and the emergence of new advances in the rational design of mols. and new techniques to predict the in vivo behavior has encouraged the research for new drugs with therapeutic potential in this area.  The classic MAOIs have been widely used as antidepressants during the two decades after its introduction in clinic.  Based on observations made on MAO inhibition by these drugs, it has been postulated hypothesis that have contributed to a better understanding of the mechanism and management of depressive disorders.  However, exaggerated concerns about food and drug interactions relegated these drugs from the pharmaceutical landscape.  The correct interpretation and the contextualization of side effects and the recent research findings, in which MAO selective inhibitors appear as promising agents in the treatment of emerging and high prevalence diseases, are placing these drugs again into the scientific and pharmacol. focus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcjQfz6ownfLVg90H21EOLACvtfcHk0lhcYKV1Z8Q4UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Gms78%253D&md5=d006b5b41bcc578adaaf401f5ce677ae</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F156802612805220011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802612805220011%26sid%3Dliteratum%253Aachs%26aulast%3DYanez%26aufirst%3DM.%26aulast%3DPadin%26aufirst%3DJ.%2BF.%26aulast%3DArranz-Tagarro%26aufirst%3DJ.%2BA.%26aulast%3DCamina%26aufirst%3DM.%26aulast%3DLaguna%26atitle%3DHistory%2520And%2520Therapeutic%2520Use%2520Of%2520MAO-A%2520Inhibitors%253A%2520A%2520Historical%2520Perspective%2520Of%2520MAO-A%2520Inhibitors%2520As%2520Antidepressant%2520Drug%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D2275%26epage%3D2282%26doi%3D10.2174%2F156802612805220011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccioni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Befani, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirilli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Torre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardia, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distinto, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Molecular Modeling Studies, And Selective Inhibitory Activity Against Monoamine Oxidase Of 1-Thiocarbamoyl-3,5-Diaryl-4,5-Dihydro-(1H)- Pyrazole Derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7113</span>– <span class="NLM_lpage">7122</span>, <span class="refDoi"> DOI: 10.1021/jm040903t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040903t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFahs7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7113-7122&author=F.+Chimentiauthor=E.+Maccioniauthor=D.+Secciauthor=A.+Bolascoauthor=P.+Chimentiauthor=A.+Graneseauthor=O.+Befaniauthor=P.+Turiniauthor=S.+Alcaroauthor=F.+Ortusoauthor=R.+Cirilliauthor=F.+La+Torreauthor=M.+C.+Cardiaauthor=S.+Distinto&title=Synthesis%2C+Molecular+Modeling+Studies%2C+And+Selective+Inhibitory+Activity+Against+Monoamine+Oxidase+Of+1-Thiocarbamoyl-3%2C5-Diaryl-4%2C5-Dihydro-%281H%29-+Pyrazole+Derivatives&doi=10.1021%2Fjm040903t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives</span></div><div class="casAuthors">Chimenti, Franco; Maccioni, Elias; Secci, Daniela; Bolasco, Adriana; Chimenti, Paola; Granese, Arianna; Befani, Olivia; Turini, Paola; Alcaro, Stefano; Ortuso, Francesco; Cirilli, Roberto; La Torre, Francesco; Cardia, Maria C.; Distinto, Simona</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7113-7122</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)-pyrazole derivs. I (R1 = 4-MeC6H4, 4-FC6H4, 2-thienyl; R2 = 4-ClC6H4, 4-Me6H4, 2-furanyl; R1 = R2 = 2-thienyl) have been synthesized and investigated for the ability to inhibit selectively the activity of the A and B isoforms of monoamine oxidase (MAO).  All the synthesized compds. show high activity against both the MAO-A and the MAO-B isoforms with Ki values between 27 and 4 nM and between 50 and 1.5 nM, resp., except for a few derivs. whose inhibitory activity against MAO-B was in the micromolar range.  Knowing that stereochem. may be an important modulator of biol. activity, we performed the semipreparative chromatog. enantiosepn. of the most potent, selective, and chiral compds.  The sepd. enantiomers were then submitted to in vitro biol. evaluation.  The selectivity of the (-)-(S)-I (R1 = 4-MeC6H4; R2 = 4-ClC6H4) enantiomer against MAO-B increases twice and a half, while the selectivity of the (-)-(S)-I (R1 = 4-FC6H4; R2 = 4-ClC6H4) enantiomer against MAO-A triples.  Both the MAO-A and MAO-B isoforms resp. of the 1O5W and 1GOS models deposited in the Protein Data Bank were considered in the computational study.  The docking study was carried out using several computational approaches with the aim of proposing possible binding modes of the MAO enantioselective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7pzRRRqEz6rVg90H21EOLACvtfcHk0lhcYKV1Z8Q4UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFahs7vE&md5=6801dd2b87c1c60e9a50cd2947996dfd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm040903t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040903t%26sid%3Dliteratum%253Aachs%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DMaccioni%26aufirst%3DE.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DGranese%26aufirst%3DA.%26aulast%3DBefani%26aufirst%3DO.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DCirilli%26aufirst%3DR.%26aulast%3DLa%2BTorre%26aufirst%3DF.%26aulast%3DCardia%26aufirst%3DM.%2BC.%26aulast%3DDistinto%26aufirst%3DS.%26atitle%3DSynthesis%252C%2520Molecular%2520Modeling%2520Studies%252C%2520And%2520Selective%2520Inhibitory%2520Activity%2520Against%2520Monoamine%2520Oxidase%2520Of%25201-Thiocarbamoyl-3%252C5-Diaryl-4%252C5-Dihydro-%25281H%2529-%2520Pyrazole%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7113%26epage%3D7122%26doi%3D10.1021%2Fjm040903t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizzarri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Befani, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondovi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tafi, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition Of Amine Oxidases Activity By 1-Acetyl-3,5-Diphenyl-4,5-Dihydro-(1H)-Pyrazole Derivatives</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3629</span>– <span class="NLM_lpage">3633</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00699-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2FS0960-894X%2802%2900699-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=12443791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD38Xoslykt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3629-3633&author=F.+Mannaauthor=F.+Chimentiauthor=A.+Bolascoauthor=D.+Secciauthor=B.+Bizzarriauthor=O.+Befaniauthor=P.+Turiniauthor=B.+Mondoviauthor=S.+Alcaroauthor=A.+Tafi&title=Inhibition+Of+Amine+Oxidases+Activity+By+1-Acetyl-3%2C5-Diphenyl-4%2C5-Dihydro-%281H%29-Pyrazole+Derivatives&doi=10.1016%2FS0960-894X%2802%2900699-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives</span></div><div class="casAuthors">Manna, Fedele; Chimenti, Franco; Bolasco, Adriana; Secci, Daniela; Bizzarri, Bruna; Befani, Olivia; Turini, Paola; Mondovi, Bruno; Alcaro, Stefano; Tafi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3629-3633</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A novel series of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivs. have been synthesized and investigated for the ability to inhibit selectively monoamine oxidases, swine kidney oxidase, and bovine serum amine oxidase.  The newly synthesized compds. proved to be reversible and non-competitive inhibitors of all types of the assayed amine oxidases.  Compds. inhibit monoamine oxidases potently, displaying low I50 values of particular interest.  In particular 1-acetyl-3-(2,4-dihydroxyphenyl)-5-(3-methylphenyl)-4,5-dihydro-(1H)-pyrazole showed to be a potent monoamine oxidase inhibitor with a Ki of about 10-8 M.  Further insights in the theor. evaluation of the possible interactions between the compds. and monoamine oxidase B have been developed through a computational approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcefOKo4lMZrVg90H21EOLACvtfcHk0lhcYKV1Z8Q4UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xoslykt7o%253D&md5=13c0b17e567f90507ebde798be595f1b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900699-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900699-6%26sid%3Dliteratum%253Aachs%26aulast%3DManna%26aufirst%3DF.%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DBizzarri%26aufirst%3DB.%26aulast%3DBefani%26aufirst%3DO.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DMondovi%26aufirst%3DB.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DTafi%26aufirst%3DA.%26atitle%3DInhibition%2520Of%2520Amine%2520Oxidases%2520Activity%2520By%25201-Acetyl-3%252C5-Diphenyl-4%252C5-Dihydro-%25281H%2529-Pyrazole%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3629%26epage%3D3633%26doi%3D10.1016%2FS0960-894X%2802%2900699-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span> <span> </span><span class="NLM_article-title">The State Of The Art Of Pyrazole Derivatives As Monoamine Oxidase Inhibitors And Antidepressant/Anticonvulsant Agents</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5114</span>– <span class="NLM_lpage">5144</span>, <span class="refDoi"> DOI: 10.2174/092986711797636090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.2174%2F092986711797636090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=22050759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ShtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=5114-5144&author=D.+Secciauthor=A.+Bolascoauthor=P.+Chimentiauthor=S.+Carradori&title=The+State+Of+The+Art+Of+Pyrazole+Derivatives+As+Monoamine+Oxidase+Inhibitors+And+Antidepressant%2FAnticonvulsant+Agents&doi=10.2174%2F092986711797636090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents</span></div><div class="casAuthors">Secci, D.; Bolasco, A.; Chimenti, P.; Carradori, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">5114-5144</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase plays a significant role in the control of intracellular concn. of monoaminergic neurotransmitters or neuromodulators and dietary amines.  The rapid degrdn. of these mols. ensures the proper functioning of synaptic neurotransmission and is critically important for the regulation of emotional and other brain functions.  The development of human MAO inhibitors led to important breakthroughs in the therapy of several neuropsychiatric disorders.  Different families of heterocycles contg. 2 or 4 nitrogen atoms have been used as scaffolds for synthesizing selective monoamine oxidase inhibitors, but the early period of the MAO-inhibitors started with hydrazine derivs.  Pyrazole, pyrazoline, and pyrazolidine derivs. can be considered as a cyclic hydrazine moiety.  This scaffold also displayed promising antidepressant and anticonvulsant properties as demonstrated by different and established animal models.  Diversely substituted pyrazoles, embedded with a variety of functional groups, are important biol. agents and a significant amt. of research activity has been directed towards this chem. class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr66QhWLGWCBLVg90H21EOLACvtfcHk0likJQ8Ad_mNDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ShtrzO&md5=cc2019fc83603bab23b443bd563f9c98</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F092986711797636090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797636090%26sid%3Dliteratum%253Aachs%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DCarradori%26aufirst%3DS.%26atitle%3DThe%2520State%2520Of%2520The%2520Art%2520Of%2520Pyrazole%2520Derivatives%2520As%2520Monoamine%2520Oxidase%2520Inhibitors%2520And%2520Antidepressant%252FAnticonvulsant%2520Agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D5114%26epage%3D5144%26doi%3D10.2174%2F092986711797636090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anbazhagan, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Preclinical Evaluation And Antidepressant Activity Of 5-Substituted Phenyl-3-(Thiophen-2-Yl)-4, 5-Dihydro-1H-Pyrazole-1-Carbothioamides</span>. <i>EXCLI J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=26417270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BC283ntFeqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=437-445&author=B.+Mathewauthor=J.+Sureshauthor=S.+Anbazhagan&title=Synthesis%2C+Preclinical+Evaluation+And+Antidepressant+Activity+Of+5-Substituted+Phenyl-3-%28Thiophen-2-Yl%29-4%2C+5-Dihydro-1H-Pyrazole-1-Carbothioamides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, preclinical evaluation and antidepressant activity of 5-substituted phenyl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazole-1-carbothioamides</span></div><div class="casAuthors">Mathew Bijo; Suresh Jerad; Anbazhagan S</div><div class="citationInfo"><span class="NLM_cas:title">EXCLI journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">437-45</span>
        ISSN:<span class="NLM_cas:issn">1611-2156</span>.
    </div><div class="casAbstract">A series of phenyl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazole-1-carbothioamides (TTa-TTg) were synthesized by the ring closure reaction of phenyl-1-(thiophen-2-yl) prop-2-en-1-ones with thiosemicarbazide in alcoholic basic medium.  All the final derivatives were evaluated for their antidepressant and neurotoxicity screening.  The structures of the compounds were characterized by IR, 1H NMR, 13C NMR, Mass and elemental analyses.  Preclinical evaluation of the compounds were ascertained by in silico toxicity, blood-brain barrier and human oral absorption prediction.  In this series, 5-(4-hydroxyphenyl)-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazole-1 carbothioamide (TTg) reduced immobility time 61.17 and 62.05 % in both force swimming and tail suspension test respectively at 10 mg/kg dose level when compared to the standard Imipramine without influencing the baseline locomotion.  Moreover it was observed that the titled scaffold possessing electron withdrawing chlorine atom in the 4(th) position of aromatic ring of the scaffold also showed good the antidepressant activity.  In conclusion, the behavioural investigation revealed that thiophene based pyrazolines having a carbothioamide tail unit in the N1 position may be therapeutically useful as potential antidepressant medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdCpEGnFjeua69lAbTj9rGfW6udTcc2eZrmgO1LFmA_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283ntFeqsQ%253D%253D&md5=484cf42aa579ba2f40eea552839b4bcd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathew%26aufirst%3DB.%26aulast%3DSuresh%26aufirst%3DJ.%26aulast%3DAnbazhagan%26aufirst%3DS.%26atitle%3DSynthesis%252C%2520Preclinical%2520Evaluation%2520And%2520Antidepressant%2520Activity%2520Of%25205-Substituted%2520Phenyl-3-%2528Thiophen-2-Yl%2529-4%252C%25205-Dihydro-1H-Pyrazole-1-Carbothioamides%26jtitle%3DEXCLI%2520J.%26date%3D2014%26volume%3D13%26spage%3D437%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Befani, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondovi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirilli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Torre, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis And Selective Inhibitory Activity Of 1-Acetyl-3,5-Diphenyl-4,5-Dihydro-(1H)-Pyrazole Derivatives Against Monoamine Oxidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2071</span>– <span class="NLM_lpage">2074</span>, <span class="refDoi"> DOI: 10.1021/jm031042b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031042b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitVOqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2071-2074&author=F.+Chimentiauthor=A.+Bolascoauthor=F.+Mannaauthor=D.+Secciauthor=P.+Chimentiauthor=O.+Befaniauthor=P.+Turiniauthor=V.+Giovanniniauthor=B.+Mondoviauthor=R.+Cirilliauthor=F.+La+Torre&title=Synthesis+And+Selective+Inhibitory+Activity+Of+1-Acetyl-3%2C5-Diphenyl-4%2C5-Dihydro-%281H%29-Pyrazole+Derivatives+Against+Monoamine+Oxidase&doi=10.1021%2Fjm031042b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Selective Inhibitory Activity of 1-Acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole Derivatives against Monoamine Oxidase</span></div><div class="casAuthors">Chimenti, Franco; Bolasco, Adriana; Manna, Fedele; Secci, Daniela; Chimenti, Paola; Befani, Olivia; Turini, Paola; Giovannini, Valentina; Mondovi, Bruno; Cirilli, Roberto; La Torre, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2071-2074</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of 1-acetyl-3-(4-hydroxy- and 2,4-dihydroxyphenyl)-5-phenyl-4,5-dihydro-(1H)-pyrazole derivs. I [R = 4-OH, 2,4-(OH)2; R1 = 2-Cl, 3-Cl, 4-Cl, 3-Me, 4-Me, 2-OMe, 4-OMe, 2,4-(OMe)2] have been synthesized and investigated for the ability to selectively inhibit the activity of the A and B isoforms of monoamine oxidase (MAO).  The new synthesized compds. I proved to be more reversible, potent, and selective inhibitors of MAO-A than of MAO-B.  Knowing that stereochem. may be an important modulator of biol. activity, we performed the semi-preparative chromatog. enantiosepn. of the most potent, selective, and chiral compds., I [R = 4-OH; R1 = 2-OMe (II)] and I [R = 2,4-(OH)2; R1 = 2-OMe (III)].  The sepd. enantiomers were then submitted to in vitro biol. evaluation while increasing their inhibitory activity and A selectivity.  The (-)-II enantiomer shows Ki(MAO-A) = 2 nM and SI = 165 000, (+)-II shows Ki(MAO-A) = 6 nM and SI = 166 666, (-)-III shows Ki(MAO-A) = 4 nM and SI = 80 000, and (+)-III shows Ki(MAO-A) = 7 nM and SI = 38 571.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosOAaBXZ93XbVg90H21EOLACvtfcHk0ljIArHUoHwbsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitVOqurw%253D&md5=cece9cc61936e1a9cfb40ff82fac01ce</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm031042b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031042b%26sid%3Dliteratum%253Aachs%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DManna%26aufirst%3DF.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DBefani%26aufirst%3DO.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DGiovannini%26aufirst%3DV.%26aulast%3DMondovi%26aufirst%3DB.%26aulast%3DCirilli%26aufirst%3DR.%26aulast%3DLa%2BTorre%26aufirst%3DF.%26atitle%3DSynthesis%2520And%2520Selective%2520Inhibitory%2520Activity%2520Of%25201-Acetyl-3%252C5-Diphenyl-4%252C5-Dihydro-%25281H%2529-Pyrazole%2520Derivatives%2520Against%2520Monoamine%2520Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2071%26epage%3D2074%26doi%3D10.1021%2Fjm031042b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioravanti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardia, M. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Molecular Modeling Studies And Selective Inhibitory Activity Against MAO Of N1-Propanoyl-3,5-Diphenyl-4,5-Dihydro-(1H)-Pyrazole Derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2262</span>– <span class="NLM_lpage">2267</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2007.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.ejmech.2007.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=18281126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CqsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=2262-2267&author=F.+Chimentiauthor=R.+Fioravantiauthor=A.+Bolascoauthor=F.+Mannaauthor=P.+Chimentiauthor=D.+Secciauthor=F.+Rossiauthor=P.+Turiniauthor=F.+Ortusoauthor=S.+Alcaroauthor=M.+C.+Cardia&title=Synthesis%2C+Molecular+Modeling+Studies+And+Selective+Inhibitory+Activity+Against+MAO+Of+N1-Propanoyl-3%2C5-Diphenyl-4%2C5-Dihydro-%281H%29-Pyrazole+Derivatives&doi=10.1016%2Fj.ejmech.2007.12.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives</span></div><div class="casAuthors">Chimenti, Franco; Fioravanti, Rossella; Bolasco, Adriana; Manna, Fedele; Chimenti, Paola; Secci, Daniela; Rossi, Francesca; Turini, Paola; Ortuso, Francesco; Alcaro, Stefano; Cardia, Maria Cristina</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2262-2267</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 1-propanoyl-3,5-diaryl-4,5-dihydro-1H-pyrazoles I (R1, R2 = Ph, 4-ClC6H4, 4-FC6H4, 4-MeC6H4, 4-MeOC6H4) was synthesized and assayed as inhibitors of MAO-A and MAO-B isoforms.  Most of the tested compds. showed inhibitory activity with micromolar values and MAO-A selectivity.  In addn. a computational work was carried out on the most selective compd. I (R1 = Ph; R2 = 4-ClC6H4) to highlight the most relevant interactions in the mechanism of recognition within both the MAO-A and the MAO-B enzyme active sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozx20F-uGUGrVg90H21EOLACvtfcHk0ljIArHUoHwbsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CqsLbF&md5=8904deec66d869109a4d621288eeb06f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DFioravanti%26aufirst%3DR.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DManna%26aufirst%3DF.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DRossi%26aufirst%3DF.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DCardia%26aufirst%3DM.%2BC.%26atitle%3DSynthesis%252C%2520Molecular%2520Modeling%2520Studies%2520And%2520Selective%2520Inhibitory%2520Activity%2520Against%2520MAO%2520Of%2520N1-Propanoyl-3%252C5-Diphenyl-4%252C5-Dihydro-%25281H%2529-Pyrazole%2520Derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D2262%26epage%3D2267%26doi%3D10.1016%2Fj.ejmech.2007.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizzarri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yáñez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orallo, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis And Inhibitory Activity Against Human Monoamine Oxidase Of N1-Thiocarbamoyl-3,5-Di(Hetero)Aryl-4,5-Dihydro-(1H)-Pyrazole Derivatives</span>. <i>Eur J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">800</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.ejmech.2009.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=19926363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Smtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=800-804&author=F.+Chimentiauthor=S.+Carradoriauthor=D.+Secciauthor=A.+Bolascoauthor=B.+Bizzarriauthor=P.+Chimentiauthor=A.+Graneseauthor=M.+Y%C3%A1%C3%B1ezauthor=F.+Orallo&title=Synthesis+And+Inhibitory+Activity+Against+Human+Monoamine+Oxidase+Of+N1-Thiocarbamoyl-3%2C5-Di%28Hetero%29Aryl-4%2C5-Dihydro-%281H%29-Pyrazole+Derivatives&doi=10.1016%2Fj.ejmech.2009.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives</span></div><div class="casAuthors">Chimenti, Franco; Carradori, Simone; Secci, Daniela; Bolasco, Adriana; Bizzarri, Bruna; Chimenti, Paola; Granese, Arianna; Yanez, Matilde; Orallo, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">800-804</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivs. has been synthesized and assayed for their ability to inhibit the activity of the A and B isoforms of human monoamine oxidase (hMAO).  Some of these compds. were endowed with a selective inhibitory activity against hMAO-B in the micromolar range.  The most active of the series is N1-thiocarbamoyl-3-(fur-2'-yl)-5-(4'-fluoro-phenyl)-4,5-dihydro-(1H)-pyrazole, with IC50 2.75 ± 0.81 μM value and selectivity ratio of 25, which is the best candidate for further investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4JGFlrp7_y7Vg90H21EOLACvtfcHk0ljIArHUoHwbsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Smtg%253D%253D&md5=ba09127c0fcb4cd7ac87c5215f2bb3e2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DBizzarri%26aufirst%3DB.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DGranese%26aufirst%3DA.%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DOrallo%26aufirst%3DF.%26atitle%3DSynthesis%2520And%2520Inhibitory%2520Activity%2520Against%2520Human%2520Monoamine%2520Oxidase%2520Of%2520N1-Thiocarbamoyl-3%252C5-Di%2528Hetero%2529Aryl-4%252C5-Dihydro-%25281H%2529-Pyrazole%2520Derivatives%26jtitle%3DEur%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D800%26epage%3D804%26doi%3D10.1016%2Fj.ejmech.2009.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamanna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinicropi, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrangeli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franchini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondovi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scilimati, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis And Biological Evaluation Of 3-Alkyloxazolidin-2-Ones As Reversible MAO Inhibitors</span>. <i>Arkivoc</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>2004</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.3998/ark.5550190.0005.512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.3998%2Fark.5550190.0005.512" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2004&publication_year=2004&pages=118-130&author=C.+Lamannaauthor=M.+S.+Sinicropiauthor=P.+Pietrangeliauthor=F.+Corboauthor=C.+Franchiniauthor=B.+Mondoviauthor=A.+Scilimati&title=Synthesis+And+Biological+Evaluation+Of+3-Alkyloxazolidin-2-Ones+As+Reversible+MAO+Inhibitors&doi=10.3998%2Fark.5550190.0005.512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3998%2Fark.5550190.0005.512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3998%252Fark.5550190.0005.512%26sid%3Dliteratum%253Aachs%26aulast%3DLamanna%26aufirst%3DC.%26aulast%3DSinicropi%26aufirst%3DM.%2BS.%26aulast%3DPietrangeli%26aufirst%3DP.%26aulast%3DCorbo%26aufirst%3DF.%26aulast%3DFranchini%26aufirst%3DC.%26aulast%3DMondovi%26aufirst%3DB.%26aulast%3DScilimati%26aufirst%3DA.%26atitle%3DSynthesis%2520And%2520Biological%2520Evaluation%2520Of%25203-Alkyloxazolidin-2-Ones%2520As%2520Reversible%2520MAO%2520Inhibitors%26jtitle%3DArkivoc%26date%3D2004%26volume%3D2004%26spage%3D118%26epage%3D130%26doi%3D10.3998%2Fark.5550190.0005.512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artico, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbardella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Befani, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondovi, B.</span></span> <span> </span><span class="NLM_article-title">3-(1H-pyrrol-1-yl)-2-oxazolidinones as Reversible, Highly Potent, And Selective Inhibitors Of Monoamine Oxidase Type A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1183</span>, <span class="refDoi"> DOI: 10.1021/jm015578d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm015578d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1180-1183&author=A.+Maiauthor=M.+Articoauthor=M.+Espositoauthor=G.+Sbardellaauthor=S.+Massaauthor=O.+Befaniauthor=P.+Turiniauthor=V.+Giovanniniauthor=B.+Mondovi&title=3-%281H-pyrrol-1-yl%29-2-oxazolidinones+as+Reversible%2C+Highly+Potent%2C+And+Selective+Inhibitors+Of+Monoamine+Oxidase+Type+A&doi=10.1021%2Fjm015578d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">3-(1H-Pyrrol-1-yl)-2-oxazolidinones as Reversible, Highly Potent, and Selective Inhibitors of Monoamine Oxidase Type A</span></div><div class="casAuthors">Mai, Antonello; Artico, Marino; Esposito, Monica; Sbardella, Gianluca; Massa, Silvio; Befani, Olivia; Turini, Paola; Giovannini, Valentina; Mondovi, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1180-1183</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-(1H-Pyrrol-1-yl)-2-oxazolidinones (R)- and (S)-I [R = OH, OPMe, N3, NH2, NMe2] have been synthesized as pyrrole analogs of toloxatone (Humoryl), an antidepressant agent belonging to the 3-phenyl-2-oxazolidinone class, and their monoamine oxidase (MAO) type A and B inhibitory activities have been evaluated.  The majority of I showed inhibitory activity against the A isoform of the enzyme higher than that exerted against the MAO-B, the sole exception being the (S)-I [R = NH2].  (R)-I [R = OMe], the most potent among test derivs., was 78-fold more potent than toloxatone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBUYCBqxcZFLVg90H21EOLACvtfcHk0ljUsvILJjWpsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWksr8%253D&md5=41304a5442efa6616730a1e0a948c2ae</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm015578d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm015578d%26sid%3Dliteratum%253Aachs%26aulast%3DMai%26aufirst%3DA.%26aulast%3DArtico%26aufirst%3DM.%26aulast%3DEsposito%26aufirst%3DM.%26aulast%3DSbardella%26aufirst%3DG.%26aulast%3DMassa%26aufirst%3DS.%26aulast%3DBefani%26aufirst%3DO.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DGiovannini%26aufirst%3DV.%26aulast%3DMondovi%26aufirst%3DB.%26atitle%3D3-%25281H-pyrrol-1-yl%2529-2-oxazolidinones%2520as%2520Reversible%252C%2520Highly%2520Potent%252C%2520And%2520Selective%2520Inhibitors%2520Of%2520Monoamine%2520Oxidase%2520Type%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1180%26epage%3D1183%26doi%3D10.1021%2Fjm015578d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Close, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiffany, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spielman, M. A.</span></span> <span> </span><span class="NLM_article-title">The Analgesic Activity of Some Benzoxazolone Derivatives</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1949</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1265</span>– <span class="NLM_lpage">1268</span>, <span class="refDoi"> DOI: 10.1021/ja01172a036</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01172a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaH1MXjs1GksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1949&pages=1265-1268&author=W.+J.+Closeauthor=B.+D.+Tiffanyauthor=M.+A.+Spielman&title=The+Analgesic+Activity+of+Some+Benzoxazolone+Derivatives&doi=10.1021%2Fja01172a036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The analgesic activity of some benzoxazolone derivatives</span></div><div class="casAuthors">Close, W. J.; Tiffany, Burris D.; Spielman, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1949</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1265-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">3-Alkyl, 3-acyl, 3-dialkylaminoalkyl, and nuclear substituted derivs. (I) of 2(3H)-benzoxazolone (II) were synthesized; about 2/3 of them induced mild analgesia.  Usually the I were prepd. by fusion of o-aminophenols (III), with improved yields of 76-90% by moderating the temp. and time.  Most III, sensitive to air, were used as HCl salts. p-PrC6H4OH, 245 g. from PrC6H4OMe 289 g., 48% HBr 450, and HOAc 450 cc. refluxed 3 days, with dry HBr added the first 2 h., b0.75 79-80°.  Modification of the method of Sandulesco and Girard (C.A. 25, 1228) gave a 300% increase in yield of p-HOC6H4COBu (IV): addn. of PhOH 72 g. in 144 cc. PhNO2 to 205 g. AlCl3 in 400 cc. PhNO2 at 10-12°, then dropwise addn. of 85 g. BuCOCl at 5-10°, addn. to ice and concd. HCl after 16 h., and NaOH extn. of the PhNO2 layer gave 87% IV, b0.7 150-60°.  Clemmensen redn. of IV gave 85% p-AmC6H4OH, b1.4 103-7°.  4,2-Me(H2N)C6H3OH.HCl (90% from 4,2-Me(O2N)C6H3OH in abs. EtOH, Raney Ni, and 1000 lb. H at 75°, evapn. of the solvent, addn. of a slight excess of alc. HCl, and pptn. with Et2O), m. 222-4°.  4,2-Pr(O2N) C6H3OH [83% by a modification of the Baranger procedure (C.A. 26, 705)], b0.85 92-6°, nD25 1.5574; redn. with Raney Ni and H gave 98% 2-amino analog HCl salt, m. 245-52° (decompn.).  Addn. of 65 g. p-AmC6H4OH in HOAc 65 to concd. HNO3 51 and HOAc 100 cc. during 2 h. at -5°, addn. to ice and 160 g. 10% NaOH, and C6H6 extn. gave 75% 4,2-Am(O2N) C6H3OH, b0.5 100-5°, nD25 1.5253; Raney Ni and H Substituents in I, Nuclear, Nitrogen, B.p., °C., mm., nD25, M.p., °C., Method, Yield, %, VII; None, H, , , , 139-40, A, 88, ..; None, Me, , , , 83-4, , , 1; None, Bu, 129-30, 1.3, 1.5316, , B, 62, 0; None, iso-Bu, , , , 63.5-5.0, B, 76, 0; None, Am, 140-2, 1.0, 1. 5268, , (b), 40, 0; None, iso-Am, 112-13, 0.4, 1.5248, 40-0.5, C, 90, 4 (a); None sec-Am, 132-4, 1.3, 1.5280, , B, 40, 3; None, Ac, , , , 92-4, , 66, 0; None, Allyl, 112-14, 0.5, 1.5536, , C, 66, 0; None, (c), , , , 171-3, C, 66, 3; 5-Me, H, , , , 128-9, A, 79, 0; 5-Me, Bu, 138-40, 1.2, 1.5300, , B, 67, 3; 5-Me, iso-Bu, , , , 61-2, B, 70, 1; 5-Me, Am, 136-8, 0.8, 1.5239, , B, 65, 2; 5-Me, iso-Am, 142-3, 1.3, 1.5230, , B, 65, 1; 5-Me, sec-Am, 130-3, 1.2, 1.5251, , B, 54, ..; 5-Pr, H, , , , 66.5-8, A, 79, 0; 5-Pr, Bu, 164-7, 1.0, 1.5196, , C, 95, 4 (a); 5-Pr, iso-Bu, 141-4, 1.2, 1.1597?, , B, 65, 3; 5-Pr, Am, 162-4, 1.4, 1.5157, , B, 66, 3; 5-Pr, iso-Am, 148-50, 0.8, 1.5167, , B, 66, 0; 5-Pr, sec-Am, 148-51, 1.1, 1.5197, , B, 38, 2; 5-Am, H, , , , 62-4, A, 90, ..;  5-Am, Me, , , , 55-6.5, (d), 96, ..; 5-Am, Pr, 167-70, 2.0, 1.5180, , C, 94, 0; 5-Am, iso-Bu, 146-8, 0.6, 1.5144, , C, 90, 2; 5-Am, Am, 178-80, 1.4, 1.5115, , C, 93, 0; 5,6-di-Me, H, , , , 177-8, (e), 68, 3; 5,6-di-Me, Et, , , , 86-7, (f), 73, 3; 5,6-di-Me, Bu, , , , 68-9, C, 80, 0; 5,6-di-Me, iso-Am, , , , 50-1, C, 86, 3; 5-MeO, H, , , , 170-2, A, 76, 3; 5-MeO, iso-Bu, , , , 57-8, C, 87, 3; 5-MeO, Am, 168-72, 1.4, 1.5299, , C, 92, 3; 5-MeO, Ac, , , , 102-3, (e), 95, 3; 6-Cl, H, , , , 194-5, (e), 81, 3; 6-Cl, Me, , , , 104-5, (d), 85, 0; 6-Cl, iso-Pr, , , , 91-2, C, 40, 2; 6-Cl, iso-Am, 157-63, 1.0, 1.5308, 46-7, C, 62, 4; (a) Tested on human volunteers with lower results; (b) prepd. with KOH in (CH2OH)2; (c) Et2NCH2CH2 HCl salt; two cryst. forms; lower-melting form, prisms from Me2CO-EtOH, m. 140-7° with resolidification to the higher-melting form; (d) prepd. with NaOMe and Me2SO4 in MeOH; (e) prepn. described in text; (f) prepd. with NaOMe and Et2SO4 in EtOH. gave 84% 4,2-Am(H2N)C6H3OH.HCl, m. 194° (from EtOH); free base m. 128° (from ligroin).  4,5,2-Me2(H2N)C6H2OH (V) (77% from NaHSO3 in basic soln. and 4,5,2-Me2(PhN2)C6H2OH) m. 171-5°.  Addn. during 1.5 h. at -5 to 0° of 1 mol PhN2Cl to p-MeOC6H4OH 124, H2O 1200, and NaOH 120 g., and acidification gave 89% 4,2-MeO(PhN2)C6H3OH (VI), m. 72.5-3.5° (from EtOH).  Addn. of NaHSO3 to VI 100, H2O 1000, and NaOH 100 g. on the steam bath until the color was gone, Et2O extn., neutralization of the aq. soln., and trituration of the dried ppt. with EtOH-HCl gave 85% 4,2-MeO(H2N)C6H3OH.HCl, crystd. from EtOH only with loss, m. 210-13° (decompn.) (pyrex tube evacuated to 0.5 mm.) (cf. m.p. of 171° of Roberts, et al., C.A. 29, 2934.7).  Most I were prepd. by fusion with urea (Method A); thus 4,2-Pr(H2N)C6H3OH 470 and urea 300 g. heated in an oil bath at 180° 2 h., cooled, dil. acid added, then Et2O extn., gave 348 g. 5-Pr deriv. of II, b0.8 180-2°.  Other I are given in the table.  Dropwise addn. of 30 g. COCl2 in 400 cc. EtOAc to V 34.2 and anhyd. KOAc 59 g. in 600 cc. EtOAc, addn. of H2O and HCl, concn. of the EtOAc layer, soln. of the ppt. in boiling 10% NaOH, chilling, and acidifying the ppt. gave 68% 5,6-di-Me deriv. of II, m. 173-7°.  Addn. of SO2Cl2 32 to HOAc 500 cc. and 50 g. II at 0°, letting stand 16 h. at room temp. and 1 h. on the steam bath, and addn. to cold H2O gave 81% 6-Cl deriv. of II, m. 189-94°.  Cleavage of the ring with NaOH gave 5,2-Cl(H2N)C6H3OH, m. and mixed m.p. 152-4°.  Method B for 3-substituted II: Addn. of 9.3 cc. iso-AmI to 0.2 g. 5-Pr deriv. of II in 60 cc. of 0.84 N KOH in Cellosolve, 6 h.' refluxing, concn. of the filtrate in vacuo, extn. from the H2O suspension with H2O, and washing with 5% NaOH gave 66% 3-isoamyl-5-Pr deriv. of II, b0.8 148-50°.  Method C: 9.9 g. 5-MeO deriv. of II, then 9.6 cc. AmBr were added to 1.6 g. Na in 30 cc.  Cellosolve (distd. over Na) in a N atm., refluxed 1 h., 0.69 g. Na in 10 cc.  Cellosolve (prepd. under N) and 4.8 cc. AmBr added, and refluxed 1 h. more; addn. of HOAc, concn. in vacuo, treatment of the residue with Et2O and H2O, washing of the Et2O layer with 5% NaOH and HCl, and distn. gave 92% 3-amyl-5-methoxy deriv. of II, b1 166-74°.  3-Ac derivs. of I were prepd. (see table) by the following procedure: addn. of 5-MeO deriv. 9.9 of II to Na 1.6 g. in 50 cc. MeOH, concn., treatment of the dry residue with 25 cc. Ac2O 10 min., and addn. to H2O gave 95% 3-acetyl-5-methoxy deriv. of II, m. 100-3°.  Analgesic activity in dogs was detd. by a modification of the method of Andrews and Workman (C.A. 35, 8102.3) with doses of 100-200 mg./kg., at which level toxic effects rarely appeared.  The increase in pain threshold (VII in table) was: 0 = none; 1, doubtful; 2, < 10%; 3, 10-20%; 4, 20-30%.  The best compds. had an activity comparable to that of aspirin, and were much weaker than Demerol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxKvNBulfSOrVg90H21EOLACvtfcHk0ljUsvILJjWpsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH1MXjs1GksQ%253D%253D&md5=b77f959c883112baccfbafbdb2d4698a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja01172a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01172a036%26sid%3Dliteratum%253Aachs%26aulast%3DClose%26aufirst%3DW.%2BJ.%26aulast%3DTiffany%26aufirst%3DB.%2BD.%26aulast%3DSpielman%26aufirst%3DM.%2BA.%26atitle%3DThe%2520Analgesic%2520Activity%2520of%2520Some%2520Benzoxazolone%2520Derivatives%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1949%26volume%3D71%26spage%3D1265%26epage%3D1268%26doi%3D10.1021%2Fja01172a036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milcent, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhnazarian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lensen, N.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 1-(2-hydroxyphenyl)-2,4-Imidazolidinedione Derivatives Through Cyclic Transformations Of Ethyl 2-Oxo-3(2H)-Benzoxazoleacetate Derivatives</span>. <i>J. Heterocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1829</span>– <span class="NLM_lpage">1833</span>, <span class="refDoi"> DOI: 10.1002/jhet.5570330645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2Fjhet.5570330645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK2sXotFCkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1996&pages=1829-1833&author=R.+Milcentauthor=A.+Akhnazarianauthor=N.+Lensen&title=Synthesis+of+1-%282-hydroxyphenyl%29-2%2C4-Imidazolidinedione+Derivatives+Through+Cyclic+Transformations+Of+Ethyl+2-Oxo-3%282H%29-Benzoxazoleacetate+Derivatives&doi=10.1002%2Fjhet.5570330645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 1-(2-hydroxyphenyl)-2,4-imidazolidinedione derivatives through cyclic transformations of ethyl 2-oxo-3(2H)-benzoxazoleacetate derivatives</span></div><div class="casAuthors">Milcent, Rene; Akhnazarian, Anna; Lensen, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1829-1833</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-152X</span>.
    
            (<span class="NLM_cas:orgname">HeteroCorporation</span>)
        </div><div class="casAbstract">The Et 2-oxo-3(2H)-benzoxazoleacetate derivs. I (R1 = H, Cl, Me; R2 = H, Et) were prepd.  By reaction with ammonia, primary amines or hydrazine, I were transformed into 1-(2-hydroxyphenyl)-2,4-imidazolidinedione derivs. (hydantoins) II (same R1, R2; R3 = Me, Et, NH2, etc.).  Some of the new hydantoins II were treated with phosphorus oxychloride to give 2-oxoimidazo[2,1-b]benzoxazoles.  Et 2-oxo-3(2H)-benzoxazolepropionate was prepd. by a Michael reaction of Et acrylate with a 2-benzoxazolone.  Cyclic transformation were not obsd. with Et 2-oxo-3(2H)-benzoxazolepropionate in the presence of ammonia or alkylamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2yJ5CZGEeKLVg90H21EOLACvtfcHk0lhlz1LRuP9R5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotFCkug%253D%253D&md5=39e9bd723528db9fe9567c6074636abd</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570330645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570330645%26sid%3Dliteratum%253Aachs%26aulast%3DMilcent%26aufirst%3DR.%26aulast%3DAkhnazarian%26aufirst%3DA.%26aulast%3DLensen%26aufirst%3DN.%26atitle%3DSynthesis%2520of%25201-%25282-hydroxyphenyl%2529-2%252C4-Imidazolidinedione%2520Derivatives%2520Through%2520Cyclic%2520Transformations%2520Of%2520Ethyl%25202-Oxo-3%25282H%2529-Benzoxazoleacetate%2520Derivatives%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1996%26volume%3D33%26spage%3D1829%26epage%3D1833%26doi%3D10.1002%2Fjhet.5570330645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Çakir, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yildirim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ercanli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erol, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahin, M. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis And Anticonvulsant Activity Of Some (2/4-Substituted)Benzaldehyde (2-Oxobenzothiazolin-3-Yl)Acetohydrazones</span>. <i>II Farmaco</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.1016/S0014-827X(99)00110-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2FS0014-827X%2899%2900110-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10668187" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=842-845&author=B.+%C3%87akirauthor=E.+Yildirimauthor=T.+Ercanliauthor=K.+Erolauthor=M.+F.+Sahin&title=Synthesis+And+Anticonvulsant+Activity+Of+Some+%282%2F4-Substituted%29Benzaldehyde+%282-Oxobenzothiazolin-3-Yl%29Acetohydrazones&doi=10.1016%2FS0014-827X%2899%2900110-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2899%2900110-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252899%252900110-X%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2587akir%26aufirst%3DB.%26aulast%3DYildirim%26aufirst%3DE.%26aulast%3DErcanli%26aufirst%3DT.%26aulast%3DErol%26aufirst%3DK.%26aulast%3DSahin%26aufirst%3DM.%2BF.%26atitle%3DSynthesis%2520And%2520Anticonvulsant%2520Activity%2520Of%2520Some%2520%25282%252F4-Substituted%2529Benzaldehyde%2520%25282-Oxobenzothiazolin-3-Yl%2529Acetohydrazones%26jtitle%3DII%2520Farmaco%26date%3D1999%26volume%3D54%26spage%3D842%26epage%3D845%26doi%3D10.1016%2FS0014-827X%2899%2900110-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gökçe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geciken, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yildirim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosuni, A. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis And Anticonvulsant Activity Of 5-Chloro-2(3H)-Benzoxazolinone-3-Acetyl-2-(O/P-Substituted Benzal) Hydrazone Derivatives</span>. <i>Arzneimittelforschung</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1055/s-0031-1296554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1055%2Fs-0031-1296554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=19137903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252Fms1ejtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=537-542&author=M.+G%C3%B6k%C3%A7eauthor=A.+E.+Gecikenauthor=E.+Yildirimauthor=A.+U.+Tosuni&title=Synthesis+And+Anticonvulsant+Activity+Of+5-Chloro-2%283H%29-Benzoxazolinone-3-Acetyl-2-%28O%2FP-Substituted+Benzal%29+Hydrazone+Derivatives&doi=10.1055%2Fs-0031-1296554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anticonvulsant activity of 5-chloro-2(3H)-benzoxazolinone-3-acetyl-2-(o/p-substituted benzal) hydrazone derivatives</span></div><div class="casAuthors">Gokce Mehtap; Geciken Ahmet Emin; Yildirim Engin; Tosuni Ali Ulvi</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">537-42</span>
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">It is well known that some hydrazone derivatives of both 2-oxobenzoxazoline and 2-oxobenzothiazoline exhibit potent anticonvulsant activity.  In order to investigate the effects of structural modifications on the biological properties, 14 new hydrazones of 5-chloro-2(3H)-benzox-azolinone-3-acetyl hydrazide were synthesized.  The chemical structures of the synthesized compounds were established by IR, 1H-NMR spectral analyses and elementary analyses.  The anticonvulsant activities of the title compounds were tested by the penthylenetetrazole induced seizure test. 5-Chloro-2(3H)-benz-oxazolinone-3-acetyl-2-(o-methoxy-benzaldehyde)-hydrazone 4d, 5-chloro-2(3H)-benzoxazolinone-3-acetyl-2-(o-methybenzaldehyde)-hydrazone 4g, 5-chloro-2(3H)-benzoxazolinone-3-acetyl-2-(p-methylbenzaldehyde)-hydrazone 4h, 5-chloro-2(3H)-benzoxazolino-ne-3-acetyl-2-(p-nitrobenzaldehyde)-hydrazone 4m, and 5-chloro-2(3H)-benzox-azolinone-3-acetyl-2-(p-dimethylaminobenzaldehyde)-hydrazone 4n were found more active than phenytoin (CAS 57-41-0) in the tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTP6mFICSo5dKe0F5ixvZgXfW6udTcc2eY_r6IES5F4ibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252Fms1ejtQ%253D%253D&md5=943dad3712dc1f8c1e8cfdce80562baf</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1296554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1296554%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6k%25C3%25A7e%26aufirst%3DM.%26aulast%3DGeciken%26aufirst%3DA.%2BE.%26aulast%3DYildirim%26aufirst%3DE.%26aulast%3DTosuni%26aufirst%3DA.%2BU.%26atitle%3DSynthesis%2520And%2520Anticonvulsant%2520Activity%2520Of%25205-Chloro-2%25283H%2529-Benzoxazolinone-3-Acetyl-2-%2528O%252FP-Substituted%2520Benzal%2529%2520Hydrazone%2520Derivatives%26jtitle%3DArzneimittelforschung%26date%3D2008%26volume%3D58%26spage%3D537%26epage%3D542%26doi%3D10.1055%2Fs-0031-1296554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salgin-Gökşen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhan-Kelekci, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goktas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koysal, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktay, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozalp, M.</span></span> <span> </span><span class="NLM_article-title">1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: Synthesis, Analgesic-Anti-Inflammatory And Antimicrobial Activities</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5738</span>– <span class="NLM_lpage">5751</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.bmc.2007.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=17587585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BD2srgt1Glsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=5738-5751&author=U.+Salgin-G%C3%B6k%C5%9Fenauthor=N.+Gokhan-Kelekciauthor=O.+Goktasauthor=Y.+Koysalauthor=E.+Kilicauthor=S.+Isikauthor=G.+Aktayauthor=M.+Ozalp&title=1-Acylthiosemicarbazides%2C+1%2C2%2C4-triazole-5%284H%29-thiones%2C+1%2C3%2C4-thiadiazoles+and+hydrazones+containing+5-methyl-2-benzoxazolinones%3A+Synthesis%2C+Analgesic-Anti-Inflammatory+And+Antimicrobial+Activities&doi=10.1016%2Fj.bmc.2007.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities</span></div><div class="casAuthors">Salgin-Goksen Umut; Gokhan-Kelekci Nesrin; Goktas Ozgur; Koysal Yavuz; Kilic Ekrem; Isik Samil; Aktay Goknur; Ozalp Meral</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5738-51</span>
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    </div><div class="casAbstract">Acetic acid hydrazide containing 5-methyl-2-benzoxazolinone (4) was synthesized by the condensation of 2-(5-methyl-2-benzoxazolinone-3-yl)acetate with hydrazine hydrate.  Thiosemicarbazide derivatives (5a-5d) were afforded by the reaction of corresponding compound 4 with substituted isothiocyanates.  The cyclization of compounds 5a-5d in the presence of triethylamine resulted in the formation of compounds 6a-6d containing 1,2,4-triazole ring.  On the other hand, the treatment of compounds 5a-5d with orthophosphoric acid caused the conversion of side chain of compounds 5a-5d into 1,3,4-thiadiazole ring: thus, compounds 7a-7c were obtained.  The treatment of compound 4 with aromatic aldehydes resulted in the formation of arylidene hydrazides as cis-trans conformers (8a-8e).  The structures of the compounds were elucidated by spectral and elemental analysis.  While most compounds were exhibiting high activity in the analgesic-anti-inflammatory field, most of them were found to be inactive against bacteria and fungi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQV215khjecIQWRJ3OJdH_qfW6udTcc2eY_r6IES5F4ibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srgt1Glsw%253D%253D&md5=33ad7908138a83bb8e5f4a8629b5906a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DSalgin-G%25C3%25B6k%25C5%259Fen%26aufirst%3DU.%26aulast%3DGokhan-Kelekci%26aufirst%3DN.%26aulast%3DGoktas%26aufirst%3DO.%26aulast%3DKoysal%26aufirst%3DY.%26aulast%3DKilic%26aufirst%3DE.%26aulast%3DIsik%26aufirst%3DS.%26aulast%3DAktay%26aufirst%3DG.%26aulast%3DOzalp%26aufirst%3DM.%26atitle%3D1-Acylthiosemicarbazides%252C%25201%252C2%252C4-triazole-5%25284H%2529-thiones%252C%25201%252C3%252C4-thiadiazoles%2520and%2520hydrazones%2520containing%25205-methyl-2-benzoxazolinones%253A%2520Synthesis%252C%2520Analgesic-Anti-Inflammatory%2520And%2520Antimicrobial%2520Activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D5738%26epage%3D5751%26doi%3D10.1016%2Fj.bmc.2007.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davey, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tivey, D. J.</span></span> <span> </span><span class="NLM_article-title">Chalcones and Related Compounds. 4. Addition of Hydrogen Cyanide to Chalcones</span>. <i>J. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1958</span>,  <span class="NLM_fpage">1230</span>– <span class="NLM_lpage">1236</span>, <span class="refDoi"> DOI: 10.1039/jr9580001230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1039%2Fjr9580001230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaG1cXmsFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1958&pages=1230-1236&author=W.+Daveyauthor=D.+J.+Tivey&title=Chalcones+and+Related+Compounds.+4.+Addition+of+Hydrogen+Cyanide+to+Chalcones&doi=10.1039%2Fjr9580001230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcones and related compounds. IV. Addition of hydrogen cyanide to chalcones</span></div><div class="casAuthors">Davey, W.; Tivey, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1230-6</span>CODEN:
                <span class="NLM_cas:coden">JCSOA9</span>;
        ISSN:<span class="NLM_cas:issn">0368-1769</span>.
    </div><div class="casAbstract">cf. C.A. 51, 10450h.  Optimum preparative conditions for RC6H4CH:CHCOC6H4R' (I) were established and new I were prepd.  Procedures for the addn. of HCN to I and hydrolysis of the adducts were improved and new lactones, pyridazinones, and diols prepd. from these adducts.  Comparative expts. showed that NaOH and NaOMe were generally more effective condensing agents than HCl, POCl3, or BF3 in the prepn. of 12 substituted I.  Kohler and Chadwell's method (Org. Syntheses, Collective Vol. I, 78 (1941)) (method A) was modified in method B.  Equimolar amts. of RC6H4CHO (II) and AcC6H4R' (III) mixed at 25° and if necessary made homogeneous with alc. at 30°, the mixt. made alk. to Brilliant Yellow with a 10% excess of 5N NaOH at 25-30° (external cooling), the mixt. kept homogeneous with addn. of alc. in 0.5-5.0 hrs., filtered, and washed with H2O, the filtrate dild. with H2O, and the product washed with H2O gave a product, crystd. once to give pure I.  In method C, 1 mole II and 1 mole III in 200 ml. Ac2O were satd. with HCl below 30°, the mixt. kept 12 hrs. at room temp. and poured into ice and NH4OH, the oily product steam, distd., and the residue recrystd.  Equimolar amts. of II and III liquefied by addn. of C6H6 were treated with a few drops of POCl3 at 30°, the mixt. kept at room temp. a few hrs., the product washed with 2N NH4OH and H2O, the C6H6 evapd. in vacuo, the residue steam-distd. and the product recrystd. (method D).  In method E, 1 mole II was treated with 1 mole 48% BF3 in sufficient AcOH at 25° to dissolve II, the soln. treated slowly with 1 mole III at 25-30°, and the red mixt. kept 12 hrs. at room temp., treated with excess NaOAc soln., and steam-distd. to give a product requiring repeated recrystn.  II (1 mole) in 200 ml. anhyd. MeOH added at 30° to 100 ml. MeOH contg 10 g. Na and the soln. treated with 1 mole III, the mixt. kept some hrs. at room temp. and filtered, the product washed, combined with the material recovered from the dild. filtrate, and recrystd. (method F).  Results of comparative prepns. of I (R = R' = H) (Ia) were tabulated [method, % yield, reaction time in hrs., and m.p. (no. of recrystns.) given]: A, 89, 2, 52° (1); B, 76, 1, 55° (0); C, 50, 12, 53° (2); D, 48, 12, 52° (2); E, 53, 6, 52° (2); F, 71, 4, 52° (1).  Similar results with substituted I were summarized [R, R', % yield (m.p.) for methods B, C, D, E, and F given]: p-MeO, H, 76 (75°), 50(72°), 47(73°), 52(70°), 61(72°); p-MeO, p-MeO, 81(100°), 66(99°), 50(100°), 62(97°), 75(98°); p-MeO, p-Me, 55(91°), -, -, 70(124°), -, -, 77(126°); p-Me, H, 42(94°), 30(95.5°), 20(96°), -, 45(95°); p-HO, H, 37(180°), 11(182°), 20(179°), 25(179°), 31(182°); H, p-MeO, 81(106°), 55(105°), 45(104°), -, 77(108°); P-O2N, H, 60(162°), 80(162°), 42(162°), 35(162°), 57(162°); H, m-O2N, 75(130°), 25(131°), 10(130°), -, tar; H, p-Me, 35(75°), 42(75°), 22(72°), 23(72°), -.  HCN was added to la and I (R = p-MeO, R' = H) by the method of Allan and Kimball (Org. Syntheses, Coll. Vol. II, 498), but the method failed with I (R = H, R' = p-MeO) (Ib), I (R = R' = p-MeO) (Ic), and I (R = H, R' = p-HO).  The method of Kohler and Leers (C.A. 28, 30646) gave a low yield of HCN adduct with Ib but failed with Ic. Ia (41.6 g.) in 700 ml. alc. stirred with cooling with slow addn. of 50 ml. 7N H2SO4, the mixt. heated to 50°, treated slowly with 50 g. KCN in 80 ml. H2O and the mixt. refluxed 5 min., dild. with 200 ml. H2O, kept 12 hrs. at 20°, and filtered, the solid product extd. 3 times with 100 ml. boiling alc., the ext. evapd., and the residue crystd. (alc.) gave 35 g. PhCH(CN)CH2Bz, m. 126°.  Similarly high yields of adducts, RCH(CN)CH2COC6H4R' (IV) were obtained by the use of 1 mole H2SO4 and 2 moles KCN (R, R', m.p., and % yield given): Ph, p-MeO, 65°, 86; p-MeOC6H4, p-MeO, 113-14°, 66; p-HOC6H4, H, 173°, 68; 2,4-(MeO)2C6H3, p-MeOC6H4, 125-6°, 83; 3,4-(MeO)2C6H3, p-MeO, 105°, 79.  Acid hydrolysis of IV was difficult, and the resultant acids, RCH(CO2H)CH2COR' (V), tended to sep. as oils.  Conversion of IV into the Me esters, RCH(CO2Me)CH2COR' (VI) by boiling with HCl in MeOH and hydrolysis of VI with dil. NaOH gave good yields of V.  IV (R = R' = H) (23.5 g.) in 200 ml. MeOH satd. with dry HCl at 25° and refluxed 1.5 hrs., 100 ml. MeOH distd., the concentrate dild. with 200 ml. H2O, the mixt. kept overnight at room temp. and filtered gave 24 g. VI (R = R' = Ph) (VIa), m. 103°.  Similarly were prepd. the esters VI [R, R', m.p. (solvent) and % yield given]: Ph, p-MeOC6H4 (VIb), 96° (MeOH), 91; p-MeOC6H4, p-MeOC6H4 (VIc), 96-7° (MeOH), 85; p-HOC6H4, Ph (VId), 143-4° (MeOH), 83; 2,4-(MeO)2C6H3, p-MeOC6H4, 128-9° (EtOH), 83; 3,4-(MeO)2C6H3, p-MeOC6H4, 74-5° (MeOH), 73.  VIa (26.8 g.) refluxed 2 hrs. in 100 ml. alc. with 100 ml. 2N NaOH, the soln. treated with 120 ml. 2N HCl, and the mixt. kept overnight at room temp. and filtered gave 23 g. V (R = R' = Ph) (Vc), m. 152° (alc.).  Similarly were obtained the acids V [R, R', m.p. (solvent) and % yield given]: Ph, p-MeOC6H4 (Vb), 139-40° (alc.), 93; p-MeOC6H4, p-MeOC6H4 (Vc), 163-4° (alc.), 91; p-HOC6H4, Ph (Vd), 143-4° (MeOH), 83; 2,4-(MeO)2C6H3, p-MeOC6H4, 127-8° (alc.), 80; 3,4-(MeO)2C6H3, p-MeOC6H4, 179-80° (alc.), 80.  Va (12.7 g.) refluxed 3 hrs. in 25 ml. Ac2O and the mixt. poured into cold H2O, kept 1 hr., and filtered, the ppt. (10 g.) taken up in 50 ml. boiling alc., and the cooled soln. filtered gave 2.6 g. material, recrystd. (alc.) to give 1.7 g. high melting unsatd. 4-hydroxy-2,4-diphenyl-2-butenoic lactone (VII), O.CO.CR:CH.CHR' (R = R' = Ph) (VIIa), m. 283-5°.  The filtrate dild. with 15 ml. H2O and the 6.1 g. dried product, m. 91°, recrystd. (alc.) yielded 3.7 g. low melting isomeric lactone (VIII), O.CO.CHR.CH:CR' (R = R' = Ph) (VIIIa), m. 107-8°.  Similarly, from Vb, Vc, and Vd were prepd. the corresponding pairs of isomeric lactones (reflux time in hrs., lactones, and m.p. given): 2, VIIb, 250-60° (decompn.), VIIIb, 92; 1.5, VIIc, 255-60° (decompn.), VIIIc, 106-7°; 1, VIId, 282-4° (decompn.), VIIId, 131-2.  Va (5 g.) heated 2 hrs. at 165° and the cooled melt taken up in 30 ml. boiling alc., the filtered soln. cooled and filtered gave 0.2 g. VIIa.  Concn. of the filtrate gave 3.7 g. VIIIa.  Similarly, small amts. of VIIa were obtained by heating Va with alc. or AcOH.  Rast mol. wt. detns. and repeated analyses confirmed the monomeric nature of the extremely insol. VII, and slightly favorable evidence was given by the infrared spectral bands of VIIc and VIIIc, ν 1763 and 1750 cm.-1, resp. (in nujol).  VIIIa (2 g.) hydrogenated in 25 ml. alc. with 0.5 g. 10% Pd-C, the filtered soln. dild. with H2O, extd. 3 times with 20 ml. 2N Na2CO3, the ext. washed twice with 20 ml. Et2O, the aq. soln. acidified with HCl, the oily product extd. twice with 20 ml. Et2O, the ext. evapd. in vacuo, and the residue crystd. (petr. ether) gave 1.5 g. PhCH2CH2CHPhCO2H, m. 73-4°.  VIa (5 g.) in 50 ml. alc. added slowly with stirring to 2 g. KBH4 in 100 ml. 19:1 alc.-H2O, the mixt. kept 5 hrs. at room temp. evapd. to 30 ml. and acidified with HCl, the viscous green sirupy extd. with C6H6, and the solidified product recrystd. (alc.) gave 3.5 g. satd. lactone (IX), O.CO.CHR.CH2.CHR' (R = R' = Ph) (IXa), m. 102° (alc.), also obtained by hydrogenation of 4 g. VIa in 50 ml. alc. with 1 g. Raney Ni and crystn. (pert. ether) of the product.  Similarly with Pd-C were obtained 62% IX (R = Ph, R' = p-MeOC6H4), m. 77° (alc.), and 90% IX (R = R' = p-MeOC6H4), m. 136-7°(alc.).  VIa (5 g.) extd. from a Soxhlet app. thimble into 150 ml. Et2O contg. 1.5 g. LiAlH4, the mixt. refluxed 2 hrs., treated with EtOAc and 100 ml. 2N H2SO4, the Et2O layer washed with H2O, the soln. dried, evapd., and the sirupy residue kept 7 days at 0° under petr. ether gave 3 g. HOCH2CHRCH2CHR'OH (X) (R = R' = Ph), m. 92°.  Similarly were prepd. 33% X (R = Ph, R' = p-MeOC6H4), m. 48-50°; 81% X (R = R' = p-MeOC6H4), m. 80-90°; and gummy X (R = p-HOC6H4, R = Ph).  VIa (20 g.) and 6.6 g. PhNHNH2 in 170 ml. AcOH heated 15 min. on a steam bath, the cooled soln. dild. with 100 ml. H2O, filtered, and the cryst. residue recrystd. (alc.) yielded 75% RCH.CO.NPh.N:CR'.CH2 (XI) (R = R' = Ph), m. 121-3°.  By the same method, or with V in the place of VI, were prepd. 85% XI (R = Ph, R' = p-MeOC6H4), m. 94-5°, and 56% XI (R = R' = p-MeOC6H4), m. 123°, ν 1696, 1601, 1514, 1490 cm.-1, confirming the assigned pyridazine structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAyRF2hDw9brVg90H21EOLACvtfcHk0liNwhCXjuQYtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXmsFyhsQ%253D%253D&md5=ba4153fda21a436dfe582b2b6d4b8157</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2Fjr9580001230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fjr9580001230%26sid%3Dliteratum%253Aachs%26aulast%3DDavey%26aufirst%3DW.%26aulast%3DTivey%26aufirst%3DD.%2BJ.%26atitle%3DChalcones%2520and%2520Related%2520Compounds.%25204.%2520Addition%2520of%2520Hydrogen%2520Cyanide%2520to%2520Chalcones%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1958%26spage%3D1230%26epage%3D1236%26doi%3D10.1039%2Fjr9580001230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goksen, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarigul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bultinck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrebout, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yelekci, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ucar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhan Kelekci, N.</span></span> <span> </span><span class="NLM_article-title">Absolute Configuration And Biological Profile Of Pyrazoline Enantiomers As MAO Inhibitory Activity</span>. <i>Chirality</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1002/chir.23027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2Fchir.23027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=30468523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ylsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2019&pages=21-33&author=U.+S.+Goksenauthor=S.+Sarigulauthor=P.+Bultinckauthor=W.+Herreboutauthor=I.+Doganauthor=K.+Yelekciauthor=G.+Ucarauthor=N.+Gokhan+Kelekci&title=Absolute+Configuration+And+Biological+Profile+Of+Pyrazoline+Enantiomers+As+MAO+Inhibitory+Activity&doi=10.1002%2Fchir.23027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Absolute configuration and biological profile of pyrazoline enantiomers as MAO inhibitory activity</span></div><div class="casAuthors">Goksen, Umut Salgin; Sarigul, Sevgi; Bultinck, Patrick; Herrebout, Wouter; Dogan, Ilknur; Yelekci, Kemal; Ucar, Gulberk; Gokhan Kelekci, Nesrin</div><div class="citationInfo"><span class="NLM_cas:title">Chirality</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-33</span>CODEN:
                <span class="NLM_cas:coden">CHRLEP</span>;
        ISSN:<span class="NLM_cas:issn">0899-0042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A new racemic pyrazoline deriv. was synthesized and resolved to its enantiomers using analytic and semipreparative high-pressure liq. chromatog.  The abs. configuration of both fractions was established using vibrational CD.  The in vitro monoamine oxidase (MAO) inhibitory profiles were evaluated for the racemate and both enantiomers sep. for the two isoforms of the enzyme.  The racemic compd. and both enantiomers were found to inhibit hMAO-A selectively and competitively.  In particular, the R enantiomer was detected as an exceptionally potent and a selective MAO-A inhibitor (Ki = 0.85 x 10-3 ± 0.05 x 10-3 μM and SI: 2.35 x 10-5), whereas S was detd. as poorer compd. than R in terms of Ki and SI (0.184 ± 0.007 and 0.001).  The selectivity of the enantiomers was explained by mol. modeling docking studies based on the PDB enzymic models of MAO isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7O71NGpQUObVg90H21EOLACvtfcHk0liNwhCXjuQYtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ylsr%252FP&md5=c04a9e6fbafd62147fbe63f76aae4dad</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fchir.23027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchir.23027%26sid%3Dliteratum%253Aachs%26aulast%3DGoksen%26aufirst%3DU.%2BS.%26aulast%3DSarigul%26aufirst%3DS.%26aulast%3DBultinck%26aufirst%3DP.%26aulast%3DHerrebout%26aufirst%3DW.%26aulast%3DDogan%26aufirst%3DI.%26aulast%3DYelekci%26aufirst%3DK.%26aulast%3DUcar%26aufirst%3DG.%26aulast%3DGokhan%2BKelekci%26aufirst%3DN.%26atitle%3DAbsolute%2520Configuration%2520And%2520Biological%2520Profile%2520Of%2520Pyrazoline%2520Enantiomers%2520As%2520MAO%2520Inhibitory%2520Activity%26jtitle%3DChirality%26date%3D2019%26volume%3D31%26spage%3D21%26epage%3D33%26doi%3D10.1002%2Fchir.23027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span> <span> </span><span class="NLM_article-title">Admetsar 2.0: Web-Service For Prediction And Optimization Of Chemical ADMET Properties</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1069</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/bty707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1093%2Fbioinformatics%2Fbty707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=30165565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvV2rsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2019&pages=1067-1069&author=H.+Yangauthor=C.+Louauthor=L.+Sunauthor=J.+Liauthor=Y.+Caiauthor=Z.+Wangauthor=W.+Liauthor=G.+Liuauthor=Y.+Tang&title=Admetsar+2.0%3A+Web-Service+For+Prediction+And+Optimization+Of+Chemical+ADMET+Properties&doi=10.1093%2Fbioinformatics%2Fbty707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties</span></div><div class="casAuthors">Yang, Hongbin; Lou, Chaofeng; Sun, Lixia; Li, Jie; Cai, Yingchun; Wang, Zhuang; Li, Weihua; Liu, Guixia; Tang, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1067-1069</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4811</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">AdmetSAR was developed as a comprehensive source and free tool for the prediction of chem. ADMET properties.  Since its first release in 2012 contg. 27 predictive models, admetSAR has been widely used in chem. and pharmaceutical fields.  This update, admetSAR 2.0, focuses on extension and optimization of existing models with significant quantity and quality improvement on training data.  Now 47 models are available for either drug discovery or environmental risk assessment.  In addn., we added a new module named ADMETopt for lead optimization based on predicted ADMET properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfhqvVz6_0frVg90H21EOLACvtfcHk0liNwhCXjuQYtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvV2rsL3O&md5=1f16a615c38981b2b29140d6d51bb46b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbty707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbty707%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLou%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DY.%26atitle%3DAdmetsar%25202.0%253A%2520Web-Service%2520For%2520Prediction%2520And%2520Optimization%2520Of%2520Chemical%2520ADMET%2520Properties%26jtitle%3DBioinformatics%26date%3D2019%26volume%3D35%26spage%3D1067%26epage%3D1069%26doi%3D10.1093%2Fbioinformatics%2Fbty707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span> <span> </span><span class="NLM_article-title">Lead- And Drug-Like Compounds: The Rule-Of-Five Revolution</span>. <i>Drug Discovery Today: Technol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/j.ddtec.2004.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.ddtec.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=24981612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=337-341&author=C.+A.+Lipinski&title=Lead-+And+Drug-Like+Compounds%3A+The+Rule-Of-Five+Revolution&doi=10.1016%2Fj.ddtec.2004.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Lead- and drug-like compounds: the rule-of-five revolution</span></div><div class="casAuthors">Lipinski, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Technologies</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-341</span>CODEN:
                <span class="NLM_cas:coden">DDTTB5</span>;
        ISSN:<span class="NLM_cas:issn">1740-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Citations in CAS SciFinder to the rule-of-five (RO5) publication will exceed 1000 by year-end 2004.  Trends in the RO5 literature explosion that can be discerned are the further definitions of drug-like.  This topic is explored in terms of drug-like physicochem. features, drug-like structural features, a comparison of drug-like and non-drug-like in drug discovery and a discussion of how drug-like features relate to clin. success.  Physicochem. features of CNS drugs and features related to CNS blood-brain transporter affinity are briefly reviewed.  Recent literature on features of non-oral drugs is reviewed and how features of lead-like compds. differ from those of drug-like compds. is discussed.  Most recently, partly driven by NIH roadmap initiatives, considerations have arisen as to what tool-like means in the search for chem. tools to probe biol. space.  All these topics frame the scope of this short review/perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjiyP3CY7lLVg90H21EOLACvtfcHk0lhCgsNVLiNvXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D&md5=952c29b47003b884116d790ae9e4721f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DLead-%2520And%2520Drug-Like%2520Compounds%253A%2520The%2520Rule-Of-Five%2520Revolution%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2004%26volume%3D1%26spage%3D337%26epage%3D341%26doi%3D10.1016%2Fj.ddtec.2004.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E. H.</span></span> <i>Drug-Like Properties: Concepts, Structure Design and Methods From ADME to Toxicity Optimization</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Massachusetts</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=L.+Di&author=E.+H.+Kerns&title=Drug-Like+Properties%3A+Concepts%2C+Structure+Design+and+Methods+From+ADME+to+Toxicity+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26btitle%3DDrug-Like%2520Properties%253A%2520Concepts%252C%2520Structure%2520Design%2520and%2520Methods%2520From%2520ADME%2520to%2520Toxicity%2520Optimization%26pub%3DAcademic%2520Press%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Şahin, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgın-Gökşen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gökhan Kelekçi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Işık, Ş.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Crystal Structures And DFT Studies Of 1-[2- (5-Methyl-2-Benzoxazolinone-3-Yl) Acetyl]-3-Phenyl-5- (3,4-Dimethoxyphenyl)-4,5-Dihydro-1H-Pyrazole And 1-[2-(5-Chloro-2-Benzoxazolinone-3-Yl)Acetyl]-3-Phenyl-5-(4-Methoxyphenyl)-4,5-Dihydro-1H-Pyrazole</span>. <i>J. Mol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1006</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1016/j.molstruc.2011.08.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.molstruc.2011.08.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyjs73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1006&publication_year=2011&pages=147-158&author=Z.+S.+%C5%9Eahinauthor=U.+Salg%C4%B1n-G%C3%B6k%C5%9Fenauthor=N.+G%C3%B6khan+Kelek%C3%A7iauthor=%C5%9E.+I%C5%9F%C4%B1k&title=Synthesis%2C+Crystal+Structures+And+DFT+Studies+Of+1-%5B2-+%285-Methyl-2-Benzoxazolinone-3-Yl%29+Acetyl%5D-3-Phenyl-5-+%283%2C4-Dimethoxyphenyl%29-4%2C5-Dihydro-1H-Pyrazole+And+1-%5B2-%285-Chloro-2-Benzoxazolinone-3-Yl%29Acetyl%5D-3-Phenyl-5-%284-Methoxyphenyl%29-4%2C5-Dihydro-1H-Pyrazole&doi=10.1016%2Fj.molstruc.2011.08.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, crystal structures and DFT studies of 1-[2-(5-methyl-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole and 1-[2-(5-chloro-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole</span></div><div class="casAuthors">Sahin, Zarife Sibel; Salgin-Goeksen, Umut; Goekhan-Kelekci, Nesrin; Isik, Samil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1006</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">147-158</span>CODEN:
                <span class="NLM_cas:coden">JMOSB4</span>;
        ISSN:<span class="NLM_cas:issn">0022-2860</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The title compds., 1-[2-(5-methyl-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole (5a) and 1-[2-(5-chloro-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole (5b), were synthesized.  The crystal and mol. structures of 5a and 5b have been detd. by elemental analyses, IR, 1H NMR, ESI-MS and single-crystal X-ray diffraction.  Mol. geometries of 5a and 5b in the ground state have been calcd. using the d. functional method (DFT) with B3LYP/6-31G(d,p) basis set and compared with the exptl. data.  In addn., the mol. electrostatic potential maps and frontier MOs of 5a and 5b were performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot-hoSFRpZFrVg90H21EOLACvtfcHk0lhCgsNVLiNvXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyjs73I&md5=571fd0d3521c19d3ecd09b77d8a84e7c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2011.08.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2011.08.061%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%259Eahin%26aufirst%3DZ.%2BS.%26aulast%3DSalg%25C4%25B1n-G%25C3%25B6k%25C5%259Fen%26aufirst%3DU.%26aulast%3DG%25C3%25B6khan%2BKelek%25C3%25A7i%26aufirst%3DN.%26aulast%3DI%25C5%259F%25C4%25B1k%26aufirst%3D%25C5%259E.%26atitle%3DSynthesis%252C%2520Crystal%2520Structures%2520And%2520DFT%2520Studies%2520Of%25201-%255B2-%2520%25285-Methyl-2-Benzoxazolinone-3-Yl%2529%2520Acetyl%255D-3-Phenyl-5-%2520%25283%252C4-Dimethoxyphenyl%2529-4%252C5-Dihydro-1H-Pyrazole%2520And%25201-%255B2-%25285-Chloro-2-Benzoxazolinone-3-Yl%2529Acetyl%255D-3-Phenyl-5-%25284-Methoxyphenyl%2529-4%252C5-Dihydro-1H-Pyrazole%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2011%26volume%3D1006%26spage%3D147%26epage%3D158%26doi%3D10.1016%2Fj.molstruc.2011.08.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gökşen, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alpaslan, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelekci, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekizoglu, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Crystal Structures And Theoretical Calculations Of New 1-[2-(5-Chloro-2-Benzoxazolinone-3-Yl)Acetyl]-3,5-Diphenyl-4,5-Dihydro-(1H)-Pyrazoles</span>. <i>J. Mol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1039</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1016/j.molstruc.2013.01.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.molstruc.2013.01.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1aqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1039&publication_year=2013&pages=71-83&author=U.+S.+G%C3%B6k%C5%9Fenauthor=Y.+B.+Alpaslanauthor=N.+Kelekciauthor=S.+Isikauthor=M.+Ekizoglu&title=Synthesis%2C+Crystal+Structures+And+Theoretical+Calculations+Of+New+1-%5B2-%285-Chloro-2-Benzoxazolinone-3-Yl%29Acetyl%5D-3%2C5-Diphenyl-4%2C5-Dihydro-%281H%29-Pyrazoles&doi=10.1016%2Fj.molstruc.2013.01.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, crystal structures and theoretical calculations of new 1-[2-(5-chloro-2-benzoxazolinone-3-yl)acetyl]-3,5-diphenyl-4,5-dihydro-(1H)-pyrazoles</span></div><div class="casAuthors">Goksen, Umut Salgin; Alpaslan, Yelda Bingol; Kelekci, Nesrin Gokhan; Isik, Samil; Ekizoglu, Melike</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1039</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71-83</span>CODEN:
                <span class="NLM_cas:coden">JMOSB4</span>;
        ISSN:<span class="NLM_cas:issn">0022-2860</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">1-[2-(5-Chloro-2-benzoxazolinone-3-yl)acetyl]-3,5-diphenyl-4,5-dihydro-(1H)-pyrazoles I (R1 = R2 = R4 = H, R3 = OMe; R1 = R4 = H, R2 = R3 = OMe; R1 = Me, R2 = H, R3 = R4 = OMe) were synthesized.  The crystal and mol. structures of the compds. I were detd. by elemental analyses, IR, 1H NMR, ESI-MS and single-crystal X-ray diffraction.  DFT method with 6-31G(d,p) basis set was used to calc. the optimized geometrical parameters, vibrational frequencies and chem. shift values.  The calcd. vibrational frequencies and chem. shift values were compared with exptl. IR and 1H NMR values.  The results represented that there was a good agreement between exptl. and calcd. values of the compds. I.  In addn., DFT calcns. of the compds., mol. electrostatic potentials (MEPs) and frontier MOs were performed at B3LYP/6-31G(d,p) level of theory.  Furthermore, compds. were tested against three Gram-pos. bacteria: Staphylococcus aureus ATCC 29213 (American Type Culture Collection), methicillin resistant S. aureus (MRSA) ATCC 43300 and Enterococcus faecalis ATCC 29212; two Gram neg. bacteria: Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853; and three fungi: Candida albicans ATCC 90028, Candida krusei ATCC 6258 and Candida parapsilosis ATCC 90018.  In general, all of the compds. were found to be slightly active against tested microorganisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZxDgeq2LXCbVg90H21EOLACvtfcHk0liUOLlFDe1rEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1aqs70%253D&md5=e54820d1a8f71cc80bdf7fa49b6f56b5</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2013.01.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2013.01.066%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6k%25C5%259Fen%26aufirst%3DU.%2BS.%26aulast%3DAlpaslan%26aufirst%3DY.%2BB.%26aulast%3DKelekci%26aufirst%3DN.%26aulast%3DIsik%26aufirst%3DS.%26aulast%3DEkizoglu%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520Crystal%2520Structures%2520And%2520Theoretical%2520Calculations%2520Of%2520New%25201-%255B2-%25285-Chloro-2-Benzoxazolinone-3-Yl%2529Acetyl%255D-3%252C5-Diphenyl-4%252C5-Dihydro-%25281H%2529-Pyrazoles%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2013%26volume%3D1039%26spage%3D71%26epage%3D83%26doi%3D10.1016%2Fj.molstruc.2013.01.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirshner, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilmeier, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lightstone, F. C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">A Method to Predict Blood-Brain Barrier Permeability of Drug-Like Compounds Using Molecular Dynamics Simulations</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">630</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1016/j.bpj.2014.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.bpj.2014.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=25099802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12msrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2014&pages=630-641&author=T.+S.+Carpenterauthor=D.+A.+Kirshnerauthor=E.+Y.+Lauauthor=S.+E.+Wongauthor=J.+P.+Nilmeierauthor=F.+C.+Lightstone&title=A+Method+to+Predict+Blood-Brain+Barrier+Permeability+of+Drug-Like+Compounds+Using+Molecular+Dynamics+Simulations&doi=10.1016%2Fj.bpj.2014.06.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A Method to Predict Blood-Brain Barrier Permeability of Drug-Like Compounds Using Molecular Dynamics Simulations</span></div><div class="casAuthors">Carpenter, Timothy S.; Kirshner, Daniel A.; Lau, Edmond Y.; Wong, Sergio E.; Nilmeier, Jerome P.; Lightstone, Felice C.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">630-641</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) is formed by specialized tight junctions between endothelial cells that line brain capillaries to create a highly selective barrier between the brain and the rest of the body.  A major problem to overcome in drug design is the ability of the compd. in question to cross the BBB.  Neuroactive drugs are required to cross the BBB to function.  Conversely, drugs that target other parts of the body ideally should not cross the BBB to avoid possible psychotropic side effects.  Thus, the task of predicting the BBB permeability of new compds. is of great importance.  Two gold-std. exptl. measures of BBB permeability are logBB (the concn. of drug in the brain divided by concn. in the blood) and logPS (permeability surface-area product).  Both methods are time-consuming and expensive, and although logPS is considered the more informative measure, it is lower throughput and more resource intensive.  With continual increases in computer power and improvements in mol. simulations, in silico methods may provide viable alternatives.  Computational predictions of these two parameters for a sample of 12 small mol. compds. were performed.  The potential of mean force for each compd. through a 1,2-dioleoyl-sn-glycero-3-phosphocholine bilayer is detd. by mol. dynamics simulations.  This system setup is often used as a simple BBB mimetic.  Addnl., one-dimensional position-dependent diffusion coeffs. are calcd. from the mol. dynamics trajectories.  The diffusion coeff. is combined with the free energy landscape to calc. the effective permeability (Peff) for each sample compd.  The relative values of these permeabilities are compared to exptl. detd. logBB and logPS values.  Our computational predictions correlate remarkably well with both logBB (R2 = 0.94) and logPS (R2 = 0.90).  Thus, we have demonstrated that this approach may have the potential to provide reliable, quant. predictive BBB permeability, using a relatively quick, inexpensive method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr97tFORPkLbLVg90H21EOLACvtfcHk0liUOLlFDe1rEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12msrrF&md5=70da942a59a290e480a88f2a1f4afb53</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bpj.2014.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpj.2014.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DCarpenter%26aufirst%3DT.%2BS.%26aulast%3DKirshner%26aufirst%3DD.%2BA.%26aulast%3DLau%26aufirst%3DE.%2BY.%26aulast%3DWong%26aufirst%3DS.%2BE.%26aulast%3DNilmeier%26aufirst%3DJ.%2BP.%26aulast%3DLightstone%26aufirst%3DF.%2BC.%26atitle%3DA%2520Method%2520to%2520Predict%2520Blood-Brain%2520Barrier%2520Permeability%2520of%2520Drug-Like%2520Compounds%2520Using%2520Molecular%2520Dynamics%2520Simulations%26jtitle%3DBiophys.%2520J.%26date%3D2014%26volume%3D107%26spage%3D630%26epage%3D641%26doi%3D10.1016%2Fj.bpj.2014.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High Throughput Artificial Membrane Permeability Assay For Blood-Brain Barrier</span>. <i>Eur J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+Throughput+Artificial+Membrane+Permeability+Assay+For+Blood-Brain+Barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0liUOLlFDe1rEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520Throughput%2520Artificial%2520Membrane%2520Permeability%2520Assay%2520For%2520Blood-Brain%2520Barrier%26jtitle%3DEur%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borsini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meli, A.</span></span> <span> </span><span class="NLM_article-title">Is The Forced Swimming Test A Suitable Model For Revealing Antidepressant Activity?</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1007/BF00176837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2FBF00176837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=3127840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaL1c7nslWnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1988&pages=147-160&author=F.+Borsiniauthor=A.+Meli&title=Is+The+Forced+Swimming+Test+A+Suitable+Model+For+Revealing+Antidepressant+Activity%3F&doi=10.1007%2FBF00176837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Is the forced swimming test a suitable model for revealing antidepressant activity?</span></div><div class="casAuthors">Borsini F; Meli A</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-60</span>
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">The forced swimming test is reviewed.  This test appears to be suitable for detecting antidepressant activity in rats but not in mice.  Difference in experimental procedure may account for the different sensitivity to drugs of the two animal species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCdVg1V6KRfxe4jJGKT5N0fW6udTcc2eYs6-XCOO8tvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c7nslWnsQ%253D%253D&md5=d7a3d707b4ab6700b0dd8f23b39aa03d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2FBF00176837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00176837%26sid%3Dliteratum%253Aachs%26aulast%3DBorsini%26aufirst%3DF.%26aulast%3DMeli%26aufirst%3DA.%26atitle%3DIs%2520The%2520Forced%2520Swimming%2520Test%2520A%2520Suitable%2520Model%2520For%2520Revealing%2520Antidepressant%2520Activity%253F%26jtitle%3DPsychopharmacology%26date%3D1988%26volume%3D94%26spage%3D147%26epage%3D160%26doi%3D10.1007%2FBF00176837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalakrishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudani, I.</span></span> <span> </span><span class="NLM_article-title">Acquaintance With The Actuality: Community Diagnosis Programme Of Kathmandu Medical College At Gundu Village, Bhaktapur, Nepal</span>. <i>Kathmandu Univ. Med. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=18604130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BD1cvjsVOqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=128-134&author=A.+Vaidyaauthor=A.+Pradhanauthor=S.+K.+Joshiauthor=S.+Gopalakrishnanauthor=I.+Dudani&title=Acquaintance+With+The+Actuality%3A+Community+Diagnosis+Programme+Of+Kathmandu+Medical+College+At+Gundu+Village%2C+Bhaktapur%2C+Nepal"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Acquaintance with the actuality: community diagnosis programme of Kathmandu Medical College at Gundu village, Bhaktapur, Nepal</span></div><div class="casAuthors">Vaidya A; Pradhan A; Joshi S K; Gopalakrishnan S; Dudani I</div><div class="citationInfo"><span class="NLM_cas:title">Kathmandu University medical journal (KUMJ)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  In Nepal, various field programs such as community diagnosis programmes (CDP) have been initiated to make the education of doctors, nurses and dentists more community oriented and relevant and suited to the health care scenario.  Community diagnosis refers to the identification and quantification of the health problems in a community and identification of their correlates for the purpose of defining those individuals or groups at risk or those in need of health care.  The article presents the main activities of community diagnosis as a core component of community-based education for the medical students at Kathmandu Medical College, Kathmandu, Nepal.  METHODOLOGY:  A 4 weeks' Community Diagnosis Programme was conducted by MBBS II students (9th Batch) of the Kathmandu Medical College under the supervision of the Department of Community Medicine in November 2006 in the rural community of Gundu VDC (village development committee).  The tools used included pre-tested questionnaires, weighing machines, measuring tapes, stethoscopes and sphygmomanometers.  After the data collection and compilation, the students presented their findings in oral presentations, accompanied by a written report, including essential recommendations for improving the health status of these communities.  RESULTS:  The students benefited from the necessary process of integrating clinical skills and a public health approach, so as to enhance their epidemiological thinking and be of greater use to the communities where they will practice.  The community also benefited by achievement of behavioral changes leading to healthier lifestyles and increased awareness of health-related matters and their role in quality of life.  CONCLUSIONS:  CDP is a way to practically demonstrate that the link between a medical college and society is possible.  That is, a medical college can serve the community and thus society, with specific activities to improve health and the skills of students who will serve as future health professionals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZa6Tg6u8uRFUIs6wFK5xJfW6udTcc2eYs6-XCOO8tvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvjsVOqtg%253D%253D&md5=508878934b776028e0f4524da24c3780</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVaidya%26aufirst%3DA.%26aulast%3DPradhan%26aufirst%3DA.%26aulast%3DJoshi%26aufirst%3DS.%2BK.%26aulast%3DGopalakrishnan%26aufirst%3DS.%26aulast%3DDudani%26aufirst%3DI.%26atitle%3DAcquaintance%2520With%2520The%2520Actuality%253A%2520Community%2520Diagnosis%2520Programme%2520Of%2520Kathmandu%2520Medical%2520College%2520At%2520Gundu%2520Village%252C%2520Bhaktapur%252C%2520Nepal%26jtitle%3DKathmandu%2520Univ.%2520Med.%2520J.%26date%3D2008%26volume%3D6%26spage%3D128%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, V.</span>; <span class="NLM_string-name">Nestler, E. J.</span></span> <span> </span><span class="NLM_article-title">Animal Models Of Depression: Molecular Perspectives</span>. In  <i>Molecular and functional models in neuropsychiatry</i>; <span class="NLM_series">Current Topics in Behavioral Neurosciences</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2011</span>; Vol.  <span class="NLM_volume">7</span>, pp  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">147</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2F7854_2010_108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=121-147&author=V.+Krishnan&author=E.+J.+Nestler&title=Molecular+and+functional+models+in+neuropsychiatry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2F7854_2010_108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F7854_2010_108%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DV.%26atitle%3DAnimal%2520Models%2520Of%2520Depression%253A%2520Molecular%2520Perspectives%26btitle%3DMolecular%2520and%2520functional%2520models%2520in%2520neuropsychiatry%26pub%3DSpringer%26date%3D2011%26volume%3D7%26spage%3D121%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petit-Demouliere, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, M.</span></span> <span> </span><span class="NLM_article-title">Forced Swimming Test In Mice: A Review Of Antidepressant Activity</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1007/s00213-004-2048-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2Fs00213-004-2048-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=15609067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVyltLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2005&pages=245-255&author=B.+Petit-Demouliereauthor=F.+Chenuauthor=M.+Bourin&title=Forced+Swimming+Test+In+Mice%3A+A+Review+Of+Antidepressant+Activity&doi=10.1007%2Fs00213-004-2048-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Forced swimming test in mice: a review of antidepressant activity</span></div><div class="casAuthors">Petit-Demouliere, Benoit; Chenu, Franck; Bourin, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-255</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Rationale: Among all animal models, the forced swimming test (FST) remains one of the most used tools for screening antidepressants.  Objective: This paper reviews some of the main aspects of the FST in mice.  Most of the sensitivity and variability factors that were assessed on the FST are summarized.  Mechanisms: We have summarized data found in the literature of antidepressant effects on the FST in mice.  From this data set, we have extrapolated information on baseline levels of strain, and sensitivity against antidepressants.  Results: We have shown that many parameters have to be considered in this test to gain good reliability.  Moreover, there was a fundamental inter-strain difference of response in the FST.  Conclusions: The FST is a good screening tool with good reliability and predictive validity.  Strain is one of the most important parameters to consider.  Swiss and NMRI mice can be used to discriminate the mechanisms of action of drugs.  CD-1 seems to be the most useful strain for screening purposes, but this needs to be confirmed with some spontaneous locomotor activity studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSv0KipleZDrVg90H21EOLACvtfcHk0li4dJwEW6WVKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVyltLrE&md5=d072eba578f8564ea4c6d15fb790d1a5</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00213-004-2048-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-004-2048-7%26sid%3Dliteratum%253Aachs%26aulast%3DPetit-Demouliere%26aufirst%3DB.%26aulast%3DChenu%26aufirst%3DF.%26aulast%3DBourin%26aufirst%3DM.%26atitle%3DForced%2520Swimming%2520Test%2520In%2520Mice%253A%2520A%2520Review%2520Of%2520Antidepressant%2520Activity%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D177%26spage%3D245%26epage%3D255%26doi%3D10.1007%2Fs00213-004-2048-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, T. M.</span></span> <span> </span><span class="NLM_article-title">Behavioral Animal Models Of Depression</span>. <i>Neurosci Bull</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1007/s12264-010-0323-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2Fs12264-010-0323-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=20651815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BC3cnpsVKltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=327-337&author=H.+C.+Yanauthor=X.+Caoauthor=M.+Dasauthor=X.+H.+Zhuauthor=T.+M.+Gao&title=Behavioral+Animal+Models+Of+Depression&doi=10.1007%2Fs12264-010-0323-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral animal models of depression</span></div><div class="casAuthors">Yan Hua-Cheng; Cao Xiong; Das Manas; Zhu Xin-Hong; Gao Tian-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience bulletin</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">327-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Depression is a chronic, recurring and potentially life-threatening illness that affects up to 20% of the population across the world.  Despite its prevalence and considerable impact on human, little is known about its pathogenesis.  One of the major reasons is the restricted availability of validated animal models due to the absence of consensus on the pathology and etiology of depression.  Besides, some core symptoms such as depressed mood, feeling of worthlessness, and recurring thoughts of death or suicide, are impossible to be modeled on laboratory animals.  Currently, the criteria for identifying animal models of depression rely on either of the 2 principles: actions of known antidepressants and responses to stress.  This review mainly focuses on the most widely used animal models of depression, including learned helplessness, chronic mild stress, and social defeat paradigms.  Also, the behavioral tests for screening antidepressants, such as forced swimming test and tail suspension test, are also discussed.  The advantages and major drawbacks of each model are evaluated.  In prospective, new techniques that will be beneficial for developing novel animal models or detecting depression are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSaY99d7aSGBPcsfMJQC1ZdfW6udTcc2eYs6-XCOO8tvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnpsVKltw%253D%253D&md5=17d9e33165a04a820c029c29c4d8b5c8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs12264-010-0323-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12264-010-0323-7%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DH.%2BC.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DDas%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%2BH.%26aulast%3DGao%26aufirst%3DT.%2BM.%26atitle%3DBehavioral%2520Animal%2520Models%2520Of%2520Depression%26jtitle%3DNeurosci%2520Bull%26date%3D2010%26volume%3D26%26spage%3D327%26epage%3D337%26doi%3D10.1007%2Fs12264-010-0323-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castagné, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porsolt, R. D.</span></span> <span> </span><span class="NLM_article-title">Rodent Models Of Depression: Forced Swim And Tail Suspension Behavioral Despair Tests In Rats And Mice</span>. <i>Curr. Protoc. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1002/0471142301.ns0810as55</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2F0471142301.ns0810as55" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=8-10&author=V.+Castagn%C3%A9author=P.+Moserauthor=S.+Rouxauthor=R.+D.+Porsolt&title=Rodent+Models+Of+Depression%3A+Forced+Swim+And+Tail+Suspension+Behavioral+Despair+Tests+In+Rats+And+Mice&doi=10.1002%2F0471142301.ns0810as55"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2F0471142301.ns0810as55&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471142301.ns0810as55%26sid%3Dliteratum%253Aachs%26aulast%3DCastagn%25C3%25A9%26aufirst%3DV.%26aulast%3DMoser%26aufirst%3DP.%26aulast%3DRoux%26aufirst%3DS.%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26atitle%3DRodent%2520Models%2520Of%2520Depression%253A%2520Forced%2520Swim%2520And%2520Tail%2520Suspension%2520Behavioral%2520Despair%2520Tests%2520In%2520Rats%2520And%2520Mice%26jtitle%3DCurr.%2520Protoc.%2520Neurosci.%26date%3D2011%26volume%3D55%26spage%3D8%26epage%3D10%26doi%3D10.1002%2F0471142301.ns0810as55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barish, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogle, W. O.</span></span> <span> </span><span class="NLM_article-title">Antidepressant-Like Effect Of Low Molecular Proanthocyanidin In Mice: Involvement Of Monoaminergic System</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2009.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.pbb.2009.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=19857512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFantb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2010&pages=447-453&author=Y.+Xuauthor=S.+Liauthor=R.+Chenauthor=G.+Liauthor=P.+A.+Barishauthor=W.+Youauthor=L.+Chenauthor=M.+Linauthor=B.+Kuauthor=J.+Panauthor=W.+O.+Ogle&title=Antidepressant-Like+Effect+Of+Low+Molecular+Proanthocyanidin+In+Mice%3A+Involvement+Of+Monoaminergic+System&doi=10.1016%2Fj.pbb.2009.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like effect of low molecular proanthocyanidin in mice: Involvement of monoaminergic system</span></div><div class="casAuthors">Xu, Ying; Li, Shan; Chen, Ruijie; Li, Gaowen; Barish, Philip A.; You, Wenting; Chen, Ling; Lin, Mengmeng; Ku, Baoshan; Pan, Jianchun; Ogle, William O.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">447-453</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Proanthocyanidin is a phenolic product present in plants which has antioxidant, antinociceptive and neuroprotective properties, without inducing significant toxicol. effects.  The present study tested the hypothesis that low mol. proanthocyanidin from grapes that has optimized bioavailability, would exert antidepressant-like activities in behavioral despair tests.  The results suggested that oral administration proanthocyanidin at doses of 25 and 50 mg/kg for 7 days significantly reduced the duration of immobility in both the tail suspension and forced swimming tests.  The doses that affected the immobile response did not affect locomotor activity.  In addn., the neurochem. and neuropharmacol. assays showed that proanthocyanidin produced a marked increase of 5-HT levels at 25 and 50 mg/kg in three brain regions, the frontal cortex, hippocampus and hypothalamus.  Noradrenaline and dopamine levels were also increased when higher dose of proanthocyanidin (50 mg/kg) administration both in the frontal cortex and hippocampus.  These effects were similar to those obsd. for the classical antidepressant imipramine (10 mg/kg, i.p.).  Moreover, Our study suggested that proanthocyanidin (12.5, 25 and 50 mg/kg) dose dependently inhibited monoamine oxidase-A (MAO-A) activity, while MAO-B inhibitory activity was also found at higher doses (25 and 50 mg/kg) after 7 days administration.  MAO-A selective inhibitor, moclobemide (20 mg/kg, i.g.) produced MAO-A inhibition of 70.5% in the mouse brain.  These findings suggest that the antidepressant-like effects of proanthocyanidin may involve the central monoaminergic neurotransmitter systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXQmYrmtO_GbVg90H21EOLACvtfcHk0ljDUoXnfSInRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFantb7J&md5=01b9f0e959e9dbd98e841131170f4d67</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2009.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2009.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DBarish%26aufirst%3DP.%2BA.%26aulast%3DYou%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DKu%26aufirst%3DB.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DOgle%26aufirst%3DW.%2BO.%26atitle%3DAntidepressant-Like%2520Effect%2520Of%2520Low%2520Molecular%2520Proanthocyanidin%2520In%2520Mice%253A%2520Involvement%2520Of%2520Monoaminergic%2520System%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2010%26volume%3D94%26spage%3D447%26epage%3D453%26doi%3D10.1016%2Fj.pbb.2009.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drigues, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poltyrev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bejar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span> <span> </span><span class="NLM_article-title">cDna Gene Expression Profile Of Rat Hippocampus After Chronic Treatment With Antidepressant Drugs</span>. <i>J. Neural Transm.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1413</span>– <span class="NLM_lpage">1436</span>, <span class="refDoi"> DOI: 10.1007/s00702-003-0077-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2Fs00702-003-0077-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=14666413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1yitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2003&pages=1413-1436&author=N.+Driguesauthor=T.+Poltyrevauthor=C.+Bejarauthor=M.+Weinstockauthor=M.+B.+Youdim&title=cDna+Gene+Expression+Profile+Of+Rat+Hippocampus+After+Chronic+Treatment+With+Antidepressant+Drugs&doi=10.1007%2Fs00702-003-0077-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs</span></div><div class="casAuthors">Drigues, N.; Poltyrev, T.; Bejar, C.; Weinstock, M.; Youdim, M. B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1413-1436</span>CODEN:
                <span class="NLM_cas:coden">JNTRF3</span>;
        ISSN:<span class="NLM_cas:issn">0300-9564</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag Wien</span>)
        </div><div class="casAbstract">Background.  Chronic antidepressant treatment causes alterations in several hippocampal genes, which participate in neuronal plasticity.  However the full picture of their mechanism of action is not known.  The advent of genomics enables to identify a broader mechanism of action and identify novel targets for antidepressant development.  Methods. The present study examd. the cDNA microarray gene expression profile in the hippocampus induced by chronic antidepressant treatment, in rats exposed to the forced swim test.  Animals were treated for 2 wk with moclobemide, clorgyline and amitriptyline.  Results. The three antidepressants significantly reduced immobility in the forced swim test and initiated significant homologous changes in gene expressions.  These include up regulation of cAMP response element binding protein and down regulation of corticotrophin releasing hormone.  Other gene changes noted were those related to neuropeptides, neurogenesis and synaptogenesis, including synaptophysin and neogenin.  Some 89 genes were changed by at least 2 drugs, out of which 53 were changed oppositely by forced swim test.  Confirmation of gene changes, have come from real time RT-PCR.  Conclusions.  A significant no. and homol. in gene expression were obsd. with the three antidepressants.  Many of the genes were assocd. with neurogenesis and synaptogenesis, including synaptophysin and neogenin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpphy2aXi1ud7Vg90H21EOLACvtfcHk0ljDUoXnfSInRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1yitL8%253D&md5=a7a94d3cedee2341f5da2adcfb2f6f46</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs00702-003-0077-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-003-0077-8%26sid%3Dliteratum%253Aachs%26aulast%3DDrigues%26aufirst%3DN.%26aulast%3DPoltyrev%26aufirst%3DT.%26aulast%3DBejar%26aufirst%3DC.%26aulast%3DWeinstock%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DcDna%2520Gene%2520Expression%2520Profile%2520Of%2520Rat%2520Hippocampus%2520After%2520Chronic%2520Treatment%2520With%2520Antidepressant%2520Drugs%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2003%26volume%3D110%26spage%3D1413%26epage%3D1436%26doi%3D10.1007%2Fs00702-003-0077-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pare, C. M.</span></span> <span> </span><span class="NLM_article-title">The Present Status Of Monoamine Oxidase Inhibitors</span>. <i>Br. J. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1192/bjp.146.6.576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1192%2Fbjp.146.6.576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=3893604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaL2M3ltlGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=1985&pages=576-584&author=C.+M.+Pare&title=The+Present+Status+Of+Monoamine+Oxidase+Inhibitors&doi=10.1192%2Fbjp.146.6.576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The present status of monoamine oxidase inhibitors</span></div><div class="casAuthors">Pare C M</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of psychiatry : the journal of mental science</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">576-84</span>
        ISSN:<span class="NLM_cas:issn">0007-1250</span>.
    </div><div class="casAbstract">The present status of monoamine oxidase inhibitors in the treatment of depression is reviewed.  With adequate doses they are effective antidepressants, but dosages have in the past been too low.  Provided proper dietary precautions are taken, the incidence of fatality from dietary interactions is very small and should not deter doctors from using these drugs, especially in those depressed patients who do not respond to tricyclic-type antidepressants.  The present status of combining monoamine oxidase inhibitors with tricyclics is discussed, as are the newer specific inhibitors particularly clorgyline and deprenyl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFSCenE3QxJhdUSIfHIn4FfW6udTcc2eav2slHT671rbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M3ltlGmtA%253D%253D&md5=5a54105f1b63320f7ef49f2fdd710925</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1192%2Fbjp.146.6.576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1192%252Fbjp.146.6.576%26sid%3Dliteratum%253Aachs%26aulast%3DPare%26aufirst%3DC.%2BM.%26atitle%3DThe%2520Present%2520Status%2520Of%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DBr.%2520J.%2520Psychiatry%26date%3D1985%26volume%3D146%26spage%3D576%26epage%3D584%26doi%3D10.1192%2Fbjp.146.6.576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutts, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherry-McKenna, R.</span></span> <span> </span><span class="NLM_article-title">Insights Into The Mechanisms Of Action Of The MAO Inhibitors Phenelzine And Tranylcypromine: A Review</span>. <i>J. Psychiatr. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1362653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaK3s7ksVaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1992&pages=206-214&author=G.+B.+Bakerauthor=R.+T.+Couttsauthor=K.+F.+McKennaauthor=R.+Sherry-McKenna&title=Insights+Into+The+Mechanisms+Of+Action+Of+The+MAO+Inhibitors+Phenelzine+And+Tranylcypromine%3A+A+Review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review</span></div><div class="casAuthors">Baker G B; Coutts R T; McKenna K F; Sherry-McKenna R L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">206-14</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">Although the non-selective monoamine oxidase inhibitors phenelzine and tranylcypromine have been used for many years, much still remains to be understood about their mechanisms of action.  Other factors, in addition to the inhibition of monoamine oxidase and the subsequent elevation of brain levels of the catecholamines and 5-hydroxytryptamine, may contribute to the overall pharmacological profiles of these drugs.  This review also considers the effects on brain levels of amino acids and trace amines, uptake and release of neurotransmitter amines at nerve terminals, receptors for amino acids and amines, and enzymes other than monoamine oxidase, including enzymes involved in metabolism of other drugs.  The possible contributions of metabolism and stereochemistry to the actions of these monoamine oxidase inhibitors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9vQr4FxqLLnELvajU9pjPfW6udTcc2eZCCOy1Esn1Yrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s7ksVaqug%253D%253D&md5=290dbaddc5da35c7cee4253a0a8ace7a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DG.%2BB.%26aulast%3DCoutts%26aufirst%3DR.%2BT.%26aulast%3DMcKenna%26aufirst%3DK.%2BF.%26aulast%3DSherry-McKenna%26aufirst%3DR.%26atitle%3DInsights%2520Into%2520The%2520Mechanisms%2520Of%2520Action%2520Of%2520The%2520MAO%2520Inhibitors%2520Phenelzine%2520And%2520Tranylcypromine%253A%2520A%2520Review%26jtitle%3DJ.%2520Psychiatr.%2520Neurosci.%26date%3D1992%26volume%3D17%26spage%3D206%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stassen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angst, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delini-Stula, A.</span></span> <span> </span><span class="NLM_article-title">Onset of improvement under fluoxetine and moclobemide</span>. <i>Eur. Psychiatr.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/S0924-9338(98)80135-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2FS0924-9338%2898%2980135-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=19698614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BD1Mrnt1Khug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1998&pages=128-133&author=H.+Stassenauthor=J.+Angstauthor=A.+Delini-Stula&title=Onset+of+improvement+under+fluoxetine+and+moclobemide&doi=10.1016%2FS0924-9338%2898%2980135-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Onset of improvement under fluoxetine and moclobemide</span></div><div class="casAuthors">Stassen H; Angst J; Delini-Stula A</div><div class="citationInfo"><span class="NLM_cas:title">European psychiatry : the journal of the Association of European Psychiatrists</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">128-33</span>
        ISSN:<span class="NLM_cas:issn">0924-9338</span>.
    </div><div class="casAbstract">In a meta-analysis of the selective serotonin reuptake inhibitor fluoxetine (n = 440) and the reversible and selective monoamine oxidase-A inhibitor moclobemide (n = 437) we investigated the time course of improvement over 6 weeks for these two classes of anti-depressants.  Two different methods of approach were applied: (1) repeated measurement analysis of variance in combination with regression analysis, and (2) a survival-analytical approach that allowed us to determine onset of improvement for the individual patient, to distinguish between early and late improvers, to assess the predictive value of early improvement, and to adequately process premature withdrawals.  The two antidepressants of large biochemical and pharmacological differences yielded virtually identical response- and drop-out rates, and exhibited no difference with respect to the time course of improvement.  Onset of improvement occurred in more than half of the patients within the first 2 weeks of treatment, and early improvement was highly predictive of later outcome.  In particular, there was no indication for a delayed onset of action of antidepressants.  We suggest that future studies should be standardised with respect to washout period and sufficiently dense assessments during the first 2 weeks of trial.  Thus, patient samples can be subdivided reproducibly into early-, late-, partial- and non-remitters.  This, in turn, may help to identify "true" drug responders, and to discover why in some patients recovery becomes "stuck".  Data already held by the pharmaceutical companies should be reanalysed in this respect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQHjWoKPYvhnxjv2lLSLOxFfW6udTcc2eZCCOy1Esn1Yrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mrnt1Khug%253D%253D&md5=b5865109528c86ba590adfb322b3dc62</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0924-9338%2898%2980135-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0924-9338%252898%252980135-1%26sid%3Dliteratum%253Aachs%26aulast%3DStassen%26aufirst%3DH.%26aulast%3DAngst%26aufirst%3DJ.%26aulast%3DDelini-Stula%26aufirst%3DA.%26atitle%3DOnset%2520of%2520improvement%2520under%2520fluoxetine%2520and%2520moclobemide%26jtitle%3DEur.%2520Psychiatr.%26date%3D1998%26volume%3D13%26spage%3D128%26epage%3D133%26doi%3D10.1016%2FS0924-9338%2898%2980135-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbelivien, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haapalinna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirvio, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition Of MAO-A Activity Enhances Behavioural Activity Of Rats Assessed Using Water Maze And Open Arena Tasks</span>. <i>Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">304</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1034/j.1600-0773.2001.880604.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1034%2Fj.1600-0773.2001.880604.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=11453370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVehs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2001&pages=304-312&author=A.+Barbelivienauthor=L.+Nymanauthor=A.+Haapalinnaauthor=J.+Sirvio&title=Inhibition+Of+MAO-A+Activity+Enhances+Behavioural+Activity+Of+Rats+Assessed+Using+Water+Maze+And+Open+Arena+Tasks&doi=10.1034%2Fj.1600-0773.2001.880604.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks</span></div><div class="casAuthors">Barbelivien, Alexandra; Nyman, Leena; Haapalinna, Antti; Sirvio, Jouni</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Toxicology (Copenhagen, Denmark)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">304-312</span>CODEN:
                <span class="NLM_cas:coden">PHTOEH</span>;
        ISSN:<span class="NLM_cas:issn">0901-9928</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">To det. if the inhibition of MAO-A and/or MAO-B activities can influence cognitive processes in adult rats, we analyzed whether chronic treatment with clorgyline, 1-deprenyl and pargyline could modify the performance of adult rats in a modified version of the water maze task.  The effects of these treatments on locomotor activity and enzyme activities were also assessed.  Rats were treated for 24 days with clorgyline (0.2 mg/kg), 1-deprenyl (0.25 mg/kg) and pargyline (1 or 10 mg/kg).  The treatments were started two weeks before the water maze expt. and continued until the end of testing.  The rats were trained to find a submerged platform (6 days:1 trial/day; 7 the day: probe trial).  Over the next three days, locomotor activity was assessed in an open arena.  Treatments with clorgyline (MAO-A inhibitor), 1-deprenyl (MAO-B inhibitor) and pargyline (non-selective MAO inhibitor) did not improve the finding of the hidden platform, when compared to treatment with saline, but significantly increased the swimming speed of the rats.  The different treatments, when compared to saline, failed to modify the distance covered and the no. of groomings performed in the open arena.  However, clorgyline and pargyline, 10 mg/kg, increased the no. of fecal boli and clorgyline enhanced the no. of rearings made when compared to saline, 1-deprenyl and pargyline, 10 mg/kg.  These results indicate that near total inhibition of MAO-A by clorgyline and pargyline as assessed by MAO activity measurement induces an increase in locomotor activity but that inhibition of MAO-A or MAO-B, either alone or combined, does not facilitate spatial learning in adult rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP09Z6v5B3iLVg90H21EOLACvtfcHk0lhxtNAT42FweA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVehs7s%253D&md5=50c703d74d811fcd2fb3744a1a051966</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-0773.2001.880604.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-0773.2001.880604.x%26sid%3Dliteratum%253Aachs%26aulast%3DBarbelivien%26aufirst%3DA.%26aulast%3DNyman%26aufirst%3DL.%26aulast%3DHaapalinna%26aufirst%3DA.%26aulast%3DSirvio%26aufirst%3DJ.%26atitle%3DInhibition%2520Of%2520MAO-A%2520Activity%2520Enhances%2520Behavioural%2520Activity%2520Of%2520Rats%2520Assessed%2520Using%2520Water%2520Maze%2520And%2520Open%2520Arena%2520Tasks%26jtitle%3DPharmacol.%2520Toxicol.%26date%3D2001%26volume%3D88%26spage%3D304%26epage%3D312%26doi%3D10.1034%2Fj.1600-0773.2001.880604.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. H.</span></span> <span> </span><span class="NLM_article-title">Aldol Condensations Catalyzed By PEG400 And Anhydrous K2CO3 Without Solvent</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1045</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1081/SCC-200054198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1081%2FSCC-200054198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsF2mtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=1045-1049&author=Y.+Q.+Caoauthor=Z.+Daiauthor=R.+Zhangauthor=B.+H.+Chen&title=Aldol+Condensations+Catalyzed+By+PEG400+And+Anhydrous+K2CO3+Without+Solvent&doi=10.1081%2FSCC-200054198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Aldol condensations catalyzed by PEG400 and anhydrous K2CO3 without solvent</span></div><div class="casAuthors">Cao, Yu-Qing; Dai, Zhi; Zhang, Rui; Chen, Bao-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1045-1049</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Aldol condensations of arom. aldehydes with ketones under solvent-free conditions to synthesize α,β-unsatd. ketones in good to excellent yields using PEG400 and powd. anhyd. K2CO3 as catalysts at 90°C and 120°C are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtU-4x6a_0qbVg90H21EOLACvtfcHk0lghVqXM_ImVAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsF2mtbc%253D&md5=946f03fae06286d6995b8384d58de2a9</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1081%2FSCC-200054198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FSCC-200054198%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DY.%2BQ.%26aulast%3DDai%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DB.%2BH.%26atitle%3DAldol%2520Condensations%2520Catalyzed%2520By%2520PEG400%2520And%2520Anhydrous%2520K2CO3%2520Without%2520Solvent%26jtitle%3DSynth.%2520Commun.%26date%3D2005%26volume%3D35%26spage%3D1045%26epage%3D1049%26doi%3D10.1081%2FSCC-200054198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarbhai, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, K. B. L.</span></span> <span> </span><span class="NLM_article-title">Some Arylation Reactions with Diazotized 3,4,5-Trimethoxyaniline - Preparation of 3,4,5-Trimethoxychalkone and 3,4,5-Trimethoxybenzaldehyde</span>. <i>Indian J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1963</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1963&pages=482&author=K.+P.+Sarbhaiauthor=K.+B.+L.+Mathur&title=Some+Arylation+Reactions+with+Diazotized+3%2C4%2C5-Trimethoxyaniline+-+Preparation+of+3%2C4%2C5-Trimethoxychalkone+and+3%2C4%2C5-Trimethoxybenzaldehyde"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarbhai%26aufirst%3DK.%2BP.%26aulast%3DMathur%26aufirst%3DK.%2BB.%2BL.%26atitle%3DSome%2520Arylation%2520Reactions%2520with%2520Diazotized%25203%252C4%252C5-Trimethoxyaniline%2520-%2520Preparation%2520of%25203%252C4%252C5-Trimethoxychalkone%2520and%25203%252C4%252C5-Trimethoxybenzaldehyde%26jtitle%3DIndian%2520J.%2520Chem.%26date%3D1963%26volume%3D1%26spage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koo, J.</span></span> <span> </span><span class="NLM_article-title">Syntheses in the Indene Series</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1953</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">2000</span>– <span class="NLM_lpage">2001</span>, <span class="refDoi"> DOI: 10.1021/ja01104a515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01104a515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaG2MXjt1eitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1953&pages=2000-2001&author=J.+Koo&title=Syntheses+in+the+Indene+Series&doi=10.1021%2Fja01104a515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses in the indene series</span></div><div class="casAuthors">Koo, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2000-1</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">For a projected synthesis of colchicine analogs, various substituted indenes were prepd. as model compds.  Substituents were introduced which, by cyclization, could yield tricyclic systems.  3,4-(MeO)2C6H3CHO (182.6 g.), 130 g. AcCH2CO2Et, and 70 cc. C6H6 refluxed 2 hrs. with 3.4 g. piperidine and 12.2 cc. AcOH (water trap), the cooled soln. dild. with 300 cc. Et2O, and the solvents removed yielded 175 g. Et veratrylideneacetoacetate (I), b1 190-2°, m. 75-81°.  Piperonal by the method used for I yielded 62% Et piperonylideneacetoacetate (II), b1.6 179°, m. 75-81°.  I (139 g.) in 150 cc. EtOAc hydrogenated 2 hrs. at room temp. and 45 lb. pressure over 9 g. 5% Pd-C yielded 100 g. Et veratrylacetoacetate (IIA), b1 169°; 2,4-dinitrophenylhydrazone, m. 116-17°.  Hydrogenation of II yielded 52% Et piperonylacetoacetate (III), b0.8 151-3°.  Veratrylideneacetone, m. 84-6°, (69 g.) in 150 cc. AcOH reduced 35 min. over 5 g. Pd-C yielded 83% veratrylacetone (IV), b0.5 127-9°, m. 53-6°.  Veratrylideneacetophenone, m. 90-2°, hydrogenated 4 hrs. in EtOAc over Pd-C yielded 93% veratrylacetophenone (V), m. 68-70°.  IIA (56 g.) in 45 cc. 85% H3PO4 added slowly to 90 cc. H2SO4 contg. 45 cc. 85% H3PO4 at 0-5°, the mixt. stirred into ice water, filtered, the solid dissolved in Et2O, washed with 10% NaHCO3, and the solvent evapd. yielded 24 g. Et 5,6-dimethoxy-3-methyl-2-indenecarboxylate (VI), m. 136-6.5°.  Acidification of the NaHCO3 washings yielded 5 g. free acid, m. 228-30°.  III (1 g.) in 3 cc. each of H2SO4 and H3PO4 allowed to stand 40 min. at 0° and treated as above yielded 0.79 g. Et 5,6-methylenedioxy-3-methyl-2-indenecarboxylate, m. 107-8°; the washings yielded 0.032 g. free acid, m. 280-1°.  IV (21 g.) in 42 cc. each H2SO4 and H3PO4 at 10-15° treated by the method used for VI (NaHCO3 washing omitted) except that the product was poured into 400 cc. of ice water after 0.5 hr., yielded 52% 5,6-dimethoxy-3-methylindene, m. 132-3°.  V (the reaction mixt. heated 30 min. at 60-70°) yielded 5,6-dimethoxy-3-phenylindene (VII), m. 112-13.5°.  Na (1.15 g.) in 50 cc. warm abs. EtOH treated rapidly with 7.5 g. (CO2Et)2, then with 18 g. VI in 100 cc. hot abs. EtOH, and the mixt. shaken 2 min., stirred into cold water, acidified with dil. HCl and filtered yielded 19 g. Et 1-ethoxalyl-5,6-dimethoxy-3-methyl-2-indenecarboxylate, m. 143-6°; 2,4-dinitrophenylhydrazone, m. 180-2°; enol acetate, m. 132-3°.  Na (0.46 g.), 15 cc. EtOH, 3 g. (CO2Et)2, and 4.2 g.  VII yielded 76% 1-ethoxalyl-5,6-dimethoxy-3-phenylindene, m. 122-4°; enol acetate, m. 165-7°.  VI (1 g.) in 15 cc. AcOH hydrogenated 2.5 hrs. in 15 cc. AcOH at 60° and 40 lb. over 0.5 g. 5% Pd-C yielded 0.85 g. Et 5,6-di-methoxy-3-methyl-2-indancarboxylate (VIII), m. 48-9°; free acid, m. 176-7°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlySn-4MzA7rVg90H21EOLACvtfcHk0lghVqXM_ImVAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2MXjt1eitQ%253D%253D&md5=f01d4723e839eedf6238060b11287363</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fja01104a515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01104a515%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DJ.%26atitle%3DSyntheses%2520in%2520the%2520Indene%2520Series%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1953%26volume%3D75%26spage%3D2000%26epage%3D2001%26doi%3D10.1021%2Fja01104a515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wattanasin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, W. S.</span></span> <span> </span><span class="NLM_article-title">An Improved Procedure for the Preparation of Chalcones and Related Enones</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>1980</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">650</span>, <span class="refDoi"> DOI: 10.1055/s-1980-29155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1055%2Fs-1980-29155" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1980&publication_year=1980&pages=647-650&author=S.+Wattanasinauthor=W.+S.+Murphy&title=An+Improved+Procedure+for+the+Preparation+of+Chalcones+and+Related+Enones&doi=10.1055%2Fs-1980-29155"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1055%2Fs-1980-29155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1980-29155%26sid%3Dliteratum%253Aachs%26aulast%3DWattanasin%26aufirst%3DS.%26aulast%3DMurphy%26aufirst%3DW.%2BS.%26atitle%3DAn%2520Improved%2520Procedure%2520for%2520the%2520Preparation%2520of%2520Chalcones%2520and%2520Related%2520Enones%26jtitle%3DSynthesis%26date%3D1980%26volume%3D1980%26spage%3D647%26epage%3D650%26doi%3D10.1055%2Fs-1980-29155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaramillo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mora, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vélez, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quijano, J.</span></span> <span> </span><span class="NLM_article-title">Biological evaluation of aromatic compounds as β-lactamase inhibitors</span>. <i>Pharmacologyonline</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=650-655&author=M.+C.+Jaramilloauthor=C.+Moraauthor=L.+E.+V%C3%A9lezauthor=G.+J.+Arangoauthor=J.+Quijano&title=Biological+evaluation+of+aromatic+compounds+as+%CE%B2-lactamase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaramillo%26aufirst%3DM.%2BC.%26aulast%3DMora%26aufirst%3DC.%26aulast%3DV%25C3%25A9lez%26aufirst%3DL.%2BE.%26aulast%3DArango%26aufirst%3DG.%2BJ.%26aulast%3DQuijano%26aufirst%3DJ.%26atitle%3DBiological%2520evaluation%2520of%2520aromatic%2520compounds%2520as%2520%25CE%25B2-lactamase%2520inhibitors%26jtitle%3DPharmacologyonline%26date%3D2006%26volume%3D3%26spage%3D650%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaramillo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mora, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velez, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quijano, J.</span></span> <span> </span><span class="NLM_article-title">Kinetic and Theoretical Study of the Chalcones as Inhibitors of beta-Lactamase Enzyme</span>. <i>Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.2174/157340609789117895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.2174%2F157340609789117895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=19799548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ertL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=434-439&author=M.+C.+Jaramilloauthor=C.+Moraauthor=L.+E.+Velezauthor=J.+Quijano&title=Kinetic+and+Theoretical+Study+of+the+Chalcones+as+Inhibitors+of+beta-Lactamase+Enzyme&doi=10.2174%2F157340609789117895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and theoretical study of the chalcones as inhibitors of β-lactamase enzyme</span></div><div class="casAuthors">Jaramillo, M. Consuelo; Mora, Cristina; Velez, Luis E.; Quijano, Jairo</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">434-439</span>CODEN:
                <span class="NLM_cas:coden">MCEHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1573-4064</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa Klebsiella pneumoniae, Acinetobacter baumannii, Enterobacter cloacae and more bacterias have shown resistance to antibiotics in Colombia, therefore, resistance to antibiotics is a problem that is on increase in Colombia.  The resistance mechanism to penicillin antibiotics in these bacterias is the expression of β-Lactamase enzyme.  To use the penicillin antibiotics which are still effective against them, the authors had evaluated 10 chalcones as inhibitors of this enzyme.  The most active chalcone showed Km, = 406.7 μM higher than clavulanic acid that showed Km, = 211.9 μM at 37° during 10 h, and using amoxycillin as substrate.  The chalcones were better competitive inhibitors because of they allowed the hydrolysis of smaller quantity of amoxycillin than the clavulanic acid, the most active chalcone showed Kcat/Km = 1.398 (minM)-1 and the clavulanic acid showed Kcat/Km = 2.674 (minM)-1.  The mol. modeling of the Enzyme-chalcones complexes showed that the chalcones with electron-donating groups on ortho, meta position of A ring favor the interaction with the residues Threonine-319, Lysine-67, Serine-64 and Tyrosine-150 of the active site of the enzyme, because of the no. and strong of Hydrogen bonds of the chalcones in the active site of the enzyme increase, and therefore the affinity of the chalcones increases too.  The electron-donating groups in the chalcones contribute to their inductive effect improving the interaction with the active site of the enzyme because of rising of electrostatic attraction between them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1e1jbX7iVjLVg90H21EOLACvtfcHk0lghVqXM_ImVAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ertL%252FL&md5=c107b92215c2146bf3a51c81061261ec</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.2174%2F157340609789117895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340609789117895%26sid%3Dliteratum%253Aachs%26aulast%3DJaramillo%26aufirst%3DM.%2BC.%26aulast%3DMora%26aufirst%3DC.%26aulast%3DVelez%26aufirst%3DL.%2BE.%26aulast%3DQuijano%26aufirst%3DJ.%26atitle%3DKinetic%2520and%2520Theoretical%2520Study%2520of%2520the%2520Chalcones%2520as%2520Inhibitors%2520of%2520beta-Lactamase%2520Enzyme%26jtitle%3DMed.%2520Chem.%26date%3D2009%26volume%3D5%26spage%3D434%26epage%3D439%26doi%3D10.2174%2F157340609789117895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manolov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danchev, N. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis And Pharmacological Investigations Of Some 4-Hydroxycoumarin Derivatives</span>. <i>Archiv Der Pharmazie</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1002/ardp.200390010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2Fardp.200390010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=12761761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslGmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2003&pages=83-94&author=I.+Manolovauthor=N.+D.+Danchev&title=Synthesis+And+Pharmacological+Investigations+Of+Some+4-Hydroxycoumarin+Derivatives&doi=10.1002%2Fardp.200390010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and pharmacological investigations of some 4-hydroxycoumarin derivatives</span></div><div class="casAuthors">Manolov, Ilia; Danchev, Nicolay D.</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-94</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The synthesis of ten coumarin derivs. of 4-hydroxycoumarin and various unsatd. ketones and aldehydes is described.  The structures of the synthesized compds. were confirmed by IR, 1H-NMR, and mass-spectral data.  Acute toxicity studies of the compds. were performed on mice by oral and i.p. administration.  A comparative pharmacol. study of the in vivo anticoagulant effects of the derivs. with respect to warfarin, showed that the compds. have anticoagulant activity.  Compds. 4-hydroxy-3-[1-phenyl-2-(4'-chlorobenzoyl)-ethyl]-2H-1-benzopyran-2-one, 4-hydroxy-3-[1-(4-fluorophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one, and 3,3'-p-bromobenzylidene-bis-(4-hydroxy-2H-1-benzopyran-2-one) showed slight acute toxicity and a greater anticoagulant effect than warfarin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfOuXWAK1THbVg90H21EOLACvtfcHk0lgqHi9GHsy7KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslGmt7o%253D&md5=19ce129b623416098602a4c06c402e05</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fardp.200390010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200390010%26sid%3Dliteratum%253Aachs%26aulast%3DManolov%26aufirst%3DI.%26aulast%3DDanchev%26aufirst%3DN.%2BD.%26atitle%3DSynthesis%2520And%2520Pharmacological%2520Investigations%2520Of%2520Some%25204-Hydroxycoumarin%2520Derivatives%26jtitle%3DArchiv%2520Der%2520Pharmazie%26date%3D2003%26volume%3D336%26spage%3D83%26epage%3D94%26doi%3D10.1002%2Fardp.200390010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis Of Substituted 2-Hydroxyisophthalic Acids</span>. <i>Bull. Soc. Chim. Belg.</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">700</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1002/bscb.19560650709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2Fbscb.19560650709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaG2sXivFyjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1956&pages=700-705&author=G.+A.+Hanson&title=Synthesis+Of+Substituted+2-Hydroxyisophthalic+Acids&doi=10.1002%2Fbscb.19560650709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of substituted 2-hydroxyisophthalic acids</span></div><div class="casAuthors">Hanson, G. A.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin des Societes Chimiques Belges</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">700-5</span>CODEN:
                <span class="NLM_cas:coden">BSCBAG</span>;
        ISSN:<span class="NLM_cas:issn">0037-9646</span>.
    </div><div class="casAbstract">cf. C.A. 50, 11938g; 51 290e.  2,3-Dimethoxychalcone (I) (94% from PhAc and 2,3-(MeO)2C6H3CHO) condensed with OC(CH2CO2Et)2 I gave OC.CH(CO2Et).CHR'.CH2.CR:CCO2Et (Ia) [R = Ph, R' = 2,3-(MeO)2C6H3] (II), converted by N-bromosuccinimide by the Wohl-Ziegler reaction to the 4-Br deriv. (III), aromatized by heating in pyridine to di-Et 2-hydroxy-4-phenyl-6-(2,3-dimethoxy)phenylisophthalate (IV) and hydrolyzed to the free diacid (V).  2,3,4'-Trimethoxychalcone (VI) and 2,4'-dimethoxychalcone (VII) condensed with OC(CH2CO2Et)2 gave Ia (R = 4-MeOC6H4, R' = 2,3-(MeO)2C6H3) (VII) and Ia (R = 4-MeOC2H2 R' = 2-MeO-C6H4) (IX).  Bromination of VIII and IX failed to give definite products and apparently another means leading to aromatization must be found.  I (12.4 g.), b10 252°, 9.4 g. OC(CH2-CO2Et)2, 60 cc. EtOH, and 3 drops piperidine refluxed 18 hrs., and the product crystd. from EtOH gave 67% II, m. 131°.  II (6.6 g.), 2.3 g. N-bromosuccinimide, and 60 cc. CCl4 gave 61% III, m. 121-2° (decompn.).  III (3 g.) heated with a small amt. of pyridine 5 min., cooled, water added, and the yellow oil crystd. from EtOH gave 74% IV, m. 79°; hydrolysis with aq. alc. KOH, acidification with HCI, crystn. from MeOH, and recrystn. from EtOAc-petr. ether gave 71% V, m. 205-6° (decompn.).  Condensation of p-MeOC6H6Ac with 2,3-(MeO)2C6H3CHO in aq. alc. NaOH gave 83% VI, pale yellow, m. 102-3°; reaction with OC(CH2CO2Et)2 gave 63% VIII, m. 149-51°.  VIII, 88%, yellow oil, b10 276° and IX, 67%, m. 119-20° were obtained similarly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd0yP88-oRLrVg90H21EOLACvtfcHk0lgqHi9GHsy7KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2sXivFyjsw%253D%253D&md5=082ec324da270e10170969162a7c5025</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fbscb.19560650709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbscb.19560650709%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DG.%2BA.%26atitle%3DSynthesis%2520Of%2520Substituted%25202-Hydroxyisophthalic%2520Acids%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Belg.%26date%3D1956%26volume%3D65%26spage%3D700%26epage%3D705%26doi%3D10.1002%2Fbscb.19560650709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, M. L.</span></span> <span> </span><span class="NLM_article-title">Antiproliferative Properties Of Piperidinylchalcones</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.bmc.2005.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=16185876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1egsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=153-163&author=X.+Liuauthor=M.+L.+Go&title=Antiproliferative+Properties+Of+Piperidinylchalcones&doi=10.1016%2Fj.bmc.2005.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative properties of piperidinylchalcones</span></div><div class="casAuthors">Liu, Xiaoling; Go, Mei-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-163</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Methoxylated chalcones bearing N-methylpiperidinyl substituents on ring A inhibited the growth of human tumor cell lines (MCF-7, HCT 116, and Jurkat) at IC50 values of <5 μM.  Investigations on a representative member (12) showed that antiproliferative activity was linked to the disruption of the cell cycle at G1 and G2/M phases.  The effect was concn. dependent and was evident at the approx. IC50 of 12.  Downregulation of cell cycle regulatory components (CDK4, cyclin B, E2F, and phosphorylated Rb) were obsd. under similar conditions.  Methoxylated chalcones without the piperidinyl substituent were found to exert equally potent and selective antiproliferative activity against HCT 116 tumor cells but did not interfere with cell cycle progression at their IC50 concns.  The presence of the piperidinyl substituent in the chalcone template is proposed to lend specificity to the mechanism of antiproliferative activity, in addn. to promoting a more desirable physicochem. profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk3n70_n19rbVg90H21EOLACvtfcHk0lgqHi9GHsy7KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1egsLzI&md5=18998e2fa837121747098d0a6e5c7c92</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGo%26aufirst%3DM.%2BL.%26atitle%3DAntiproliferative%2520Properties%2520Of%2520Piperidinylchalcones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D153%26epage%3D163%26doi%3D10.1016%2Fj.bmc.2005.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biradar, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gau, H. M.</span></span> <span> </span><span class="NLM_article-title">Highly Enantioselective Conjugate Addition Of Diethylzinc To Substituted Chalcones Catalyzed By Cu(II) Complexes Of A Tridentate P,N,O Ligand</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2008.02.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.tetasy.2008.02.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlOmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=733-738&author=D.+B.+Biradarauthor=H.+M.+Gau&title=Highly+Enantioselective+Conjugate+Addition+Of+Diethylzinc+To+Substituted+Chalcones+Catalyzed+By+Cu%28II%29+Complexes+Of+A+Tridentate+P%2CN%2CO+Ligand&doi=10.1016%2Fj.tetasy.2008.02.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Highly enantioselective conjugate addition of diethylzinc to substituted chalcones catalyzed by Cu(II) complexes of a tridentate P,N,O ligand</span></div><div class="casAuthors">Biradar, Deepak Baburao; Gau, Han-Mou</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">733-738</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new series of tridentate P,N,O ligands, e.g., I, having hard and soft donor atoms derived from chiral amino alcs. were developed and employed in the Cu(II)-catalyzed conjugate addn. of diethylzinc to substituted chalcones.  The asym. addns. to a variety of substituted chalcones afforded products in excellent yields and good to excellent enantioselectivities up to 97% ee.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzglwhavi0uLVg90H21EOLACvtfcHk0lj_TniNDcdfaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlOmsrk%253D&md5=24aa2c7f2a3f0d80a424b8fad3825834</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2008.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2008.02.027%26sid%3Dliteratum%253Aachs%26aulast%3DBiradar%26aufirst%3DD.%2BB.%26aulast%3DGau%26aufirst%3DH.%2BM.%26atitle%3DHighly%2520Enantioselective%2520Conjugate%2520Addition%2520Of%2520Diethylzinc%2520To%2520Substituted%2520Chalcones%2520Catalyzed%2520By%2520Cu%2528II%2529%2520Complexes%2520Of%2520A%2520Tridentate%2520P%252CN%252CO%2520Ligand%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2008%26volume%3D19%26spage%3D733%26epage%3D738%26doi%3D10.1016%2Fj.tetasy.2008.02.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">Evaluation And Discovery Of Novel Synthetic Chalcone Derivatives As Anti-Inflammatory Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8110</span>– <span class="NLM_lpage">8123</span>, <span class="refDoi"> DOI: 10.1021/jm200946h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200946h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWmsrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8110-8123&author=J.+Wuauthor=J.+Liauthor=Y.+Caiauthor=Y.+Panauthor=F.+Yeauthor=Y.+Zhangauthor=Y.+Zhaoauthor=S.+Yangauthor=X.+Liauthor=G.+Liang&title=Evaluation+And+Discovery+Of+Novel+Synthetic+Chalcone+Derivatives+As+Anti-Inflammatory+Agents&doi=10.1021%2Fjm200946h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and Discovery of Novel Synthetic Chalcone Derivatives as Anti-Inflammatory Agents</span></div><div class="casAuthors">Wu, Jianzhang; Li, Jianling; Cai, Yuepiao; Pan, Yong; Ye, Faqing; Zhang, Yali; Zhao, Yunjie; Yang, Shulin; Li, Xiaokun; Liang, Guang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8110-8123</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Major anti-inflammatory agents, steroids and cyclooxygenase, were proved to have serious side effects.  Here, a series of chalcone derivs. were synthesized and screened for anti-inflammatory activities.  QSAR study revealed that the presence of electron-withdrawing groups in B-ring and electron-donating groups in A-ring of chalcones was important for inhibition of LPS-induced IL-6 expression.  Further, several compds. inhibited TNF-α and IL-6 release in a dose-dependent manner and decreased LPS-induced TNF-α, IL-1β, IL-6, IL-12, and COX-2 mRNA prodn.  Mechanistically, two compds. interfered with JNK/NF-κB signaling and dose-dependently prevented ERK and p38 activation.  In addn., these two compds. exhibited a significant protection against LPS-induced death and were able to block high glucose-activated cytokine profiles in macrophages.  Together, these data show a series of anti-inflammatory chalcones with potential therapeutic effects in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK2UFg4jjfZLVg90H21EOLACvtfcHk0lj_TniNDcdfaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWmsrfM&md5=e88959e6a6cf48ccd5e20a168853086a</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm200946h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200946h%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DEvaluation%2520And%2520Discovery%2520Of%2520Novel%2520Synthetic%2520Chalcone%2520Derivatives%2520As%2520Anti-Inflammatory%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8110%26epage%3D8123%26doi%3D10.1021%2Fjm200946h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Agilent</span>, (<span class="NLM_year">2012</span>).  <i>CrysAlis PRO</i>; <span class="NLM_publisher-name">Agilent Technologies, Y.</span>: <span class="NLM_publisher-loc">Oxfordshire,
England</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=Agilent&title=CrysAlis+PRO"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2012%26btitle%3DCrysAlis%2520PRO%26pub%3DAgilent%2520Technologies%252C%2520Y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> (<span class="NLM_year">1997</span>).  <i>SHELXS97. Program For The Solution Of Crystal Structures</i>; <span class="NLM_publisher-name">University of Göttingen</span>: <span class="NLM_publisher-loc">Germany</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=G.+M.+Sheldrick&title=SHELXS97.+Program+For+The+Solution+Of+Crystal+Structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26date%3D1997%26btitle%3DSHELXS97.%2520Program%2520For%2520The%2520Solution%2520Of%2520Crystal%2520Structures%26pub%3DUniversity%2520of%2520G%25C3%25B6ttingen" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrugia, L. J.</span></span> <span> </span><span class="NLM_article-title">WinGX. Suite For Small-Molecule Single-Crystal Crystallography</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">838</span>, <span class="refDoi"> DOI: 10.1107/S0021889899006020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1107%2FS0021889899006020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVSlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1999&pages=837-838&author=L.+J.+Farrugia&title=WinGX.+Suite+For+Small-Molecule+Single-Crystal+Crystallography&doi=10.1107%2FS0021889899006020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">WinGX suite for small-molecule single-crystal crystallography</span></div><div class="casAuthors">Farrugia, Louis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">837-838</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">The crystallog. problem:  The processing of a small-mol. structure from single-crystal X-ray or neutron diffraction data through structure soln. and refinement to prepn. of publication material is a well established and usually a reasonably automated procedure.  There are several excellent com. software packages, such as SHELXTL (Siemens, 1995) and TEXSAN (Mol. Structure Corporation, 1995), which provide all the necessary programs to undertake this procedure, but these packages are often quite expensive and usually tied to the sale of specific diffractometer hardware.  The WinGX suite provides an integrated and freely available set of Microsoft Windows programs to accomplish this task.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr53gZdiGzSn7Vg90H21EOLACvtfcHk0lj_TniNDcdfaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVSlurk%253D&md5=06e3e6a405d75250687285442cbbf70a</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1107%2FS0021889899006020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889899006020%26sid%3Dliteratum%253Aachs%26aulast%3DFarrugia%26aufirst%3DL.%2BJ.%26atitle%3DWinGX.%2520Suite%2520For%2520Small-Molecule%2520Single-Crystal%2520Crystallography%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1999%26volume%3D32%26spage%3D837%26epage%3D838%26doi%3D10.1107%2FS0021889899006020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> (<span class="NLM_year">1997</span>).  <i>SHELXL97 Program For The Refinement Of Crystal Structures</i>. <span class="NLM_publisher-name">University of Göttingen</span>: <span class="NLM_publisher-loc">Germany</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=G.+M.+Sheldrick&title=SHELXL97+Program+For+The+Refinement+Of+Crystal+Structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26date%3D1997%26btitle%3DSHELXL97%2520Program%2520For%2520The%2520Refinement%2520Of%2520Crystal%2520Structures%26pub%3DUniversity%2520of%2520G%25C3%25B6ttingen" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrugia, L. J.</span></span> <span> </span><span class="NLM_article-title">ORTEP-3 for Windows-A Version of It ORTEP-III with a Graphical User Interface (GUI)</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">565</span>, <span class="refDoi"> DOI: 10.1107/S0021889897003117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1107%2FS0021889897003117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1KgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1997&pages=565&author=L.+J.+Farrugia&title=ORTEP-3+for+Windows-A+Version+of+It+ORTEP-III+with+a+Graphical+User+Interface+%28GUI%29&doi=10.1107%2FS0021889897003117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">ORTEP-3 for windows - a version of ORTEP-III with a graphical user interface (GUI)</span></div><div class="casAuthors">Farrugia, Louis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5, Pt. 1</span>),
    <span class="NLM_cas:pages">565</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptCm7bJRBPGLVg90H21EOLACvtfcHk0lgaYOoGXDs-vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1KgsLg%253D&md5=b6bc45c46612ef8e647b884772f53312</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1107%2FS0021889897003117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889897003117%26sid%3Dliteratum%253Aachs%26aulast%3DFarrugia%26aufirst%3DL.%2BJ.%26atitle%3DORTEP-3%2520for%2520Windows-A%2520Version%2520of%2520It%2520ORTEP-III%2520with%2520a%2520Graphical%2520User%2520Interface%2520%2528GUI%2529%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1997%26volume%3D30%26spage%3D565%26doi%3D10.1107%2FS0021889897003117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spek, A. L.</span></span> <span> </span><span class="NLM_article-title">PLATON. An Integrated Tool For The Analysis Of The Results Of A Single Crystal Structure Determination</span>. <i>Acta Crystallogr., Sect. A: Found. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>A46</i></span>,  <span class="NLM_fpage">c34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A46&publication_year=1990&pages=c34&author=A.+L.+Spek&title=PLATON.+An+Integrated+Tool+For+The+Analysis+Of+The+Results+Of+A+Single+Crystal+Structure+Determination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpek%26aufirst%3DA.%2BL.%26atitle%3DPLATON.%2520An%2520Integrated%2520Tool%2520For%2520The%2520Analysis%2520Of%2520The%2520Results%2520Of%2520A%2520Single%2520Crystal%2520Structure%2520Determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D1990%26volume%3DA46%26spage%3Dc34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Son, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukihara, T.</span></span> <span> </span><span class="NLM_article-title">Structure Of Human Monoamine Oxidase A At 2.2-A Resolution: The Control Of Opening The Entry For Substrates/Inhibitors</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">5739</span>– <span class="NLM_lpage">5744</span>, <span class="refDoi"> DOI: 10.1073/pnas.0710626105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1073%2Fpnas.0710626105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=18391214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=5739-5744&author=S.+Y.+Sonauthor=J.+Maauthor=Y.+Kondouauthor=M.+Yoshimuraauthor=E.+Yamashitaauthor=T.+Tsukihara&title=Structure+Of+Human+Monoamine+Oxidase+A+At+2.2-A+Resolution%3A+The+Control+Of+Opening+The+Entry+For+Substrates%2FInhibitors&doi=10.1073%2Fpnas.0710626105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors</span></div><div class="casAuthors">Son, Se-Young; Mat, Jichun; Kondou, Youhei; Yoshimura, Masato; Yamashita, Eiki; Tsukihara, Tomitake</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5739-5744</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mitochondrial outer membrane-anchored monoamine oxidase (MAO) is a biochem. important flavoenzyme that catalyzes the deamination of biogenic and xenobiotic amines.  Its 2 subtypes, MAOA and MAOB, are linked to several psychiatric disorders and therefore are interesting targets for drug design.  To understand the relation between structure and function of this enzyme, the authors extended their previously reported low-resoln. rat MAOA structure to the high-resoln. wild-type and G110A mutant structures of human MAOA complexed with the reversible inhibitor, harmine, at 2.2 and 2.17 Å, resp.  The high-resoln. MAOA structures were similar to those of rat MAOA and human MAOB, but different from the known structure of human MAOA, specifically regarding residues 108-118 and 210-216, which surround the substrate/inhibitor cavity.  The results confirmed that the inhibitor selectivity of MAOA and MAOB is caused by the structural differences arising from Ile-335 in MAOA vs. Tyr-326 in MAOB.  The structures exhibited a C-terminal transmembrane helix with clear electron d., as is also seen in rat MAOA.  Mutations on one residue of loop 108-118, Gly-110, which is far from the active center but close to the membrane surface, caused the solubilized enzyme to undergo a dramatic drop in activity, but have less effect when the enzyme was anchored in the membrane.  These results suggest that the flexibility of loop 108-118, facilitated by anchoring the enzyme into the membrane, is essential for controlling substrate access to the active site.  The authors report on the observation of the structure-function relation between a transmembrane helical anchor and an extra-membrane domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdm8Cs1NxHxLVg90H21EOLACvtfcHk0lgaYOoGXDs-vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D&md5=7443fe77547220547312f7259df590df</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710626105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710626105%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DS.%2BY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DKondou%26aufirst%3DY.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DE.%26aulast%3DTsukihara%26aufirst%3DT.%26atitle%3DStructure%2520Of%2520Human%2520Monoamine%2520Oxidase%2520A%2520At%25202.2-A%2520Resolution%253A%2520The%2520Control%2520Of%2520Opening%2520The%2520Entry%2520For%2520Substrates%252FInhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D5739%26epage%3D5744%26doi%3D10.1073%2Fpnas.0710626105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Structures Of Human Monoamine Oxidase B Complexes With Selective Noncovalent Inhibitors: Safinamide And Coumarin Analogs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5848</span>– <span class="NLM_lpage">5852</span>, <span class="refDoi"> DOI: 10.1021/jm070677y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070677y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5848-5852&author=C.+Bindaauthor=J.+Wangauthor=L.+Pisaniauthor=C.+Cacciaauthor=A.+Carottiauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structures+Of+Human+Monoamine+Oxidase+B+Complexes+With+Selective+Noncovalent+Inhibitors%3A+Safinamide+And+Coumarin+Analogs&doi=10.1021%2Fjm070677y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span></div><div class="casAuthors">Binda, Claudia; Wang, Jin; Pisani, Leonardo; Caccia, Carla; Carotti, Angelo; Salvati, Patricia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5848-5852</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structures of human monoamine oxidase B (MAO B) in complex with safinamide and two coumarin derivs., all sharing a common benzyloxy substituent, were detd. by x-ray crystallog.  These compds. competitively inhibit MAO B with Ki values in the 0.1-0.5 μM range that are 30-700-fold lower than those obsd. with MAO A.  The inhibitors bind noncovalently to MAO B, occupying both the entrance and the substrate cavities and showing a similarly oriented benzyloxy substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPIubufo89bVg90H21EOLACvtfcHk0lgaYOoGXDs-vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI&md5=448f65696f4870e2301f46a6f015e35c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm070677y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070677y%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructures%2520Of%2520Human%2520Monoamine%2520Oxidase%2520B%2520Complexes%2520With%2520Selective%2520Noncovalent%2520Inhibitors%253A%2520Safinamide%2520And%2520Coumarin%2520Analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5848%26epage%3D5852%26doi%3D10.1021%2Fjm070677y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated Docking With Selective Receptor Flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+Docking+With+Selective+Receptor+Flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0ljbQFvTcSUPfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520Docking%2520With%2520Selective%2520Receptor%2520Flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halliday, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">Automated Docking Using A Lamarckian Genetic Algorithm And Empirical Binding Free Energy Function</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1639</span>– <span class="NLM_lpage">1662</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=1639-1662&author=G.+M.+Morrisauthor=D.+S.+Goodsellauthor=R.+S.+Hallidayauthor=R.+Hueyauthor=W.+E.+Hartauthor=R.+K.+Belewauthor=A.+J.+Olson&title=Automated+Docking+Using+A+Lamarckian+Genetic+Algorithm+And+Empirical+Binding+Free+Energy+Function&doi=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function</span></div><div class="casAuthors">Morris, Garrett M.; Goodsell, David S.; Halliday, Robert S.; Huey, Ruth; Hart, William E.; Belew, Richard K.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1639-1662</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review, with 81 refs.  A novel and robust automated docking method that predicts the bound conformations of flexible ligands to macromol. targets has been developed and tested, in combination with a new scoring function that ests. the free energy change upon binding.  Interestingly, this method applies a Lamarckian model of genetics, in which environmental adaptations of an individual's phenotype are reverse transcribed into its genotype and become heritable traits (sic).  We consider three search methods, Monte Carlo simulated annealing, a traditional genetic algorithm, and the Lamarckian genetic algorithm, and compare their performance in dockings of seven protein-ligand test systems having known three-dimensional structure.  We show that both the traditional and Lamarckian genetic algorithms can handle ligands with more degrees of freedom than the simulated annealing method used in earlier versions of AuToDOCK, and that the Lamarckian genetic algorithm is the most efficient, reliable, and successful of the three.  The empirical free energy function was calibrated using a set of 30 structurally known protein-ligand complexes with exptl. detd. binding consts.  Linear regression anal. of the obsd. binding consts. in terms of a wide variety of structure-derived mol. properties was performed.  The final model had a residual std. error of 9.11 kJ mol-1 (2.177 kcal mol-1) and was chosen as the new energy function.  The new search methods and empirical free energy function are available in AUTODOCK, version 3.0.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWXZfPvnZWcbVg90H21EOLACvtfcHk0ljbQFvTcSUPfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D&md5=804b9f797c0b2cf942444c17b5653659</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%252819981115%252919%253A14%253C1639%253A%253AAID-JCC10%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DHalliday%26aufirst%3DR.%2BS.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DW.%2BE.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutomated%2520Docking%2520Using%2520A%2520Lamarckian%2520Genetic%2520Algorithm%2520And%2520Empirical%2520Binding%2520Free%2520Energy%2520Function%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1998%26volume%3D19%26spage%3D1639%26epage%3D1662%26doi%3D10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akdoğan, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yelekçi, K.</span></span> <span> </span><span class="NLM_article-title">In Silico Design Of Novel And Highly Selective Lysine-Specific Histone Demethylase Inhibitors</span>. <i>Turk J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">542</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1CjtLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=523-542&author=E.+D.+Akdo%C4%9Fanauthor=B.+Ermanauthor=K.+Yelek%C3%A7i&title=In+Silico+Design+Of+Novel+And+Highly+Selective+Lysine-Specific+Histone+Demethylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">In silico design of novel and highly selective lysine-specific histone demethylase inhibitors</span></div><div class="casAuthors">Akdogan, Ebru Demet; Erman, Burak; Yelekci, Kemal</div><div class="citationInfo"><span class="NLM_cas:title">Turkish Journal of Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">523-542</span>CODEN:
                <span class="NLM_cas:coden">TJCHE3</span>;
        ISSN:<span class="NLM_cas:issn">1300-0527</span>.
    
            (<span class="NLM_cas:orgname">Scientific and Technological Research Council of Turkey</span>)
        </div><div class="casAbstract">Histone lysine-specific demethylase (LSD1) is involved in a wide range of epigenetic processes and plays important roles in gene silencing, DNA transcription, DNA replication, DNA repair, and heterochromatin formation.  Its active site shows a resemblance to those of 2 homologous enzymes, monamine oxidase A and B (MAO-A and MAO-B.).  In the present work, starting from suitable scaffolds and generating thousands of structures from them, 10 potential inhibitors were obtained with structural and physicochem. properties selectively suitable for inhibiting LSD1.  ILib Diverse software was used to generate the diverse structures and 3 docking tools, CDOCKER, GOLD, and AutoDock, were used to find the most probable potential inhibitor based on its binding affinity.  The dispositions of the candidate mols. within the organism were checked by ADMET_PSA_2D (polar surface area) vs. ADMET_AlogP98 (the logarithm of the partition coeff. between n-octanol and water), and their suitability is discussed.  The LSD1 inhibition activities of the candidates were compared with the properties of trans-2-phenylcyclopropylamine (tranylcypromine) and 2-(4-methoxy-phenyl) cyclopropylamine, which are the 2 known inhibitors of LSD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpshEPGmO3hyLVg90H21EOLACvtfcHk0ljbQFvTcSUPfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1CjtLbP&md5=646a1bc8d06df633316ba5eea0452625</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkdo%25C4%259Fan%26aufirst%3DE.%2BD.%26aulast%3DErman%26aufirst%3DB.%26aulast%3DYelek%25C3%25A7i%26aufirst%3DK.%26atitle%3DIn%2520Silico%2520Design%2520Of%2520Novel%2520And%2520Highly%2520Selective%2520Lysine-Specific%2520Histone%2520Demethylase%2520Inhibitors%26jtitle%3DTurk%2520J.%2520Chem.%26date%3D2011%26volume%3D35%26spage%3D523%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yáñez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraiz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orallo, F.</span></span> <span> </span><span class="NLM_article-title">Inhibitory Effects Of Cis- And Trans-Resveratrol On Noradrenaline And 5-Hydroxytryptamine Uptake And On Monoamine Oxidase Activity</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>344</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2006.03.190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.bbrc.2006.03.190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=16631124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFWnsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2006&pages=688-695&author=M.+Y%C3%A1%C3%B1ezauthor=N.+Fraizauthor=E.+Canoauthor=F.+Orallo&title=Inhibitory+Effects+Of+Cis-+And+Trans-Resveratrol+On+Noradrenaline+And+5-Hydroxytryptamine+Uptake+And+On+Monoamine+Oxidase+Activity&doi=10.1016%2Fj.bbrc.2006.03.190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity</span></div><div class="casAuthors">Yanez, Matilde; Fraiz, Nuria; Cano, Ernesto; Orallo, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">688-695</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This study investigated for the first time the potential effects of cis- and trans-resveratrol (c-RESV and t-RESV) on noradrenaline (NA) and 5-hydroxytryptamine (5-HT) uptake by synaptosomes from rat brain, on 5-HT uptake by human platelets, and on monoamine oxidase (MAO) isoform activity.  Both c-RESV and t-RESV (5-200 μM) concn.-dependently inhibited the uptake of [3H]NA and [3H]5-HT by synaptosomes from rat brain and the uptake of [3H]5-HT by human platelets.  In both exptl. models, t-RESV was slightly more efficient than c-RESV.  Furthermore, in synaptosomes from rat brain, the RESV isomers were less selective against [3H]5-HT uptake than the ref. drug fluoxetine (0.1 - 30 μM).  On the other hand, both c-RESV and t-RESV (5-200 μM) concn.-dependently inhibited the enzymic activity of com. (human recombinant) MAO isoform (MAO-A and MAO-B) activity, c-RESV being slightly less effective than t-RESV.  In addn., both RESV isomers were slight but significantly more selective against MAO-A than against MAO-B.  Since the principal groups of drugs used in the treatment of depressive disorders are NA/5-HT uptake or MAO inhibitors, under the assumption that the RESV isomers exhibit a similar behavior in humans in vivo, our results suggest that these natural polyphenols may be of value as structural templates for the design and development of new antidepressant drugs with two important biochem. activities combined in the same chem. structure: NA/5-HT uptake and MAO inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLoapdpA6vZrVg90H21EOLACvtfcHk0ljgPYwsdsF9Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFWnsrg%253D&md5=bfa66795e41cb8f2ccf13c665c4b437d</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.03.190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.03.190%26sid%3Dliteratum%253Aachs%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DFraiz%26aufirst%3DN.%26aulast%3DCano%26aufirst%3DE.%26aulast%3DOrallo%26aufirst%3DF.%26atitle%3DInhibitory%2520Effects%2520Of%2520Cis-%2520And%2520Trans-Resveratrol%2520On%2520Noradrenaline%2520And%25205-Hydroxytryptamine%2520Uptake%2520And%2520On%2520Monoamine%2520Oxidase%2520Activity%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D344%26spage%3D688%26epage%3D695%26doi%3D10.1016%2Fj.bbrc.2006.03.190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccioni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardia, M. C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Synthesis, Stereochemical Identification, And Selective Inhibitory Activity Against Human Monoamine Oxidase-B Of 2-Methylcyclohexylidene-(4-Arylthiazol-2-Yl)Hydrazones</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4874</span>– <span class="NLM_lpage">4880</span>, <span class="refDoi"> DOI: 10.1021/jm800132g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800132g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt1ygtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4874-4880&author=F.+Chimentiauthor=E.+Maccioniauthor=A.+Bolascoauthor=F.+Mannaauthor=P.+Chimentiauthor=D.+Secciauthor=F.+Rossiauthor=P.+Turiniauthor=F.+Ortusoauthor=S.+Alcaroauthor=M.+C.+Cardia&title=Synthesis%2C+Stereochemical+Identification%2C+And+Selective+Inhibitory+Activity+Against+Human+Monoamine+Oxidase-B+Of+2-Methylcyclohexylidene-%284-Arylthiazol-2-Yl%29Hydrazones&doi=10.1021%2Fjm800132g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Stereochemical Identification, and Selective Inhibitory Activity against Human Monoamine Oxidase-B of 2-Methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones</span></div><div class="casAuthors">Chimenti, Franco; Maccioni, Elias; Secci, Daniela; Bolasco, Adriana; Chimenti, Paola; Granese, Arianna; Carradori, Simone; Alcaro, Stefano; Ortuso, Francesco; Yanez, Matilde; Orallo, Francisco; Cirilli, Roberto; Ferretti, Rosella; La Torre, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4874-4880</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones I (R = H, 4-Cl, 4-OMe, etc.) have been investigated for their ability to inhibit selectively the activity of the human A and B isoforms of monoamine oxidase (MAO).  The target compds., which present a stereogenic center on the cyclohexane ring, were obtained as pure (R) and (S) enantiomers by enantioselective HPLC.  The abs. configuration of homochiral forms isolated on a semipreparative scale was obtained by a combined strategy based on chem. correlation and single-crystal X-ray diffraction.  All compds. showed higher activity against the human MAO-B isoform with IC50 values ranging between 26.81 ± 2.74 μM and 14.20 ± 0.26 nM; and the assays carried out on the pure enantiomers showed higher activity for the (R) form.  A computational study was performed by mol. mechanics, DFT-based quantomechanics, and docking techniques on the most active and human MAO-B selective inhibitor I (R = NO2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL59tOyfDXKLVg90H21EOLACvtfcHk0ljgPYwsdsF9Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt1ygtb8%253D&md5=b17d3d31d0744088d5efe0c4d67b7a44</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm800132g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800132g%26sid%3Dliteratum%253Aachs%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DMaccioni%26aufirst%3DE.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DManna%26aufirst%3DF.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DRossi%26aufirst%3DF.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DCardia%26aufirst%3DM.%2BC.%26atitle%3DSynthesis%252C%2520Stereochemical%2520Identification%252C%2520And%2520Selective%2520Inhibitory%2520Activity%2520Against%2520Human%2520Monoamine%2520Oxidase-B%2520Of%25202-Methylcyclohexylidene-%25284-Arylthiazol-2-Yl%2529Hydrazones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4874%26epage%3D4880%26doi%3D10.1021%2Fjm800132g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, M. M.</span></span> <span> </span><span class="NLM_article-title">A Rapid And Sensitive Method For The Quantitation Of Microgram Quantities Of Protein Utilizing The Principle Of Protein-Dye Binding</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/0003-2697(76)90527-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2F0003-2697%2876%2990527-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=942051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.+M.+Bradford&title=A+Rapid+And+Sensitive+Method+For+The+Quantitation+Of+Microgram+Quantities+Of+Protein+Utilizing+The+Principle+Of+Protein-Dye+Binding&doi=10.1016%2F0003-2697%2876%2990527-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span></div><div class="casAuthors">Bradford, Marion M.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">248-54</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A protein detn. method that involves the binding of coomassie Brilliant Blue G 250 to protein is described.  The binding of the dye to protein causes a shift in the absorption max. of the dye from 465 to 595 nm, and it is the increase in absorption at 595 nm that is monitored.  This assay is very reproducible and rapid with the dye binding process virtually complete in ∼ 2 min with good color stability for 1 hr.  There is little or no interference from cations such as Na+ or K+ nor from carbohydrates such as sucrose.  A small amt. of color is developed in the presence of strongly alk. buffering agents, but the assay may be run accurately by the use of proper buffer controls.  The only components found to give excessive interfering color in the assay are relatively large amts. of detergents such as Na dodecyl sulfate, Triton X 100, and commercial glassware detergents.  Interference by small amts. of detergent may be eliminated by the use of proper control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_T_d0trcNrVg90H21EOLACvtfcHk0ljgPYwsdsF9Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D&md5=43f388a493becc4193c7a49d9de0e1db</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990527-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990527-3%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520Rapid%2520And%2520Sensitive%2520Method%2520For%2520The%2520Quantitation%2520Of%2520Microgram%2520Quantities%2520Of%2520Protein%2520Utilizing%2520The%2520Principle%2520Of%2520Protein-Dye%2520Binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254%26doi%3D10.1016%2F0003-2697%2876%2990527-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pienaar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzer, J. P.</span></span> <span> </span><span class="NLM_article-title">The Inhibition Of Monoamine Oxidase By Esomeprazole</span>. <i>Drug Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">462</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1055/s-0033-1345163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1055%2Fs-0033-1345163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aksr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2013&pages=462-467&author=A.+Petzerauthor=A.+Pienaarauthor=J.+P.+Petzer&title=The+Inhibition+Of+Monoamine+Oxidase+By+Esomeprazole&doi=10.1055%2Fs-0033-1345163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibition of monoamine oxidase by esomeprazole</span></div><div class="casAuthors">Petzer, A.; Pienaar, A.; Petzer, J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Research (Stuttgart, Germany)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">462-467, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">DRSGAO</span>;
        ISSN:<span class="NLM_cas:issn">2194-9379</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Virtual screening of a library of drugs has suggested that esomeprazole, the S-enantiomer of omeprazole, may possess binding affinities for the active sites of the monoamine oxidase (MAO) A and B enzymes.  Based on this finding, the current study examines the MAO inhibitory properties of esomeprazole.  Using recombinant human MAO-A and MAO-B, IC50 values for the inhibition of these enzymes by esomeprazole were exptl. detd.  To examine the reversibility of MAO inhibition by esomeprazole, the recoveries of the enzymic activities after diln. of the enzyme-inhibitor complexes were evaluated.  In addn., reversibility of inhibition was also examd. by measuring the recoveries of enzyme activities after dialysis of enzymeinhibitor mixts.  Lineweaver-Burk plots were constructed to evaluate the mode of MAO inhibition and to measure Ki values.  The results document that esomeprazole inhibits both MAO-A and MAO-B with IC50 values of 23 μM and 48 μM, resp.  The interactions of esomeprazole with MAO-A and MAO-B are reversible and most likely competitive with Ki values for the inhibition of the resp. enzymes of 8.99 μM and 31.7 μM.  Considering the available pharmacokinetic data and typical therapeutic doses of esomeprazole, these inhibitory potencies are unlikely to be of pharmacol. relevance in humans.  The MAO inhibitory eff ects of esomeprazole should however be taken into consideration when using this drug in animal expts. where higher doses are often administered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9g2183sAW57Vg90H21EOLACvtfcHk0li6gfdpfSXe0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aksr3L&md5=6c821d6421a8acc52c515381ea29bc86</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1055%2Fs-0033-1345163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0033-1345163%26sid%3Dliteratum%253Aachs%26aulast%3DPetzer%26aufirst%3DA.%26aulast%3DPienaar%26aufirst%3DA.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520Inhibition%2520Of%2520Monoamine%2520Oxidase%2520By%2520Esomeprazole%26jtitle%3DDrug%2520Res.%26date%3D2013%26volume%3D63%26spage%3D462%26epage%3D467%26doi%3D10.1055%2Fs-0033-1345163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, K.</span></span> <span> </span><span class="NLM_article-title">Re-Examination And Further Development Of A Precise And Rapid Dye Method For Measuring Cell Growth/Cell Kill</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1016/0022-1759(89)90397-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2F0022-1759%2889%2990397-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=2470825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaL1M3ls1OitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1989&pages=203-210&author=M.+B.+Hansenauthor=S.+E.+Nielsenauthor=K.+Berg&title=Re-Examination+And+Further+Development+Of+A+Precise+And+Rapid+Dye+Method+For+Measuring+Cell+Growth%2FCell+Kill&doi=10.1016%2F0022-1759%2889%2990397-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill</span></div><div class="casAuthors">Hansen M B; Nielsen S E; Berg K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-10</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">The tetrazolium salt (MTT) method involving conversion of MTT to coloured formazan by cells serving as indirect measurements of cell growth/cell kill has been reported by several groups, although technical problems have been encountered.  The present investigation was undertaken in order to delineate what laboratory variables have direct influence on the sensitivity and reproducibility of the method.  The pH of the extraction buffer was of the utmost importance, since it was demonstrated that a pH greater than 5 would give rise to false signals.  Furthermore, modifying the composition of the extraction buffer, all formazan dye grains were solubilised, totally.  A direct comparison with published methods demonstrated that only the modified method would yield 100% higher signals without increasing the background.  In contrast to previous reports, it was shown that phenol red does not interfere with the measurements and no washing steps are required since all ingredients can be added subsequently.  Serum proteins at concentrations up to 25% have no influence on the result.  All samples can be measured in an ELISA scanner at 570 nm with little intra-assay variation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1mSAw6T_dDENoizSOkG_FfW6udTcc2eZ1xw4ZCcUKxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M3ls1OitA%253D%253D&md5=6dc9f7c84ff6489920976bae15a19632</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2889%2990397-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252889%252990397-9%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DM.%2BB.%26aulast%3DNielsen%26aufirst%3DS.%2BE.%26aulast%3DBerg%26aufirst%3DK.%26atitle%3DRe-Examination%2520And%2520Further%2520Development%2520Of%2520A%2520Precise%2520And%2520Rapid%2520Dye%2520Method%2520For%2520Measuring%2520Cell%2520Growth%252FCell%2520Kill%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1989%26volume%3D119%26spage%3D203%26epage%3D210%26doi%3D10.1016%2F0022-1759%2889%2990397-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porsolt, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blavet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalfre, M.</span></span> <span> </span><span class="NLM_article-title">Behavioural Despair In Rats: A New Model Sensitive To Antidepressant Treatments</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">391</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(78)90118-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2F0014-2999%2878%2990118-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=204499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaE1cXhvVagsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1978&pages=379-391&author=R.+D.+Porsoltauthor=G.+Antonauthor=N.+Blavetauthor=M.+Jalfre&title=Behavioural+Despair+In+Rats%3A+A+New+Model+Sensitive+To+Antidepressant+Treatments&doi=10.1016%2F0014-2999%2878%2990118-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral despair in rats:  a new model sensitive to antidepressant treatments</span></div><div class="casAuthors">Porsolt, Roger D.; Anton, Guy; Blavet, Nadine; Jalfre, Maurice</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-91</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Rats when forced to swim in a cylinder from which they cannot escape will, after an initial period of vigorous activity, adopt a characteristic immobile posture which can be readily identified.  Immobility was decreased by various clin. effective antidepressant drugs at doses which otherwise decreased spontaneous motor activity in an open field.  Antidepressants could thus be distinguished from psychostimulants which decreased immobility at doses which increased general activity.  Anxiolytic compds. did not affect immobility, whereas major tranquilizers enhanced it.  Thus, immobility reflects a state of lowered mood in the rat which is selectively sensitive to antidepressant treatments.  Pos. findings with atypical antidepressant drugs such as iprindole and mianserin suggest that the method may be capable of discovering new antidepressants hitherto undetectable with classical pharmacol. tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0oUdFHAF1sLVg90H21EOLACvtfcHk0ljCyLoeDR9QTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhvVagsr0%253D&md5=293e1fe8766c76315e86bc375c810a58</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2878%2990118-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252878%252990118-8%26sid%3Dliteratum%253Aachs%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DAnton%26aufirst%3DG.%26aulast%3DBlavet%26aufirst%3DN.%26aulast%3DJalfre%26aufirst%3DM.%26atitle%3DBehavioural%2520Despair%2520In%2520Rats%253A%2520A%2520New%2520Model%2520Sensitive%2520To%2520Antidepressant%2520Treatments%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1978%26volume%3D47%26spage%3D379%26epage%3D391%26doi%3D10.1016%2F0014-2999%2878%2990118-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegwood, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baruah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waziri, R.</span></span> <span> </span><span class="NLM_article-title">Presynaptic Modulation Of Amino Acid Release From Synaptosomes</span>. <i>Neurochem Res.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1007/BF00966789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2FBF00966789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1371602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK38XpvF2htg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1992&pages=125-128&author=A.+D.+Shermanauthor=T.+S.+Hegwoodauthor=S.+Baruahauthor=R.+Waziri&title=Presynaptic+Modulation+Of+Amino+Acid+Release+From+Synaptosomes&doi=10.1007%2FBF00966789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Presynaptic modulation of amino acid release from synaptosomes</span></div><div class="casAuthors">Sherman, A. D.; Hegwood, T. S.; Baruah, S.; Waziri, R.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-8</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    </div><div class="casAbstract">Using synaptosomes prepd. from whole rat brain, the spontaneous, Ca-independent, and Ca-dependent release of glutamate and GABA was assessed.  Time intervals of 1-30 s were studied.  Spontaneous release of glutamate (but not GABA) was elevated by 10 μM NMDA or AMPA by 30 s.  This stimulation was partially Ca-dependent.  Ca-dependent release induced by 30 mM KCl was biphasic, confirming previous findings.  This release was stimulated at all time periods by the presence of 10 μM NMDA or AMPA in an antagonist-sensitive manner.  These data suggest that glutamate and GABA are released from vesicular stores in rat synaptosomes and that some of this release is modulated by presynaptic glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLLm0p4CY5YrVg90H21EOLACvtfcHk0ljCyLoeDR9QTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XpvF2htg%253D%253D&md5=19115863e857202f6bb7263c09b9490b</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1007%2FBF00966789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00966789%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DA.%2BD.%26aulast%3DHegwood%26aufirst%3DT.%2BS.%26aulast%3DBaruah%26aufirst%3DS.%26aulast%3DWaziri%26aufirst%3DR.%26atitle%3DPresynaptic%2520Modulation%2520Of%2520Amino%2520Acid%2520Release%2520From%2520Synaptosomes%26jtitle%3DNeurochem%2520Res.%26date%3D1992%26volume%3D17%26spage%3D125%26epage%3D128%26doi%3D10.1007%2FBF00966789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Painsipp, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wultsch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edelsbrunner, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasan, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singewald, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, P.</span></span> <span> </span><span class="NLM_article-title">Reduced Anxiety-Like And Depression-Related Behavior In Neuropeptide Y Y4 Receptor Knockout Mice</span>. <i>Genes, Brain Behav.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1111/j.1601-183X.2008.00389.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1111%2Fj.1601-183X.2008.00389.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=18221379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BD1cvosl2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=532-542&author=E.+Painsippauthor=T.+Wultschauthor=M.+E.+Edelsbrunnerauthor=R.+O.+Tasanauthor=N.+Singewaldauthor=H.+Herzogauthor=P.+Holzer&title=Reduced+Anxiety-Like+And+Depression-Related+Behavior+In+Neuropeptide+Y+Y4+Receptor+Knockout+Mice&doi=10.1111%2Fj.1601-183X.2008.00389.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice</span></div><div class="casAuthors">Painsipp E; Wultsch T; Edelsbrunner M E; Tasan R O; Singewald N; Herzog H; Holzer P</div><div class="citationInfo"><span class="NLM_cas:title">Genes, brain, and behavior</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">532-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropeptide Y (NPY) acting through Y1 receptors reduces anxiety- and depression-like behavior in rodents, whereas Y2 receptor stimulation has the opposite effect.  This study addressed the implication of Y4 receptors in emotional behavior by comparing female germ line Y4 knockout (Y4-/-) mice with control and germ line Y2-/- animals.  Anxiety- and depression-like behavior was assessed with the open field (OF), elevated plus maze (EPM), stress-induced hyperthermia (SIH) and tail suspension tests (TST), respectively.  Learning and memory were evaluated with the object recognition test (ORT).  In the OF and EPM, both Y4-/- and Y2-/- mice exhibited reduced anxiety-related behavior and enhanced locomotor activity relative to control animals.  Locomotor activity in a familiar environment was unchanged in Y4-/- but reduced in Y2-/- mice.  The basal rectal temperature exhibited diurnal and genotype-related alterations.  Control mice had temperature minima at noon and midnight, whereas Y4-/- and Y2-/- mice displayed only one temperature minimum at noon.  The magnitude of SIH was related to time of the day and genotype in a complex manner.  In the TST, the duration of immobility was significantly shorter in Y4-/- and Y2-/- mice than in controls.  Object memory 6 h after initial exposure to the ORT was impaired in Y2-/- but not in Y4-/- mice, relative to control mice.  These results show that genetic deletion of Y4 receptors, like that of Y2 receptors, reduces anxiety-like and depression-related behavior.  Unlike Y2 receptor knockout, Y4 receptor knockout does not impair object memory.  We propose that Y4 receptors play an important role in the regulation of behavioral homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5o5Ddy9v0ayXXDYhVZBdlfW6udTcc2eZ0NWj99nUhSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvosl2huw%253D%253D&md5=2ac07540935848f0063184fbf299ae6a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1111%2Fj.1601-183X.2008.00389.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1601-183X.2008.00389.x%26sid%3Dliteratum%253Aachs%26aulast%3DPainsipp%26aufirst%3DE.%26aulast%3DWultsch%26aufirst%3DT.%26aulast%3DEdelsbrunner%26aufirst%3DM.%2BE.%26aulast%3DTasan%26aufirst%3DR.%2BO.%26aulast%3DSingewald%26aufirst%3DN.%26aulast%3DHerzog%26aufirst%3DH.%26aulast%3DHolzer%26aufirst%3DP.%26atitle%3DReduced%2520Anxiety-Like%2520And%2520Depression-Related%2520Behavior%2520In%2520Neuropeptide%2520Y%2520Y4%2520Receptor%2520Knockout%2520Mice%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2008%26volume%3D7%26spage%3D532%26epage%3D542%26doi%3D10.1111%2Fj.1601-183X.2008.00389.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locker, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holub, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drexel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayr, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilches, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kofler, B.</span></span> <span> </span><span class="NLM_article-title">GAL3 Receptor KO Mice Exhibit An Anxiety-Like Phenotype</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">7138</span>– <span class="NLM_lpage">7143</span>, <span class="refDoi"> DOI: 10.1073/pnas.1318066111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1073%2Fpnas.1318066111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=24782539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFGmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=7138-7143&author=S.+M.+Brunnerauthor=A.+Farziauthor=F.+Lockerauthor=B.+S.+Holubauthor=M.+Drexelauthor=F.+Reichmannauthor=A.+A.+Langauthor=J.+A.+Mayrauthor=J.+J.+Vilchesauthor=X.+Navarroauthor=R.+Langauthor=G.+Sperkauthor=P.+Holzerauthor=B.+Kofler&title=GAL3+Receptor+KO+Mice+Exhibit+An+Anxiety-Like+Phenotype&doi=10.1073%2Fpnas.1318066111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">GAL3 receptor KO mice exhibit an anxiety-like phenotype</span></div><div class="casAuthors">Brunner, Susanne M.; Farzi, Aitak; Locker, Felix; Holub, Barbara S.; Drexel, Meinrad; Reichmann, Florian; Lang, Andreas A.; Mayr, Johannes A.; Vilches, Jorge J.; Navarro, Xavier; Lang, Roland; Sperk, Guenther; Holzer, Peter; Kofler, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7138-7143</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The neuropeptide galanin (GAL) is widely distributed in the central and peripheral nervous systems.  It is a modulator of various physiol. and pathol. processes, and it mediates its effects via three G protein-coupled receptors (GAL1-3 receptors).  A role for GAL as a modulator of mood and anxiety was suggested, because GAL and its receptors are highly expressed in limbic brain structures of rodents.  In recent years, numerous studies of animal models have suggested an involvement of GAL and GAL1 and GAL2 receptors in anxiety- and depression-related behavior.  However, to date, there is sparse literature implicating GAL3 receptors in behavioral functions.  Therefore, we studied the behavior of GAL3 receptor-deficient (GAL3-KO) mice to elucidate whether GAL3 receptors are involved in mediating behavior-assocd. actions of GAL.  The GAL3-KO mouse line exhibited normal breeding and phys. development.  In addn. to behavioral tests, phenotypic characterization included anal. of hematol., amino acid profiles, metab., and sudomotor function.  In contrast to WT littermates, male GAL3-KO mice exhibited an anxiety-like phenotype in the elevated plus maze, open field, and light/dark box tests, and they were less socially affiliated than WT animals to a stranger mouse in a social interaction test.  In conclusion, our data suggest involvement of GAL3 receptors in GAL-mediated effects on mood, anxiety, and behavior, making it a possible target for alternative treatment strategies for mood disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkpHwt2vTrVbVg90H21EOLACvtfcHk0liaQ980OU5yyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFGmsL8%253D&md5=5d2251ab2211d03b33422160cb05cec9</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1318066111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1318066111%26sid%3Dliteratum%253Aachs%26aulast%3DBrunner%26aufirst%3DS.%2BM.%26aulast%3DFarzi%26aufirst%3DA.%26aulast%3DLocker%26aufirst%3DF.%26aulast%3DHolub%26aufirst%3DB.%2BS.%26aulast%3DDrexel%26aufirst%3DM.%26aulast%3DReichmann%26aufirst%3DF.%26aulast%3DLang%26aufirst%3DA.%2BA.%26aulast%3DMayr%26aufirst%3DJ.%2BA.%26aulast%3DVilches%26aufirst%3DJ.%2BJ.%26aulast%3DNavarro%26aufirst%3DX.%26aulast%3DLang%26aufirst%3DR.%26aulast%3DSperk%26aufirst%3DG.%26aulast%3DHolzer%26aufirst%3DP.%26aulast%3DKofler%26aufirst%3DB.%26atitle%3DGAL3%2520Receptor%2520KO%2520Mice%2520Exhibit%2520An%2520Anxiety-Like%2520Phenotype%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2014%26volume%3D111%26spage%3D7138%26epage%3D7143%26doi%3D10.1073%2Fpnas.1318066111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panfili, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernster, L.</span></span> <span> </span><span class="NLM_article-title">Hydrogen Peroxide Production By Monoamine Oxidase In Isolated Rat-Brain Mitochondria: Its Effect On Glutathione Levels And Ca2+ Efflux</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>1035</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1016/0304-4165(90)90092-B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2F0304-4165%2890%2990092-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK3MXhvVyr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1035&publication_year=1990&pages=300-305&author=G.+Sandriauthor=E.+Panfiliauthor=L.+Ernster&title=Hydrogen+Peroxide+Production+By+Monoamine+Oxidase+In+Isolated+Rat-Brain+Mitochondria%3A+Its+Effect+On+Glutathione+Levels+And+Ca2%2B+Efflux&doi=10.1016%2F0304-4165%2890%2990092-B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen peroxide production by monoamine oxidase in isolated rat brain mitochondria:  its effect on glutathione levels and calcium efflux</span></div><div class="casAuthors">Sandri, Gabriella; Panfili, Enrico; Ernster, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">1035</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-5</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    </div><div class="casAbstract">H2O2 prodn. and accumulation during incubation of isolated rat-brain mitochondria with substrates of monoamine oxidase A and B were investigated.  All substrates gave rise to an accumulation of H2O2 which was inhibited by malate + pyruvate or isocitrate, consistent with a need for mitochondrial NADPH to maintain glutathione in the reduced state.  However, in the absence of these addns. the level of reduced glutathione decreased only by ∼30%, indicating that only a fraction of the mitochondrial glutathione pool was accessible to the glutathione peroxidase and glutathione reductase activities responsible for the continuous removal of H2O2 generated by monoamine oxidase.  The H2O2 accumulation was also inhibited by externally added reduced glutathione or NADPH but not NADH.  External NADPH was oxidized by added oxidized glutathione but not α-ketoglutarate + NH4+.  These results suggest that the removal of H2O2 generated by monoamine oxidase proceeds by way of special fractions of glutathione peroxidase and glutathione reductase that are located in the intermembrane space of mitochondria in such a way that they can react with both intra- and extramitochondrial glutathione and NADPH, possibly at the contact sites between the inner and outer mitochondrial membranes.  Evidence is also presented that H2O2 generated by monoamine oxidase enhances Ca2+ release from mitochondria and may thus function as a regulator of mitochondrial Ca2+ efflux.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofK6Etqzaam7Vg90H21EOLACvtfcHk0liaQ980OU5yyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhvVyr&md5=abe22ac23e89ed7be36f963da1b87b12</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2F0304-4165%2890%2990092-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-4165%252890%252990092-B%26sid%3Dliteratum%253Aachs%26aulast%3DSandri%26aufirst%3DG.%26aulast%3DPanfili%26aufirst%3DE.%26aulast%3DErnster%26aufirst%3DL.%26atitle%3DHydrogen%2520Peroxide%2520Production%2520By%2520Monoamine%2520Oxidase%2520In%2520Isolated%2520Rat-Brain%2520Mitochondria%253A%2520Its%2520Effect%2520On%2520Glutathione%2520Levels%2520And%2520Ca2%252B%2520Efflux%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D1990%26volume%3D1035%26spage%3D300%26epage%3D305%26doi%3D10.1016%2F0304-4165%2890%2990092-B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mena, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia de Yebenes, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casarejos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia de
Yebenes, J.</span></span> <span> </span><span class="NLM_article-title">Effects Of Calcium Antagonists On The Dopamine System</span>. <i>Clin. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1097/00002826-199510000-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1097%2F00002826-199510000-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=8665555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK28Xhs1WjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1995&pages=410-426&author=M.+A.+Menaauthor=M.+J.+Garcia+de+Yebenesauthor=C.+Taberneroauthor=M.+J.+Casarejosauthor=B.+Pardoauthor=J.+Garcia+de%0AYebenes&title=Effects+Of+Calcium+Antagonists+On+The+Dopamine+System&doi=10.1097%2F00002826-199510000-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of calcium antagonists on the dopamine system</span></div><div class="casAuthors">Mena, Maria Angeles; Yebenes, Maria Jesus Garcia de; Tabernero, Cesar; Casarejos, Maria Jose; Pardo, Beatriz; Yebenes, Justo Garcia de</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Neuropharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">410-26</span>CODEN:
                <span class="NLM_cas:coden">CLNEDB</span>;
        ISSN:<span class="NLM_cas:issn">0362-5664</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Calcium channel antagonists are drugs currently used in the treatment of neurol. and cardiovascular disorders and occasionally produce parkinsonism and movement disorders as a side effect.  We investigated the effects of calcium channel antagonists on the pharmacol. of dopamine systems in vivo and in vitro.  Flunarizine, cinnarizine, and diltiazem reduce the viability of dopamine-rich human neuroblastoma cells in vitro.  These compds. plus verapamil, nifedipine, and nicardipine reduce 3H-spiperone binding to bovine striatal membranes, 3H-dopamine uptake, K+-induced 3H-dopamine release, and apomorphine-induced rotation, but not amphetamine-induced rotation, in 6-OH-dopamine-lesioned rats.  Therefore, all calcium channel antagonists tested reduce dopamine neurotransmission in vitro and in vivo, whereas the evidence of toxicity for dopamine cells in vitro is restricted to flunarizine, cinnarizine, and diltiazem.  The clin. relevance of these toxic effects may depend on several factors, including age, penetration across the blood-brain barrier, and types of calcium channels present in the different neuronal subtypes.  On the other hand, the finding of dopamine-regulating properties not assocd. to neurotoxic effects in the dihydropyridines and verapamil provides new putative therapeutic tools for the treatment of neurol. disorders assocd. with dopamine hyperactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCHzAWuvco1LVg90H21EOLACvtfcHk0liaQ980OU5yyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhs1WjtLw%253D&md5=718a9befafaa1f7dffc9644e09228f0d</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1097%2F00002826-199510000-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002826-199510000-00004%26sid%3Dliteratum%253Aachs%26aulast%3DMena%26aufirst%3DM.%2BA.%26aulast%3DGarcia%2Bde%2BYebenes%26aufirst%3DM.%2BJ.%26aulast%3DTabernero%26aufirst%3DC.%26aulast%3DCasarejos%26aufirst%3DM.%2BJ.%26aulast%3DPardo%26aufirst%3DB.%26aulast%3DGarcia%2Bde%2BYebenes%26aufirst%3DJ.%26atitle%3DEffects%2520Of%2520Calcium%2520Antagonists%2520On%2520The%2520Dopamine%2520System%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D1995%26volume%3D18%26spage%3D410%26epage%3D426%26doi%3D10.1097%2F00002826-199510000-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teymour  Vahedpour</span>, <span class="hlFld-ContribAuthor ">Maryam  Hamzeh‐Mivehroud</span>, <span class="hlFld-ContribAuthor ">Salar  Hemmati</span>, <span class="hlFld-ContribAuthor ">Siavoush  Dastmalchi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2‐Pyrazolines from Hydrazines: Mechanisms Explained. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (25)
                                     , 6483-6506. <a href="https://doi.org/10.1002/slct.202101467" title="DOI URL">https://doi.org/10.1002/slct.202101467</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202101467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202101467%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Bof%252B2%2525E2%252580%252590Pyrazolines%252Bfrom%252BHydrazines%25253A%252BMechanisms%252BExplained%26aulast%3DVahedpour%26aufirst%3DTeymour%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D25%26spage%3D6483%26epage%3D6506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Aryloxazolidinone derivatives of MAOIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overall design strategy for 2-pyrazoline and hydrazone derivatives (the color code indicates common chemical structures).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis and Structure of the Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A–C) 3D representations of compound <b>38</b> docked in the MAO-A (2Z5X) (A) active site. Magnified view of the active site (B). 2D interaction diagrams of compound <b>38</b> with amino acid residues lining the MAO-A active site (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A–C) 3D representations of compound <b>38</b> docked in the MAO-B (2V5Z) (B) active site. Magnified view of the active site (B). 2D interaction diagrams of compound <b>38</b> with amino acid residues lining the MAO-B active site (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A, B). Effects of a single-dose (A) and subchronic administrations (B) of the compounds and moclobemide on the immobility time in the PFST; <i>n</i> = 8–12, *<i>p</i> < 0.05. The immobility times of mice administrated with moclobemide or the test compounds were compared with the control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Total distance traveled in the open-field test by mice administrated subchronically 30 mg/kg of the test compounds and 20 mg/kg moclobemide. <i>n</i> = 8–10.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/medium/jm0c01504_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A, B). Dose–response data with the PFST at 1, 3,10, and 30 mg/kg doses of the test compounds and 1, 3, 10, and 20 mg/kg doses of moclobemide (A); <i>n</i> = 8–12, *<i>p</i> < 0.05. The immobility times of mice treated with test compounds or moclobemide were compared to those of the control mice. Dose–response curves of moclobemide and compounds <b>21</b> and <b>42</b>. Increase in the activity % of the most effective compounds and moclobemide with increasing doses (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01504/20210218/images/large/jm0c01504_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01504&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i92">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 82 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">World Federation for Mental
Health</span>, <span class="NLM_year">2012</span>. <span> </span><span class="NLM_article-title">DEPRESSION: A Global
Crisis</span>. <a href="https://www.who.int/mental_health/management/depression/wfmh_paper_depression_wmhd_2012.pdf?Ua=1" class="extLink">https://www.who.int/mental_health/management/depression/wfmh_paper_depression_wmhd_2012.pdf?Ua=1</a> (accessed Jun 25, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=World+Federation+for+Mental%0AHealth&title=DEPRESSION%3A+A+Global%0ACrisis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2012%26atitle%3DDEPRESSION%253A%2520A%2520Global%250ACrisis" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, A. D.</span></span> <span> </span><span class="NLM_article-title">Alternative Projections of Mortality and Disability by Cause 1990-2020: Global Burden of Disease Study</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">1498</span>– <span class="NLM_lpage">1504</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(96)07492-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2FS0140-6736%2896%2907492-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=9167458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaK2szhtVaqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=1997&pages=1498-1504&author=C.+J.+Murrayauthor=A.+D.+Lopez&title=Alternative+Projections+of+Mortality+and+Disability+by+Cause+1990-2020%3A+Global+Burden+of+Disease+Study&doi=10.1016%2FS0140-6736%2896%2907492-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study</span></div><div class="casAuthors">Murray C J; Lopez A D</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">9064</span>),
    <span class="NLM_cas:pages">1498-504</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">BACKGROUND:  Plausible projections of future mortality and disability are a useful aid in decisions on priorities for health research, capital investment, and training.  Rates and patterns of ill health are determined by factors such as socioeconomic development, educational attainment, technological developments, and their dispersion among populations, as well as exposure to hazards such as tobacco.  As part of the Global Burden of Disease Study (GBD), we developed three scenarios of future mortality and disability for different age-sex groups, causes, and regions.  METHODS:  We used the most important disease and injury trends since 1950 in nine cause-of-death clusters.  Regression equations for mortality rates for each cluster by region were developed from gross domestic product per person (in international dollars), average number of years of education, time (in years, as a surrogate for technological change), and smoking intensity, which shows the cumulative effects based on data for 47 countries in 1950-90.  Optimistic, pessimistic, and baseline projections of the independent variables were made.  We related mortality from detailed causes to mortality from a cause cluster to project more detailed causes.  Based on projected numbers of deaths by cause, years of life lived with disability (YLDs) were projected from different relation models of YLDs to years of life lost (YLLs).  Population projections were prepared from World Bank projections of fertility and the projected mortality rates.  FINDINGS:  Life expectancy at birth for women was projected to increase in all three scenarios; in established market economies to about 90 years by 2020.  Far smaller gains in male life expectancy were projected than in females; in formerly socialist economies of Europe, male life expectancy may not increase at all.  Worldwide mortality from communicable maternal, perinatal, and nutritional disorders was expected to decline in the baseline scenario from 17.2 million deaths in 1990 to 10.3 million in 2020.  We projected that non-communicable disease mortality will increase from 28.1 million deaths in 1990 to 49.7 million in 2020.  Deaths from injury may increase from 5.1 million to 8.4 million.  Leading causes of disability-adjusted life years (DALYs) predicted by the baseline model were (in descending order): ischaemic heart disease, unipolar major depression, road-traffic accidents, cerebrovascular disease, chronic obstructive pulmonary disease, lower respiratory infections, tuberculosis, war injuries, diarrhoeal diseases, and HIV.  Tobacco-attributable mortality is projected to increase from 3.0 million deaths in 1990 to 8.4 million deaths in 2020.  INTERPRETATION:  Health trends in the next 25 years will be determined mainly by the ageing of the world's population, the decline in age-specific mortality rates from communicable, maternal, perinatal, and nutritional disorders, the spread of HIV, and the increase in tobacco-related mortality and disability.  Projections, by their nature, are highly uncertain, but we found some robust results with implications for health policy.  As part of the Global Burden of Disease Study, three scenarios of future mortality and disability were identified.  The scenarios were based on future health status as a function of projected changes in key socioeconomic variables that influence health status.  Regression equations for mortality rates for nine cause-of-death clusters were developed by region based on gross domestic product per person, average number of years of education, time (as a proxy for technological change), and smoking intensity.  Life expectancy at birth was projected, in all three scenarios, to increase for women (to about 90 years in established market economies by 2020), with far smaller gains in male life expectancy.  Worldwide, annual mortality from communicable maternal, perinatal, and nutritional disorders (group 1 causes) is expected to decline from 17.2 million to 10.3 million in 2020 in the baseline model.  Also expected is a very large increase in deaths from non-communicable diseases (group 2 causes) from 28.1 million in 1990 to 49.7 million in 2020.  Deaths from injuries (group 3) are projected to increase from 5.1 million to 8.4 million.  Diarrheal diseases, perinatal disorders, measles, and malaria are expected to decline dramatically as causes of death in the 1990-2020 period, while lung cancer, stomach cancer, war injuries, liver cancer, and HIV are expected to move up five or more places in the ranking.  In 2020, the 10 leading causes of disability-adjusted life-years (in descending order) are projected to be ischemic heart disease, unipolar major depression, road traffic accidents, cerebrovascular disease, chronic obstructive pulmonary disease, lower respiratory infections, tuberculosis, war injuries, diarrheal diseases, and HIV.  Tobacco-attributable mortality is projected to increase from 3.0 million in 1990 to 8.4 million in 2020 (9% of the worldwide mortality burden).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXx1ktA_8fRDDnmmyUf5qOfW6udTcc2eZxZ1rbCDJS3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szhtVaqsw%253D%253D&md5=8663247d3d31df40c48d824a647a8b6a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2896%2907492-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252896%252907492-2%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BJ.%26aulast%3DLopez%26aufirst%3DA.%2BD.%26atitle%3DAlternative%2520Projections%2520of%2520Mortality%2520and%2520Disability%2520by%2520Cause%25201990-2020%253A%2520Global%2520Burden%2520of%2520Disease%2520Study%26jtitle%3DLancet%26date%3D1997%26volume%3D349%26spage%3D1498%26epage%3D1504%26doi%3D10.1016%2FS0140-6736%2896%2907492-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musselman, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemeroff, C. B.</span></span> <span> </span><span class="NLM_article-title">The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment</span>. <i>Arch. Gen. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1001/archpsyc.55.7.580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1001%2Farchpsyc.55.7.580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=9672048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaK1czjsFOluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1998&pages=580-592&author=D.+L.+Musselmanauthor=D.+L.+Evansauthor=C.+B.+Nemeroff&title=The+relationship+of+depression+to+cardiovascular+disease%3A+epidemiology%2C+biology%2C+and+treatment&doi=10.1001%2Farchpsyc.55.7.580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment</span></div><div class="casAuthors">Musselman D L; Evans D L; Nemeroff C B</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">580-92</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">This article reviews the burgeoning literature on the relationship of mood disorders and heart disease.  Major depression and depressive symptoms, although commonly encountered in medical populations, are frequently underdiagnosed and undertreated in patients with cardiovascular disease (CVD).  This is of particular importance because several studies have shown depression and its associated symptoms to be a major risk factor for both the development of CVD and death after an index myocardial infarction.  This review of the extant literature is derived from MEDLINE searches (1966-1997) using the search terms "major depression," "psychiatry," "cardiovascular disease," and "pathophysiology." Studies investigating pathophysiological alterations related to CVD in depressed patients are reviewed.  The few studies on treatment of depression in patients with CVD are also described.  Treatment of depression in patients with CVD improves their dysphoria and other signs and symptoms of depression, improves quality of life, and perhaps even increases longevity.  Recommendations for future research are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQv6YMhZTa63FQKX3ooHxWjfW6udTcc2eZxZ1rbCDJS3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czjsFOluw%253D%253D&md5=365f9e9f0c687382a5f4ab09bb98766f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.55.7.580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.55.7.580%26sid%3Dliteratum%253Aachs%26aulast%3DMusselman%26aufirst%3DD.%2BL.%26aulast%3DEvans%26aufirst%3DD.%2BL.%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DThe%2520relationship%2520of%2520depression%2520to%2520cardiovascular%2520disease%253A%2520epidemiology%252C%2520biology%252C%2520and%2520treatment%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1998%26volume%3D55%26spage%3D580%26epage%3D592%26doi%3D10.1001%2Farchpsyc.55.7.580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michelson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galliven, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrousos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, P.</span></span> <span> </span><span class="NLM_article-title">Bone Mineral Density in Women with Depression</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>335</i></span>,  <span class="NLM_fpage">1176</span>– <span class="NLM_lpage">1181</span>, <span class="refDoi"> DOI: 10.1056/NEJM199610173351602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1056%2FNEJM199610173351602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=8815939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaK28zpvFShtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=1996&pages=1176-1181&author=D.+Michelsonauthor=C.+Stratakisauthor=L.+Hillauthor=J.+Reynoldsauthor=E.+Gallivenauthor=G.+Chrousosauthor=P.+Gold&title=Bone+Mineral+Density+in+Women+with+Depression&doi=10.1056%2FNEJM199610173351602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Bone mineral density in women with depression</span></div><div class="casAuthors">Michelson D; Stratakis C; Hill L; Reynolds J; Galliven E; Chrousos G; Gold P</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1176-81</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Depression is associated with alterations in behavior and neuroendocrine systems that are risk factors for decreased bone mineral density.  This study was undertaken to determine whether women with past or current major depression have demonstrable decreases in bone density.  METHODS:  We measured bone mineral density at the hip, spine, and radius in 24 women with past or current major depression and 24 normal women matched for age, body-mass index, menopausal status, and race, using dual-energy x-ray absorptiometry.  We also evaluated cortisol and growth hormone secretion, bone metabolism, and vitamin D-receptor alleles.  RESULTS:  As compared with the normal women, the mean (+/-SD) bone density in the women with past or current depression was 6.5 percent lower at the spine (1.00+/-0.15 vs. 1.07+/-0.09 g per square centimeter, P=0.02), 13.6 percent lower at the femoral neck (0.76+/-0.11 vs. 0.88+/-0.11 g per square centimeter, P<0.001), 13.6 percent lower at Ward's triangle (0.70+/-0.14 vs. 0.81+/-0.13 g per square centimeter, P<0.001), and 10.8 percent lower at the trochanter (0.66+/-0.11 vs. 0.74+/-0.08 g per square centimeter, P<0.001).  In addition, women with past or current depression had higher urinary cortisol excretion (71+/-29 vs. 51+/-19 micrograms per day [196+/-80 vs. 141+/-52 nmol per day], P=0.006), lower serum osteocalcin concentration (P=0.04), and lower urinary excretion of deoxypyridinoline (P=0.02).  CONCLUSIONS:  Past or current depression in women is associated with decreased bone mineral density.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTfCfbsJ2oADUg6wdEZmT2rfW6udTcc2eZxZ1rbCDJS3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zpvFShtg%253D%253D&md5=25a371981daa5a08577000cf2b6f38ee</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJM199610173351602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199610173351602%26sid%3Dliteratum%253Aachs%26aulast%3DMichelson%26aufirst%3DD.%26aulast%3DStratakis%26aufirst%3DC.%26aulast%3DHill%26aufirst%3DL.%26aulast%3DReynolds%26aufirst%3DJ.%26aulast%3DGalliven%26aufirst%3DE.%26aulast%3DChrousos%26aufirst%3DG.%26aulast%3DGold%26aufirst%3DP.%26atitle%3DBone%2520Mineral%2520Density%2520in%2520Women%2520with%2520Depression%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1996%26volume%3D335%26spage%3D1176%26epage%3D1181%26doi%3D10.1056%2FNEJM199610173351602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beach, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ives, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martire, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariyo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kop, W. J.</span></span> <span> </span><span class="NLM_article-title">Association Between Depression and Mortality in Older Adults: the Cardiovascular Health Study</span>. <i>Arch. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">1761</span>– <span class="NLM_lpage">1768</span>, <span class="refDoi"> DOI: 10.1001/archinte.160.12.1761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1001%2Farchinte.160.12.1761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10871968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BD3czjtlCqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2000&pages=1761-1768&author=R.+Schulzauthor=S.+R.+Beachauthor=D.+G.+Ivesauthor=L.+M.+Martireauthor=A.+A.+Ariyoauthor=W.+J.+Kop&title=Association+Between+Depression+and+Mortality+in+Older+Adults%3A+the+Cardiovascular+Health+Study&doi=10.1001%2Farchinte.160.12.1761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Association between depression and mortality in older adults: the Cardiovascular Health Study</span></div><div class="casAuthors">Schulz R; Beach S R; Ives D G; Martire L M; Ariyo A A; Kop W J</div><div class="citationInfo"><span class="NLM_cas:title">Archives of internal medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1761-8</span>
        ISSN:<span class="NLM_cas:issn">0003-9926</span>.
    </div><div class="casAbstract">BACKGROUND:  Studies of the association between depressive symptoms and mortality in elderly populations have yielded contradictory findings.  To address these discrepancies, we test this association using the most extensive array of sociodemographic and physical health control variables ever studied, to our knowledge, in a large population-based sample of elderly individuals.  OBJECTIVE:  To examine the relation between baseline depressive symptoms and 6-year all-cause mortality in older persons, systematically controlling for sociodemographic factors, clinical disease, subclinical disease, and health risk factors.  METHODS:  A total of 5201 men and women aged 65 years and older from 4 US communities participated in the study.  Depressive symptoms and 4 categories of covariates were assessed at baseline.  The primary outcome measure was 6-year mortality.  RESULTS:  Of the 5201 participants, 984 (18.9%) died within 6 years.  High baseline depressive symptoms were associated with a higher mortality rate (23.9%) than low baseline depression scores (17.7%) (unadjusted relative risk [RR], 1.41; 95% confidence interval [CI], 1.22-1.63).  Depression was also an independent predictor of mortality when controlling for sociodemographic factors (RR, 1.43; 95% CI, 1.23-1.66), prevalent clinical disease (RR, 1.25; 95% CI, 1.07-1.45), subclinical disease indicators (RR, 1.35; 95% CI, 1.15-1.58), or biological or behavioral risk factors (RR, 1.42; 95% CI, 1.22-1.65).  When the best predictors from all 4 classes of variables were included as covariates, high depressive symptoms remained an independent predictor of mortality (RR, 1.24; 95% CI, 1.06-1.46).  CONCLUSIONS:  High levels of depressive symptoms are an independent risk factor for mortality in community-residing older adults.  Motivational depletion may be a key underlying mechanism for the depression-mortality effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_dbJ_OElGFYYPsCkJIw00fW6udTcc2eaZQznYW8e0eLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3czjtlCqug%253D%253D&md5=8afdd61834ce62f17cea3f2f5a3e5a1e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1001%2Farchinte.160.12.1761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.160.12.1761%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DR.%26aulast%3DBeach%26aufirst%3DS.%2BR.%26aulast%3DIves%26aufirst%3DD.%2BG.%26aulast%3DMartire%26aufirst%3DL.%2BM.%26aulast%3DAriyo%26aufirst%3DA.%2BA.%26aulast%3DKop%26aufirst%3DW.%2BJ.%26atitle%3DAssociation%2520Between%2520Depression%2520and%2520Mortality%2520in%2520Older%2520Adults%253A%2520the%2520Cardiovascular%2520Health%2520Study%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D2000%26volume%3D160%26spage%3D1761%26epage%3D1768%26doi%3D10.1001%2Farchinte.160.12.1761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seney, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibille, E.</span></span> <span> </span><span class="NLM_article-title">Sex Differences in Mood Disorders: Perspectives from Humans and Rodent Models</span>. <i>Biol. Sex Differ.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">17</span> <span class="refDoi"> DOI: 10.1186/s13293-014-0017-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1186%2Fs13293-014-0017-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=25520774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BC2MvgvVyjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=M.+L.+Seneyauthor=E.+Sibille&title=Sex+Differences+in+Mood+Disorders%3A+Perspectives+from+Humans+and+Rodent+Models&doi=10.1186%2Fs13293-014-0017-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Sex differences in mood disorders: perspectives from humans and rodent models</span></div><div class="casAuthors">Seney Marianne L; Sibille Etienne</div><div class="citationInfo"><span class="NLM_cas:title">Biology of sex differences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17</span>
        ISSN:<span class="NLM_cas:issn">2042-6410</span>.
    </div><div class="casAbstract">Mood disorders are devastating, often chronic illnesses characterized by low mood, poor affect, and anhedonia.  Notably, mood disorders are approximately twice as prevalent in women compared to men.  If sex differences in mood are due to underlying biological sex differences, a better understanding of the biology is warranted to develop better treatment or even prevention of these debilitating disorders.  In this review, our goals are to: 1) summarize the literature related to mood disorders with respect to sex differences in prevalence, 2) introduce the corticolimbic brain network of mood regulation, 3) discuss strategies and challenges of modeling mood disorders in mice, 4) discuss mechanisms underlying sex differences and how these can be tested in mice, and 5) discuss how our group and others have used a translational approach to investigate mechanisms underlying sex differences in mood disorders in humans and mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOCl0Oo1R-_MERNNga7KD-fW6udTcc2eaZQznYW8e0eLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvgvVyjsw%253D%253D&md5=2e9ca6457bc4a8a8f2969ba5f6b81bf2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2Fs13293-014-0017-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13293-014-0017-3%26sid%3Dliteratum%253Aachs%26aulast%3DSeney%26aufirst%3DM.%2BL.%26aulast%3DSibille%26aufirst%3DE.%26atitle%3DSex%2520Differences%2520in%2520Mood%2520Disorders%253A%2520Perspectives%2520from%2520Humans%2520and%2520Rodent%2520Models%26jtitle%3DBiol.%2520Sex%2520Differ.%26date%3D2014%26volume%3D5%26doi%3D10.1186%2Fs13293-014-0017-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collins, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span> <span> </span><span class="NLM_article-title">Multiple Forms Of Human Brain Mitochondrial Monoamine Oxidase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>225</i></span>,  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1038/225817a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1038%2F225817a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=5415111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaE3cXht1yrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=1970&pages=817-820&author=G.+G.+Collinsauthor=M.+Sandlerauthor=E.+D.+Williamsauthor=M.+B.+Youdim&title=Multiple+Forms+Of+Human+Brain+Mitochondrial+Monoamine+Oxidase&doi=10.1038%2F225817a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple forms of human brain mitochondrial monoamine oxidase</span></div><div class="casAuthors">Collins, Godfrey G. S.; Sandler, Merton; Williams, Edward Dillwyn; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">5235</span>),
    <span class="NLM_cas:pages">817-20</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The presence of at least 4 monoamine oxidase (I) isoenzymes was obsd. in human brain.  Their sp. activities differed from one area to another.  It was suggested that a simple regulatory mechanism existed by which an in traneuronal concn. of a particular amine was accompanied by the activation of a relatively specific isoenzyme of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsajQ4LcUEnLVg90H21EOLACvtfcHk0liqimuRQsR-hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXht1yrurs%253D&md5=6d48451a49211b914136a880d842f64b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F225817a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F225817a0%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DG.%2BG.%26aulast%3DSandler%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DE.%2BD.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DMultiple%2520Forms%2520Of%2520Human%2520Brain%2520Mitochondrial%2520Monoamine%2520Oxidase%26jtitle%3DNature%26date%3D1970%26volume%3D225%26spage%3D817%26epage%3D820%26doi%3D10.1038%2F225817a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, J. P.</span></span> <span> </span><span class="NLM_article-title">Some Observations Upon A New Inhibitor Of Monoamine Oxidase In Brain Tissue</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1285</span>– <span class="NLM_lpage">1297</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(68)90066-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2F0006-2952%2868%2990066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=5659776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaF1cXktlCnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1968&pages=1285-1297&author=J.+P.+Johnston&title=Some+Observations+Upon+A+New+Inhibitor+Of+Monoamine+Oxidase+In+Brain+Tissue&doi=10.1016%2F0006-2952%2868%2990066-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Some observations on a new inhibitor of monoamine oxidase in brain tissue</span></div><div class="casAuthors">Johnston, J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1285-97</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The inhibition of monoamine oxidase (MAO) in vitro and in vivo by N-methyl-N-propargyl-3-(2,4-dichlorophenoxy)propylamine-HCl (M&B 9302) is described.  The kinetics of the MAO-M&B 9302 reaction show a unique abnormality as compared with known inhibitors.  The plot of percent inhibition vs. concn. of M&B 9302 does not show a simple sigmoid curve, but reveals a pair of sigmoid curves joined by a horizontal section where the inhibition is invariant.  The hypothesis that in the enzyme prepn., the MAO is a binary system of enzymes, each of which has a detectably different sensitivity to this particular inhibitor, is put forward and discussed.  Evidence after dialysis supports this hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdnWyFh0aO2rVg90H21EOLACvtfcHk0lgqobd4cyndNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXktlCnsro%253D&md5=9987689810991f980e64f5b24665af02</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2868%2990066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252868%252990066-X%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DJ.%2BP.%26atitle%3DSome%2520Observations%2520Upon%2520A%2520New%2520Inhibitor%2520Of%2520Monoamine%2520Oxidase%2520In%2520Brain%2520Tissue%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1968%26volume%3D17%26spage%3D1285%26epage%3D1297%26doi%3D10.1016%2F0006-2952%2868%2990066-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, K.</span></span> <span> </span><span class="NLM_article-title">Some Puzzling Pharmacological Effects Of Monoamine Oxidase Inhibitors</span>. <i>Adv. Biochem. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">408</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=5066229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaE3sXhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1972&pages=393-408&author=J.+Knollauthor=K.+Magyar&title=Some+Puzzling+Pharmacological+Effects+Of+Monoamine+Oxidase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Puzzling pharmacological effects of monoamine oxidase [MAO] inhibitors</span></div><div class="casAuthors">Knoll, J.; Magyar, K.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biochemical Psychopharmacology</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">393-408</span>CODEN:
                <span class="NLM_cas:coden">ABPYBL</span>;
        ISSN:<span class="NLM_cas:issn">0065-2229</span>.
    </div><div class="casAbstract">A discussion and review with 17 refs. of some dissimilar effects various monoamine oxidase inhibitors may have on the metabolism of biogenic amines.  Studies with the optical isomers of Deprenil [2079-54-1] indicate that multiple forms of the enzyme monoamine oxidase may exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCM6fPp82whLVg90H21EOLACvtfcHk0lgqobd4cyndNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhsA%253D%253D&md5=8a0fe1c36cedef71af1bde3b408913f9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnoll%26aufirst%3DJ.%26aulast%3DMagyar%26aufirst%3DK.%26atitle%3DSome%2520Puzzling%2520Pharmacological%2520Effects%2520Of%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DAdv.%2520Biochem.%2520Psychopharmacol.%26date%3D1972%26volume%3D5%26spage%3D393%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Carroll, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobbia, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tipton, K. F.</span></span> <span> </span><span class="NLM_article-title">The Deamination Of Dopamine By Human Brain Monoamine Oxidase. Specificity For The Two Enzyme Forms In Seven Brain Regions</span>. <i>Naunyn-Schmiedeberg’s Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>322</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1007/BF00500765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2FBF00500765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=6408492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaL3sXitFSmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=1983&pages=198-202&author=A.+M.+O%E2%80%99Carrollauthor=C.+J.+Fowlerauthor=J.+P.+Phillipsauthor=I.+Tobbiaauthor=K.+F.+Tipton&title=The+Deamination+Of+Dopamine+By+Human+Brain+Monoamine+Oxidase.+Specificity+For+The+Two+Enzyme+Forms+In+Seven+Brain+Regions&doi=10.1007%2FBF00500765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The deamination of dopamine by human brain monoamine oxidase.  Specificity for the two enzyme forms in seven brain regions</span></div><div class="casAuthors">O'Carroll, Anne Marie; Fowler, Christopher J.; Phillips, Jack P.; Tobbia, Iqdam; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">198-202</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">The deamination of dopamine (I)  [51-61-6] was studied in 7 regions of human brain.  Both A and B forms of monamine oxidase (MAO)  [9001-66-5] were active towards I.  The ratio of activities of MAO-A:MAO-B varied considerably from brain region to brain region, from about 1:1 for the cerebral and cerebellar cortex to about 1:2 for the pons and medulla oblongata.  Enzyme titrn. studies and comparisons of the substrate specificities of MAO-A and MAO-B across the brain indicated that I was metabolized by the same MAO active centers as other monoamines.  In the cerebral cortex, the Km values of MAO-A and -B towards I were 210 and 230 μM, resp., indicating that the relative contributions of these 2 forms towards the oxidn. of I will not be affected by changes in its concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd11w8nQN5OrVg90H21EOLACvtfcHk0lgqobd4cyndNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitFSmtrk%253D&md5=ac03f33b62d3b917845cf5441904dac0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2FBF00500765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00500765%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Carroll%26aufirst%3DA.%2BM.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DPhillips%26aufirst%3DJ.%2BP.%26aulast%3DTobbia%26aufirst%3DI.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520Deamination%2520Of%2520Dopamine%2520By%2520Human%2520Brain%2520Monoamine%2520Oxidase.%2520Specificity%2520For%2520The%2520Two%2520Enzyme%2520Forms%2520In%2520Seven%2520Brain%2520Regions%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1983%26volume%3D322%26spage%3D198%26epage%3D202%26doi%3D10.1007%2FBF00500765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, J.</span></span> <span> </span><span class="NLM_article-title">Structural Aspects Of Monoamine Oxidase And Its Reversible Inhibition</span>. <i>Curr Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=9481038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK1cXisVWmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1998&pages=137-162&author=J.+Wouters&title=Structural+Aspects+Of+Monoamine+Oxidase+And+Its+Reversible+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structural aspects of monoamine oxidase and its reversible inhibition</span></div><div class="casAuthors">Wouters, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-162</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 152 refs. on the major structural aspects of MAO in relation to its primary sequence (site-directed mutagenesis, chimeric constructions) and secondary and three-dimensional structures.  The consequences of the inhibition of monoamine oxidase are considered, mainly focusing on the new generations of reversible and selective MAO inhibitors (utilized as antidepressants antiparkinsonian agents).  Recent efforts to design and develop these inhibitors are emphasized and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotbNNQZ7IslLVg90H21EOLACvtfcHk0lgqobd4cyndNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisVWmurw%253D&md5=02266afed9ece8986df53752e9aab5cd</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWouters%26aufirst%3DJ.%26atitle%3DStructural%2520Aspects%2520Of%2520Monoamine%2520Oxidase%2520And%2520Its%2520Reversible%2520Inhibition%26jtitle%3DCurr%2520Med.%2520Chem.%26date%3D1998%26volume%3D5%26spage%3D137%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carreiras, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco, J. L.</span></span> <span> </span><span class="NLM_article-title">Recent Approaches To Novel Anti-Alzheimer Therapy</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3167</span>– <span class="NLM_lpage">3175</span>, <span class="refDoi"> DOI: 10.2174/1381612043383421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.2174%2F1381612043383421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=15544506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslCktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3167-3175&author=C.+Carreirasauthor=J.+L.+Marco&title=Recent+Approaches+To+Novel+Anti-Alzheimer+Therapy&doi=10.2174%2F1381612043383421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Recent approaches to novel anti-Alzheimer therapy</span></div><div class="casAuthors">Carreiras, M. C.; Marco, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3167-3175</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Insufficient cholinergic neurotransmission in AD is responsible for a progressive loss of cognition and motor capacities.  The cholinergic hypothesis has provided the rationale for the current treatment approaches based on acetylcholinesterase inhibitors.  However, recent data focus on the complex nature of AD and disclose the involvement of other neurotransmitters such as serotonin, noradrenalin, dopamine, histamine, excitatory amino acids, and neuropeptides, among others.  Interestingly, recent research has revealed that in severe AD brains the levels of AChE are considerably reduced whereas BuChE activity increases, thus aggravating the toxicity of βA.  In such instances, it is possible that BuChE may be a more suitable target than AChE.  Oxidative stress has been implicated in CNS degenerative disorders such as AD and PD.  Therefore, owing to their capacity to inhibit oxidative damage, MAOIs are potential candidates as anti-Alzheimer drugs.  More recently, a novel drug - TV3326 - was designed, based upon 2 pharmacophores: the carbamate moiety from Rivastigmine, an AChE inhibitor; and the propargyl group from Rasagiline, a MAO inhibitor.  This drug exhibits cholinesterase and selective brain MAO inhibitory activities, reduces apoptosis, and stimulates the processing of APPα, hence reducing the possibility of generation of the toxic βA.  Thus, TV3326 may be expected to contribute pos. to the cognitive benefits of Alzheimer's patients.  Anyhow, the development of drugs with several targets and diverse pharmacol. properties may conclusively demonstrate the most beneficial therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyyCavRdcJObVg90H21EOLACvtfcHk0librMqSxTSIug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslCktrY%253D&md5=a5c994c025780f2d02462eea9ad221e6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1381612043383421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043383421%26sid%3Dliteratum%253Aachs%26aulast%3DCarreiras%26aufirst%3DC.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26atitle%3DRecent%2520Approaches%2520To%2520Novel%2520Anti-Alzheimer%2520Therapy%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D3167%26epage%3D3175%26doi%3D10.2174%2F1381612043383421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finberg, J. P. M.</span></span> <span> </span><span class="NLM_article-title">Update On The Pharmacology Of Selective Inhibitors Of Mao-A And Mao-B: Focus On Modulation Of Cns Monoamine Neurotransmitter Release</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2014.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.pharmthera.2014.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=24607445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=133-152&author=J.+P.+M.+Finberg&title=Update+On+The+Pharmacology+Of+Selective+Inhibitors+Of+Mao-A+And+Mao-B%3A+Focus+On+Modulation+Of+Cns+Monoamine+Neurotransmitter+Release&doi=10.1016%2Fj.pharmthera.2014.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release</span></div><div class="casAuthors">Finberg, John P. M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-152</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Inhibitors of monoamine oxidase (MAO) were initially used in medicine following the discovery of their antidepressant action.  Subsequently their ability to potentiate the effects of an indirectly-acting sympathomimetic amine such as tyramine was discovered, leading to their limitation in clin. use, except for cases of treatment-resistant depression.  More recently, the understanding that: a) potentiation of indirectly-acting sympathomimetic amines is caused by inhibitors of MAO-A but not by inhibitors of MAO-B, and b) that reversible inhibitors of MAO-A cause minimal tyramine potentiation, has led to their re-introduction to clin. use for treatment of depression (reversible MAO-A inhibitors and new dose form MAO-B inhibitor) and treatment of Parkinson's disease (MAO-B inhibitors).  The profound neuroprotective properties of propargyl-based inhibitors of MAO-B in preclin. expts. have drawn attention to the possibility of employing these drugs for their neuroprotective effect in neurodegenerative diseases, and have raised the question of the involvement of the MAO-mediated reaction as a source of reactive free radicals.  Despite the long-standing history of MAO inhibitors in medicine, the way in which they affect neuronal release of monoamine neurotransmitters is still poorly understood.  In recent years, the detailed chem. structure of MAO-B and MAO-A has become available, providing new possibilities for synthesis of mechanism-based inhibitors.  This review describes the latest advances in understanding the way in which MAO inhibitors affect the release of the monoamine neurotransmitters dopamine, noradrenaline and serotonin (5-HT) in the CNS, with an accent on the importance of these effects for the clin. actions of the drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSGMvtQ1Ca5bVg90H21EOLACvtfcHk0librMqSxTSIug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslGht7o%253D&md5=0f31959bad34842d4aaaba7b8162e5b8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%2BM.%26atitle%3DUpdate%2520On%2520The%2520Pharmacology%2520Of%2520Selective%2520Inhibitors%2520Of%2520Mao-A%2520And%2520Mao-B%253A%2520Focus%2520On%2520Modulation%2520Of%2520Cns%2520Monoamine%2520Neurotransmitter%2520Release%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D143%26spage%3D133%26epage%3D152%26doi%3D10.1016%2Fj.pharmthera.2014.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padin, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arranz-Tagarro, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laguna</span></span> <span> </span><span class="NLM_article-title">History And Therapeutic Use Of MAO-A Inhibitors: A Historical Perspective Of MAO-A Inhibitors As Antidepressant Drug</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2275</span>– <span class="NLM_lpage">2282</span>, <span class="refDoi"> DOI: 10.2174/156802612805220011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.2174%2F156802612805220011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Gms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=2275-2282&author=M.+Yanezauthor=J.+F.+Padinauthor=J.+A.+Arranz-Tagarroauthor=M.+Caminaauthor=+Laguna&title=History+And+Therapeutic+Use+Of+MAO-A+Inhibitors%3A+A+Historical+Perspective+Of+MAO-A+Inhibitors+As+Antidepressant+Drug&doi=10.2174%2F156802612805220011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">History and therapeutic use of MAO-A inhibitors: a historical perspective of MAO-A inhibitors as antidepressant drug</span></div><div class="casAuthors">Yanez, Matilde; Padin, Juan Fernando; Arranz-Tagarro, Juan Alberto; Camina, Mercedes; Laguna, Reyes</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2275-2282</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the first generation of MAO inhibitors was developed, more than fifty years ago, this family of drugs has been ups and downs over the last decades.  Actually, interest in MAO inhibitors is reviving and the emergence of new advances in the rational design of mols. and new techniques to predict the in vivo behavior has encouraged the research for new drugs with therapeutic potential in this area.  The classic MAOIs have been widely used as antidepressants during the two decades after its introduction in clinic.  Based on observations made on MAO inhibition by these drugs, it has been postulated hypothesis that have contributed to a better understanding of the mechanism and management of depressive disorders.  However, exaggerated concerns about food and drug interactions relegated these drugs from the pharmaceutical landscape.  The correct interpretation and the contextualization of side effects and the recent research findings, in which MAO selective inhibitors appear as promising agents in the treatment of emerging and high prevalence diseases, are placing these drugs again into the scientific and pharmacol. focus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcjQfz6ownfLVg90H21EOLACvtfcHk0librMqSxTSIug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Gms78%253D&md5=d006b5b41bcc578adaaf401f5ce677ae</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F156802612805220011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802612805220011%26sid%3Dliteratum%253Aachs%26aulast%3DYanez%26aufirst%3DM.%26aulast%3DPadin%26aufirst%3DJ.%2BF.%26aulast%3DArranz-Tagarro%26aufirst%3DJ.%2BA.%26aulast%3DCamina%26aufirst%3DM.%26aulast%3DLaguna%26atitle%3DHistory%2520And%2520Therapeutic%2520Use%2520Of%2520MAO-A%2520Inhibitors%253A%2520A%2520Historical%2520Perspective%2520Of%2520MAO-A%2520Inhibitors%2520As%2520Antidepressant%2520Drug%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D2275%26epage%3D2282%26doi%3D10.2174%2F156802612805220011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccioni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Befani, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirilli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Torre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardia, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distinto, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Molecular Modeling Studies, And Selective Inhibitory Activity Against Monoamine Oxidase Of 1-Thiocarbamoyl-3,5-Diaryl-4,5-Dihydro-(1H)- Pyrazole Derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7113</span>– <span class="NLM_lpage">7122</span>, <span class="refDoi"> DOI: 10.1021/jm040903t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040903t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFahs7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7113-7122&author=F.+Chimentiauthor=E.+Maccioniauthor=D.+Secciauthor=A.+Bolascoauthor=P.+Chimentiauthor=A.+Graneseauthor=O.+Befaniauthor=P.+Turiniauthor=S.+Alcaroauthor=F.+Ortusoauthor=R.+Cirilliauthor=F.+La+Torreauthor=M.+C.+Cardiaauthor=S.+Distinto&title=Synthesis%2C+Molecular+Modeling+Studies%2C+And+Selective+Inhibitory+Activity+Against+Monoamine+Oxidase+Of+1-Thiocarbamoyl-3%2C5-Diaryl-4%2C5-Dihydro-%281H%29-+Pyrazole+Derivatives&doi=10.1021%2Fjm040903t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives</span></div><div class="casAuthors">Chimenti, Franco; Maccioni, Elias; Secci, Daniela; Bolasco, Adriana; Chimenti, Paola; Granese, Arianna; Befani, Olivia; Turini, Paola; Alcaro, Stefano; Ortuso, Francesco; Cirilli, Roberto; La Torre, Francesco; Cardia, Maria C.; Distinto, Simona</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7113-7122</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)-pyrazole derivs. I (R1 = 4-MeC6H4, 4-FC6H4, 2-thienyl; R2 = 4-ClC6H4, 4-Me6H4, 2-furanyl; R1 = R2 = 2-thienyl) have been synthesized and investigated for the ability to inhibit selectively the activity of the A and B isoforms of monoamine oxidase (MAO).  All the synthesized compds. show high activity against both the MAO-A and the MAO-B isoforms with Ki values between 27 and 4 nM and between 50 and 1.5 nM, resp., except for a few derivs. whose inhibitory activity against MAO-B was in the micromolar range.  Knowing that stereochem. may be an important modulator of biol. activity, we performed the semipreparative chromatog. enantiosepn. of the most potent, selective, and chiral compds.  The sepd. enantiomers were then submitted to in vitro biol. evaluation.  The selectivity of the (-)-(S)-I (R1 = 4-MeC6H4; R2 = 4-ClC6H4) enantiomer against MAO-B increases twice and a half, while the selectivity of the (-)-(S)-I (R1 = 4-FC6H4; R2 = 4-ClC6H4) enantiomer against MAO-A triples.  Both the MAO-A and MAO-B isoforms resp. of the 1O5W and 1GOS models deposited in the Protein Data Bank were considered in the computational study.  The docking study was carried out using several computational approaches with the aim of proposing possible binding modes of the MAO enantioselective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7pzRRRqEz6rVg90H21EOLACvtfcHk0lhil3-7x0y8BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFahs7vE&md5=6801dd2b87c1c60e9a50cd2947996dfd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm040903t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040903t%26sid%3Dliteratum%253Aachs%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DMaccioni%26aufirst%3DE.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DGranese%26aufirst%3DA.%26aulast%3DBefani%26aufirst%3DO.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DCirilli%26aufirst%3DR.%26aulast%3DLa%2BTorre%26aufirst%3DF.%26aulast%3DCardia%26aufirst%3DM.%2BC.%26aulast%3DDistinto%26aufirst%3DS.%26atitle%3DSynthesis%252C%2520Molecular%2520Modeling%2520Studies%252C%2520And%2520Selective%2520Inhibitory%2520Activity%2520Against%2520Monoamine%2520Oxidase%2520Of%25201-Thiocarbamoyl-3%252C5-Diaryl-4%252C5-Dihydro-%25281H%2529-%2520Pyrazole%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7113%26epage%3D7122%26doi%3D10.1021%2Fjm040903t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizzarri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Befani, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondovi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tafi, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition Of Amine Oxidases Activity By 1-Acetyl-3,5-Diphenyl-4,5-Dihydro-(1H)-Pyrazole Derivatives</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3629</span>– <span class="NLM_lpage">3633</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00699-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2FS0960-894X%2802%2900699-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=12443791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD38Xoslykt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3629-3633&author=F.+Mannaauthor=F.+Chimentiauthor=A.+Bolascoauthor=D.+Secciauthor=B.+Bizzarriauthor=O.+Befaniauthor=P.+Turiniauthor=B.+Mondoviauthor=S.+Alcaroauthor=A.+Tafi&title=Inhibition+Of+Amine+Oxidases+Activity+By+1-Acetyl-3%2C5-Diphenyl-4%2C5-Dihydro-%281H%29-Pyrazole+Derivatives&doi=10.1016%2FS0960-894X%2802%2900699-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives</span></div><div class="casAuthors">Manna, Fedele; Chimenti, Franco; Bolasco, Adriana; Secci, Daniela; Bizzarri, Bruna; Befani, Olivia; Turini, Paola; Mondovi, Bruno; Alcaro, Stefano; Tafi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3629-3633</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A novel series of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivs. have been synthesized and investigated for the ability to inhibit selectively monoamine oxidases, swine kidney oxidase, and bovine serum amine oxidase.  The newly synthesized compds. proved to be reversible and non-competitive inhibitors of all types of the assayed amine oxidases.  Compds. inhibit monoamine oxidases potently, displaying low I50 values of particular interest.  In particular 1-acetyl-3-(2,4-dihydroxyphenyl)-5-(3-methylphenyl)-4,5-dihydro-(1H)-pyrazole showed to be a potent monoamine oxidase inhibitor with a Ki of about 10-8 M.  Further insights in the theor. evaluation of the possible interactions between the compds. and monoamine oxidase B have been developed through a computational approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcefOKo4lMZrVg90H21EOLACvtfcHk0lhil3-7x0y8BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xoslykt7o%253D&md5=13c0b17e567f90507ebde798be595f1b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900699-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900699-6%26sid%3Dliteratum%253Aachs%26aulast%3DManna%26aufirst%3DF.%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DBizzarri%26aufirst%3DB.%26aulast%3DBefani%26aufirst%3DO.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DMondovi%26aufirst%3DB.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DTafi%26aufirst%3DA.%26atitle%3DInhibition%2520Of%2520Amine%2520Oxidases%2520Activity%2520By%25201-Acetyl-3%252C5-Diphenyl-4%252C5-Dihydro-%25281H%2529-Pyrazole%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3629%26epage%3D3633%26doi%3D10.1016%2FS0960-894X%2802%2900699-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span> <span> </span><span class="NLM_article-title">The State Of The Art Of Pyrazole Derivatives As Monoamine Oxidase Inhibitors And Antidepressant/Anticonvulsant Agents</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5114</span>– <span class="NLM_lpage">5144</span>, <span class="refDoi"> DOI: 10.2174/092986711797636090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.2174%2F092986711797636090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=22050759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ShtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=5114-5144&author=D.+Secciauthor=A.+Bolascoauthor=P.+Chimentiauthor=S.+Carradori&title=The+State+Of+The+Art+Of+Pyrazole+Derivatives+As+Monoamine+Oxidase+Inhibitors+And+Antidepressant%2FAnticonvulsant+Agents&doi=10.2174%2F092986711797636090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents</span></div><div class="casAuthors">Secci, D.; Bolasco, A.; Chimenti, P.; Carradori, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">5114-5144</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase plays a significant role in the control of intracellular concn. of monoaminergic neurotransmitters or neuromodulators and dietary amines.  The rapid degrdn. of these mols. ensures the proper functioning of synaptic neurotransmission and is critically important for the regulation of emotional and other brain functions.  The development of human MAO inhibitors led to important breakthroughs in the therapy of several neuropsychiatric disorders.  Different families of heterocycles contg. 2 or 4 nitrogen atoms have been used as scaffolds for synthesizing selective monoamine oxidase inhibitors, but the early period of the MAO-inhibitors started with hydrazine derivs.  Pyrazole, pyrazoline, and pyrazolidine derivs. can be considered as a cyclic hydrazine moiety.  This scaffold also displayed promising antidepressant and anticonvulsant properties as demonstrated by different and established animal models.  Diversely substituted pyrazoles, embedded with a variety of functional groups, are important biol. agents and a significant amt. of research activity has been directed towards this chem. class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr66QhWLGWCBLVg90H21EOLACvtfcHk0lhil3-7x0y8BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ShtrzO&md5=cc2019fc83603bab23b443bd563f9c98</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F092986711797636090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797636090%26sid%3Dliteratum%253Aachs%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DCarradori%26aufirst%3DS.%26atitle%3DThe%2520State%2520Of%2520The%2520Art%2520Of%2520Pyrazole%2520Derivatives%2520As%2520Monoamine%2520Oxidase%2520Inhibitors%2520And%2520Antidepressant%252FAnticonvulsant%2520Agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D5114%26epage%3D5144%26doi%3D10.2174%2F092986711797636090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anbazhagan, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Preclinical Evaluation And Antidepressant Activity Of 5-Substituted Phenyl-3-(Thiophen-2-Yl)-4, 5-Dihydro-1H-Pyrazole-1-Carbothioamides</span>. <i>EXCLI J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=26417270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BC283ntFeqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=437-445&author=B.+Mathewauthor=J.+Sureshauthor=S.+Anbazhagan&title=Synthesis%2C+Preclinical+Evaluation+And+Antidepressant+Activity+Of+5-Substituted+Phenyl-3-%28Thiophen-2-Yl%29-4%2C+5-Dihydro-1H-Pyrazole-1-Carbothioamides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, preclinical evaluation and antidepressant activity of 5-substituted phenyl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazole-1-carbothioamides</span></div><div class="casAuthors">Mathew Bijo; Suresh Jerad; Anbazhagan S</div><div class="citationInfo"><span class="NLM_cas:title">EXCLI journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">437-45</span>
        ISSN:<span class="NLM_cas:issn">1611-2156</span>.
    </div><div class="casAbstract">A series of phenyl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazole-1-carbothioamides (TTa-TTg) were synthesized by the ring closure reaction of phenyl-1-(thiophen-2-yl) prop-2-en-1-ones with thiosemicarbazide in alcoholic basic medium.  All the final derivatives were evaluated for their antidepressant and neurotoxicity screening.  The structures of the compounds were characterized by IR, 1H NMR, 13C NMR, Mass and elemental analyses.  Preclinical evaluation of the compounds were ascertained by in silico toxicity, blood-brain barrier and human oral absorption prediction.  In this series, 5-(4-hydroxyphenyl)-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazole-1 carbothioamide (TTg) reduced immobility time 61.17 and 62.05 % in both force swimming and tail suspension test respectively at 10 mg/kg dose level when compared to the standard Imipramine without influencing the baseline locomotion.  Moreover it was observed that the titled scaffold possessing electron withdrawing chlorine atom in the 4(th) position of aromatic ring of the scaffold also showed good the antidepressant activity.  In conclusion, the behavioural investigation revealed that thiophene based pyrazolines having a carbothioamide tail unit in the N1 position may be therapeutically useful as potential antidepressant medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdCpEGnFjeua69lAbTj9rGfW6udTcc2eZvZBjSY2NTk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283ntFeqsQ%253D%253D&md5=484cf42aa579ba2f40eea552839b4bcd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathew%26aufirst%3DB.%26aulast%3DSuresh%26aufirst%3DJ.%26aulast%3DAnbazhagan%26aufirst%3DS.%26atitle%3DSynthesis%252C%2520Preclinical%2520Evaluation%2520And%2520Antidepressant%2520Activity%2520Of%25205-Substituted%2520Phenyl-3-%2528Thiophen-2-Yl%2529-4%252C%25205-Dihydro-1H-Pyrazole-1-Carbothioamides%26jtitle%3DEXCLI%2520J.%26date%3D2014%26volume%3D13%26spage%3D437%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Befani, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondovi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirilli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Torre, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis And Selective Inhibitory Activity Of 1-Acetyl-3,5-Diphenyl-4,5-Dihydro-(1H)-Pyrazole Derivatives Against Monoamine Oxidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2071</span>– <span class="NLM_lpage">2074</span>, <span class="refDoi"> DOI: 10.1021/jm031042b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031042b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitVOqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2071-2074&author=F.+Chimentiauthor=A.+Bolascoauthor=F.+Mannaauthor=D.+Secciauthor=P.+Chimentiauthor=O.+Befaniauthor=P.+Turiniauthor=V.+Giovanniniauthor=B.+Mondoviauthor=R.+Cirilliauthor=F.+La+Torre&title=Synthesis+And+Selective+Inhibitory+Activity+Of+1-Acetyl-3%2C5-Diphenyl-4%2C5-Dihydro-%281H%29-Pyrazole+Derivatives+Against+Monoamine+Oxidase&doi=10.1021%2Fjm031042b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Selective Inhibitory Activity of 1-Acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole Derivatives against Monoamine Oxidase</span></div><div class="casAuthors">Chimenti, Franco; Bolasco, Adriana; Manna, Fedele; Secci, Daniela; Chimenti, Paola; Befani, Olivia; Turini, Paola; Giovannini, Valentina; Mondovi, Bruno; Cirilli, Roberto; La Torre, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2071-2074</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of 1-acetyl-3-(4-hydroxy- and 2,4-dihydroxyphenyl)-5-phenyl-4,5-dihydro-(1H)-pyrazole derivs. I [R = 4-OH, 2,4-(OH)2; R1 = 2-Cl, 3-Cl, 4-Cl, 3-Me, 4-Me, 2-OMe, 4-OMe, 2,4-(OMe)2] have been synthesized and investigated for the ability to selectively inhibit the activity of the A and B isoforms of monoamine oxidase (MAO).  The new synthesized compds. I proved to be more reversible, potent, and selective inhibitors of MAO-A than of MAO-B.  Knowing that stereochem. may be an important modulator of biol. activity, we performed the semi-preparative chromatog. enantiosepn. of the most potent, selective, and chiral compds., I [R = 4-OH; R1 = 2-OMe (II)] and I [R = 2,4-(OH)2; R1 = 2-OMe (III)].  The sepd. enantiomers were then submitted to in vitro biol. evaluation while increasing their inhibitory activity and A selectivity.  The (-)-II enantiomer shows Ki(MAO-A) = 2 nM and SI = 165 000, (+)-II shows Ki(MAO-A) = 6 nM and SI = 166 666, (-)-III shows Ki(MAO-A) = 4 nM and SI = 80 000, and (+)-III shows Ki(MAO-A) = 7 nM and SI = 38 571.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosOAaBXZ93XbVg90H21EOLACvtfcHk0lgmBA7-GboE_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitVOqurw%253D&md5=cece9cc61936e1a9cfb40ff82fac01ce</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm031042b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031042b%26sid%3Dliteratum%253Aachs%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DManna%26aufirst%3DF.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DBefani%26aufirst%3DO.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DGiovannini%26aufirst%3DV.%26aulast%3DMondovi%26aufirst%3DB.%26aulast%3DCirilli%26aufirst%3DR.%26aulast%3DLa%2BTorre%26aufirst%3DF.%26atitle%3DSynthesis%2520And%2520Selective%2520Inhibitory%2520Activity%2520Of%25201-Acetyl-3%252C5-Diphenyl-4%252C5-Dihydro-%25281H%2529-Pyrazole%2520Derivatives%2520Against%2520Monoamine%2520Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2071%26epage%3D2074%26doi%3D10.1021%2Fjm031042b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioravanti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardia, M. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Molecular Modeling Studies And Selective Inhibitory Activity Against MAO Of N1-Propanoyl-3,5-Diphenyl-4,5-Dihydro-(1H)-Pyrazole Derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2262</span>– <span class="NLM_lpage">2267</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2007.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.ejmech.2007.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=18281126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CqsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=2262-2267&author=F.+Chimentiauthor=R.+Fioravantiauthor=A.+Bolascoauthor=F.+Mannaauthor=P.+Chimentiauthor=D.+Secciauthor=F.+Rossiauthor=P.+Turiniauthor=F.+Ortusoauthor=S.+Alcaroauthor=M.+C.+Cardia&title=Synthesis%2C+Molecular+Modeling+Studies+And+Selective+Inhibitory+Activity+Against+MAO+Of+N1-Propanoyl-3%2C5-Diphenyl-4%2C5-Dihydro-%281H%29-Pyrazole+Derivatives&doi=10.1016%2Fj.ejmech.2007.12.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives</span></div><div class="casAuthors">Chimenti, Franco; Fioravanti, Rossella; Bolasco, Adriana; Manna, Fedele; Chimenti, Paola; Secci, Daniela; Rossi, Francesca; Turini, Paola; Ortuso, Francesco; Alcaro, Stefano; Cardia, Maria Cristina</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2262-2267</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 1-propanoyl-3,5-diaryl-4,5-dihydro-1H-pyrazoles I (R1, R2 = Ph, 4-ClC6H4, 4-FC6H4, 4-MeC6H4, 4-MeOC6H4) was synthesized and assayed as inhibitors of MAO-A and MAO-B isoforms.  Most of the tested compds. showed inhibitory activity with micromolar values and MAO-A selectivity.  In addn. a computational work was carried out on the most selective compd. I (R1 = Ph; R2 = 4-ClC6H4) to highlight the most relevant interactions in the mechanism of recognition within both the MAO-A and the MAO-B enzyme active sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozx20F-uGUGrVg90H21EOLACvtfcHk0lgmBA7-GboE_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CqsLbF&md5=8904deec66d869109a4d621288eeb06f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DFioravanti%26aufirst%3DR.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DManna%26aufirst%3DF.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DRossi%26aufirst%3DF.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DCardia%26aufirst%3DM.%2BC.%26atitle%3DSynthesis%252C%2520Molecular%2520Modeling%2520Studies%2520And%2520Selective%2520Inhibitory%2520Activity%2520Against%2520MAO%2520Of%2520N1-Propanoyl-3%252C5-Diphenyl-4%252C5-Dihydro-%25281H%2529-Pyrazole%2520Derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D2262%26epage%3D2267%26doi%3D10.1016%2Fj.ejmech.2007.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizzarri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yáñez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orallo, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis And Inhibitory Activity Against Human Monoamine Oxidase Of N1-Thiocarbamoyl-3,5-Di(Hetero)Aryl-4,5-Dihydro-(1H)-Pyrazole Derivatives</span>. <i>Eur J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">800</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.ejmech.2009.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=19926363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Smtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=800-804&author=F.+Chimentiauthor=S.+Carradoriauthor=D.+Secciauthor=A.+Bolascoauthor=B.+Bizzarriauthor=P.+Chimentiauthor=A.+Graneseauthor=M.+Y%C3%A1%C3%B1ezauthor=F.+Orallo&title=Synthesis+And+Inhibitory+Activity+Against+Human+Monoamine+Oxidase+Of+N1-Thiocarbamoyl-3%2C5-Di%28Hetero%29Aryl-4%2C5-Dihydro-%281H%29-Pyrazole+Derivatives&doi=10.1016%2Fj.ejmech.2009.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives</span></div><div class="casAuthors">Chimenti, Franco; Carradori, Simone; Secci, Daniela; Bolasco, Adriana; Bizzarri, Bruna; Chimenti, Paola; Granese, Arianna; Yanez, Matilde; Orallo, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">800-804</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivs. has been synthesized and assayed for their ability to inhibit the activity of the A and B isoforms of human monoamine oxidase (hMAO).  Some of these compds. were endowed with a selective inhibitory activity against hMAO-B in the micromolar range.  The most active of the series is N1-thiocarbamoyl-3-(fur-2'-yl)-5-(4'-fluoro-phenyl)-4,5-dihydro-(1H)-pyrazole, with IC50 2.75 ± 0.81 μM value and selectivity ratio of 25, which is the best candidate for further investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4JGFlrp7_y7Vg90H21EOLACvtfcHk0lgmBA7-GboE_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Smtg%253D%253D&md5=ba09127c0fcb4cd7ac87c5215f2bb3e2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DBizzarri%26aufirst%3DB.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DGranese%26aufirst%3DA.%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DOrallo%26aufirst%3DF.%26atitle%3DSynthesis%2520And%2520Inhibitory%2520Activity%2520Against%2520Human%2520Monoamine%2520Oxidase%2520Of%2520N1-Thiocarbamoyl-3%252C5-Di%2528Hetero%2529Aryl-4%252C5-Dihydro-%25281H%2529-Pyrazole%2520Derivatives%26jtitle%3DEur%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D800%26epage%3D804%26doi%3D10.1016%2Fj.ejmech.2009.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamanna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinicropi, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrangeli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franchini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondovi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scilimati, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis And Biological Evaluation Of 3-Alkyloxazolidin-2-Ones As Reversible MAO Inhibitors</span>. <i>Arkivoc</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>2004</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.3998/ark.5550190.0005.512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.3998%2Fark.5550190.0005.512" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2004&publication_year=2004&pages=118-130&author=C.+Lamannaauthor=M.+S.+Sinicropiauthor=P.+Pietrangeliauthor=F.+Corboauthor=C.+Franchiniauthor=B.+Mondoviauthor=A.+Scilimati&title=Synthesis+And+Biological+Evaluation+Of+3-Alkyloxazolidin-2-Ones+As+Reversible+MAO+Inhibitors&doi=10.3998%2Fark.5550190.0005.512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3998%2Fark.5550190.0005.512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3998%252Fark.5550190.0005.512%26sid%3Dliteratum%253Aachs%26aulast%3DLamanna%26aufirst%3DC.%26aulast%3DSinicropi%26aufirst%3DM.%2BS.%26aulast%3DPietrangeli%26aufirst%3DP.%26aulast%3DCorbo%26aufirst%3DF.%26aulast%3DFranchini%26aufirst%3DC.%26aulast%3DMondovi%26aufirst%3DB.%26aulast%3DScilimati%26aufirst%3DA.%26atitle%3DSynthesis%2520And%2520Biological%2520Evaluation%2520Of%25203-Alkyloxazolidin-2-Ones%2520As%2520Reversible%2520MAO%2520Inhibitors%26jtitle%3DArkivoc%26date%3D2004%26volume%3D2004%26spage%3D118%26epage%3D130%26doi%3D10.3998%2Fark.5550190.0005.512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artico, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbardella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Befani, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondovi, B.</span></span> <span> </span><span class="NLM_article-title">3-(1H-pyrrol-1-yl)-2-oxazolidinones as Reversible, Highly Potent, And Selective Inhibitors Of Monoamine Oxidase Type A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1183</span>, <span class="refDoi"> DOI: 10.1021/jm015578d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm015578d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1180-1183&author=A.+Maiauthor=M.+Articoauthor=M.+Espositoauthor=G.+Sbardellaauthor=S.+Massaauthor=O.+Befaniauthor=P.+Turiniauthor=V.+Giovanniniauthor=B.+Mondovi&title=3-%281H-pyrrol-1-yl%29-2-oxazolidinones+as+Reversible%2C+Highly+Potent%2C+And+Selective+Inhibitors+Of+Monoamine+Oxidase+Type+A&doi=10.1021%2Fjm015578d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">3-(1H-Pyrrol-1-yl)-2-oxazolidinones as Reversible, Highly Potent, and Selective Inhibitors of Monoamine Oxidase Type A</span></div><div class="casAuthors">Mai, Antonello; Artico, Marino; Esposito, Monica; Sbardella, Gianluca; Massa, Silvio; Befani, Olivia; Turini, Paola; Giovannini, Valentina; Mondovi, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1180-1183</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-(1H-Pyrrol-1-yl)-2-oxazolidinones (R)- and (S)-I [R = OH, OPMe, N3, NH2, NMe2] have been synthesized as pyrrole analogs of toloxatone (Humoryl), an antidepressant agent belonging to the 3-phenyl-2-oxazolidinone class, and their monoamine oxidase (MAO) type A and B inhibitory activities have been evaluated.  The majority of I showed inhibitory activity against the A isoform of the enzyme higher than that exerted against the MAO-B, the sole exception being the (S)-I [R = NH2].  (R)-I [R = OMe], the most potent among test derivs., was 78-fold more potent than toloxatone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBUYCBqxcZFLVg90H21EOLACvtfcHk0ljidFfCj2KDkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWksr8%253D&md5=41304a5442efa6616730a1e0a948c2ae</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm015578d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm015578d%26sid%3Dliteratum%253Aachs%26aulast%3DMai%26aufirst%3DA.%26aulast%3DArtico%26aufirst%3DM.%26aulast%3DEsposito%26aufirst%3DM.%26aulast%3DSbardella%26aufirst%3DG.%26aulast%3DMassa%26aufirst%3DS.%26aulast%3DBefani%26aufirst%3DO.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DGiovannini%26aufirst%3DV.%26aulast%3DMondovi%26aufirst%3DB.%26atitle%3D3-%25281H-pyrrol-1-yl%2529-2-oxazolidinones%2520as%2520Reversible%252C%2520Highly%2520Potent%252C%2520And%2520Selective%2520Inhibitors%2520Of%2520Monoamine%2520Oxidase%2520Type%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1180%26epage%3D1183%26doi%3D10.1021%2Fjm015578d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Close, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiffany, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spielman, M. A.</span></span> <span> </span><span class="NLM_article-title">The Analgesic Activity of Some Benzoxazolone Derivatives</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1949</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1265</span>– <span class="NLM_lpage">1268</span>, <span class="refDoi"> DOI: 10.1021/ja01172a036</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01172a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaH1MXjs1GksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1949&pages=1265-1268&author=W.+J.+Closeauthor=B.+D.+Tiffanyauthor=M.+A.+Spielman&title=The+Analgesic+Activity+of+Some+Benzoxazolone+Derivatives&doi=10.1021%2Fja01172a036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The analgesic activity of some benzoxazolone derivatives</span></div><div class="casAuthors">Close, W. J.; Tiffany, Burris D.; Spielman, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1949</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1265-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">3-Alkyl, 3-acyl, 3-dialkylaminoalkyl, and nuclear substituted derivs. (I) of 2(3H)-benzoxazolone (II) were synthesized; about 2/3 of them induced mild analgesia.  Usually the I were prepd. by fusion of o-aminophenols (III), with improved yields of 76-90% by moderating the temp. and time.  Most III, sensitive to air, were used as HCl salts. p-PrC6H4OH, 245 g. from PrC6H4OMe 289 g., 48% HBr 450, and HOAc 450 cc. refluxed 3 days, with dry HBr added the first 2 h., b0.75 79-80°.  Modification of the method of Sandulesco and Girard (C.A. 25, 1228) gave a 300% increase in yield of p-HOC6H4COBu (IV): addn. of PhOH 72 g. in 144 cc. PhNO2 to 205 g. AlCl3 in 400 cc. PhNO2 at 10-12°, then dropwise addn. of 85 g. BuCOCl at 5-10°, addn. to ice and concd. HCl after 16 h., and NaOH extn. of the PhNO2 layer gave 87% IV, b0.7 150-60°.  Clemmensen redn. of IV gave 85% p-AmC6H4OH, b1.4 103-7°.  4,2-Me(H2N)C6H3OH.HCl (90% from 4,2-Me(O2N)C6H3OH in abs. EtOH, Raney Ni, and 1000 lb. H at 75°, evapn. of the solvent, addn. of a slight excess of alc. HCl, and pptn. with Et2O), m. 222-4°.  4,2-Pr(O2N) C6H3OH [83% by a modification of the Baranger procedure (C.A. 26, 705)], b0.85 92-6°, nD25 1.5574; redn. with Raney Ni and H gave 98% 2-amino analog HCl salt, m. 245-52° (decompn.).  Addn. of 65 g. p-AmC6H4OH in HOAc 65 to concd. HNO3 51 and HOAc 100 cc. during 2 h. at -5°, addn. to ice and 160 g. 10% NaOH, and C6H6 extn. gave 75% 4,2-Am(O2N) C6H3OH, b0.5 100-5°, nD25 1.5253; Raney Ni and H Substituents in I, Nuclear, Nitrogen, B.p., °C., mm., nD25, M.p., °C., Method, Yield, %, VII; None, H, , , , 139-40, A, 88, ..; None, Me, , , , 83-4, , , 1; None, Bu, 129-30, 1.3, 1.5316, , B, 62, 0; None, iso-Bu, , , , 63.5-5.0, B, 76, 0; None, Am, 140-2, 1.0, 1. 5268, , (b), 40, 0; None, iso-Am, 112-13, 0.4, 1.5248, 40-0.5, C, 90, 4 (a); None sec-Am, 132-4, 1.3, 1.5280, , B, 40, 3; None, Ac, , , , 92-4, , 66, 0; None, Allyl, 112-14, 0.5, 1.5536, , C, 66, 0; None, (c), , , , 171-3, C, 66, 3; 5-Me, H, , , , 128-9, A, 79, 0; 5-Me, Bu, 138-40, 1.2, 1.5300, , B, 67, 3; 5-Me, iso-Bu, , , , 61-2, B, 70, 1; 5-Me, Am, 136-8, 0.8, 1.5239, , B, 65, 2; 5-Me, iso-Am, 142-3, 1.3, 1.5230, , B, 65, 1; 5-Me, sec-Am, 130-3, 1.2, 1.5251, , B, 54, ..; 5-Pr, H, , , , 66.5-8, A, 79, 0; 5-Pr, Bu, 164-7, 1.0, 1.5196, , C, 95, 4 (a); 5-Pr, iso-Bu, 141-4, 1.2, 1.1597?, , B, 65, 3; 5-Pr, Am, 162-4, 1.4, 1.5157, , B, 66, 3; 5-Pr, iso-Am, 148-50, 0.8, 1.5167, , B, 66, 0; 5-Pr, sec-Am, 148-51, 1.1, 1.5197, , B, 38, 2; 5-Am, H, , , , 62-4, A, 90, ..;  5-Am, Me, , , , 55-6.5, (d), 96, ..; 5-Am, Pr, 167-70, 2.0, 1.5180, , C, 94, 0; 5-Am, iso-Bu, 146-8, 0.6, 1.5144, , C, 90, 2; 5-Am, Am, 178-80, 1.4, 1.5115, , C, 93, 0; 5,6-di-Me, H, , , , 177-8, (e), 68, 3; 5,6-di-Me, Et, , , , 86-7, (f), 73, 3; 5,6-di-Me, Bu, , , , 68-9, C, 80, 0; 5,6-di-Me, iso-Am, , , , 50-1, C, 86, 3; 5-MeO, H, , , , 170-2, A, 76, 3; 5-MeO, iso-Bu, , , , 57-8, C, 87, 3; 5-MeO, Am, 168-72, 1.4, 1.5299, , C, 92, 3; 5-MeO, Ac, , , , 102-3, (e), 95, 3; 6-Cl, H, , , , 194-5, (e), 81, 3; 6-Cl, Me, , , , 104-5, (d), 85, 0; 6-Cl, iso-Pr, , , , 91-2, C, 40, 2; 6-Cl, iso-Am, 157-63, 1.0, 1.5308, 46-7, C, 62, 4; (a) Tested on human volunteers with lower results; (b) prepd. with KOH in (CH2OH)2; (c) Et2NCH2CH2 HCl salt; two cryst. forms; lower-melting form, prisms from Me2CO-EtOH, m. 140-7° with resolidification to the higher-melting form; (d) prepd. with NaOMe and Me2SO4 in MeOH; (e) prepn. described in text; (f) prepd. with NaOMe and Et2SO4 in EtOH. gave 84% 4,2-Am(H2N)C6H3OH.HCl, m. 194° (from EtOH); free base m. 128° (from ligroin).  4,5,2-Me2(H2N)C6H2OH (V) (77% from NaHSO3 in basic soln. and 4,5,2-Me2(PhN2)C6H2OH) m. 171-5°.  Addn. during 1.5 h. at -5 to 0° of 1 mol PhN2Cl to p-MeOC6H4OH 124, H2O 1200, and NaOH 120 g., and acidification gave 89% 4,2-MeO(PhN2)C6H3OH (VI), m. 72.5-3.5° (from EtOH).  Addn. of NaHSO3 to VI 100, H2O 1000, and NaOH 100 g. on the steam bath until the color was gone, Et2O extn., neutralization of the aq. soln., and trituration of the dried ppt. with EtOH-HCl gave 85% 4,2-MeO(H2N)C6H3OH.HCl, crystd. from EtOH only with loss, m. 210-13° (decompn.) (pyrex tube evacuated to 0.5 mm.) (cf. m.p. of 171° of Roberts, et al., C.A. 29, 2934.7).  Most I were prepd. by fusion with urea (Method A); thus 4,2-Pr(H2N)C6H3OH 470 and urea 300 g. heated in an oil bath at 180° 2 h., cooled, dil. acid added, then Et2O extn., gave 348 g. 5-Pr deriv. of II, b0.8 180-2°.  Other I are given in the table.  Dropwise addn. of 30 g. COCl2 in 400 cc. EtOAc to V 34.2 and anhyd. KOAc 59 g. in 600 cc. EtOAc, addn. of H2O and HCl, concn. of the EtOAc layer, soln. of the ppt. in boiling 10% NaOH, chilling, and acidifying the ppt. gave 68% 5,6-di-Me deriv. of II, m. 173-7°.  Addn. of SO2Cl2 32 to HOAc 500 cc. and 50 g. II at 0°, letting stand 16 h. at room temp. and 1 h. on the steam bath, and addn. to cold H2O gave 81% 6-Cl deriv. of II, m. 189-94°.  Cleavage of the ring with NaOH gave 5,2-Cl(H2N)C6H3OH, m. and mixed m.p. 152-4°.  Method B for 3-substituted II: Addn. of 9.3 cc. iso-AmI to 0.2 g. 5-Pr deriv. of II in 60 cc. of 0.84 N KOH in Cellosolve, 6 h.' refluxing, concn. of the filtrate in vacuo, extn. from the H2O suspension with H2O, and washing with 5% NaOH gave 66% 3-isoamyl-5-Pr deriv. of II, b0.8 148-50°.  Method C: 9.9 g. 5-MeO deriv. of II, then 9.6 cc. AmBr were added to 1.6 g. Na in 30 cc.  Cellosolve (distd. over Na) in a N atm., refluxed 1 h., 0.69 g. Na in 10 cc.  Cellosolve (prepd. under N) and 4.8 cc. AmBr added, and refluxed 1 h. more; addn. of HOAc, concn. in vacuo, treatment of the residue with Et2O and H2O, washing of the Et2O layer with 5% NaOH and HCl, and distn. gave 92% 3-amyl-5-methoxy deriv. of II, b1 166-74°.  3-Ac derivs. of I were prepd. (see table) by the following procedure: addn. of 5-MeO deriv. 9.9 of II to Na 1.6 g. in 50 cc. MeOH, concn., treatment of the dry residue with 25 cc. Ac2O 10 min., and addn. to H2O gave 95% 3-acetyl-5-methoxy deriv. of II, m. 100-3°.  Analgesic activity in dogs was detd. by a modification of the method of Andrews and Workman (C.A. 35, 8102.3) with doses of 100-200 mg./kg., at which level toxic effects rarely appeared.  The increase in pain threshold (VII in table) was: 0 = none; 1, doubtful; 2, < 10%; 3, 10-20%; 4, 20-30%.  The best compds. had an activity comparable to that of aspirin, and were much weaker than Demerol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxKvNBulfSOrVg90H21EOLACvtfcHk0ljidFfCj2KDkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH1MXjs1GksQ%253D%253D&md5=b77f959c883112baccfbafbdb2d4698a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja01172a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01172a036%26sid%3Dliteratum%253Aachs%26aulast%3DClose%26aufirst%3DW.%2BJ.%26aulast%3DTiffany%26aufirst%3DB.%2BD.%26aulast%3DSpielman%26aufirst%3DM.%2BA.%26atitle%3DThe%2520Analgesic%2520Activity%2520of%2520Some%2520Benzoxazolone%2520Derivatives%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1949%26volume%3D71%26spage%3D1265%26epage%3D1268%26doi%3D10.1021%2Fja01172a036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milcent, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhnazarian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lensen, N.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 1-(2-hydroxyphenyl)-2,4-Imidazolidinedione Derivatives Through Cyclic Transformations Of Ethyl 2-Oxo-3(2H)-Benzoxazoleacetate Derivatives</span>. <i>J. Heterocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1829</span>– <span class="NLM_lpage">1833</span>, <span class="refDoi"> DOI: 10.1002/jhet.5570330645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2Fjhet.5570330645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK2sXotFCkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1996&pages=1829-1833&author=R.+Milcentauthor=A.+Akhnazarianauthor=N.+Lensen&title=Synthesis+of+1-%282-hydroxyphenyl%29-2%2C4-Imidazolidinedione+Derivatives+Through+Cyclic+Transformations+Of+Ethyl+2-Oxo-3%282H%29-Benzoxazoleacetate+Derivatives&doi=10.1002%2Fjhet.5570330645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 1-(2-hydroxyphenyl)-2,4-imidazolidinedione derivatives through cyclic transformations of ethyl 2-oxo-3(2H)-benzoxazoleacetate derivatives</span></div><div class="casAuthors">Milcent, Rene; Akhnazarian, Anna; Lensen, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1829-1833</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-152X</span>.
    
            (<span class="NLM_cas:orgname">HeteroCorporation</span>)
        </div><div class="casAbstract">The Et 2-oxo-3(2H)-benzoxazoleacetate derivs. I (R1 = H, Cl, Me; R2 = H, Et) were prepd.  By reaction with ammonia, primary amines or hydrazine, I were transformed into 1-(2-hydroxyphenyl)-2,4-imidazolidinedione derivs. (hydantoins) II (same R1, R2; R3 = Me, Et, NH2, etc.).  Some of the new hydantoins II were treated with phosphorus oxychloride to give 2-oxoimidazo[2,1-b]benzoxazoles.  Et 2-oxo-3(2H)-benzoxazolepropionate was prepd. by a Michael reaction of Et acrylate with a 2-benzoxazolone.  Cyclic transformation were not obsd. with Et 2-oxo-3(2H)-benzoxazolepropionate in the presence of ammonia or alkylamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2yJ5CZGEeKLVg90H21EOLACvtfcHk0lixGQKL4AVGGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotFCkug%253D%253D&md5=39e9bd723528db9fe9567c6074636abd</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570330645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570330645%26sid%3Dliteratum%253Aachs%26aulast%3DMilcent%26aufirst%3DR.%26aulast%3DAkhnazarian%26aufirst%3DA.%26aulast%3DLensen%26aufirst%3DN.%26atitle%3DSynthesis%2520of%25201-%25282-hydroxyphenyl%2529-2%252C4-Imidazolidinedione%2520Derivatives%2520Through%2520Cyclic%2520Transformations%2520Of%2520Ethyl%25202-Oxo-3%25282H%2529-Benzoxazoleacetate%2520Derivatives%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1996%26volume%3D33%26spage%3D1829%26epage%3D1833%26doi%3D10.1002%2Fjhet.5570330645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Çakir, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yildirim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ercanli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erol, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahin, M. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis And Anticonvulsant Activity Of Some (2/4-Substituted)Benzaldehyde (2-Oxobenzothiazolin-3-Yl)Acetohydrazones</span>. <i>II Farmaco</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.1016/S0014-827X(99)00110-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2FS0014-827X%2899%2900110-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10668187" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=842-845&author=B.+%C3%87akirauthor=E.+Yildirimauthor=T.+Ercanliauthor=K.+Erolauthor=M.+F.+Sahin&title=Synthesis+And+Anticonvulsant+Activity+Of+Some+%282%2F4-Substituted%29Benzaldehyde+%282-Oxobenzothiazolin-3-Yl%29Acetohydrazones&doi=10.1016%2FS0014-827X%2899%2900110-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2899%2900110-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252899%252900110-X%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2587akir%26aufirst%3DB.%26aulast%3DYildirim%26aufirst%3DE.%26aulast%3DErcanli%26aufirst%3DT.%26aulast%3DErol%26aufirst%3DK.%26aulast%3DSahin%26aufirst%3DM.%2BF.%26atitle%3DSynthesis%2520And%2520Anticonvulsant%2520Activity%2520Of%2520Some%2520%25282%252F4-Substituted%2529Benzaldehyde%2520%25282-Oxobenzothiazolin-3-Yl%2529Acetohydrazones%26jtitle%3DII%2520Farmaco%26date%3D1999%26volume%3D54%26spage%3D842%26epage%3D845%26doi%3D10.1016%2FS0014-827X%2899%2900110-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gökçe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geciken, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yildirim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosuni, A. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis And Anticonvulsant Activity Of 5-Chloro-2(3H)-Benzoxazolinone-3-Acetyl-2-(O/P-Substituted Benzal) Hydrazone Derivatives</span>. <i>Arzneimittelforschung</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1055/s-0031-1296554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1055%2Fs-0031-1296554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=19137903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252Fms1ejtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=537-542&author=M.+G%C3%B6k%C3%A7eauthor=A.+E.+Gecikenauthor=E.+Yildirimauthor=A.+U.+Tosuni&title=Synthesis+And+Anticonvulsant+Activity+Of+5-Chloro-2%283H%29-Benzoxazolinone-3-Acetyl-2-%28O%2FP-Substituted+Benzal%29+Hydrazone+Derivatives&doi=10.1055%2Fs-0031-1296554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anticonvulsant activity of 5-chloro-2(3H)-benzoxazolinone-3-acetyl-2-(o/p-substituted benzal) hydrazone derivatives</span></div><div class="casAuthors">Gokce Mehtap; Geciken Ahmet Emin; Yildirim Engin; Tosuni Ali Ulvi</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">537-42</span>
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">It is well known that some hydrazone derivatives of both 2-oxobenzoxazoline and 2-oxobenzothiazoline exhibit potent anticonvulsant activity.  In order to investigate the effects of structural modifications on the biological properties, 14 new hydrazones of 5-chloro-2(3H)-benzox-azolinone-3-acetyl hydrazide were synthesized.  The chemical structures of the synthesized compounds were established by IR, 1H-NMR spectral analyses and elementary analyses.  The anticonvulsant activities of the title compounds were tested by the penthylenetetrazole induced seizure test. 5-Chloro-2(3H)-benz-oxazolinone-3-acetyl-2-(o-methoxy-benzaldehyde)-hydrazone 4d, 5-chloro-2(3H)-benzoxazolinone-3-acetyl-2-(o-methybenzaldehyde)-hydrazone 4g, 5-chloro-2(3H)-benzoxazolinone-3-acetyl-2-(p-methylbenzaldehyde)-hydrazone 4h, 5-chloro-2(3H)-benzoxazolino-ne-3-acetyl-2-(p-nitrobenzaldehyde)-hydrazone 4m, and 5-chloro-2(3H)-benzox-azolinone-3-acetyl-2-(p-dimethylaminobenzaldehyde)-hydrazone 4n were found more active than phenytoin (CAS 57-41-0) in the tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTP6mFICSo5dKe0F5ixvZgXfW6udTcc2eZZM8Kp30z2Dbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252Fms1ejtQ%253D%253D&md5=943dad3712dc1f8c1e8cfdce80562baf</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1296554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1296554%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6k%25C3%25A7e%26aufirst%3DM.%26aulast%3DGeciken%26aufirst%3DA.%2BE.%26aulast%3DYildirim%26aufirst%3DE.%26aulast%3DTosuni%26aufirst%3DA.%2BU.%26atitle%3DSynthesis%2520And%2520Anticonvulsant%2520Activity%2520Of%25205-Chloro-2%25283H%2529-Benzoxazolinone-3-Acetyl-2-%2528O%252FP-Substituted%2520Benzal%2529%2520Hydrazone%2520Derivatives%26jtitle%3DArzneimittelforschung%26date%3D2008%26volume%3D58%26spage%3D537%26epage%3D542%26doi%3D10.1055%2Fs-0031-1296554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salgin-Gökşen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhan-Kelekci, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goktas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koysal, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktay, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozalp, M.</span></span> <span> </span><span class="NLM_article-title">1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: Synthesis, Analgesic-Anti-Inflammatory And Antimicrobial Activities</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5738</span>– <span class="NLM_lpage">5751</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.bmc.2007.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=17587585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BD2srgt1Glsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=5738-5751&author=U.+Salgin-G%C3%B6k%C5%9Fenauthor=N.+Gokhan-Kelekciauthor=O.+Goktasauthor=Y.+Koysalauthor=E.+Kilicauthor=S.+Isikauthor=G.+Aktayauthor=M.+Ozalp&title=1-Acylthiosemicarbazides%2C+1%2C2%2C4-triazole-5%284H%29-thiones%2C+1%2C3%2C4-thiadiazoles+and+hydrazones+containing+5-methyl-2-benzoxazolinones%3A+Synthesis%2C+Analgesic-Anti-Inflammatory+And+Antimicrobial+Activities&doi=10.1016%2Fj.bmc.2007.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities</span></div><div class="casAuthors">Salgin-Goksen Umut; Gokhan-Kelekci Nesrin; Goktas Ozgur; Koysal Yavuz; Kilic Ekrem; Isik Samil; Aktay Goknur; Ozalp Meral</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5738-51</span>
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    </div><div class="casAbstract">Acetic acid hydrazide containing 5-methyl-2-benzoxazolinone (4) was synthesized by the condensation of 2-(5-methyl-2-benzoxazolinone-3-yl)acetate with hydrazine hydrate.  Thiosemicarbazide derivatives (5a-5d) were afforded by the reaction of corresponding compound 4 with substituted isothiocyanates.  The cyclization of compounds 5a-5d in the presence of triethylamine resulted in the formation of compounds 6a-6d containing 1,2,4-triazole ring.  On the other hand, the treatment of compounds 5a-5d with orthophosphoric acid caused the conversion of side chain of compounds 5a-5d into 1,3,4-thiadiazole ring: thus, compounds 7a-7c were obtained.  The treatment of compound 4 with aromatic aldehydes resulted in the formation of arylidene hydrazides as cis-trans conformers (8a-8e).  The structures of the compounds were elucidated by spectral and elemental analysis.  While most compounds were exhibiting high activity in the analgesic-anti-inflammatory field, most of them were found to be inactive against bacteria and fungi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQV215khjecIQWRJ3OJdH_qfW6udTcc2eZZM8Kp30z2Dbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srgt1Glsw%253D%253D&md5=33ad7908138a83bb8e5f4a8629b5906a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DSalgin-G%25C3%25B6k%25C5%259Fen%26aufirst%3DU.%26aulast%3DGokhan-Kelekci%26aufirst%3DN.%26aulast%3DGoktas%26aufirst%3DO.%26aulast%3DKoysal%26aufirst%3DY.%26aulast%3DKilic%26aufirst%3DE.%26aulast%3DIsik%26aufirst%3DS.%26aulast%3DAktay%26aufirst%3DG.%26aulast%3DOzalp%26aufirst%3DM.%26atitle%3D1-Acylthiosemicarbazides%252C%25201%252C2%252C4-triazole-5%25284H%2529-thiones%252C%25201%252C3%252C4-thiadiazoles%2520and%2520hydrazones%2520containing%25205-methyl-2-benzoxazolinones%253A%2520Synthesis%252C%2520Analgesic-Anti-Inflammatory%2520And%2520Antimicrobial%2520Activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D5738%26epage%3D5751%26doi%3D10.1016%2Fj.bmc.2007.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davey, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tivey, D. J.</span></span> <span> </span><span class="NLM_article-title">Chalcones and Related Compounds. 4. Addition of Hydrogen Cyanide to Chalcones</span>. <i>J. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1958</span>,  <span class="NLM_fpage">1230</span>– <span class="NLM_lpage">1236</span>, <span class="refDoi"> DOI: 10.1039/jr9580001230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1039%2Fjr9580001230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaG1cXmsFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1958&pages=1230-1236&author=W.+Daveyauthor=D.+J.+Tivey&title=Chalcones+and+Related+Compounds.+4.+Addition+of+Hydrogen+Cyanide+to+Chalcones&doi=10.1039%2Fjr9580001230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcones and related compounds. IV. Addition of hydrogen cyanide to chalcones</span></div><div class="casAuthors">Davey, W.; Tivey, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1230-6</span>CODEN:
                <span class="NLM_cas:coden">JCSOA9</span>;
        ISSN:<span class="NLM_cas:issn">0368-1769</span>.
    </div><div class="casAbstract">cf. C.A. 51, 10450h.  Optimum preparative conditions for RC6H4CH:CHCOC6H4R' (I) were established and new I were prepd.  Procedures for the addn. of HCN to I and hydrolysis of the adducts were improved and new lactones, pyridazinones, and diols prepd. from these adducts.  Comparative expts. showed that NaOH and NaOMe were generally more effective condensing agents than HCl, POCl3, or BF3 in the prepn. of 12 substituted I.  Kohler and Chadwell's method (Org. Syntheses, Collective Vol. I, 78 (1941)) (method A) was modified in method B.  Equimolar amts. of RC6H4CHO (II) and AcC6H4R' (III) mixed at 25° and if necessary made homogeneous with alc. at 30°, the mixt. made alk. to Brilliant Yellow with a 10% excess of 5N NaOH at 25-30° (external cooling), the mixt. kept homogeneous with addn. of alc. in 0.5-5.0 hrs., filtered, and washed with H2O, the filtrate dild. with H2O, and the product washed with H2O gave a product, crystd. once to give pure I.  In method C, 1 mole II and 1 mole III in 200 ml. Ac2O were satd. with HCl below 30°, the mixt. kept 12 hrs. at room temp. and poured into ice and NH4OH, the oily product steam, distd., and the residue recrystd.  Equimolar amts. of II and III liquefied by addn. of C6H6 were treated with a few drops of POCl3 at 30°, the mixt. kept at room temp. a few hrs., the product washed with 2N NH4OH and H2O, the C6H6 evapd. in vacuo, the residue steam-distd. and the product recrystd. (method D).  In method E, 1 mole II was treated with 1 mole 48% BF3 in sufficient AcOH at 25° to dissolve II, the soln. treated slowly with 1 mole III at 25-30°, and the red mixt. kept 12 hrs. at room temp., treated with excess NaOAc soln., and steam-distd. to give a product requiring repeated recrystn.  II (1 mole) in 200 ml. anhyd. MeOH added at 30° to 100 ml. MeOH contg 10 g. Na and the soln. treated with 1 mole III, the mixt. kept some hrs. at room temp. and filtered, the product washed, combined with the material recovered from the dild. filtrate, and recrystd. (method F).  Results of comparative prepns. of I (R = R' = H) (Ia) were tabulated [method, % yield, reaction time in hrs., and m.p. (no. of recrystns.) given]: A, 89, 2, 52° (1); B, 76, 1, 55° (0); C, 50, 12, 53° (2); D, 48, 12, 52° (2); E, 53, 6, 52° (2); F, 71, 4, 52° (1).  Similar results with substituted I were summarized [R, R', % yield (m.p.) for methods B, C, D, E, and F given]: p-MeO, H, 76 (75°), 50(72°), 47(73°), 52(70°), 61(72°); p-MeO, p-MeO, 81(100°), 66(99°), 50(100°), 62(97°), 75(98°); p-MeO, p-Me, 55(91°), -, -, 70(124°), -, -, 77(126°); p-Me, H, 42(94°), 30(95.5°), 20(96°), -, 45(95°); p-HO, H, 37(180°), 11(182°), 20(179°), 25(179°), 31(182°); H, p-MeO, 81(106°), 55(105°), 45(104°), -, 77(108°); P-O2N, H, 60(162°), 80(162°), 42(162°), 35(162°), 57(162°); H, m-O2N, 75(130°), 25(131°), 10(130°), -, tar; H, p-Me, 35(75°), 42(75°), 22(72°), 23(72°), -.  HCN was added to la and I (R = p-MeO, R' = H) by the method of Allan and Kimball (Org. Syntheses, Coll. Vol. II, 498), but the method failed with I (R = H, R' = p-MeO) (Ib), I (R = R' = p-MeO) (Ic), and I (R = H, R' = p-HO).  The method of Kohler and Leers (C.A. 28, 30646) gave a low yield of HCN adduct with Ib but failed with Ic. Ia (41.6 g.) in 700 ml. alc. stirred with cooling with slow addn. of 50 ml. 7N H2SO4, the mixt. heated to 50°, treated slowly with 50 g. KCN in 80 ml. H2O and the mixt. refluxed 5 min., dild. with 200 ml. H2O, kept 12 hrs. at 20°, and filtered, the solid product extd. 3 times with 100 ml. boiling alc., the ext. evapd., and the residue crystd. (alc.) gave 35 g. PhCH(CN)CH2Bz, m. 126°.  Similarly high yields of adducts, RCH(CN)CH2COC6H4R' (IV) were obtained by the use of 1 mole H2SO4 and 2 moles KCN (R, R', m.p., and % yield given): Ph, p-MeO, 65°, 86; p-MeOC6H4, p-MeO, 113-14°, 66; p-HOC6H4, H, 173°, 68; 2,4-(MeO)2C6H3, p-MeOC6H4, 125-6°, 83; 3,4-(MeO)2C6H3, p-MeO, 105°, 79.  Acid hydrolysis of IV was difficult, and the resultant acids, RCH(CO2H)CH2COR' (V), tended to sep. as oils.  Conversion of IV into the Me esters, RCH(CO2Me)CH2COR' (VI) by boiling with HCl in MeOH and hydrolysis of VI with dil. NaOH gave good yields of V.  IV (R = R' = H) (23.5 g.) in 200 ml. MeOH satd. with dry HCl at 25° and refluxed 1.5 hrs., 100 ml. MeOH distd., the concentrate dild. with 200 ml. H2O, the mixt. kept overnight at room temp. and filtered gave 24 g. VI (R = R' = Ph) (VIa), m. 103°.  Similarly were prepd. the esters VI [R, R', m.p. (solvent) and % yield given]: Ph, p-MeOC6H4 (VIb), 96° (MeOH), 91; p-MeOC6H4, p-MeOC6H4 (VIc), 96-7° (MeOH), 85; p-HOC6H4, Ph (VId), 143-4° (MeOH), 83; 2,4-(MeO)2C6H3, p-MeOC6H4, 128-9° (EtOH), 83; 3,4-(MeO)2C6H3, p-MeOC6H4, 74-5° (MeOH), 73.  VIa (26.8 g.) refluxed 2 hrs. in 100 ml. alc. with 100 ml. 2N NaOH, the soln. treated with 120 ml. 2N HCl, and the mixt. kept overnight at room temp. and filtered gave 23 g. V (R = R' = Ph) (Vc), m. 152° (alc.).  Similarly were obtained the acids V [R, R', m.p. (solvent) and % yield given]: Ph, p-MeOC6H4 (Vb), 139-40° (alc.), 93; p-MeOC6H4, p-MeOC6H4 (Vc), 163-4° (alc.), 91; p-HOC6H4, Ph (Vd), 143-4° (MeOH), 83; 2,4-(MeO)2C6H3, p-MeOC6H4, 127-8° (alc.), 80; 3,4-(MeO)2C6H3, p-MeOC6H4, 179-80° (alc.), 80.  Va (12.7 g.) refluxed 3 hrs. in 25 ml. Ac2O and the mixt. poured into cold H2O, kept 1 hr., and filtered, the ppt. (10 g.) taken up in 50 ml. boiling alc., and the cooled soln. filtered gave 2.6 g. material, recrystd. (alc.) to give 1.7 g. high melting unsatd. 4-hydroxy-2,4-diphenyl-2-butenoic lactone (VII), O.CO.CR:CH.CHR' (R = R' = Ph) (VIIa), m. 283-5°.  The filtrate dild. with 15 ml. H2O and the 6.1 g. dried product, m. 91°, recrystd. (alc.) yielded 3.7 g. low melting isomeric lactone (VIII), O.CO.CHR.CH:CR' (R = R' = Ph) (VIIIa), m. 107-8°.  Similarly, from Vb, Vc, and Vd were prepd. the corresponding pairs of isomeric lactones (reflux time in hrs., lactones, and m.p. given): 2, VIIb, 250-60° (decompn.), VIIIb, 92; 1.5, VIIc, 255-60° (decompn.), VIIIc, 106-7°; 1, VIId, 282-4° (decompn.), VIIId, 131-2.  Va (5 g.) heated 2 hrs. at 165° and the cooled melt taken up in 30 ml. boiling alc., the filtered soln. cooled and filtered gave 0.2 g. VIIa.  Concn. of the filtrate gave 3.7 g. VIIIa.  Similarly, small amts. of VIIa were obtained by heating Va with alc. or AcOH.  Rast mol. wt. detns. and repeated analyses confirmed the monomeric nature of the extremely insol. VII, and slightly favorable evidence was given by the infrared spectral bands of VIIc and VIIIc, ν 1763 and 1750 cm.-1, resp. (in nujol).  VIIIa (2 g.) hydrogenated in 25 ml. alc. with 0.5 g. 10% Pd-C, the filtered soln. dild. with H2O, extd. 3 times with 20 ml. 2N Na2CO3, the ext. washed twice with 20 ml. Et2O, the aq. soln. acidified with HCl, the oily product extd. twice with 20 ml. Et2O, the ext. evapd. in vacuo, and the residue crystd. (petr. ether) gave 1.5 g. PhCH2CH2CHPhCO2H, m. 73-4°.  VIa (5 g.) in 50 ml. alc. added slowly with stirring to 2 g. KBH4 in 100 ml. 19:1 alc.-H2O, the mixt. kept 5 hrs. at room temp. evapd. to 30 ml. and acidified with HCl, the viscous green sirupy extd. with C6H6, and the solidified product recrystd. (alc.) gave 3.5 g. satd. lactone (IX), O.CO.CHR.CH2.CHR' (R = R' = Ph) (IXa), m. 102° (alc.), also obtained by hydrogenation of 4 g. VIa in 50 ml. alc. with 1 g. Raney Ni and crystn. (pert. ether) of the product.  Similarly with Pd-C were obtained 62% IX (R = Ph, R' = p-MeOC6H4), m. 77° (alc.), and 90% IX (R = R' = p-MeOC6H4), m. 136-7°(alc.).  VIa (5 g.) extd. from a Soxhlet app. thimble into 150 ml. Et2O contg. 1.5 g. LiAlH4, the mixt. refluxed 2 hrs., treated with EtOAc and 100 ml. 2N H2SO4, the Et2O layer washed with H2O, the soln. dried, evapd., and the sirupy residue kept 7 days at 0° under petr. ether gave 3 g. HOCH2CHRCH2CHR'OH (X) (R = R' = Ph), m. 92°.  Similarly were prepd. 33% X (R = Ph, R' = p-MeOC6H4), m. 48-50°; 81% X (R = R' = p-MeOC6H4), m. 80-90°; and gummy X (R = p-HOC6H4, R = Ph).  VIa (20 g.) and 6.6 g. PhNHNH2 in 170 ml. AcOH heated 15 min. on a steam bath, the cooled soln. dild. with 100 ml. H2O, filtered, and the cryst. residue recrystd. (alc.) yielded 75% RCH.CO.NPh.N:CR'.CH2 (XI) (R = R' = Ph), m. 121-3°.  By the same method, or with V in the place of VI, were prepd. 85% XI (R = Ph, R' = p-MeOC6H4), m. 94-5°, and 56% XI (R = R' = p-MeOC6H4), m. 123°, ν 1696, 1601, 1514, 1490 cm.-1, confirming the assigned pyridazine structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAyRF2hDw9brVg90H21EOLACvtfcHk0lh_wMcPGaPSiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXmsFyhsQ%253D%253D&md5=ba4153fda21a436dfe582b2b6d4b8157</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2Fjr9580001230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fjr9580001230%26sid%3Dliteratum%253Aachs%26aulast%3DDavey%26aufirst%3DW.%26aulast%3DTivey%26aufirst%3DD.%2BJ.%26atitle%3DChalcones%2520and%2520Related%2520Compounds.%25204.%2520Addition%2520of%2520Hydrogen%2520Cyanide%2520to%2520Chalcones%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1958%26spage%3D1230%26epage%3D1236%26doi%3D10.1039%2Fjr9580001230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goksen, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarigul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bultinck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrebout, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yelekci, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ucar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhan Kelekci, N.</span></span> <span> </span><span class="NLM_article-title">Absolute Configuration And Biological Profile Of Pyrazoline Enantiomers As MAO Inhibitory Activity</span>. <i>Chirality</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1002/chir.23027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2Fchir.23027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=30468523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ylsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2019&pages=21-33&author=U.+S.+Goksenauthor=S.+Sarigulauthor=P.+Bultinckauthor=W.+Herreboutauthor=I.+Doganauthor=K.+Yelekciauthor=G.+Ucarauthor=N.+Gokhan+Kelekci&title=Absolute+Configuration+And+Biological+Profile+Of+Pyrazoline+Enantiomers+As+MAO+Inhibitory+Activity&doi=10.1002%2Fchir.23027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Absolute configuration and biological profile of pyrazoline enantiomers as MAO inhibitory activity</span></div><div class="casAuthors">Goksen, Umut Salgin; Sarigul, Sevgi; Bultinck, Patrick; Herrebout, Wouter; Dogan, Ilknur; Yelekci, Kemal; Ucar, Gulberk; Gokhan Kelekci, Nesrin</div><div class="citationInfo"><span class="NLM_cas:title">Chirality</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-33</span>CODEN:
                <span class="NLM_cas:coden">CHRLEP</span>;
        ISSN:<span class="NLM_cas:issn">0899-0042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A new racemic pyrazoline deriv. was synthesized and resolved to its enantiomers using analytic and semipreparative high-pressure liq. chromatog.  The abs. configuration of both fractions was established using vibrational CD.  The in vitro monoamine oxidase (MAO) inhibitory profiles were evaluated for the racemate and both enantiomers sep. for the two isoforms of the enzyme.  The racemic compd. and both enantiomers were found to inhibit hMAO-A selectively and competitively.  In particular, the R enantiomer was detected as an exceptionally potent and a selective MAO-A inhibitor (Ki = 0.85 x 10-3 ± 0.05 x 10-3 μM and SI: 2.35 x 10-5), whereas S was detd. as poorer compd. than R in terms of Ki and SI (0.184 ± 0.007 and 0.001).  The selectivity of the enantiomers was explained by mol. modeling docking studies based on the PDB enzymic models of MAO isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7O71NGpQUObVg90H21EOLACvtfcHk0lh_wMcPGaPSiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ylsr%252FP&md5=c04a9e6fbafd62147fbe63f76aae4dad</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fchir.23027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchir.23027%26sid%3Dliteratum%253Aachs%26aulast%3DGoksen%26aufirst%3DU.%2BS.%26aulast%3DSarigul%26aufirst%3DS.%26aulast%3DBultinck%26aufirst%3DP.%26aulast%3DHerrebout%26aufirst%3DW.%26aulast%3DDogan%26aufirst%3DI.%26aulast%3DYelekci%26aufirst%3DK.%26aulast%3DUcar%26aufirst%3DG.%26aulast%3DGokhan%2BKelekci%26aufirst%3DN.%26atitle%3DAbsolute%2520Configuration%2520And%2520Biological%2520Profile%2520Of%2520Pyrazoline%2520Enantiomers%2520As%2520MAO%2520Inhibitory%2520Activity%26jtitle%3DChirality%26date%3D2019%26volume%3D31%26spage%3D21%26epage%3D33%26doi%3D10.1002%2Fchir.23027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span> <span> </span><span class="NLM_article-title">Admetsar 2.0: Web-Service For Prediction And Optimization Of Chemical ADMET Properties</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1069</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/bty707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1093%2Fbioinformatics%2Fbty707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=30165565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvV2rsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2019&pages=1067-1069&author=H.+Yangauthor=C.+Louauthor=L.+Sunauthor=J.+Liauthor=Y.+Caiauthor=Z.+Wangauthor=W.+Liauthor=G.+Liuauthor=Y.+Tang&title=Admetsar+2.0%3A+Web-Service+For+Prediction+And+Optimization+Of+Chemical+ADMET+Properties&doi=10.1093%2Fbioinformatics%2Fbty707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties</span></div><div class="casAuthors">Yang, Hongbin; Lou, Chaofeng; Sun, Lixia; Li, Jie; Cai, Yingchun; Wang, Zhuang; Li, Weihua; Liu, Guixia; Tang, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1067-1069</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4811</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">AdmetSAR was developed as a comprehensive source and free tool for the prediction of chem. ADMET properties.  Since its first release in 2012 contg. 27 predictive models, admetSAR has been widely used in chem. and pharmaceutical fields.  This update, admetSAR 2.0, focuses on extension and optimization of existing models with significant quantity and quality improvement on training data.  Now 47 models are available for either drug discovery or environmental risk assessment.  In addn., we added a new module named ADMETopt for lead optimization based on predicted ADMET properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfhqvVz6_0frVg90H21EOLACvtfcHk0lh_wMcPGaPSiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvV2rsL3O&md5=1f16a615c38981b2b29140d6d51bb46b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbty707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbty707%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLou%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DY.%26atitle%3DAdmetsar%25202.0%253A%2520Web-Service%2520For%2520Prediction%2520And%2520Optimization%2520Of%2520Chemical%2520ADMET%2520Properties%26jtitle%3DBioinformatics%26date%3D2019%26volume%3D35%26spage%3D1067%26epage%3D1069%26doi%3D10.1093%2Fbioinformatics%2Fbty707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span> <span> </span><span class="NLM_article-title">Lead- And Drug-Like Compounds: The Rule-Of-Five Revolution</span>. <i>Drug Discovery Today: Technol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/j.ddtec.2004.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.ddtec.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=24981612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=337-341&author=C.+A.+Lipinski&title=Lead-+And+Drug-Like+Compounds%3A+The+Rule-Of-Five+Revolution&doi=10.1016%2Fj.ddtec.2004.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Lead- and drug-like compounds: the rule-of-five revolution</span></div><div class="casAuthors">Lipinski, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Technologies</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-341</span>CODEN:
                <span class="NLM_cas:coden">DDTTB5</span>;
        ISSN:<span class="NLM_cas:issn">1740-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Citations in CAS SciFinder to the rule-of-five (RO5) publication will exceed 1000 by year-end 2004.  Trends in the RO5 literature explosion that can be discerned are the further definitions of drug-like.  This topic is explored in terms of drug-like physicochem. features, drug-like structural features, a comparison of drug-like and non-drug-like in drug discovery and a discussion of how drug-like features relate to clin. success.  Physicochem. features of CNS drugs and features related to CNS blood-brain transporter affinity are briefly reviewed.  Recent literature on features of non-oral drugs is reviewed and how features of lead-like compds. differ from those of drug-like compds. is discussed.  Most recently, partly driven by NIH roadmap initiatives, considerations have arisen as to what tool-like means in the search for chem. tools to probe biol. space.  All these topics frame the scope of this short review/perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjiyP3CY7lLVg90H21EOLACvtfcHk0liP61O5N3FPqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D&md5=952c29b47003b884116d790ae9e4721f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DLead-%2520And%2520Drug-Like%2520Compounds%253A%2520The%2520Rule-Of-Five%2520Revolution%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2004%26volume%3D1%26spage%3D337%26epage%3D341%26doi%3D10.1016%2Fj.ddtec.2004.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E. H.</span></span> <i>Drug-Like Properties: Concepts, Structure Design and Methods From ADME to Toxicity Optimization</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Massachusetts</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=L.+Di&author=E.+H.+Kerns&title=Drug-Like+Properties%3A+Concepts%2C+Structure+Design+and+Methods+From+ADME+to+Toxicity+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26btitle%3DDrug-Like%2520Properties%253A%2520Concepts%252C%2520Structure%2520Design%2520and%2520Methods%2520From%2520ADME%2520to%2520Toxicity%2520Optimization%26pub%3DAcademic%2520Press%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Şahin, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgın-Gökşen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gökhan Kelekçi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Işık, Ş.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Crystal Structures And DFT Studies Of 1-[2- (5-Methyl-2-Benzoxazolinone-3-Yl) Acetyl]-3-Phenyl-5- (3,4-Dimethoxyphenyl)-4,5-Dihydro-1H-Pyrazole And 1-[2-(5-Chloro-2-Benzoxazolinone-3-Yl)Acetyl]-3-Phenyl-5-(4-Methoxyphenyl)-4,5-Dihydro-1H-Pyrazole</span>. <i>J. Mol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1006</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1016/j.molstruc.2011.08.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.molstruc.2011.08.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyjs73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1006&publication_year=2011&pages=147-158&author=Z.+S.+%C5%9Eahinauthor=U.+Salg%C4%B1n-G%C3%B6k%C5%9Fenauthor=N.+G%C3%B6khan+Kelek%C3%A7iauthor=%C5%9E.+I%C5%9F%C4%B1k&title=Synthesis%2C+Crystal+Structures+And+DFT+Studies+Of+1-%5B2-+%285-Methyl-2-Benzoxazolinone-3-Yl%29+Acetyl%5D-3-Phenyl-5-+%283%2C4-Dimethoxyphenyl%29-4%2C5-Dihydro-1H-Pyrazole+And+1-%5B2-%285-Chloro-2-Benzoxazolinone-3-Yl%29Acetyl%5D-3-Phenyl-5-%284-Methoxyphenyl%29-4%2C5-Dihydro-1H-Pyrazole&doi=10.1016%2Fj.molstruc.2011.08.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, crystal structures and DFT studies of 1-[2-(5-methyl-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole and 1-[2-(5-chloro-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole</span></div><div class="casAuthors">Sahin, Zarife Sibel; Salgin-Goeksen, Umut; Goekhan-Kelekci, Nesrin; Isik, Samil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1006</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">147-158</span>CODEN:
                <span class="NLM_cas:coden">JMOSB4</span>;
        ISSN:<span class="NLM_cas:issn">0022-2860</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The title compds., 1-[2-(5-methyl-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole (5a) and 1-[2-(5-chloro-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole (5b), were synthesized.  The crystal and mol. structures of 5a and 5b have been detd. by elemental analyses, IR, 1H NMR, ESI-MS and single-crystal X-ray diffraction.  Mol. geometries of 5a and 5b in the ground state have been calcd. using the d. functional method (DFT) with B3LYP/6-31G(d,p) basis set and compared with the exptl. data.  In addn., the mol. electrostatic potential maps and frontier MOs of 5a and 5b were performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot-hoSFRpZFrVg90H21EOLACvtfcHk0liP61O5N3FPqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyjs73I&md5=571fd0d3521c19d3ecd09b77d8a84e7c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2011.08.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2011.08.061%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%259Eahin%26aufirst%3DZ.%2BS.%26aulast%3DSalg%25C4%25B1n-G%25C3%25B6k%25C5%259Fen%26aufirst%3DU.%26aulast%3DG%25C3%25B6khan%2BKelek%25C3%25A7i%26aufirst%3DN.%26aulast%3DI%25C5%259F%25C4%25B1k%26aufirst%3D%25C5%259E.%26atitle%3DSynthesis%252C%2520Crystal%2520Structures%2520And%2520DFT%2520Studies%2520Of%25201-%255B2-%2520%25285-Methyl-2-Benzoxazolinone-3-Yl%2529%2520Acetyl%255D-3-Phenyl-5-%2520%25283%252C4-Dimethoxyphenyl%2529-4%252C5-Dihydro-1H-Pyrazole%2520And%25201-%255B2-%25285-Chloro-2-Benzoxazolinone-3-Yl%2529Acetyl%255D-3-Phenyl-5-%25284-Methoxyphenyl%2529-4%252C5-Dihydro-1H-Pyrazole%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2011%26volume%3D1006%26spage%3D147%26epage%3D158%26doi%3D10.1016%2Fj.molstruc.2011.08.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gökşen, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alpaslan, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelekci, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekizoglu, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Crystal Structures And Theoretical Calculations Of New 1-[2-(5-Chloro-2-Benzoxazolinone-3-Yl)Acetyl]-3,5-Diphenyl-4,5-Dihydro-(1H)-Pyrazoles</span>. <i>J. Mol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1039</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1016/j.molstruc.2013.01.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.molstruc.2013.01.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1aqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1039&publication_year=2013&pages=71-83&author=U.+S.+G%C3%B6k%C5%9Fenauthor=Y.+B.+Alpaslanauthor=N.+Kelekciauthor=S.+Isikauthor=M.+Ekizoglu&title=Synthesis%2C+Crystal+Structures+And+Theoretical+Calculations+Of+New+1-%5B2-%285-Chloro-2-Benzoxazolinone-3-Yl%29Acetyl%5D-3%2C5-Diphenyl-4%2C5-Dihydro-%281H%29-Pyrazoles&doi=10.1016%2Fj.molstruc.2013.01.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, crystal structures and theoretical calculations of new 1-[2-(5-chloro-2-benzoxazolinone-3-yl)acetyl]-3,5-diphenyl-4,5-dihydro-(1H)-pyrazoles</span></div><div class="casAuthors">Goksen, Umut Salgin; Alpaslan, Yelda Bingol; Kelekci, Nesrin Gokhan; Isik, Samil; Ekizoglu, Melike</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1039</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71-83</span>CODEN:
                <span class="NLM_cas:coden">JMOSB4</span>;
        ISSN:<span class="NLM_cas:issn">0022-2860</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">1-[2-(5-Chloro-2-benzoxazolinone-3-yl)acetyl]-3,5-diphenyl-4,5-dihydro-(1H)-pyrazoles I (R1 = R2 = R4 = H, R3 = OMe; R1 = R4 = H, R2 = R3 = OMe; R1 = Me, R2 = H, R3 = R4 = OMe) were synthesized.  The crystal and mol. structures of the compds. I were detd. by elemental analyses, IR, 1H NMR, ESI-MS and single-crystal X-ray diffraction.  DFT method with 6-31G(d,p) basis set was used to calc. the optimized geometrical parameters, vibrational frequencies and chem. shift values.  The calcd. vibrational frequencies and chem. shift values were compared with exptl. IR and 1H NMR values.  The results represented that there was a good agreement between exptl. and calcd. values of the compds. I.  In addn., DFT calcns. of the compds., mol. electrostatic potentials (MEPs) and frontier MOs were performed at B3LYP/6-31G(d,p) level of theory.  Furthermore, compds. were tested against three Gram-pos. bacteria: Staphylococcus aureus ATCC 29213 (American Type Culture Collection), methicillin resistant S. aureus (MRSA) ATCC 43300 and Enterococcus faecalis ATCC 29212; two Gram neg. bacteria: Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853; and three fungi: Candida albicans ATCC 90028, Candida krusei ATCC 6258 and Candida parapsilosis ATCC 90018.  In general, all of the compds. were found to be slightly active against tested microorganisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZxDgeq2LXCbVg90H21EOLACvtfcHk0liP61O5N3FPqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1aqs70%253D&md5=e54820d1a8f71cc80bdf7fa49b6f56b5</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2013.01.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2013.01.066%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6k%25C5%259Fen%26aufirst%3DU.%2BS.%26aulast%3DAlpaslan%26aufirst%3DY.%2BB.%26aulast%3DKelekci%26aufirst%3DN.%26aulast%3DIsik%26aufirst%3DS.%26aulast%3DEkizoglu%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520Crystal%2520Structures%2520And%2520Theoretical%2520Calculations%2520Of%2520New%25201-%255B2-%25285-Chloro-2-Benzoxazolinone-3-Yl%2529Acetyl%255D-3%252C5-Diphenyl-4%252C5-Dihydro-%25281H%2529-Pyrazoles%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2013%26volume%3D1039%26spage%3D71%26epage%3D83%26doi%3D10.1016%2Fj.molstruc.2013.01.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirshner, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilmeier, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lightstone, F. C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">A Method to Predict Blood-Brain Barrier Permeability of Drug-Like Compounds Using Molecular Dynamics Simulations</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">630</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1016/j.bpj.2014.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.bpj.2014.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=25099802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12msrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2014&pages=630-641&author=T.+S.+Carpenterauthor=D.+A.+Kirshnerauthor=E.+Y.+Lauauthor=S.+E.+Wongauthor=J.+P.+Nilmeierauthor=F.+C.+Lightstone&title=A+Method+to+Predict+Blood-Brain+Barrier+Permeability+of+Drug-Like+Compounds+Using+Molecular+Dynamics+Simulations&doi=10.1016%2Fj.bpj.2014.06.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A Method to Predict Blood-Brain Barrier Permeability of Drug-Like Compounds Using Molecular Dynamics Simulations</span></div><div class="casAuthors">Carpenter, Timothy S.; Kirshner, Daniel A.; Lau, Edmond Y.; Wong, Sergio E.; Nilmeier, Jerome P.; Lightstone, Felice C.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">630-641</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) is formed by specialized tight junctions between endothelial cells that line brain capillaries to create a highly selective barrier between the brain and the rest of the body.  A major problem to overcome in drug design is the ability of the compd. in question to cross the BBB.  Neuroactive drugs are required to cross the BBB to function.  Conversely, drugs that target other parts of the body ideally should not cross the BBB to avoid possible psychotropic side effects.  Thus, the task of predicting the BBB permeability of new compds. is of great importance.  Two gold-std. exptl. measures of BBB permeability are logBB (the concn. of drug in the brain divided by concn. in the blood) and logPS (permeability surface-area product).  Both methods are time-consuming and expensive, and although logPS is considered the more informative measure, it is lower throughput and more resource intensive.  With continual increases in computer power and improvements in mol. simulations, in silico methods may provide viable alternatives.  Computational predictions of these two parameters for a sample of 12 small mol. compds. were performed.  The potential of mean force for each compd. through a 1,2-dioleoyl-sn-glycero-3-phosphocholine bilayer is detd. by mol. dynamics simulations.  This system setup is often used as a simple BBB mimetic.  Addnl., one-dimensional position-dependent diffusion coeffs. are calcd. from the mol. dynamics trajectories.  The diffusion coeff. is combined with the free energy landscape to calc. the effective permeability (Peff) for each sample compd.  The relative values of these permeabilities are compared to exptl. detd. logBB and logPS values.  Our computational predictions correlate remarkably well with both logBB (R2 = 0.94) and logPS (R2 = 0.90).  Thus, we have demonstrated that this approach may have the potential to provide reliable, quant. predictive BBB permeability, using a relatively quick, inexpensive method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr97tFORPkLbLVg90H21EOLACvtfcHk0lgP4cnlURVxgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12msrrF&md5=70da942a59a290e480a88f2a1f4afb53</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bpj.2014.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpj.2014.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DCarpenter%26aufirst%3DT.%2BS.%26aulast%3DKirshner%26aufirst%3DD.%2BA.%26aulast%3DLau%26aufirst%3DE.%2BY.%26aulast%3DWong%26aufirst%3DS.%2BE.%26aulast%3DNilmeier%26aufirst%3DJ.%2BP.%26aulast%3DLightstone%26aufirst%3DF.%2BC.%26atitle%3DA%2520Method%2520to%2520Predict%2520Blood-Brain%2520Barrier%2520Permeability%2520of%2520Drug-Like%2520Compounds%2520Using%2520Molecular%2520Dynamics%2520Simulations%26jtitle%3DBiophys.%2520J.%26date%3D2014%26volume%3D107%26spage%3D630%26epage%3D641%26doi%3D10.1016%2Fj.bpj.2014.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High Throughput Artificial Membrane Permeability Assay For Blood-Brain Barrier</span>. <i>Eur J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+Throughput+Artificial+Membrane+Permeability+Assay+For+Blood-Brain+Barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lgP4cnlURVxgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520Throughput%2520Artificial%2520Membrane%2520Permeability%2520Assay%2520For%2520Blood-Brain%2520Barrier%26jtitle%3DEur%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borsini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meli, A.</span></span> <span> </span><span class="NLM_article-title">Is The Forced Swimming Test A Suitable Model For Revealing Antidepressant Activity?</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1007/BF00176837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2FBF00176837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=3127840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaL1c7nslWnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1988&pages=147-160&author=F.+Borsiniauthor=A.+Meli&title=Is+The+Forced+Swimming+Test+A+Suitable+Model+For+Revealing+Antidepressant+Activity%3F&doi=10.1007%2FBF00176837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Is the forced swimming test a suitable model for revealing antidepressant activity?</span></div><div class="casAuthors">Borsini F; Meli A</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-60</span>
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">The forced swimming test is reviewed.  This test appears to be suitable for detecting antidepressant activity in rats but not in mice.  Difference in experimental procedure may account for the different sensitivity to drugs of the two animal species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCdVg1V6KRfxe4jJGKT5N0fW6udTcc2ebntx_Ba5_jlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c7nslWnsQ%253D%253D&md5=d7a3d707b4ab6700b0dd8f23b39aa03d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2FBF00176837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00176837%26sid%3Dliteratum%253Aachs%26aulast%3DBorsini%26aufirst%3DF.%26aulast%3DMeli%26aufirst%3DA.%26atitle%3DIs%2520The%2520Forced%2520Swimming%2520Test%2520A%2520Suitable%2520Model%2520For%2520Revealing%2520Antidepressant%2520Activity%253F%26jtitle%3DPsychopharmacology%26date%3D1988%26volume%3D94%26spage%3D147%26epage%3D160%26doi%3D10.1007%2FBF00176837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalakrishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudani, I.</span></span> <span> </span><span class="NLM_article-title">Acquaintance With The Actuality: Community Diagnosis Programme Of Kathmandu Medical College At Gundu Village, Bhaktapur, Nepal</span>. <i>Kathmandu Univ. Med. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=18604130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BD1cvjsVOqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=128-134&author=A.+Vaidyaauthor=A.+Pradhanauthor=S.+K.+Joshiauthor=S.+Gopalakrishnanauthor=I.+Dudani&title=Acquaintance+With+The+Actuality%3A+Community+Diagnosis+Programme+Of+Kathmandu+Medical+College+At+Gundu+Village%2C+Bhaktapur%2C+Nepal"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Acquaintance with the actuality: community diagnosis programme of Kathmandu Medical College at Gundu village, Bhaktapur, Nepal</span></div><div class="casAuthors">Vaidya A; Pradhan A; Joshi S K; Gopalakrishnan S; Dudani I</div><div class="citationInfo"><span class="NLM_cas:title">Kathmandu University medical journal (KUMJ)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  In Nepal, various field programs such as community diagnosis programmes (CDP) have been initiated to make the education of doctors, nurses and dentists more community oriented and relevant and suited to the health care scenario.  Community diagnosis refers to the identification and quantification of the health problems in a community and identification of their correlates for the purpose of defining those individuals or groups at risk or those in need of health care.  The article presents the main activities of community diagnosis as a core component of community-based education for the medical students at Kathmandu Medical College, Kathmandu, Nepal.  METHODOLOGY:  A 4 weeks' Community Diagnosis Programme was conducted by MBBS II students (9th Batch) of the Kathmandu Medical College under the supervision of the Department of Community Medicine in November 2006 in the rural community of Gundu VDC (village development committee).  The tools used included pre-tested questionnaires, weighing machines, measuring tapes, stethoscopes and sphygmomanometers.  After the data collection and compilation, the students presented their findings in oral presentations, accompanied by a written report, including essential recommendations for improving the health status of these communities.  RESULTS:  The students benefited from the necessary process of integrating clinical skills and a public health approach, so as to enhance their epidemiological thinking and be of greater use to the communities where they will practice.  The community also benefited by achievement of behavioral changes leading to healthier lifestyles and increased awareness of health-related matters and their role in quality of life.  CONCLUSIONS:  CDP is a way to practically demonstrate that the link between a medical college and society is possible.  That is, a medical college can serve the community and thus society, with specific activities to improve health and the skills of students who will serve as future health professionals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZa6Tg6u8uRFUIs6wFK5xJfW6udTcc2ebntx_Ba5_jlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvjsVOqtg%253D%253D&md5=508878934b776028e0f4524da24c3780</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVaidya%26aufirst%3DA.%26aulast%3DPradhan%26aufirst%3DA.%26aulast%3DJoshi%26aufirst%3DS.%2BK.%26aulast%3DGopalakrishnan%26aufirst%3DS.%26aulast%3DDudani%26aufirst%3DI.%26atitle%3DAcquaintance%2520With%2520The%2520Actuality%253A%2520Community%2520Diagnosis%2520Programme%2520Of%2520Kathmandu%2520Medical%2520College%2520At%2520Gundu%2520Village%252C%2520Bhaktapur%252C%2520Nepal%26jtitle%3DKathmandu%2520Univ.%2520Med.%2520J.%26date%3D2008%26volume%3D6%26spage%3D128%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, V.</span>; <span class="NLM_string-name">Nestler, E. J.</span></span> <span> </span><span class="NLM_article-title">Animal Models Of Depression: Molecular Perspectives</span>. In  <i>Molecular and functional models in neuropsychiatry</i>; <span class="NLM_series">Current Topics in Behavioral Neurosciences</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2011</span>; Vol.  <span class="NLM_volume">7</span>, pp  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">147</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2F7854_2010_108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=121-147&author=V.+Krishnan&author=E.+J.+Nestler&title=Molecular+and+functional+models+in+neuropsychiatry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2F7854_2010_108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F7854_2010_108%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DV.%26atitle%3DAnimal%2520Models%2520Of%2520Depression%253A%2520Molecular%2520Perspectives%26btitle%3DMolecular%2520and%2520functional%2520models%2520in%2520neuropsychiatry%26pub%3DSpringer%26date%3D2011%26volume%3D7%26spage%3D121%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petit-Demouliere, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, M.</span></span> <span> </span><span class="NLM_article-title">Forced Swimming Test In Mice: A Review Of Antidepressant Activity</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1007/s00213-004-2048-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2Fs00213-004-2048-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=15609067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVyltLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2005&pages=245-255&author=B.+Petit-Demouliereauthor=F.+Chenuauthor=M.+Bourin&title=Forced+Swimming+Test+In+Mice%3A+A+Review+Of+Antidepressant+Activity&doi=10.1007%2Fs00213-004-2048-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Forced swimming test in mice: a review of antidepressant activity</span></div><div class="casAuthors">Petit-Demouliere, Benoit; Chenu, Franck; Bourin, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-255</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Rationale: Among all animal models, the forced swimming test (FST) remains one of the most used tools for screening antidepressants.  Objective: This paper reviews some of the main aspects of the FST in mice.  Most of the sensitivity and variability factors that were assessed on the FST are summarized.  Mechanisms: We have summarized data found in the literature of antidepressant effects on the FST in mice.  From this data set, we have extrapolated information on baseline levels of strain, and sensitivity against antidepressants.  Results: We have shown that many parameters have to be considered in this test to gain good reliability.  Moreover, there was a fundamental inter-strain difference of response in the FST.  Conclusions: The FST is a good screening tool with good reliability and predictive validity.  Strain is one of the most important parameters to consider.  Swiss and NMRI mice can be used to discriminate the mechanisms of action of drugs.  CD-1 seems to be the most useful strain for screening purposes, but this needs to be confirmed with some spontaneous locomotor activity studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSv0KipleZDrVg90H21EOLACvtfcHk0lg_ehCtR1I1DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVyltLrE&md5=d072eba578f8564ea4c6d15fb790d1a5</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00213-004-2048-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-004-2048-7%26sid%3Dliteratum%253Aachs%26aulast%3DPetit-Demouliere%26aufirst%3DB.%26aulast%3DChenu%26aufirst%3DF.%26aulast%3DBourin%26aufirst%3DM.%26atitle%3DForced%2520Swimming%2520Test%2520In%2520Mice%253A%2520A%2520Review%2520Of%2520Antidepressant%2520Activity%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D177%26spage%3D245%26epage%3D255%26doi%3D10.1007%2Fs00213-004-2048-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, T. M.</span></span> <span> </span><span class="NLM_article-title">Behavioral Animal Models Of Depression</span>. <i>Neurosci Bull</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1007/s12264-010-0323-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2Fs12264-010-0323-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=20651815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BC3cnpsVKltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=327-337&author=H.+C.+Yanauthor=X.+Caoauthor=M.+Dasauthor=X.+H.+Zhuauthor=T.+M.+Gao&title=Behavioral+Animal+Models+Of+Depression&doi=10.1007%2Fs12264-010-0323-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral animal models of depression</span></div><div class="casAuthors">Yan Hua-Cheng; Cao Xiong; Das Manas; Zhu Xin-Hong; Gao Tian-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience bulletin</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">327-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Depression is a chronic, recurring and potentially life-threatening illness that affects up to 20% of the population across the world.  Despite its prevalence and considerable impact on human, little is known about its pathogenesis.  One of the major reasons is the restricted availability of validated animal models due to the absence of consensus on the pathology and etiology of depression.  Besides, some core symptoms such as depressed mood, feeling of worthlessness, and recurring thoughts of death or suicide, are impossible to be modeled on laboratory animals.  Currently, the criteria for identifying animal models of depression rely on either of the 2 principles: actions of known antidepressants and responses to stress.  This review mainly focuses on the most widely used animal models of depression, including learned helplessness, chronic mild stress, and social defeat paradigms.  Also, the behavioral tests for screening antidepressants, such as forced swimming test and tail suspension test, are also discussed.  The advantages and major drawbacks of each model are evaluated.  In prospective, new techniques that will be beneficial for developing novel animal models or detecting depression are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSaY99d7aSGBPcsfMJQC1ZdfW6udTcc2eYEVE2VVnhDBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnpsVKltw%253D%253D&md5=17d9e33165a04a820c029c29c4d8b5c8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs12264-010-0323-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12264-010-0323-7%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DH.%2BC.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DDas%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%2BH.%26aulast%3DGao%26aufirst%3DT.%2BM.%26atitle%3DBehavioral%2520Animal%2520Models%2520Of%2520Depression%26jtitle%3DNeurosci%2520Bull%26date%3D2010%26volume%3D26%26spage%3D327%26epage%3D337%26doi%3D10.1007%2Fs12264-010-0323-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castagné, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porsolt, R. D.</span></span> <span> </span><span class="NLM_article-title">Rodent Models Of Depression: Forced Swim And Tail Suspension Behavioral Despair Tests In Rats And Mice</span>. <i>Curr. Protoc. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1002/0471142301.ns0810as55</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2F0471142301.ns0810as55" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=8-10&author=V.+Castagn%C3%A9author=P.+Moserauthor=S.+Rouxauthor=R.+D.+Porsolt&title=Rodent+Models+Of+Depression%3A+Forced+Swim+And+Tail+Suspension+Behavioral+Despair+Tests+In+Rats+And+Mice&doi=10.1002%2F0471142301.ns0810as55"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2F0471142301.ns0810as55&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471142301.ns0810as55%26sid%3Dliteratum%253Aachs%26aulast%3DCastagn%25C3%25A9%26aufirst%3DV.%26aulast%3DMoser%26aufirst%3DP.%26aulast%3DRoux%26aufirst%3DS.%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26atitle%3DRodent%2520Models%2520Of%2520Depression%253A%2520Forced%2520Swim%2520And%2520Tail%2520Suspension%2520Behavioral%2520Despair%2520Tests%2520In%2520Rats%2520And%2520Mice%26jtitle%3DCurr.%2520Protoc.%2520Neurosci.%26date%3D2011%26volume%3D55%26spage%3D8%26epage%3D10%26doi%3D10.1002%2F0471142301.ns0810as55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barish, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogle, W. O.</span></span> <span> </span><span class="NLM_article-title">Antidepressant-Like Effect Of Low Molecular Proanthocyanidin In Mice: Involvement Of Monoaminergic System</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2009.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.pbb.2009.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=19857512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFantb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2010&pages=447-453&author=Y.+Xuauthor=S.+Liauthor=R.+Chenauthor=G.+Liauthor=P.+A.+Barishauthor=W.+Youauthor=L.+Chenauthor=M.+Linauthor=B.+Kuauthor=J.+Panauthor=W.+O.+Ogle&title=Antidepressant-Like+Effect+Of+Low+Molecular+Proanthocyanidin+In+Mice%3A+Involvement+Of+Monoaminergic+System&doi=10.1016%2Fj.pbb.2009.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like effect of low molecular proanthocyanidin in mice: Involvement of monoaminergic system</span></div><div class="casAuthors">Xu, Ying; Li, Shan; Chen, Ruijie; Li, Gaowen; Barish, Philip A.; You, Wenting; Chen, Ling; Lin, Mengmeng; Ku, Baoshan; Pan, Jianchun; Ogle, William O.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">447-453</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Proanthocyanidin is a phenolic product present in plants which has antioxidant, antinociceptive and neuroprotective properties, without inducing significant toxicol. effects.  The present study tested the hypothesis that low mol. proanthocyanidin from grapes that has optimized bioavailability, would exert antidepressant-like activities in behavioral despair tests.  The results suggested that oral administration proanthocyanidin at doses of 25 and 50 mg/kg for 7 days significantly reduced the duration of immobility in both the tail suspension and forced swimming tests.  The doses that affected the immobile response did not affect locomotor activity.  In addn., the neurochem. and neuropharmacol. assays showed that proanthocyanidin produced a marked increase of 5-HT levels at 25 and 50 mg/kg in three brain regions, the frontal cortex, hippocampus and hypothalamus.  Noradrenaline and dopamine levels were also increased when higher dose of proanthocyanidin (50 mg/kg) administration both in the frontal cortex and hippocampus.  These effects were similar to those obsd. for the classical antidepressant imipramine (10 mg/kg, i.p.).  Moreover, Our study suggested that proanthocyanidin (12.5, 25 and 50 mg/kg) dose dependently inhibited monoamine oxidase-A (MAO-A) activity, while MAO-B inhibitory activity was also found at higher doses (25 and 50 mg/kg) after 7 days administration.  MAO-A selective inhibitor, moclobemide (20 mg/kg, i.g.) produced MAO-A inhibition of 70.5% in the mouse brain.  These findings suggest that the antidepressant-like effects of proanthocyanidin may involve the central monoaminergic neurotransmitter systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXQmYrmtO_GbVg90H21EOLACvtfcHk0lg_ehCtR1I1DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFantb7J&md5=01b9f0e959e9dbd98e841131170f4d67</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2009.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2009.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DBarish%26aufirst%3DP.%2BA.%26aulast%3DYou%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DKu%26aufirst%3DB.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DOgle%26aufirst%3DW.%2BO.%26atitle%3DAntidepressant-Like%2520Effect%2520Of%2520Low%2520Molecular%2520Proanthocyanidin%2520In%2520Mice%253A%2520Involvement%2520Of%2520Monoaminergic%2520System%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2010%26volume%3D94%26spage%3D447%26epage%3D453%26doi%3D10.1016%2Fj.pbb.2009.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drigues, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poltyrev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bejar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span> <span> </span><span class="NLM_article-title">cDna Gene Expression Profile Of Rat Hippocampus After Chronic Treatment With Antidepressant Drugs</span>. <i>J. Neural Transm.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1413</span>– <span class="NLM_lpage">1436</span>, <span class="refDoi"> DOI: 10.1007/s00702-003-0077-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2Fs00702-003-0077-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=14666413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1yitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2003&pages=1413-1436&author=N.+Driguesauthor=T.+Poltyrevauthor=C.+Bejarauthor=M.+Weinstockauthor=M.+B.+Youdim&title=cDna+Gene+Expression+Profile+Of+Rat+Hippocampus+After+Chronic+Treatment+With+Antidepressant+Drugs&doi=10.1007%2Fs00702-003-0077-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs</span></div><div class="casAuthors">Drigues, N.; Poltyrev, T.; Bejar, C.; Weinstock, M.; Youdim, M. B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1413-1436</span>CODEN:
                <span class="NLM_cas:coden">JNTRF3</span>;
        ISSN:<span class="NLM_cas:issn">0300-9564</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag Wien</span>)
        </div><div class="casAbstract">Background.  Chronic antidepressant treatment causes alterations in several hippocampal genes, which participate in neuronal plasticity.  However the full picture of their mechanism of action is not known.  The advent of genomics enables to identify a broader mechanism of action and identify novel targets for antidepressant development.  Methods. The present study examd. the cDNA microarray gene expression profile in the hippocampus induced by chronic antidepressant treatment, in rats exposed to the forced swim test.  Animals were treated for 2 wk with moclobemide, clorgyline and amitriptyline.  Results. The three antidepressants significantly reduced immobility in the forced swim test and initiated significant homologous changes in gene expressions.  These include up regulation of cAMP response element binding protein and down regulation of corticotrophin releasing hormone.  Other gene changes noted were those related to neuropeptides, neurogenesis and synaptogenesis, including synaptophysin and neogenin.  Some 89 genes were changed by at least 2 drugs, out of which 53 were changed oppositely by forced swim test.  Confirmation of gene changes, have come from real time RT-PCR.  Conclusions.  A significant no. and homol. in gene expression were obsd. with the three antidepressants.  Many of the genes were assocd. with neurogenesis and synaptogenesis, including synaptophysin and neogenin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpphy2aXi1ud7Vg90H21EOLACvtfcHk0lj0hItR1g8wCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1yitL8%253D&md5=a7a94d3cedee2341f5da2adcfb2f6f46</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs00702-003-0077-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-003-0077-8%26sid%3Dliteratum%253Aachs%26aulast%3DDrigues%26aufirst%3DN.%26aulast%3DPoltyrev%26aufirst%3DT.%26aulast%3DBejar%26aufirst%3DC.%26aulast%3DWeinstock%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DcDna%2520Gene%2520Expression%2520Profile%2520Of%2520Rat%2520Hippocampus%2520After%2520Chronic%2520Treatment%2520With%2520Antidepressant%2520Drugs%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2003%26volume%3D110%26spage%3D1413%26epage%3D1436%26doi%3D10.1007%2Fs00702-003-0077-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pare, C. M.</span></span> <span> </span><span class="NLM_article-title">The Present Status Of Monoamine Oxidase Inhibitors</span>. <i>Br. J. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1192/bjp.146.6.576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1192%2Fbjp.146.6.576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=3893604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaL2M3ltlGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=1985&pages=576-584&author=C.+M.+Pare&title=The+Present+Status+Of+Monoamine+Oxidase+Inhibitors&doi=10.1192%2Fbjp.146.6.576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The present status of monoamine oxidase inhibitors</span></div><div class="casAuthors">Pare C M</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of psychiatry : the journal of mental science</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">576-84</span>
        ISSN:<span class="NLM_cas:issn">0007-1250</span>.
    </div><div class="casAbstract">The present status of monoamine oxidase inhibitors in the treatment of depression is reviewed.  With adequate doses they are effective antidepressants, but dosages have in the past been too low.  Provided proper dietary precautions are taken, the incidence of fatality from dietary interactions is very small and should not deter doctors from using these drugs, especially in those depressed patients who do not respond to tricyclic-type antidepressants.  The present status of combining monoamine oxidase inhibitors with tricyclics is discussed, as are the newer specific inhibitors particularly clorgyline and deprenyl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFSCenE3QxJhdUSIfHIn4FfW6udTcc2ebIylkuFsW6d7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M3ltlGmtA%253D%253D&md5=5a54105f1b63320f7ef49f2fdd710925</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1192%2Fbjp.146.6.576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1192%252Fbjp.146.6.576%26sid%3Dliteratum%253Aachs%26aulast%3DPare%26aufirst%3DC.%2BM.%26atitle%3DThe%2520Present%2520Status%2520Of%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DBr.%2520J.%2520Psychiatry%26date%3D1985%26volume%3D146%26spage%3D576%26epage%3D584%26doi%3D10.1192%2Fbjp.146.6.576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutts, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherry-McKenna, R.</span></span> <span> </span><span class="NLM_article-title">Insights Into The Mechanisms Of Action Of The MAO Inhibitors Phenelzine And Tranylcypromine: A Review</span>. <i>J. Psychiatr. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1362653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaK3s7ksVaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1992&pages=206-214&author=G.+B.+Bakerauthor=R.+T.+Couttsauthor=K.+F.+McKennaauthor=R.+Sherry-McKenna&title=Insights+Into+The+Mechanisms+Of+Action+Of+The+MAO+Inhibitors+Phenelzine+And+Tranylcypromine%3A+A+Review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review</span></div><div class="casAuthors">Baker G B; Coutts R T; McKenna K F; Sherry-McKenna R L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">206-14</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">Although the non-selective monoamine oxidase inhibitors phenelzine and tranylcypromine have been used for many years, much still remains to be understood about their mechanisms of action.  Other factors, in addition to the inhibition of monoamine oxidase and the subsequent elevation of brain levels of the catecholamines and 5-hydroxytryptamine, may contribute to the overall pharmacological profiles of these drugs.  This review also considers the effects on brain levels of amino acids and trace amines, uptake and release of neurotransmitter amines at nerve terminals, receptors for amino acids and amines, and enzymes other than monoamine oxidase, including enzymes involved in metabolism of other drugs.  The possible contributions of metabolism and stereochemistry to the actions of these monoamine oxidase inhibitors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9vQr4FxqLLnELvajU9pjPfW6udTcc2ebIylkuFsW6d7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s7ksVaqug%253D%253D&md5=290dbaddc5da35c7cee4253a0a8ace7a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DG.%2BB.%26aulast%3DCoutts%26aufirst%3DR.%2BT.%26aulast%3DMcKenna%26aufirst%3DK.%2BF.%26aulast%3DSherry-McKenna%26aufirst%3DR.%26atitle%3DInsights%2520Into%2520The%2520Mechanisms%2520Of%2520Action%2520Of%2520The%2520MAO%2520Inhibitors%2520Phenelzine%2520And%2520Tranylcypromine%253A%2520A%2520Review%26jtitle%3DJ.%2520Psychiatr.%2520Neurosci.%26date%3D1992%26volume%3D17%26spage%3D206%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stassen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angst, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delini-Stula, A.</span></span> <span> </span><span class="NLM_article-title">Onset of improvement under fluoxetine and moclobemide</span>. <i>Eur. Psychiatr.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/S0924-9338(98)80135-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2FS0924-9338%2898%2980135-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=19698614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BD1Mrnt1Khug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1998&pages=128-133&author=H.+Stassenauthor=J.+Angstauthor=A.+Delini-Stula&title=Onset+of+improvement+under+fluoxetine+and+moclobemide&doi=10.1016%2FS0924-9338%2898%2980135-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Onset of improvement under fluoxetine and moclobemide</span></div><div class="casAuthors">Stassen H; Angst J; Delini-Stula A</div><div class="citationInfo"><span class="NLM_cas:title">European psychiatry : the journal of the Association of European Psychiatrists</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">128-33</span>
        ISSN:<span class="NLM_cas:issn">0924-9338</span>.
    </div><div class="casAbstract">In a meta-analysis of the selective serotonin reuptake inhibitor fluoxetine (n = 440) and the reversible and selective monoamine oxidase-A inhibitor moclobemide (n = 437) we investigated the time course of improvement over 6 weeks for these two classes of anti-depressants.  Two different methods of approach were applied: (1) repeated measurement analysis of variance in combination with regression analysis, and (2) a survival-analytical approach that allowed us to determine onset of improvement for the individual patient, to distinguish between early and late improvers, to assess the predictive value of early improvement, and to adequately process premature withdrawals.  The two antidepressants of large biochemical and pharmacological differences yielded virtually identical response- and drop-out rates, and exhibited no difference with respect to the time course of improvement.  Onset of improvement occurred in more than half of the patients within the first 2 weeks of treatment, and early improvement was highly predictive of later outcome.  In particular, there was no indication for a delayed onset of action of antidepressants.  We suggest that future studies should be standardised with respect to washout period and sufficiently dense assessments during the first 2 weeks of trial.  Thus, patient samples can be subdivided reproducibly into early-, late-, partial- and non-remitters.  This, in turn, may help to identify "true" drug responders, and to discover why in some patients recovery becomes "stuck".  Data already held by the pharmaceutical companies should be reanalysed in this respect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQHjWoKPYvhnxjv2lLSLOxFfW6udTcc2eaxIhkGzYilULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mrnt1Khug%253D%253D&md5=b5865109528c86ba590adfb322b3dc62</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0924-9338%2898%2980135-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0924-9338%252898%252980135-1%26sid%3Dliteratum%253Aachs%26aulast%3DStassen%26aufirst%3DH.%26aulast%3DAngst%26aufirst%3DJ.%26aulast%3DDelini-Stula%26aufirst%3DA.%26atitle%3DOnset%2520of%2520improvement%2520under%2520fluoxetine%2520and%2520moclobemide%26jtitle%3DEur.%2520Psychiatr.%26date%3D1998%26volume%3D13%26spage%3D128%26epage%3D133%26doi%3D10.1016%2FS0924-9338%2898%2980135-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbelivien, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haapalinna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirvio, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition Of MAO-A Activity Enhances Behavioural Activity Of Rats Assessed Using Water Maze And Open Arena Tasks</span>. <i>Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">304</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1034/j.1600-0773.2001.880604.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1034%2Fj.1600-0773.2001.880604.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=11453370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVehs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2001&pages=304-312&author=A.+Barbelivienauthor=L.+Nymanauthor=A.+Haapalinnaauthor=J.+Sirvio&title=Inhibition+Of+MAO-A+Activity+Enhances+Behavioural+Activity+Of+Rats+Assessed+Using+Water+Maze+And+Open+Arena+Tasks&doi=10.1034%2Fj.1600-0773.2001.880604.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks</span></div><div class="casAuthors">Barbelivien, Alexandra; Nyman, Leena; Haapalinna, Antti; Sirvio, Jouni</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Toxicology (Copenhagen, Denmark)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">304-312</span>CODEN:
                <span class="NLM_cas:coden">PHTOEH</span>;
        ISSN:<span class="NLM_cas:issn">0901-9928</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">To det. if the inhibition of MAO-A and/or MAO-B activities can influence cognitive processes in adult rats, we analyzed whether chronic treatment with clorgyline, 1-deprenyl and pargyline could modify the performance of adult rats in a modified version of the water maze task.  The effects of these treatments on locomotor activity and enzyme activities were also assessed.  Rats were treated for 24 days with clorgyline (0.2 mg/kg), 1-deprenyl (0.25 mg/kg) and pargyline (1 or 10 mg/kg).  The treatments were started two weeks before the water maze expt. and continued until the end of testing.  The rats were trained to find a submerged platform (6 days:1 trial/day; 7 the day: probe trial).  Over the next three days, locomotor activity was assessed in an open arena.  Treatments with clorgyline (MAO-A inhibitor), 1-deprenyl (MAO-B inhibitor) and pargyline (non-selective MAO inhibitor) did not improve the finding of the hidden platform, when compared to treatment with saline, but significantly increased the swimming speed of the rats.  The different treatments, when compared to saline, failed to modify the distance covered and the no. of groomings performed in the open arena.  However, clorgyline and pargyline, 10 mg/kg, increased the no. of fecal boli and clorgyline enhanced the no. of rearings made when compared to saline, 1-deprenyl and pargyline, 10 mg/kg.  These results indicate that near total inhibition of MAO-A by clorgyline and pargyline as assessed by MAO activity measurement induces an increase in locomotor activity but that inhibition of MAO-A or MAO-B, either alone or combined, does not facilitate spatial learning in adult rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP09Z6v5B3iLVg90H21EOLACvtfcHk0liEGIaGwtxWjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVehs7s%253D&md5=50c703d74d811fcd2fb3744a1a051966</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-0773.2001.880604.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-0773.2001.880604.x%26sid%3Dliteratum%253Aachs%26aulast%3DBarbelivien%26aufirst%3DA.%26aulast%3DNyman%26aufirst%3DL.%26aulast%3DHaapalinna%26aufirst%3DA.%26aulast%3DSirvio%26aufirst%3DJ.%26atitle%3DInhibition%2520Of%2520MAO-A%2520Activity%2520Enhances%2520Behavioural%2520Activity%2520Of%2520Rats%2520Assessed%2520Using%2520Water%2520Maze%2520And%2520Open%2520Arena%2520Tasks%26jtitle%3DPharmacol.%2520Toxicol.%26date%3D2001%26volume%3D88%26spage%3D304%26epage%3D312%26doi%3D10.1034%2Fj.1600-0773.2001.880604.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. H.</span></span> <span> </span><span class="NLM_article-title">Aldol Condensations Catalyzed By PEG400 And Anhydrous K2CO3 Without Solvent</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1045</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1081/SCC-200054198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1081%2FSCC-200054198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsF2mtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=1045-1049&author=Y.+Q.+Caoauthor=Z.+Daiauthor=R.+Zhangauthor=B.+H.+Chen&title=Aldol+Condensations+Catalyzed+By+PEG400+And+Anhydrous+K2CO3+Without+Solvent&doi=10.1081%2FSCC-200054198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Aldol condensations catalyzed by PEG400 and anhydrous K2CO3 without solvent</span></div><div class="casAuthors">Cao, Yu-Qing; Dai, Zhi; Zhang, Rui; Chen, Bao-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1045-1049</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Aldol condensations of arom. aldehydes with ketones under solvent-free conditions to synthesize α,β-unsatd. ketones in good to excellent yields using PEG400 and powd. anhyd. K2CO3 as catalysts at 90°C and 120°C are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtU-4x6a_0qbVg90H21EOLACvtfcHk0liEGIaGwtxWjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsF2mtbc%253D&md5=946f03fae06286d6995b8384d58de2a9</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1081%2FSCC-200054198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FSCC-200054198%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DY.%2BQ.%26aulast%3DDai%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DB.%2BH.%26atitle%3DAldol%2520Condensations%2520Catalyzed%2520By%2520PEG400%2520And%2520Anhydrous%2520K2CO3%2520Without%2520Solvent%26jtitle%3DSynth.%2520Commun.%26date%3D2005%26volume%3D35%26spage%3D1045%26epage%3D1049%26doi%3D10.1081%2FSCC-200054198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarbhai, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, K. B. L.</span></span> <span> </span><span class="NLM_article-title">Some Arylation Reactions with Diazotized 3,4,5-Trimethoxyaniline - Preparation of 3,4,5-Trimethoxychalkone and 3,4,5-Trimethoxybenzaldehyde</span>. <i>Indian J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1963</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1963&pages=482&author=K.+P.+Sarbhaiauthor=K.+B.+L.+Mathur&title=Some+Arylation+Reactions+with+Diazotized+3%2C4%2C5-Trimethoxyaniline+-+Preparation+of+3%2C4%2C5-Trimethoxychalkone+and+3%2C4%2C5-Trimethoxybenzaldehyde"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarbhai%26aufirst%3DK.%2BP.%26aulast%3DMathur%26aufirst%3DK.%2BB.%2BL.%26atitle%3DSome%2520Arylation%2520Reactions%2520with%2520Diazotized%25203%252C4%252C5-Trimethoxyaniline%2520-%2520Preparation%2520of%25203%252C4%252C5-Trimethoxychalkone%2520and%25203%252C4%252C5-Trimethoxybenzaldehyde%26jtitle%3DIndian%2520J.%2520Chem.%26date%3D1963%26volume%3D1%26spage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koo, J.</span></span> <span> </span><span class="NLM_article-title">Syntheses in the Indene Series</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1953</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">2000</span>– <span class="NLM_lpage">2001</span>, <span class="refDoi"> DOI: 10.1021/ja01104a515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01104a515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaG2MXjt1eitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1953&pages=2000-2001&author=J.+Koo&title=Syntheses+in+the+Indene+Series&doi=10.1021%2Fja01104a515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses in the indene series</span></div><div class="casAuthors">Koo, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2000-1</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">For a projected synthesis of colchicine analogs, various substituted indenes were prepd. as model compds.  Substituents were introduced which, by cyclization, could yield tricyclic systems.  3,4-(MeO)2C6H3CHO (182.6 g.), 130 g. AcCH2CO2Et, and 70 cc. C6H6 refluxed 2 hrs. with 3.4 g. piperidine and 12.2 cc. AcOH (water trap), the cooled soln. dild. with 300 cc. Et2O, and the solvents removed yielded 175 g. Et veratrylideneacetoacetate (I), b1 190-2°, m. 75-81°.  Piperonal by the method used for I yielded 62% Et piperonylideneacetoacetate (II), b1.6 179°, m. 75-81°.  I (139 g.) in 150 cc. EtOAc hydrogenated 2 hrs. at room temp. and 45 lb. pressure over 9 g. 5% Pd-C yielded 100 g. Et veratrylacetoacetate (IIA), b1 169°; 2,4-dinitrophenylhydrazone, m. 116-17°.  Hydrogenation of II yielded 52% Et piperonylacetoacetate (III), b0.8 151-3°.  Veratrylideneacetone, m. 84-6°, (69 g.) in 150 cc. AcOH reduced 35 min. over 5 g. Pd-C yielded 83% veratrylacetone (IV), b0.5 127-9°, m. 53-6°.  Veratrylideneacetophenone, m. 90-2°, hydrogenated 4 hrs. in EtOAc over Pd-C yielded 93% veratrylacetophenone (V), m. 68-70°.  IIA (56 g.) in 45 cc. 85% H3PO4 added slowly to 90 cc. H2SO4 contg. 45 cc. 85% H3PO4 at 0-5°, the mixt. stirred into ice water, filtered, the solid dissolved in Et2O, washed with 10% NaHCO3, and the solvent evapd. yielded 24 g. Et 5,6-dimethoxy-3-methyl-2-indenecarboxylate (VI), m. 136-6.5°.  Acidification of the NaHCO3 washings yielded 5 g. free acid, m. 228-30°.  III (1 g.) in 3 cc. each of H2SO4 and H3PO4 allowed to stand 40 min. at 0° and treated as above yielded 0.79 g. Et 5,6-methylenedioxy-3-methyl-2-indenecarboxylate, m. 107-8°; the washings yielded 0.032 g. free acid, m. 280-1°.  IV (21 g.) in 42 cc. each H2SO4 and H3PO4 at 10-15° treated by the method used for VI (NaHCO3 washing omitted) except that the product was poured into 400 cc. of ice water after 0.5 hr., yielded 52% 5,6-dimethoxy-3-methylindene, m. 132-3°.  V (the reaction mixt. heated 30 min. at 60-70°) yielded 5,6-dimethoxy-3-phenylindene (VII), m. 112-13.5°.  Na (1.15 g.) in 50 cc. warm abs. EtOH treated rapidly with 7.5 g. (CO2Et)2, then with 18 g. VI in 100 cc. hot abs. EtOH, and the mixt. shaken 2 min., stirred into cold water, acidified with dil. HCl and filtered yielded 19 g. Et 1-ethoxalyl-5,6-dimethoxy-3-methyl-2-indenecarboxylate, m. 143-6°; 2,4-dinitrophenylhydrazone, m. 180-2°; enol acetate, m. 132-3°.  Na (0.46 g.), 15 cc. EtOH, 3 g. (CO2Et)2, and 4.2 g.  VII yielded 76% 1-ethoxalyl-5,6-dimethoxy-3-phenylindene, m. 122-4°; enol acetate, m. 165-7°.  VI (1 g.) in 15 cc. AcOH hydrogenated 2.5 hrs. in 15 cc. AcOH at 60° and 40 lb. over 0.5 g. 5% Pd-C yielded 0.85 g. Et 5,6-di-methoxy-3-methyl-2-indancarboxylate (VIII), m. 48-9°; free acid, m. 176-7°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlySn-4MzA7rVg90H21EOLACvtfcHk0lhHiOuYfc963g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2MXjt1eitQ%253D%253D&md5=f01d4723e839eedf6238060b11287363</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fja01104a515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01104a515%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DJ.%26atitle%3DSyntheses%2520in%2520the%2520Indene%2520Series%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1953%26volume%3D75%26spage%3D2000%26epage%3D2001%26doi%3D10.1021%2Fja01104a515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wattanasin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, W. S.</span></span> <span> </span><span class="NLM_article-title">An Improved Procedure for the Preparation of Chalcones and Related Enones</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>1980</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">650</span>, <span class="refDoi"> DOI: 10.1055/s-1980-29155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1055%2Fs-1980-29155" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1980&publication_year=1980&pages=647-650&author=S.+Wattanasinauthor=W.+S.+Murphy&title=An+Improved+Procedure+for+the+Preparation+of+Chalcones+and+Related+Enones&doi=10.1055%2Fs-1980-29155"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1055%2Fs-1980-29155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1980-29155%26sid%3Dliteratum%253Aachs%26aulast%3DWattanasin%26aufirst%3DS.%26aulast%3DMurphy%26aufirst%3DW.%2BS.%26atitle%3DAn%2520Improved%2520Procedure%2520for%2520the%2520Preparation%2520of%2520Chalcones%2520and%2520Related%2520Enones%26jtitle%3DSynthesis%26date%3D1980%26volume%3D1980%26spage%3D647%26epage%3D650%26doi%3D10.1055%2Fs-1980-29155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaramillo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mora, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vélez, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quijano, J.</span></span> <span> </span><span class="NLM_article-title">Biological evaluation of aromatic compounds as β-lactamase inhibitors</span>. <i>Pharmacologyonline</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=650-655&author=M.+C.+Jaramilloauthor=C.+Moraauthor=L.+E.+V%C3%A9lezauthor=G.+J.+Arangoauthor=J.+Quijano&title=Biological+evaluation+of+aromatic+compounds+as+%CE%B2-lactamase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaramillo%26aufirst%3DM.%2BC.%26aulast%3DMora%26aufirst%3DC.%26aulast%3DV%25C3%25A9lez%26aufirst%3DL.%2BE.%26aulast%3DArango%26aufirst%3DG.%2BJ.%26aulast%3DQuijano%26aufirst%3DJ.%26atitle%3DBiological%2520evaluation%2520of%2520aromatic%2520compounds%2520as%2520%25CE%25B2-lactamase%2520inhibitors%26jtitle%3DPharmacologyonline%26date%3D2006%26volume%3D3%26spage%3D650%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaramillo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mora, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velez, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quijano, J.</span></span> <span> </span><span class="NLM_article-title">Kinetic and Theoretical Study of the Chalcones as Inhibitors of beta-Lactamase Enzyme</span>. <i>Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.2174/157340609789117895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.2174%2F157340609789117895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=19799548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ertL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=434-439&author=M.+C.+Jaramilloauthor=C.+Moraauthor=L.+E.+Velezauthor=J.+Quijano&title=Kinetic+and+Theoretical+Study+of+the+Chalcones+as+Inhibitors+of+beta-Lactamase+Enzyme&doi=10.2174%2F157340609789117895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and theoretical study of the chalcones as inhibitors of β-lactamase enzyme</span></div><div class="casAuthors">Jaramillo, M. Consuelo; Mora, Cristina; Velez, Luis E.; Quijano, Jairo</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">434-439</span>CODEN:
                <span class="NLM_cas:coden">MCEHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1573-4064</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa Klebsiella pneumoniae, Acinetobacter baumannii, Enterobacter cloacae and more bacterias have shown resistance to antibiotics in Colombia, therefore, resistance to antibiotics is a problem that is on increase in Colombia.  The resistance mechanism to penicillin antibiotics in these bacterias is the expression of β-Lactamase enzyme.  To use the penicillin antibiotics which are still effective against them, the authors had evaluated 10 chalcones as inhibitors of this enzyme.  The most active chalcone showed Km, = 406.7 μM higher than clavulanic acid that showed Km, = 211.9 μM at 37° during 10 h, and using amoxycillin as substrate.  The chalcones were better competitive inhibitors because of they allowed the hydrolysis of smaller quantity of amoxycillin than the clavulanic acid, the most active chalcone showed Kcat/Km = 1.398 (minM)-1 and the clavulanic acid showed Kcat/Km = 2.674 (minM)-1.  The mol. modeling of the Enzyme-chalcones complexes showed that the chalcones with electron-donating groups on ortho, meta position of A ring favor the interaction with the residues Threonine-319, Lysine-67, Serine-64 and Tyrosine-150 of the active site of the enzyme, because of the no. and strong of Hydrogen bonds of the chalcones in the active site of the enzyme increase, and therefore the affinity of the chalcones increases too.  The electron-donating groups in the chalcones contribute to their inductive effect improving the interaction with the active site of the enzyme because of rising of electrostatic attraction between them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1e1jbX7iVjLVg90H21EOLACvtfcHk0lhHiOuYfc963g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ertL%252FL&md5=c107b92215c2146bf3a51c81061261ec</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.2174%2F157340609789117895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340609789117895%26sid%3Dliteratum%253Aachs%26aulast%3DJaramillo%26aufirst%3DM.%2BC.%26aulast%3DMora%26aufirst%3DC.%26aulast%3DVelez%26aufirst%3DL.%2BE.%26aulast%3DQuijano%26aufirst%3DJ.%26atitle%3DKinetic%2520and%2520Theoretical%2520Study%2520of%2520the%2520Chalcones%2520as%2520Inhibitors%2520of%2520beta-Lactamase%2520Enzyme%26jtitle%3DMed.%2520Chem.%26date%3D2009%26volume%3D5%26spage%3D434%26epage%3D439%26doi%3D10.2174%2F157340609789117895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manolov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danchev, N. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis And Pharmacological Investigations Of Some 4-Hydroxycoumarin Derivatives</span>. <i>Archiv Der Pharmazie</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1002/ardp.200390010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2Fardp.200390010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=12761761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslGmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2003&pages=83-94&author=I.+Manolovauthor=N.+D.+Danchev&title=Synthesis+And+Pharmacological+Investigations+Of+Some+4-Hydroxycoumarin+Derivatives&doi=10.1002%2Fardp.200390010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and pharmacological investigations of some 4-hydroxycoumarin derivatives</span></div><div class="casAuthors">Manolov, Ilia; Danchev, Nicolay D.</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-94</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The synthesis of ten coumarin derivs. of 4-hydroxycoumarin and various unsatd. ketones and aldehydes is described.  The structures of the synthesized compds. were confirmed by IR, 1H-NMR, and mass-spectral data.  Acute toxicity studies of the compds. were performed on mice by oral and i.p. administration.  A comparative pharmacol. study of the in vivo anticoagulant effects of the derivs. with respect to warfarin, showed that the compds. have anticoagulant activity.  Compds. 4-hydroxy-3-[1-phenyl-2-(4'-chlorobenzoyl)-ethyl]-2H-1-benzopyran-2-one, 4-hydroxy-3-[1-(4-fluorophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one, and 3,3'-p-bromobenzylidene-bis-(4-hydroxy-2H-1-benzopyran-2-one) showed slight acute toxicity and a greater anticoagulant effect than warfarin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfOuXWAK1THbVg90H21EOLACvtfcHk0lhHiOuYfc963g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslGmt7o%253D&md5=19ce129b623416098602a4c06c402e05</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1002%2Fardp.200390010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200390010%26sid%3Dliteratum%253Aachs%26aulast%3DManolov%26aufirst%3DI.%26aulast%3DDanchev%26aufirst%3DN.%2BD.%26atitle%3DSynthesis%2520And%2520Pharmacological%2520Investigations%2520Of%2520Some%25204-Hydroxycoumarin%2520Derivatives%26jtitle%3DArchiv%2520Der%2520Pharmazie%26date%3D2003%26volume%3D336%26spage%3D83%26epage%3D94%26doi%3D10.1002%2Fardp.200390010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis Of Substituted 2-Hydroxyisophthalic Acids</span>. <i>Bull. Soc. Chim. Belg.</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">700</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1002/bscb.19560650709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2Fbscb.19560650709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaG2sXivFyjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1956&pages=700-705&author=G.+A.+Hanson&title=Synthesis+Of+Substituted+2-Hydroxyisophthalic+Acids&doi=10.1002%2Fbscb.19560650709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of substituted 2-hydroxyisophthalic acids</span></div><div class="casAuthors">Hanson, G. A.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin des Societes Chimiques Belges</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">700-5</span>CODEN:
                <span class="NLM_cas:coden">BSCBAG</span>;
        ISSN:<span class="NLM_cas:issn">0037-9646</span>.
    </div><div class="casAbstract">cf. C.A. 50, 11938g; 51 290e.  2,3-Dimethoxychalcone (I) (94% from PhAc and 2,3-(MeO)2C6H3CHO) condensed with OC(CH2CO2Et)2 I gave OC.CH(CO2Et).CHR'.CH2.CR:CCO2Et (Ia) [R = Ph, R' = 2,3-(MeO)2C6H3] (II), converted by N-bromosuccinimide by the Wohl-Ziegler reaction to the 4-Br deriv. (III), aromatized by heating in pyridine to di-Et 2-hydroxy-4-phenyl-6-(2,3-dimethoxy)phenylisophthalate (IV) and hydrolyzed to the free diacid (V).  2,3,4'-Trimethoxychalcone (VI) and 2,4'-dimethoxychalcone (VII) condensed with OC(CH2CO2Et)2 gave Ia (R = 4-MeOC6H4, R' = 2,3-(MeO)2C6H3) (VII) and Ia (R = 4-MeOC2H2 R' = 2-MeO-C6H4) (IX).  Bromination of VIII and IX failed to give definite products and apparently another means leading to aromatization must be found.  I (12.4 g.), b10 252°, 9.4 g. OC(CH2-CO2Et)2, 60 cc. EtOH, and 3 drops piperidine refluxed 18 hrs., and the product crystd. from EtOH gave 67% II, m. 131°.  II (6.6 g.), 2.3 g. N-bromosuccinimide, and 60 cc. CCl4 gave 61% III, m. 121-2° (decompn.).  III (3 g.) heated with a small amt. of pyridine 5 min., cooled, water added, and the yellow oil crystd. from EtOH gave 74% IV, m. 79°; hydrolysis with aq. alc. KOH, acidification with HCI, crystn. from MeOH, and recrystn. from EtOAc-petr. ether gave 71% V, m. 205-6° (decompn.).  Condensation of p-MeOC6H6Ac with 2,3-(MeO)2C6H3CHO in aq. alc. NaOH gave 83% VI, pale yellow, m. 102-3°; reaction with OC(CH2CO2Et)2 gave 63% VIII, m. 149-51°.  VIII, 88%, yellow oil, b10 276° and IX, 67%, m. 119-20° were obtained similarly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd0yP88-oRLrVg90H21EOLACvtfcHk0liE_egGlBJueg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2sXivFyjsw%253D%253D&md5=082ec324da270e10170969162a7c5025</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fbscb.19560650709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbscb.19560650709%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DG.%2BA.%26atitle%3DSynthesis%2520Of%2520Substituted%25202-Hydroxyisophthalic%2520Acids%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Belg.%26date%3D1956%26volume%3D65%26spage%3D700%26epage%3D705%26doi%3D10.1002%2Fbscb.19560650709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, M. L.</span></span> <span> </span><span class="NLM_article-title">Antiproliferative Properties Of Piperidinylchalcones</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.bmc.2005.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=16185876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1egsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=153-163&author=X.+Liuauthor=M.+L.+Go&title=Antiproliferative+Properties+Of+Piperidinylchalcones&doi=10.1016%2Fj.bmc.2005.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative properties of piperidinylchalcones</span></div><div class="casAuthors">Liu, Xiaoling; Go, Mei-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-163</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Methoxylated chalcones bearing N-methylpiperidinyl substituents on ring A inhibited the growth of human tumor cell lines (MCF-7, HCT 116, and Jurkat) at IC50 values of <5 μM.  Investigations on a representative member (12) showed that antiproliferative activity was linked to the disruption of the cell cycle at G1 and G2/M phases.  The effect was concn. dependent and was evident at the approx. IC50 of 12.  Downregulation of cell cycle regulatory components (CDK4, cyclin B, E2F, and phosphorylated Rb) were obsd. under similar conditions.  Methoxylated chalcones without the piperidinyl substituent were found to exert equally potent and selective antiproliferative activity against HCT 116 tumor cells but did not interfere with cell cycle progression at their IC50 concns.  The presence of the piperidinyl substituent in the chalcone template is proposed to lend specificity to the mechanism of antiproliferative activity, in addn. to promoting a more desirable physicochem. profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk3n70_n19rbVg90H21EOLACvtfcHk0liE_egGlBJueg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1egsLzI&md5=18998e2fa837121747098d0a6e5c7c92</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGo%26aufirst%3DM.%2BL.%26atitle%3DAntiproliferative%2520Properties%2520Of%2520Piperidinylchalcones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D153%26epage%3D163%26doi%3D10.1016%2Fj.bmc.2005.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biradar, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gau, H. M.</span></span> <span> </span><span class="NLM_article-title">Highly Enantioselective Conjugate Addition Of Diethylzinc To Substituted Chalcones Catalyzed By Cu(II) Complexes Of A Tridentate P,N,O Ligand</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2008.02.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.tetasy.2008.02.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlOmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=733-738&author=D.+B.+Biradarauthor=H.+M.+Gau&title=Highly+Enantioselective+Conjugate+Addition+Of+Diethylzinc+To+Substituted+Chalcones+Catalyzed+By+Cu%28II%29+Complexes+Of+A+Tridentate+P%2CN%2CO+Ligand&doi=10.1016%2Fj.tetasy.2008.02.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Highly enantioselective conjugate addition of diethylzinc to substituted chalcones catalyzed by Cu(II) complexes of a tridentate P,N,O ligand</span></div><div class="casAuthors">Biradar, Deepak Baburao; Gau, Han-Mou</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">733-738</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new series of tridentate P,N,O ligands, e.g., I, having hard and soft donor atoms derived from chiral amino alcs. were developed and employed in the Cu(II)-catalyzed conjugate addn. of diethylzinc to substituted chalcones.  The asym. addns. to a variety of substituted chalcones afforded products in excellent yields and good to excellent enantioselectivities up to 97% ee.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzglwhavi0uLVg90H21EOLACvtfcHk0liE_egGlBJueg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlOmsrk%253D&md5=24aa2c7f2a3f0d80a424b8fad3825834</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2008.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2008.02.027%26sid%3Dliteratum%253Aachs%26aulast%3DBiradar%26aufirst%3DD.%2BB.%26aulast%3DGau%26aufirst%3DH.%2BM.%26atitle%3DHighly%2520Enantioselective%2520Conjugate%2520Addition%2520Of%2520Diethylzinc%2520To%2520Substituted%2520Chalcones%2520Catalyzed%2520By%2520Cu%2528II%2529%2520Complexes%2520Of%2520A%2520Tridentate%2520P%252CN%252CO%2520Ligand%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2008%26volume%3D19%26spage%3D733%26epage%3D738%26doi%3D10.1016%2Fj.tetasy.2008.02.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">Evaluation And Discovery Of Novel Synthetic Chalcone Derivatives As Anti-Inflammatory Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8110</span>– <span class="NLM_lpage">8123</span>, <span class="refDoi"> DOI: 10.1021/jm200946h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200946h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWmsrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8110-8123&author=J.+Wuauthor=J.+Liauthor=Y.+Caiauthor=Y.+Panauthor=F.+Yeauthor=Y.+Zhangauthor=Y.+Zhaoauthor=S.+Yangauthor=X.+Liauthor=G.+Liang&title=Evaluation+And+Discovery+Of+Novel+Synthetic+Chalcone+Derivatives+As+Anti-Inflammatory+Agents&doi=10.1021%2Fjm200946h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation and Discovery of Novel Synthetic Chalcone Derivatives as Anti-Inflammatory Agents</span></div><div class="casAuthors">Wu, Jianzhang; Li, Jianling; Cai, Yuepiao; Pan, Yong; Ye, Faqing; Zhang, Yali; Zhao, Yunjie; Yang, Shulin; Li, Xiaokun; Liang, Guang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8110-8123</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Major anti-inflammatory agents, steroids and cyclooxygenase, were proved to have serious side effects.  Here, a series of chalcone derivs. were synthesized and screened for anti-inflammatory activities.  QSAR study revealed that the presence of electron-withdrawing groups in B-ring and electron-donating groups in A-ring of chalcones was important for inhibition of LPS-induced IL-6 expression.  Further, several compds. inhibited TNF-α and IL-6 release in a dose-dependent manner and decreased LPS-induced TNF-α, IL-1β, IL-6, IL-12, and COX-2 mRNA prodn.  Mechanistically, two compds. interfered with JNK/NF-κB signaling and dose-dependently prevented ERK and p38 activation.  In addn., these two compds. exhibited a significant protection against LPS-induced death and were able to block high glucose-activated cytokine profiles in macrophages.  Together, these data show a series of anti-inflammatory chalcones with potential therapeutic effects in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK2UFg4jjfZLVg90H21EOLACvtfcHk0liE_egGlBJueg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWmsrfM&md5=e88959e6a6cf48ccd5e20a168853086a</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm200946h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200946h%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DEvaluation%2520And%2520Discovery%2520Of%2520Novel%2520Synthetic%2520Chalcone%2520Derivatives%2520As%2520Anti-Inflammatory%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8110%26epage%3D8123%26doi%3D10.1021%2Fjm200946h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Agilent</span>, (<span class="NLM_year">2012</span>).  <i>CrysAlis PRO</i>; <span class="NLM_publisher-name">Agilent Technologies, Y.</span>: <span class="NLM_publisher-loc">Oxfordshire,
England</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=Agilent&title=CrysAlis+PRO"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2012%26btitle%3DCrysAlis%2520PRO%26pub%3DAgilent%2520Technologies%252C%2520Y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> (<span class="NLM_year">1997</span>).  <i>SHELXS97. Program For The Solution Of Crystal Structures</i>; <span class="NLM_publisher-name">University of Göttingen</span>: <span class="NLM_publisher-loc">Germany</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=G.+M.+Sheldrick&title=SHELXS97.+Program+For+The+Solution+Of+Crystal+Structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26date%3D1997%26btitle%3DSHELXS97.%2520Program%2520For%2520The%2520Solution%2520Of%2520Crystal%2520Structures%26pub%3DUniversity%2520of%2520G%25C3%25B6ttingen" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrugia, L. J.</span></span> <span> </span><span class="NLM_article-title">WinGX. Suite For Small-Molecule Single-Crystal Crystallography</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">838</span>, <span class="refDoi"> DOI: 10.1107/S0021889899006020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1107%2FS0021889899006020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVSlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1999&pages=837-838&author=L.+J.+Farrugia&title=WinGX.+Suite+For+Small-Molecule+Single-Crystal+Crystallography&doi=10.1107%2FS0021889899006020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">WinGX suite for small-molecule single-crystal crystallography</span></div><div class="casAuthors">Farrugia, Louis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">837-838</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">The crystallog. problem:  The processing of a small-mol. structure from single-crystal X-ray or neutron diffraction data through structure soln. and refinement to prepn. of publication material is a well established and usually a reasonably automated procedure.  There are several excellent com. software packages, such as SHELXTL (Siemens, 1995) and TEXSAN (Mol. Structure Corporation, 1995), which provide all the necessary programs to undertake this procedure, but these packages are often quite expensive and usually tied to the sale of specific diffractometer hardware.  The WinGX suite provides an integrated and freely available set of Microsoft Windows programs to accomplish this task.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr53gZdiGzSn7Vg90H21EOLACvtfcHk0lgkpjdXAZEGUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVSlurk%253D&md5=06e3e6a405d75250687285442cbbf70a</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1107%2FS0021889899006020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889899006020%26sid%3Dliteratum%253Aachs%26aulast%3DFarrugia%26aufirst%3DL.%2BJ.%26atitle%3DWinGX.%2520Suite%2520For%2520Small-Molecule%2520Single-Crystal%2520Crystallography%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1999%26volume%3D32%26spage%3D837%26epage%3D838%26doi%3D10.1107%2FS0021889899006020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> (<span class="NLM_year">1997</span>).  <i>SHELXL97 Program For The Refinement Of Crystal Structures</i>. <span class="NLM_publisher-name">University of Göttingen</span>: <span class="NLM_publisher-loc">Germany</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=G.+M.+Sheldrick&title=SHELXL97+Program+For+The+Refinement+Of+Crystal+Structures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26date%3D1997%26btitle%3DSHELXL97%2520Program%2520For%2520The%2520Refinement%2520Of%2520Crystal%2520Structures%26pub%3DUniversity%2520of%2520G%25C3%25B6ttingen" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrugia, L. J.</span></span> <span> </span><span class="NLM_article-title">ORTEP-3 for Windows-A Version of It ORTEP-III with a Graphical User Interface (GUI)</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">565</span>, <span class="refDoi"> DOI: 10.1107/S0021889897003117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1107%2FS0021889897003117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1KgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1997&pages=565&author=L.+J.+Farrugia&title=ORTEP-3+for+Windows-A+Version+of+It+ORTEP-III+with+a+Graphical+User+Interface+%28GUI%29&doi=10.1107%2FS0021889897003117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">ORTEP-3 for windows - a version of ORTEP-III with a graphical user interface (GUI)</span></div><div class="casAuthors">Farrugia, Louis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5, Pt. 1</span>),
    <span class="NLM_cas:pages">565</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptCm7bJRBPGLVg90H21EOLACvtfcHk0lgkpjdXAZEGUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1KgsLg%253D&md5=b6bc45c46612ef8e647b884772f53312</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1107%2FS0021889897003117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889897003117%26sid%3Dliteratum%253Aachs%26aulast%3DFarrugia%26aufirst%3DL.%2BJ.%26atitle%3DORTEP-3%2520for%2520Windows-A%2520Version%2520of%2520It%2520ORTEP-III%2520with%2520a%2520Graphical%2520User%2520Interface%2520%2528GUI%2529%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1997%26volume%3D30%26spage%3D565%26doi%3D10.1107%2FS0021889897003117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spek, A. L.</span></span> <span> </span><span class="NLM_article-title">PLATON. An Integrated Tool For The Analysis Of The Results Of A Single Crystal Structure Determination</span>. <i>Acta Crystallogr., Sect. A: Found. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>A46</i></span>,  <span class="NLM_fpage">c34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A46&publication_year=1990&pages=c34&author=A.+L.+Spek&title=PLATON.+An+Integrated+Tool+For+The+Analysis+Of+The+Results+Of+A+Single+Crystal+Structure+Determination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpek%26aufirst%3DA.%2BL.%26atitle%3DPLATON.%2520An%2520Integrated%2520Tool%2520For%2520The%2520Analysis%2520Of%2520The%2520Results%2520Of%2520A%2520Single%2520Crystal%2520Structure%2520Determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D1990%26volume%3DA46%26spage%3Dc34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Son, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukihara, T.</span></span> <span> </span><span class="NLM_article-title">Structure Of Human Monoamine Oxidase A At 2.2-A Resolution: The Control Of Opening The Entry For Substrates/Inhibitors</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">5739</span>– <span class="NLM_lpage">5744</span>, <span class="refDoi"> DOI: 10.1073/pnas.0710626105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1073%2Fpnas.0710626105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=18391214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=5739-5744&author=S.+Y.+Sonauthor=J.+Maauthor=Y.+Kondouauthor=M.+Yoshimuraauthor=E.+Yamashitaauthor=T.+Tsukihara&title=Structure+Of+Human+Monoamine+Oxidase+A+At+2.2-A+Resolution%3A+The+Control+Of+Opening+The+Entry+For+Substrates%2FInhibitors&doi=10.1073%2Fpnas.0710626105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors</span></div><div class="casAuthors">Son, Se-Young; Mat, Jichun; Kondou, Youhei; Yoshimura, Masato; Yamashita, Eiki; Tsukihara, Tomitake</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5739-5744</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mitochondrial outer membrane-anchored monoamine oxidase (MAO) is a biochem. important flavoenzyme that catalyzes the deamination of biogenic and xenobiotic amines.  Its 2 subtypes, MAOA and MAOB, are linked to several psychiatric disorders and therefore are interesting targets for drug design.  To understand the relation between structure and function of this enzyme, the authors extended their previously reported low-resoln. rat MAOA structure to the high-resoln. wild-type and G110A mutant structures of human MAOA complexed with the reversible inhibitor, harmine, at 2.2 and 2.17 Å, resp.  The high-resoln. MAOA structures were similar to those of rat MAOA and human MAOB, but different from the known structure of human MAOA, specifically regarding residues 108-118 and 210-216, which surround the substrate/inhibitor cavity.  The results confirmed that the inhibitor selectivity of MAOA and MAOB is caused by the structural differences arising from Ile-335 in MAOA vs. Tyr-326 in MAOB.  The structures exhibited a C-terminal transmembrane helix with clear electron d., as is also seen in rat MAOA.  Mutations on one residue of loop 108-118, Gly-110, which is far from the active center but close to the membrane surface, caused the solubilized enzyme to undergo a dramatic drop in activity, but have less effect when the enzyme was anchored in the membrane.  These results suggest that the flexibility of loop 108-118, facilitated by anchoring the enzyme into the membrane, is essential for controlling substrate access to the active site.  The authors report on the observation of the structure-function relation between a transmembrane helical anchor and an extra-membrane domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdm8Cs1NxHxLVg90H21EOLACvtfcHk0lgkpjdXAZEGUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D&md5=7443fe77547220547312f7259df590df</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710626105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710626105%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DS.%2BY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DKondou%26aufirst%3DY.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DE.%26aulast%3DTsukihara%26aufirst%3DT.%26atitle%3DStructure%2520Of%2520Human%2520Monoamine%2520Oxidase%2520A%2520At%25202.2-A%2520Resolution%253A%2520The%2520Control%2520Of%2520Opening%2520The%2520Entry%2520For%2520Substrates%252FInhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D5739%26epage%3D5744%26doi%3D10.1073%2Fpnas.0710626105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Structures Of Human Monoamine Oxidase B Complexes With Selective Noncovalent Inhibitors: Safinamide And Coumarin Analogs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5848</span>– <span class="NLM_lpage">5852</span>, <span class="refDoi"> DOI: 10.1021/jm070677y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070677y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5848-5852&author=C.+Bindaauthor=J.+Wangauthor=L.+Pisaniauthor=C.+Cacciaauthor=A.+Carottiauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structures+Of+Human+Monoamine+Oxidase+B+Complexes+With+Selective+Noncovalent+Inhibitors%3A+Safinamide+And+Coumarin+Analogs&doi=10.1021%2Fjm070677y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span></div><div class="casAuthors">Binda, Claudia; Wang, Jin; Pisani, Leonardo; Caccia, Carla; Carotti, Angelo; Salvati, Patricia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5848-5852</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structures of human monoamine oxidase B (MAO B) in complex with safinamide and two coumarin derivs., all sharing a common benzyloxy substituent, were detd. by x-ray crystallog.  These compds. competitively inhibit MAO B with Ki values in the 0.1-0.5 μM range that are 30-700-fold lower than those obsd. with MAO A.  The inhibitors bind noncovalently to MAO B, occupying both the entrance and the substrate cavities and showing a similarly oriented benzyloxy substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPIubufo89bVg90H21EOLACvtfcHk0lhchG4D0vEAvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI&md5=448f65696f4870e2301f46a6f015e35c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm070677y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070677y%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructures%2520Of%2520Human%2520Monoamine%2520Oxidase%2520B%2520Complexes%2520With%2520Selective%2520Noncovalent%2520Inhibitors%253A%2520Safinamide%2520And%2520Coumarin%2520Analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5848%26epage%3D5852%26doi%3D10.1021%2Fjm070677y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated Docking With Selective Receptor Flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+Docking+With+Selective+Receptor+Flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0lhchG4D0vEAvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520Docking%2520With%2520Selective%2520Receptor%2520Flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halliday, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">Automated Docking Using A Lamarckian Genetic Algorithm And Empirical Binding Free Energy Function</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1639</span>– <span class="NLM_lpage">1662</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=1639-1662&author=G.+M.+Morrisauthor=D.+S.+Goodsellauthor=R.+S.+Hallidayauthor=R.+Hueyauthor=W.+E.+Hartauthor=R.+K.+Belewauthor=A.+J.+Olson&title=Automated+Docking+Using+A+Lamarckian+Genetic+Algorithm+And+Empirical+Binding+Free+Energy+Function&doi=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function</span></div><div class="casAuthors">Morris, Garrett M.; Goodsell, David S.; Halliday, Robert S.; Huey, Ruth; Hart, William E.; Belew, Richard K.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1639-1662</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review, with 81 refs.  A novel and robust automated docking method that predicts the bound conformations of flexible ligands to macromol. targets has been developed and tested, in combination with a new scoring function that ests. the free energy change upon binding.  Interestingly, this method applies a Lamarckian model of genetics, in which environmental adaptations of an individual's phenotype are reverse transcribed into its genotype and become heritable traits (sic).  We consider three search methods, Monte Carlo simulated annealing, a traditional genetic algorithm, and the Lamarckian genetic algorithm, and compare their performance in dockings of seven protein-ligand test systems having known three-dimensional structure.  We show that both the traditional and Lamarckian genetic algorithms can handle ligands with more degrees of freedom than the simulated annealing method used in earlier versions of AuToDOCK, and that the Lamarckian genetic algorithm is the most efficient, reliable, and successful of the three.  The empirical free energy function was calibrated using a set of 30 structurally known protein-ligand complexes with exptl. detd. binding consts.  Linear regression anal. of the obsd. binding consts. in terms of a wide variety of structure-derived mol. properties was performed.  The final model had a residual std. error of 9.11 kJ mol-1 (2.177 kcal mol-1) and was chosen as the new energy function.  The new search methods and empirical free energy function are available in AUTODOCK, version 3.0.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWXZfPvnZWcbVg90H21EOLACvtfcHk0lhchG4D0vEAvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D&md5=804b9f797c0b2cf942444c17b5653659</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%252819981115%252919%253A14%253C1639%253A%253AAID-JCC10%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DHalliday%26aufirst%3DR.%2BS.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DW.%2BE.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutomated%2520Docking%2520Using%2520A%2520Lamarckian%2520Genetic%2520Algorithm%2520And%2520Empirical%2520Binding%2520Free%2520Energy%2520Function%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1998%26volume%3D19%26spage%3D1639%26epage%3D1662%26doi%3D10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akdoğan, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yelekçi, K.</span></span> <span> </span><span class="NLM_article-title">In Silico Design Of Novel And Highly Selective Lysine-Specific Histone Demethylase Inhibitors</span>. <i>Turk J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">542</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1CjtLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=523-542&author=E.+D.+Akdo%C4%9Fanauthor=B.+Ermanauthor=K.+Yelek%C3%A7i&title=In+Silico+Design+Of+Novel+And+Highly+Selective+Lysine-Specific+Histone+Demethylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">In silico design of novel and highly selective lysine-specific histone demethylase inhibitors</span></div><div class="casAuthors">Akdogan, Ebru Demet; Erman, Burak; Yelekci, Kemal</div><div class="citationInfo"><span class="NLM_cas:title">Turkish Journal of Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">523-542</span>CODEN:
                <span class="NLM_cas:coden">TJCHE3</span>;
        ISSN:<span class="NLM_cas:issn">1300-0527</span>.
    
            (<span class="NLM_cas:orgname">Scientific and Technological Research Council of Turkey</span>)
        </div><div class="casAbstract">Histone lysine-specific demethylase (LSD1) is involved in a wide range of epigenetic processes and plays important roles in gene silencing, DNA transcription, DNA replication, DNA repair, and heterochromatin formation.  Its active site shows a resemblance to those of 2 homologous enzymes, monamine oxidase A and B (MAO-A and MAO-B.).  In the present work, starting from suitable scaffolds and generating thousands of structures from them, 10 potential inhibitors were obtained with structural and physicochem. properties selectively suitable for inhibiting LSD1.  ILib Diverse software was used to generate the diverse structures and 3 docking tools, CDOCKER, GOLD, and AutoDock, were used to find the most probable potential inhibitor based on its binding affinity.  The dispositions of the candidate mols. within the organism were checked by ADMET_PSA_2D (polar surface area) vs. ADMET_AlogP98 (the logarithm of the partition coeff. between n-octanol and water), and their suitability is discussed.  The LSD1 inhibition activities of the candidates were compared with the properties of trans-2-phenylcyclopropylamine (tranylcypromine) and 2-(4-methoxy-phenyl) cyclopropylamine, which are the 2 known inhibitors of LSD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpshEPGmO3hyLVg90H21EOLACvtfcHk0lgA-Uiy4vMfQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1CjtLbP&md5=646a1bc8d06df633316ba5eea0452625</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkdo%25C4%259Fan%26aufirst%3DE.%2BD.%26aulast%3DErman%26aufirst%3DB.%26aulast%3DYelek%25C3%25A7i%26aufirst%3DK.%26atitle%3DIn%2520Silico%2520Design%2520Of%2520Novel%2520And%2520Highly%2520Selective%2520Lysine-Specific%2520Histone%2520Demethylase%2520Inhibitors%26jtitle%3DTurk%2520J.%2520Chem.%26date%3D2011%26volume%3D35%26spage%3D523%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yáñez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraiz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orallo, F.</span></span> <span> </span><span class="NLM_article-title">Inhibitory Effects Of Cis- And Trans-Resveratrol On Noradrenaline And 5-Hydroxytryptamine Uptake And On Monoamine Oxidase Activity</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>344</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2006.03.190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2Fj.bbrc.2006.03.190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=16631124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFWnsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2006&pages=688-695&author=M.+Y%C3%A1%C3%B1ezauthor=N.+Fraizauthor=E.+Canoauthor=F.+Orallo&title=Inhibitory+Effects+Of+Cis-+And+Trans-Resveratrol+On+Noradrenaline+And+5-Hydroxytryptamine+Uptake+And+On+Monoamine+Oxidase+Activity&doi=10.1016%2Fj.bbrc.2006.03.190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity</span></div><div class="casAuthors">Yanez, Matilde; Fraiz, Nuria; Cano, Ernesto; Orallo, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">688-695</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This study investigated for the first time the potential effects of cis- and trans-resveratrol (c-RESV and t-RESV) on noradrenaline (NA) and 5-hydroxytryptamine (5-HT) uptake by synaptosomes from rat brain, on 5-HT uptake by human platelets, and on monoamine oxidase (MAO) isoform activity.  Both c-RESV and t-RESV (5-200 μM) concn.-dependently inhibited the uptake of [3H]NA and [3H]5-HT by synaptosomes from rat brain and the uptake of [3H]5-HT by human platelets.  In both exptl. models, t-RESV was slightly more efficient than c-RESV.  Furthermore, in synaptosomes from rat brain, the RESV isomers were less selective against [3H]5-HT uptake than the ref. drug fluoxetine (0.1 - 30 μM).  On the other hand, both c-RESV and t-RESV (5-200 μM) concn.-dependently inhibited the enzymic activity of com. (human recombinant) MAO isoform (MAO-A and MAO-B) activity, c-RESV being slightly less effective than t-RESV.  In addn., both RESV isomers were slight but significantly more selective against MAO-A than against MAO-B.  Since the principal groups of drugs used in the treatment of depressive disorders are NA/5-HT uptake or MAO inhibitors, under the assumption that the RESV isomers exhibit a similar behavior in humans in vivo, our results suggest that these natural polyphenols may be of value as structural templates for the design and development of new antidepressant drugs with two important biochem. activities combined in the same chem. structure: NA/5-HT uptake and MAO inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLoapdpA6vZrVg90H21EOLACvtfcHk0lgA-Uiy4vMfQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFWnsrg%253D&md5=bfa66795e41cb8f2ccf13c665c4b437d</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.03.190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.03.190%26sid%3Dliteratum%253Aachs%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DFraiz%26aufirst%3DN.%26aulast%3DCano%26aufirst%3DE.%26aulast%3DOrallo%26aufirst%3DF.%26atitle%3DInhibitory%2520Effects%2520Of%2520Cis-%2520And%2520Trans-Resveratrol%2520On%2520Noradrenaline%2520And%25205-Hydroxytryptamine%2520Uptake%2520And%2520On%2520Monoamine%2520Oxidase%2520Activity%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D344%26spage%3D688%26epage%3D695%26doi%3D10.1016%2Fj.bbrc.2006.03.190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccioni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardia, M. C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Synthesis, Stereochemical Identification, And Selective Inhibitory Activity Against Human Monoamine Oxidase-B Of 2-Methylcyclohexylidene-(4-Arylthiazol-2-Yl)Hydrazones</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4874</span>– <span class="NLM_lpage">4880</span>, <span class="refDoi"> DOI: 10.1021/jm800132g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800132g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt1ygtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4874-4880&author=F.+Chimentiauthor=E.+Maccioniauthor=A.+Bolascoauthor=F.+Mannaauthor=P.+Chimentiauthor=D.+Secciauthor=F.+Rossiauthor=P.+Turiniauthor=F.+Ortusoauthor=S.+Alcaroauthor=M.+C.+Cardia&title=Synthesis%2C+Stereochemical+Identification%2C+And+Selective+Inhibitory+Activity+Against+Human+Monoamine+Oxidase-B+Of+2-Methylcyclohexylidene-%284-Arylthiazol-2-Yl%29Hydrazones&doi=10.1021%2Fjm800132g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Stereochemical Identification, and Selective Inhibitory Activity against Human Monoamine Oxidase-B of 2-Methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones</span></div><div class="casAuthors">Chimenti, Franco; Maccioni, Elias; Secci, Daniela; Bolasco, Adriana; Chimenti, Paola; Granese, Arianna; Carradori, Simone; Alcaro, Stefano; Ortuso, Francesco; Yanez, Matilde; Orallo, Francisco; Cirilli, Roberto; Ferretti, Rosella; La Torre, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4874-4880</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones I (R = H, 4-Cl, 4-OMe, etc.) have been investigated for their ability to inhibit selectively the activity of the human A and B isoforms of monoamine oxidase (MAO).  The target compds., which present a stereogenic center on the cyclohexane ring, were obtained as pure (R) and (S) enantiomers by enantioselective HPLC.  The abs. configuration of homochiral forms isolated on a semipreparative scale was obtained by a combined strategy based on chem. correlation and single-crystal X-ray diffraction.  All compds. showed higher activity against the human MAO-B isoform with IC50 values ranging between 26.81 ± 2.74 μM and 14.20 ± 0.26 nM; and the assays carried out on the pure enantiomers showed higher activity for the (R) form.  A computational study was performed by mol. mechanics, DFT-based quantomechanics, and docking techniques on the most active and human MAO-B selective inhibitor I (R = NO2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL59tOyfDXKLVg90H21EOLACvtfcHk0lgA-Uiy4vMfQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt1ygtb8%253D&md5=b17d3d31d0744088d5efe0c4d67b7a44</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm800132g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800132g%26sid%3Dliteratum%253Aachs%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DMaccioni%26aufirst%3DE.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DManna%26aufirst%3DF.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DRossi%26aufirst%3DF.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DCardia%26aufirst%3DM.%2BC.%26atitle%3DSynthesis%252C%2520Stereochemical%2520Identification%252C%2520And%2520Selective%2520Inhibitory%2520Activity%2520Against%2520Human%2520Monoamine%2520Oxidase-B%2520Of%25202-Methylcyclohexylidene-%25284-Arylthiazol-2-Yl%2529Hydrazones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4874%26epage%3D4880%26doi%3D10.1021%2Fjm800132g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, M. M.</span></span> <span> </span><span class="NLM_article-title">A Rapid And Sensitive Method For The Quantitation Of Microgram Quantities Of Protein Utilizing The Principle Of Protein-Dye Binding</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/0003-2697(76)90527-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2F0003-2697%2876%2990527-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=942051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1976&pages=248-254&author=M.+M.+Bradford&title=A+Rapid+And+Sensitive+Method+For+The+Quantitation+Of+Microgram+Quantities+Of+Protein+Utilizing+The+Principle+Of+Protein-Dye+Binding&doi=10.1016%2F0003-2697%2876%2990527-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</span></div><div class="casAuthors">Bradford, Marion M.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">248-54</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A protein detn. method that involves the binding of coomassie Brilliant Blue G 250 to protein is described.  The binding of the dye to protein causes a shift in the absorption max. of the dye from 465 to 595 nm, and it is the increase in absorption at 595 nm that is monitored.  This assay is very reproducible and rapid with the dye binding process virtually complete in ∼ 2 min with good color stability for 1 hr.  There is little or no interference from cations such as Na+ or K+ nor from carbohydrates such as sucrose.  A small amt. of color is developed in the presence of strongly alk. buffering agents, but the assay may be run accurately by the use of proper buffer controls.  The only components found to give excessive interfering color in the assay are relatively large amts. of detergents such as Na dodecyl sulfate, Triton X 100, and commercial glassware detergents.  Interference by small amts. of detergent may be eliminated by the use of proper control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_T_d0trcNrVg90H21EOLACvtfcHk0lgizrTnA0Zb3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XksVehtrY%253D&md5=43f388a493becc4193c7a49d9de0e1db</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990527-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990527-3%26sid%3Dliteratum%253Aachs%26aulast%3DBradford%26aufirst%3DM.%2BM.%26atitle%3DA%2520Rapid%2520And%2520Sensitive%2520Method%2520For%2520The%2520Quantitation%2520Of%2520Microgram%2520Quantities%2520Of%2520Protein%2520Utilizing%2520The%2520Principle%2520Of%2520Protein-Dye%2520Binding%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D72%26spage%3D248%26epage%3D254%26doi%3D10.1016%2F0003-2697%2876%2990527-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pienaar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzer, J. P.</span></span> <span> </span><span class="NLM_article-title">The Inhibition Of Monoamine Oxidase By Esomeprazole</span>. <i>Drug Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">462</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1055/s-0033-1345163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1055%2Fs-0033-1345163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aksr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2013&pages=462-467&author=A.+Petzerauthor=A.+Pienaarauthor=J.+P.+Petzer&title=The+Inhibition+Of+Monoamine+Oxidase+By+Esomeprazole&doi=10.1055%2Fs-0033-1345163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibition of monoamine oxidase by esomeprazole</span></div><div class="casAuthors">Petzer, A.; Pienaar, A.; Petzer, J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Research (Stuttgart, Germany)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">462-467, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">DRSGAO</span>;
        ISSN:<span class="NLM_cas:issn">2194-9379</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Virtual screening of a library of drugs has suggested that esomeprazole, the S-enantiomer of omeprazole, may possess binding affinities for the active sites of the monoamine oxidase (MAO) A and B enzymes.  Based on this finding, the current study examines the MAO inhibitory properties of esomeprazole.  Using recombinant human MAO-A and MAO-B, IC50 values for the inhibition of these enzymes by esomeprazole were exptl. detd.  To examine the reversibility of MAO inhibition by esomeprazole, the recoveries of the enzymic activities after diln. of the enzyme-inhibitor complexes were evaluated.  In addn., reversibility of inhibition was also examd. by measuring the recoveries of enzyme activities after dialysis of enzymeinhibitor mixts.  Lineweaver-Burk plots were constructed to evaluate the mode of MAO inhibition and to measure Ki values.  The results document that esomeprazole inhibits both MAO-A and MAO-B with IC50 values of 23 μM and 48 μM, resp.  The interactions of esomeprazole with MAO-A and MAO-B are reversible and most likely competitive with Ki values for the inhibition of the resp. enzymes of 8.99 μM and 31.7 μM.  Considering the available pharmacokinetic data and typical therapeutic doses of esomeprazole, these inhibitory potencies are unlikely to be of pharmacol. relevance in humans.  The MAO inhibitory eff ects of esomeprazole should however be taken into consideration when using this drug in animal expts. where higher doses are often administered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9g2183sAW57Vg90H21EOLACvtfcHk0lgizrTnA0Zb3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aksr3L&md5=6c821d6421a8acc52c515381ea29bc86</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1055%2Fs-0033-1345163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0033-1345163%26sid%3Dliteratum%253Aachs%26aulast%3DPetzer%26aufirst%3DA.%26aulast%3DPienaar%26aufirst%3DA.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520Inhibition%2520Of%2520Monoamine%2520Oxidase%2520By%2520Esomeprazole%26jtitle%3DDrug%2520Res.%26date%3D2013%26volume%3D63%26spage%3D462%26epage%3D467%26doi%3D10.1055%2Fs-0033-1345163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, K.</span></span> <span> </span><span class="NLM_article-title">Re-Examination And Further Development Of A Precise And Rapid Dye Method For Measuring Cell Growth/Cell Kill</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1016/0022-1759(89)90397-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2F0022-1759%2889%2990397-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=2470825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADyaL1M3ls1OitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1989&pages=203-210&author=M.+B.+Hansenauthor=S.+E.+Nielsenauthor=K.+Berg&title=Re-Examination+And+Further+Development+Of+A+Precise+And+Rapid+Dye+Method+For+Measuring+Cell+Growth%2FCell+Kill&doi=10.1016%2F0022-1759%2889%2990397-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill</span></div><div class="casAuthors">Hansen M B; Nielsen S E; Berg K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-10</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">The tetrazolium salt (MTT) method involving conversion of MTT to coloured formazan by cells serving as indirect measurements of cell growth/cell kill has been reported by several groups, although technical problems have been encountered.  The present investigation was undertaken in order to delineate what laboratory variables have direct influence on the sensitivity and reproducibility of the method.  The pH of the extraction buffer was of the utmost importance, since it was demonstrated that a pH greater than 5 would give rise to false signals.  Furthermore, modifying the composition of the extraction buffer, all formazan dye grains were solubilised, totally.  A direct comparison with published methods demonstrated that only the modified method would yield 100% higher signals without increasing the background.  In contrast to previous reports, it was shown that phenol red does not interfere with the measurements and no washing steps are required since all ingredients can be added subsequently.  Serum proteins at concentrations up to 25% have no influence on the result.  All samples can be measured in an ELISA scanner at 570 nm with little intra-assay variation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1mSAw6T_dDENoizSOkG_FfW6udTcc2eZTnVPjDglSJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M3ls1OitA%253D%253D&md5=6dc9f7c84ff6489920976bae15a19632</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2889%2990397-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252889%252990397-9%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DM.%2BB.%26aulast%3DNielsen%26aufirst%3DS.%2BE.%26aulast%3DBerg%26aufirst%3DK.%26atitle%3DRe-Examination%2520And%2520Further%2520Development%2520Of%2520A%2520Precise%2520And%2520Rapid%2520Dye%2520Method%2520For%2520Measuring%2520Cell%2520Growth%252FCell%2520Kill%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1989%26volume%3D119%26spage%3D203%26epage%3D210%26doi%3D10.1016%2F0022-1759%2889%2990397-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porsolt, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blavet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalfre, M.</span></span> <span> </span><span class="NLM_article-title">Behavioural Despair In Rats: A New Model Sensitive To Antidepressant Treatments</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">391</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(78)90118-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2F0014-2999%2878%2990118-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=204499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaE1cXhvVagsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1978&pages=379-391&author=R.+D.+Porsoltauthor=G.+Antonauthor=N.+Blavetauthor=M.+Jalfre&title=Behavioural+Despair+In+Rats%3A+A+New+Model+Sensitive+To+Antidepressant+Treatments&doi=10.1016%2F0014-2999%2878%2990118-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral despair in rats:  a new model sensitive to antidepressant treatments</span></div><div class="casAuthors">Porsolt, Roger D.; Anton, Guy; Blavet, Nadine; Jalfre, Maurice</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-91</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Rats when forced to swim in a cylinder from which they cannot escape will, after an initial period of vigorous activity, adopt a characteristic immobile posture which can be readily identified.  Immobility was decreased by various clin. effective antidepressant drugs at doses which otherwise decreased spontaneous motor activity in an open field.  Antidepressants could thus be distinguished from psychostimulants which decreased immobility at doses which increased general activity.  Anxiolytic compds. did not affect immobility, whereas major tranquilizers enhanced it.  Thus, immobility reflects a state of lowered mood in the rat which is selectively sensitive to antidepressant treatments.  Pos. findings with atypical antidepressant drugs such as iprindole and mianserin suggest that the method may be capable of discovering new antidepressants hitherto undetectable with classical pharmacol. tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0oUdFHAF1sLVg90H21EOLACvtfcHk0lipzoPeBN8jHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhvVagsr0%253D&md5=293e1fe8766c76315e86bc375c810a58</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2878%2990118-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252878%252990118-8%26sid%3Dliteratum%253Aachs%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DAnton%26aufirst%3DG.%26aulast%3DBlavet%26aufirst%3DN.%26aulast%3DJalfre%26aufirst%3DM.%26atitle%3DBehavioural%2520Despair%2520In%2520Rats%253A%2520A%2520New%2520Model%2520Sensitive%2520To%2520Antidepressant%2520Treatments%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1978%26volume%3D47%26spage%3D379%26epage%3D391%26doi%3D10.1016%2F0014-2999%2878%2990118-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegwood, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baruah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waziri, R.</span></span> <span> </span><span class="NLM_article-title">Presynaptic Modulation Of Amino Acid Release From Synaptosomes</span>. <i>Neurochem Res.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1007/BF00966789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1007%2FBF00966789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1371602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK38XpvF2htg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1992&pages=125-128&author=A.+D.+Shermanauthor=T.+S.+Hegwoodauthor=S.+Baruahauthor=R.+Waziri&title=Presynaptic+Modulation+Of+Amino+Acid+Release+From+Synaptosomes&doi=10.1007%2FBF00966789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Presynaptic modulation of amino acid release from synaptosomes</span></div><div class="casAuthors">Sherman, A. D.; Hegwood, T. S.; Baruah, S.; Waziri, R.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-8</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    </div><div class="casAbstract">Using synaptosomes prepd. from whole rat brain, the spontaneous, Ca-independent, and Ca-dependent release of glutamate and GABA was assessed.  Time intervals of 1-30 s were studied.  Spontaneous release of glutamate (but not GABA) was elevated by 10 μM NMDA or AMPA by 30 s.  This stimulation was partially Ca-dependent.  Ca-dependent release induced by 30 mM KCl was biphasic, confirming previous findings.  This release was stimulated at all time periods by the presence of 10 μM NMDA or AMPA in an antagonist-sensitive manner.  These data suggest that glutamate and GABA are released from vesicular stores in rat synaptosomes and that some of this release is modulated by presynaptic glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLLm0p4CY5YrVg90H21EOLACvtfcHk0lipzoPeBN8jHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XpvF2htg%253D%253D&md5=19115863e857202f6bb7263c09b9490b</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1007%2FBF00966789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00966789%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DA.%2BD.%26aulast%3DHegwood%26aufirst%3DT.%2BS.%26aulast%3DBaruah%26aufirst%3DS.%26aulast%3DWaziri%26aufirst%3DR.%26atitle%3DPresynaptic%2520Modulation%2520Of%2520Amino%2520Acid%2520Release%2520From%2520Synaptosomes%26jtitle%3DNeurochem%2520Res.%26date%3D1992%26volume%3D17%26spage%3D125%26epage%3D128%26doi%3D10.1007%2FBF00966789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Painsipp, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wultsch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edelsbrunner, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasan, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singewald, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, P.</span></span> <span> </span><span class="NLM_article-title">Reduced Anxiety-Like And Depression-Related Behavior In Neuropeptide Y Y4 Receptor Knockout Mice</span>. <i>Genes, Brain Behav.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1111/j.1601-183X.2008.00389.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1111%2Fj.1601-183X.2008.00389.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=18221379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A280%3ADC%252BD1cvosl2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=532-542&author=E.+Painsippauthor=T.+Wultschauthor=M.+E.+Edelsbrunnerauthor=R.+O.+Tasanauthor=N.+Singewaldauthor=H.+Herzogauthor=P.+Holzer&title=Reduced+Anxiety-Like+And+Depression-Related+Behavior+In+Neuropeptide+Y+Y4+Receptor+Knockout+Mice&doi=10.1111%2Fj.1601-183X.2008.00389.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice</span></div><div class="casAuthors">Painsipp E; Wultsch T; Edelsbrunner M E; Tasan R O; Singewald N; Herzog H; Holzer P</div><div class="citationInfo"><span class="NLM_cas:title">Genes, brain, and behavior</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">532-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropeptide Y (NPY) acting through Y1 receptors reduces anxiety- and depression-like behavior in rodents, whereas Y2 receptor stimulation has the opposite effect.  This study addressed the implication of Y4 receptors in emotional behavior by comparing female germ line Y4 knockout (Y4-/-) mice with control and germ line Y2-/- animals.  Anxiety- and depression-like behavior was assessed with the open field (OF), elevated plus maze (EPM), stress-induced hyperthermia (SIH) and tail suspension tests (TST), respectively.  Learning and memory were evaluated with the object recognition test (ORT).  In the OF and EPM, both Y4-/- and Y2-/- mice exhibited reduced anxiety-related behavior and enhanced locomotor activity relative to control animals.  Locomotor activity in a familiar environment was unchanged in Y4-/- but reduced in Y2-/- mice.  The basal rectal temperature exhibited diurnal and genotype-related alterations.  Control mice had temperature minima at noon and midnight, whereas Y4-/- and Y2-/- mice displayed only one temperature minimum at noon.  The magnitude of SIH was related to time of the day and genotype in a complex manner.  In the TST, the duration of immobility was significantly shorter in Y4-/- and Y2-/- mice than in controls.  Object memory 6 h after initial exposure to the ORT was impaired in Y2-/- but not in Y4-/- mice, relative to control mice.  These results show that genetic deletion of Y4 receptors, like that of Y2 receptors, reduces anxiety-like and depression-related behavior.  Unlike Y2 receptor knockout, Y4 receptor knockout does not impair object memory.  We propose that Y4 receptors play an important role in the regulation of behavioral homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5o5Ddy9v0ayXXDYhVZBdlfW6udTcc2eZd61MirAuHr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvosl2huw%253D%253D&md5=2ac07540935848f0063184fbf299ae6a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1111%2Fj.1601-183X.2008.00389.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1601-183X.2008.00389.x%26sid%3Dliteratum%253Aachs%26aulast%3DPainsipp%26aufirst%3DE.%26aulast%3DWultsch%26aufirst%3DT.%26aulast%3DEdelsbrunner%26aufirst%3DM.%2BE.%26aulast%3DTasan%26aufirst%3DR.%2BO.%26aulast%3DSingewald%26aufirst%3DN.%26aulast%3DHerzog%26aufirst%3DH.%26aulast%3DHolzer%26aufirst%3DP.%26atitle%3DReduced%2520Anxiety-Like%2520And%2520Depression-Related%2520Behavior%2520In%2520Neuropeptide%2520Y%2520Y4%2520Receptor%2520Knockout%2520Mice%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2008%26volume%3D7%26spage%3D532%26epage%3D542%26doi%3D10.1111%2Fj.1601-183X.2008.00389.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locker, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holub, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drexel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayr, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilches, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kofler, B.</span></span> <span> </span><span class="NLM_article-title">GAL3 Receptor KO Mice Exhibit An Anxiety-Like Phenotype</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">7138</span>– <span class="NLM_lpage">7143</span>, <span class="refDoi"> DOI: 10.1073/pnas.1318066111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1073%2Fpnas.1318066111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=24782539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFGmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=7138-7143&author=S.+M.+Brunnerauthor=A.+Farziauthor=F.+Lockerauthor=B.+S.+Holubauthor=M.+Drexelauthor=F.+Reichmannauthor=A.+A.+Langauthor=J.+A.+Mayrauthor=J.+J.+Vilchesauthor=X.+Navarroauthor=R.+Langauthor=G.+Sperkauthor=P.+Holzerauthor=B.+Kofler&title=GAL3+Receptor+KO+Mice+Exhibit+An+Anxiety-Like+Phenotype&doi=10.1073%2Fpnas.1318066111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">GAL3 receptor KO mice exhibit an anxiety-like phenotype</span></div><div class="casAuthors">Brunner, Susanne M.; Farzi, Aitak; Locker, Felix; Holub, Barbara S.; Drexel, Meinrad; Reichmann, Florian; Lang, Andreas A.; Mayr, Johannes A.; Vilches, Jorge J.; Navarro, Xavier; Lang, Roland; Sperk, Guenther; Holzer, Peter; Kofler, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7138-7143</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The neuropeptide galanin (GAL) is widely distributed in the central and peripheral nervous systems.  It is a modulator of various physiol. and pathol. processes, and it mediates its effects via three G protein-coupled receptors (GAL1-3 receptors).  A role for GAL as a modulator of mood and anxiety was suggested, because GAL and its receptors are highly expressed in limbic brain structures of rodents.  In recent years, numerous studies of animal models have suggested an involvement of GAL and GAL1 and GAL2 receptors in anxiety- and depression-related behavior.  However, to date, there is sparse literature implicating GAL3 receptors in behavioral functions.  Therefore, we studied the behavior of GAL3 receptor-deficient (GAL3-KO) mice to elucidate whether GAL3 receptors are involved in mediating behavior-assocd. actions of GAL.  The GAL3-KO mouse line exhibited normal breeding and phys. development.  In addn. to behavioral tests, phenotypic characterization included anal. of hematol., amino acid profiles, metab., and sudomotor function.  In contrast to WT littermates, male GAL3-KO mice exhibited an anxiety-like phenotype in the elevated plus maze, open field, and light/dark box tests, and they were less socially affiliated than WT animals to a stranger mouse in a social interaction test.  In conclusion, our data suggest involvement of GAL3 receptors in GAL-mediated effects on mood, anxiety, and behavior, making it a possible target for alternative treatment strategies for mood disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkpHwt2vTrVbVg90H21EOLACvtfcHk0lgJl93_T8yZng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFGmsL8%253D&md5=5d2251ab2211d03b33422160cb05cec9</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1318066111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1318066111%26sid%3Dliteratum%253Aachs%26aulast%3DBrunner%26aufirst%3DS.%2BM.%26aulast%3DFarzi%26aufirst%3DA.%26aulast%3DLocker%26aufirst%3DF.%26aulast%3DHolub%26aufirst%3DB.%2BS.%26aulast%3DDrexel%26aufirst%3DM.%26aulast%3DReichmann%26aufirst%3DF.%26aulast%3DLang%26aufirst%3DA.%2BA.%26aulast%3DMayr%26aufirst%3DJ.%2BA.%26aulast%3DVilches%26aufirst%3DJ.%2BJ.%26aulast%3DNavarro%26aufirst%3DX.%26aulast%3DLang%26aufirst%3DR.%26aulast%3DSperk%26aufirst%3DG.%26aulast%3DHolzer%26aufirst%3DP.%26aulast%3DKofler%26aufirst%3DB.%26atitle%3DGAL3%2520Receptor%2520KO%2520Mice%2520Exhibit%2520An%2520Anxiety-Like%2520Phenotype%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2014%26volume%3D111%26spage%3D7138%26epage%3D7143%26doi%3D10.1073%2Fpnas.1318066111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panfili, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernster, L.</span></span> <span> </span><span class="NLM_article-title">Hydrogen Peroxide Production By Monoamine Oxidase In Isolated Rat-Brain Mitochondria: Its Effect On Glutathione Levels And Ca2+ Efflux</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>1035</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1016/0304-4165(90)90092-B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1016%2F0304-4165%2890%2990092-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK3MXhvVyr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1035&publication_year=1990&pages=300-305&author=G.+Sandriauthor=E.+Panfiliauthor=L.+Ernster&title=Hydrogen+Peroxide+Production+By+Monoamine+Oxidase+In+Isolated+Rat-Brain+Mitochondria%3A+Its+Effect+On+Glutathione+Levels+And+Ca2%2B+Efflux&doi=10.1016%2F0304-4165%2890%2990092-B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen peroxide production by monoamine oxidase in isolated rat brain mitochondria:  its effect on glutathione levels and calcium efflux</span></div><div class="casAuthors">Sandri, Gabriella; Panfili, Enrico; Ernster, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">1035</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-5</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    </div><div class="casAbstract">H2O2 prodn. and accumulation during incubation of isolated rat-brain mitochondria with substrates of monoamine oxidase A and B were investigated.  All substrates gave rise to an accumulation of H2O2 which was inhibited by malate + pyruvate or isocitrate, consistent with a need for mitochondrial NADPH to maintain glutathione in the reduced state.  However, in the absence of these addns. the level of reduced glutathione decreased only by ∼30%, indicating that only a fraction of the mitochondrial glutathione pool was accessible to the glutathione peroxidase and glutathione reductase activities responsible for the continuous removal of H2O2 generated by monoamine oxidase.  The H2O2 accumulation was also inhibited by externally added reduced glutathione or NADPH but not NADH.  External NADPH was oxidized by added oxidized glutathione but not α-ketoglutarate + NH4+.  These results suggest that the removal of H2O2 generated by monoamine oxidase proceeds by way of special fractions of glutathione peroxidase and glutathione reductase that are located in the intermembrane space of mitochondria in such a way that they can react with both intra- and extramitochondrial glutathione and NADPH, possibly at the contact sites between the inner and outer mitochondrial membranes.  Evidence is also presented that H2O2 generated by monoamine oxidase enhances Ca2+ release from mitochondria and may thus function as a regulator of mitochondrial Ca2+ efflux.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofK6Etqzaam7Vg90H21EOLACvtfcHk0lgJl93_T8yZng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhvVyr&md5=abe22ac23e89ed7be36f963da1b87b12</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2F0304-4165%2890%2990092-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-4165%252890%252990092-B%26sid%3Dliteratum%253Aachs%26aulast%3DSandri%26aufirst%3DG.%26aulast%3DPanfili%26aufirst%3DE.%26aulast%3DErnster%26aufirst%3DL.%26atitle%3DHydrogen%2520Peroxide%2520Production%2520By%2520Monoamine%2520Oxidase%2520In%2520Isolated%2520Rat-Brain%2520Mitochondria%253A%2520Its%2520Effect%2520On%2520Glutathione%2520Levels%2520And%2520Ca2%252B%2520Efflux%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D1990%26volume%3D1035%26spage%3D300%26epage%3D305%26doi%3D10.1016%2F0304-4165%2890%2990092-B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mena, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia de Yebenes, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casarejos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia de
Yebenes, J.</span></span> <span> </span><span class="NLM_article-title">Effects Of Calcium Antagonists On The Dopamine System</span>. <i>Clin. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1097/00002826-199510000-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=10.1097%2F00002826-199510000-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=8665555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;key=1%3ACAS%3A528%3ADyaK28Xhs1WjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1995&pages=410-426&author=M.+A.+Menaauthor=M.+J.+Garcia+de+Yebenesauthor=C.+Taberneroauthor=M.+J.+Casarejosauthor=B.+Pardoauthor=J.+Garcia+de%0AYebenes&title=Effects+Of+Calcium+Antagonists+On+The+Dopamine+System&doi=10.1097%2F00002826-199510000-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of calcium antagonists on the dopamine system</span></div><div class="casAuthors">Mena, Maria Angeles; Yebenes, Maria Jesus Garcia de; Tabernero, Cesar; Casarejos, Maria Jose; Pardo, Beatriz; Yebenes, Justo Garcia de</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Neuropharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">410-26</span>CODEN:
                <span class="NLM_cas:coden">CLNEDB</span>;
        ISSN:<span class="NLM_cas:issn">0362-5664</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Calcium channel antagonists are drugs currently used in the treatment of neurol. and cardiovascular disorders and occasionally produce parkinsonism and movement disorders as a side effect.  We investigated the effects of calcium channel antagonists on the pharmacol. of dopamine systems in vivo and in vitro.  Flunarizine, cinnarizine, and diltiazem reduce the viability of dopamine-rich human neuroblastoma cells in vitro.  These compds. plus verapamil, nifedipine, and nicardipine reduce 3H-spiperone binding to bovine striatal membranes, 3H-dopamine uptake, K+-induced 3H-dopamine release, and apomorphine-induced rotation, but not amphetamine-induced rotation, in 6-OH-dopamine-lesioned rats.  Therefore, all calcium channel antagonists tested reduce dopamine neurotransmission in vitro and in vivo, whereas the evidence of toxicity for dopamine cells in vitro is restricted to flunarizine, cinnarizine, and diltiazem.  The clin. relevance of these toxic effects may depend on several factors, including age, penetration across the blood-brain barrier, and types of calcium channels present in the different neuronal subtypes.  On the other hand, the finding of dopamine-regulating properties not assocd. to neurotoxic effects in the dihydropyridines and verapamil provides new putative therapeutic tools for the treatment of neurol. disorders assocd. with dopamine hyperactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCHzAWuvco1LVg90H21EOLACvtfcHk0lgJl93_T8yZng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhs1WjtLw%253D&md5=718a9befafaa1f7dffc9644e09228f0d</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1097%2F00002826-199510000-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002826-199510000-00004%26sid%3Dliteratum%253Aachs%26aulast%3DMena%26aufirst%3DM.%2BA.%26aulast%3DGarcia%2Bde%2BYebenes%26aufirst%3DM.%2BJ.%26aulast%3DTabernero%26aufirst%3DC.%26aulast%3DCasarejos%26aufirst%3DM.%2BJ.%26aulast%3DPardo%26aufirst%3DB.%26aulast%3DGarcia%2Bde%2BYebenes%26aufirst%3DJ.%26atitle%3DEffects%2520Of%2520Calcium%2520Antagonists%2520On%2520The%2520Dopamine%2520System%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D1995%26volume%3D18%26spage%3D410%26epage%3D426%26doi%3D10.1097%2F00002826-199510000-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X','PDB','2Z5X'); return false;">PDB: 2Z5X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z','PDB','2V5Z'); return false;">PDB: 2V5Z</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i87"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01504">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62882"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01504?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01504</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Spectral data of the newly synthesized compounds; X-ray crystal structure; druglikeness and ADMET predictions; and additional molecular modeling data of selected compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for the newly synthesized compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_001.pdf">jm0c01504_si_001.pdf (11.75 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01504/suppl_file/jm0c01504_si_002.csv">jm0c01504_si_002.csv (20.47 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01504&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01504%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-4%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01504" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799227af9373bf8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
